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ABSTRACT 
This thesis examines the synthesis of bromo acylatad anamlno asters, of the type 
(4.01), and protio acylatad anamlno asters, of the type (4.02), designed as a new class of 
potential mechanism-basad inactivators and alternate substrata inhibitors, respectively, 
of chymotrypsin. 
Et02C X 
4.01 X= Br 
4.02 X= H 
Chapter 1 describes the synthesis of succinic-, glutaric- and phthalic-basad, 
bromo and chloro anollactonas ( 1.11-1.15, 1.17) via a new reaction involving halo enol-
lactonizatlon of keto acid phosphoranas (1.06-1.1 0). The phthalic bromo anollactonas 
( 1.17) are also synthesized via the reaction of Ph3P=CBrC02Et with 4,5-dichlorophthalic 
anhydride. The reactions are extensions of the SCOOPY and Wittig anhydride carbonyl 
olafination reactions. 
Chapter 2 describes the synthesis of simple succinimida- and phthallmida-basad 
protio and chloro anamlno asters (2.09, 2.63-2.75, 2.93, 2.95, 2.98) via a versatile new 
reaction in which an anollactona (2.33, 1.11, 2.115) and amine react to form an isoiabla 
keto-amide (2.37-2.47, 2.94, 2.96, 2.116) and/or hydroxy lactam (2.48-2.50, 2.97) 
intermediate. Subsequent elimination of H20 on heating gives the anamino aster via an 
overall Insertion process. 
Chapter 3 describes the synthesis of simple succinimida-basad protio and bromo 
anamlno asters (2.66, 2.71, 3.02-3.03) from the reaction of ~-keto aster (3.01), via an isolable 
anamina intermediate (3.07-3.10). The synthesis of a 3-substitutad enamino aster (3.04) 
via the insertion and ~-keto aster routes is also described. 
Chapter 4 describes the synthesis of the target 3,3-disubstltuted enamlno esters 
(4.01-4.07) via the Insertion reaction and a TICI4 mediated ~-keto ester reaction. The 
benzyl group at position 3, required for recognition by chymotrypsin, is introduced 
stereoselectively using methodology developed largely by Seebach and coworkers for 
the asymmetric synthesis of a,o;-disubstltuted amino acids. By changing this residue 
other serine proteases can be targeted. The proposed Inhibitors (4.01-4.07) are 
designed to be incorporated into an oligopeptide having optimum Interaction with the 
target enzyme. Preliminary testing of enamlno esters and enollactones (2.71, 3.04, 4.01-
4.02, 4.03, 4.06, 4.42, 4.43) for chymotrypsin Inhibition is also described. 
Chapter 5 examines trends in the 13c NMR, 31 P NMR and FAB mass spectra of keto 
acid and keto ester phosphoranes (4.15, 4.26, 4.40-4.41 , 5.04-5.06); key intermediates to 
enamino esters and enollactones ( eg 4.01-4.06, 4.42, 4.43). 
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INTRODUCTION 
Introduction 1 
SECTION i.l 
PROTEASE ENZYMES 
Proteases constitute a large family of enzyme$ which catalyze the hydrolytic 
cleavage of amide linkages in proteins and polypeptides. Proteases are involved In 
almost every aspect of life. The functions of proteasesi.Ol Include hydrolysis of proteins 
and polypeptides for digestive and nutritional purposes, release of peptide hormones 
and neuromodulators from Inactive precursors, activation of enzymes, for example 
clotting factors, and termination of biological responses by degradation of the 
message-transmitting peptide. 
Four classes of proteases, each with a distinct catalytic mechanism, have been 
ldentlfledi.02-I.03, Classification as serine, aspartic, cysteine or metallo protease Is based 
on the most significant catalytic functional group, or prosthetic group (in the case of 
metallo proteases) in the active site of the enzyme. TABLE 1.01 lists examples of 
proteases in each mechanistic category. 
SECTION i.2 
SERINE PROTEASES AND THEIR MECHANISM OF PEPTIDE 
HYDROLYSIS 
Serine proteases are involved in digestion, processing of peptide prohormones, 
thrombolysis and fibrinolysis, fertilization and blastocyst implantatloni.04-I.05. Even though 
the physiological functions of serine prot eases are diverse, all employ a common 
catalytic mechanism. 
Chymotrypsini.06-1.07, a serine protease from the mammalian pancreas Involved 
In digestion, is representative mechanistically of the whole class of serine proteases. 
Chymotrypsin has been studied intensively and more information is available on Its mode 
of catalysis than for almost any other enzymei.OB-1.09. The active site has been well 
characterized by X-ray crystallography and Intermediates of the hydrolysis reaction are 
known1.06-1.09. 
Introduction 2 
TABLE 1.01: Examples of Proteases, Subdivided Into Mechanistic Categories 
Protease Significant Active Representative Enzymes 
Site Groups 
Serine Ser (hydroxyl) 
His (Imidazole) 
Asp (carboxyl) 
Metallo Zinc ion 
Aspartic Asp (carboxyl) 
Cysteine Cys (thlol) 
thrombin, plasma kallikrein, 
factors VIla, IXa-XIIa, 
activated protein C 
factors Clr, Cis D and B, 
C3 convertase 
trypsin, chymotrypsin, 
pancreatic elastase 
entereokinase plasmin, 
plasminogen activator 
tissue kallikrein, post protein 
cleaving enzyme 
elastase, cathepsin G, 
most cell chymases, 
tryptases 
ATP dependent proteases 
angiotensin converting 
enzyme, aminopeptidases, 
renal dlpeptidases 
collagenase 
macrophage elastase 
carboxypeptidase 
renin 
HIV protease 
thermolysln, pepsin 
cathepslns B, H, L, calcium 
activated neutral proteases 
Normal Function 
blood coagulation 
complement 
activation 
digestion 
fibrinolysis 
hormone 
metabolism 
phagocytosis 
protein turnover 
blood pressure 
regulation 
tissue elasticity 
blood pressure 
regulation, 
peptide 
metabolism 
digestion 
blood pressure 
· regulation 
HIV replication 
digestion 
protein turnover, 
bone resorption 
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Chymotrypsin cleaves peptldes on the carboxyl side of aromatic residues; 
phenylalanine, tyrosine and tryptophan. The aromatic side chain fits Into a 
complementary hydrophobic pocket in the enzyme, known as the primary specificity 
pocket. The proposed mechanism of peptide hydrolysis by chymotrypsin is illustrated in 
SCHEME 1.01. The driving force tor hydrolysis is the catalytic triad of Asp102, His57 and 
Ser195. (The numbers 102,57 and 195 denote the position of the amino acid residues Asp, 
His, and Ser, respectively in the polypeptide chain of the enzyme.) 
SCHEME 1.01: Proposed Mechanism of Peptide Hydrolysis by Chymotrypsin 
oxyanion hole 
hydrophobic pocket 
1.01 enzyme-substrate complex 
H step a 
His57 
ro ~ ser•s rl- I' o:.---H -N N-H-·· 0 .. H -N 
-...? IJ -;-.. ~ •• Asp1o2 · •. J " o: .... 
.. N "H-N 
R CHR' 
I 
Ar 
I. 0 2 tetrahedral intermediate 
H 
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SCHEME 1.01 continued 
,H 
R-N 
.H 
i. 0 3 acyl enzyme 
H step b 
His57 
0 ~ Ser'95 
a+ ,. o:. ... H-N N- H--- 0 . H-N 
A 102 v;;..; \ cv:a:·· sp 0 ,, 
H" 'H-N 
CHR' 
I 
Ar 
i. 04 tetrahedral intermediate 
i.OS product and enzyme 
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Catalysis Is Initiated by nucleophilic attack of the Ser195 hydroxyL which is 
activated by the Imidazole of His57, on the susceptible carbonyl carbon of the substrate 
(i.O 1, SCHEME 1.01 ). This step forms the tetrahedral intermediate, the oxyanion of which Is 
stabilized by hydrogen-bonding to the backbone NH groups of Gly 193 and Ser 195 (1.02, 
SCHEME 1.01). Collapse of the tetrahedral adduct in the forward direction leads to release 
of theN-terminal amino acid and generation of an acyl enzyme (1.03, SCHEME i.Ol). 
Deacylatlon, facilitated by the above reactions operating In reverse (1.04, SCHEME i.Ol), 
yields the C-terminal amino acid and regenerates the enzyme (i.05, SCHEME 1.01). 
Chymotrypsin also displays esterase activity In addition to Its peptidase (or 
amidase) activity. 
SECTION 1.3 
INHIBITION OF PROTEASE ENZYMES 
Proteases are strictly regulated by endogenous protease inhibitorsl.lO. However, 
a number of disease states, for example emphysema, Inflammation, tumor metastasis, 
muscular dystrophy and hypertension, appear to be caused by excessive proteolytic 
activity brought on by abnormally low levels of endogenous protease lnhibltori.04. 1.11. 
Serine proteases, In particular, have been Implicated In emphysema. adult respiratory 
distress syndrome, rheumatoid arthritis, pancreatitis, inflammation and digestive 
disordersi.04 • 1.12. 
The involvement of serine proteases in a wide variety of physiological and 
pathological processes, coupled with their well studied mechanism of action, has made 
this class of enzyme attractive targets for the preparation of inhibitors. 
Many strategies, Including mechanism-based lnactivatlonl.13-!.19, alternate 
substrate inhibition1.20-1.25, conformationally restricted peptldesl.26, transition state 
analoguesl.27 and affinity labelsl.28, have been used to develop effective and selective 
Inhibitors of serine proteases. 
Inhibitors acting In the enzyme active site are classically categorized as 
reversible or irreverslbie1.13. Reversible inhibitors closely resemble the normal substrate 
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and generally form a stable, non~covalent inhibltor~enzyme complex, whereas 
Irreversible Inhibitors form a covalent or particularly strong Inhibitor-enzyme association. 
Inactivation refers to an Irreversible inhibition process. Inactivation Is viewed as a distinct 
advantage over reversible Inhibition as a means of achieving a prolonged effect. 
Optimum activity of reversible Inhibitors requires maintenance of a high Inhibitor 
concentration at the active site. This can present dosage problems in clinical 
applications. 
The main Impetus for the development of enzyme inhibitors has been the rational 
design of drugs to specifically target key metabolic pathways under enzymatic control. 
However, Inhibition studies have also revealed information regarding sub~trate 
specificity and the catalytic mechanism of enzymes. 
SECTION i.3. 1 
MECHANISM-BASED INACTIVATION 
Mechanism-based inactivatorsl.l 3 (also known as suicide Inhibitors and kcat 
Inhibitors) are reasonably unreactive compounds which contain a latent reactive 
functionality. A mechanism-based inactivator is recognized by the target enzyme as a 
natural substrate. During catalysis, the latent reactive functionality in the lnactlvator Is 
unmasked by the normal catalytic machinery of the target enzyme. The reactive group 
(generally an electrophlllc site) becomes covalently bound to the enzyme (due to 
reaction with a nucleophilic residue In the enzyme). This renders the active site 
irreversibly blocked and the enzyme inactivated. 
The design of mechanism~based inactivators for a target enzyme requires a 
knowledge of the enzyme mechanism and structure. As discussed earlier (Section 1.2), 
the mechanism of serine protease catalyzed peptide hydrolysis has been extensively 
studied and consequently this class of enzyme Is a popular target for mechanism-based 
inactivation1.13-1.19, TABLE 1.02 shows enollactonesl.l4 (1.06), chloroisocoumarins1.15 (i.07-
i.08), ynenollactonesl.l~ (1.09) and lmldesl.17 (1.10). and their corresponding reactive 
groups, which are known mechanism-based inactlvators of serine proteases. 
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TABLE 1.02: Examples of Mechanism-Based lnactivators of Serine Proteases 
Masked Species Target Enzyme(s) Reactive Group 
0 0 
R R 0Ser195 
chymotrypsin 0 
X 
1.40 X= Cl, Br, I 
0 
R elastoses 
R2 
0 
chymotrypsin 
Cl trypsin 
Cl 
coagulation enzymes 
Cl complement enzymes 
1.07b 
human leukocyte + 0Ser195 H2N H2N elastase CHLE) 
chymases C~R OR 
* 
Cl 
l.osb 
0 0 
0Ser195 
R2 human leukocyte R2 
0 elastase (HLE) 
~ * 
~ 
R3 
CyH 
1.09 a I R3 
0 0 
PhCH,'( PhCH,~ ~Ser195 
N-OS~Me human leukocyte 
elastase (HLE) N~c::o 
0 
i.10 
* Indicates position for covalent bond formation to the enzyme 
a Nature of R determines efficiency of inactivation 
b Nature of R determines enzyme specificity 
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The proposed mechanism of chymotrypsin inactivation by halo enollactonesl.14. 
a class of inhibitor studied in this thesis. is shown in SCHEME 1.02. Acyl transfer to the Ser 195 
hydroxyl (step a) followed by a tautomeric shift (step b) reveals a reactive electrophilic 
a-halo ketone. Alkylation by an accessible active site nucleophilic amino acid residue. 
Y (probably His57), renders chymotrypsin inactive (step c). The link to Ser195 may 
subsequently be hydrolyzed (step d). 
SCHEME 1.02: Mechanism-Based Inactivation of Chymotrypsin by Halo Enollactones 
Ar 
X= Cl, Br, I 
-Y 
0 
Ar~ ... OSer195 
( 0 
n 
~) 
-Y 
H- 0Ser195 
HO--'f~: ~ 
Ar~l 
--Y+. 
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A combination of computer graphics and molecular mechanics supports the 
proposed mechanism of chymotrypsin Inactivation (SCHEME 1.02) by the (R)- and (S)-a-
phenyl- and a -benzyl-substituted bromo and lodo enollactones 1.29 (1.11 and 1.12). 
0 R 
Ph 
1.11 X= Br, I i.12 X= Br, I 
R =Ph, CH 2 Ph 
The process of enzyme (E) inactivation by a mechanism-based lnactivator (I) 
can be represented by the simple steady state hypothesis shown In Equation i.Ol. The 
Initially formed non-covalent enzyme-inactlvator complex (EI) gives rise to the activated 
species (EI*) on specific enzyme action. A competition then exists between Irreversible 
covalent Inactivation (formation of E*) and the non-Inactivation release of products 
(E + P). 
Equation 1.01 
El El* ---~~a- E* 
To establish the occurrence of mechanism-based inactivation a number of 
crlterla must be satisfledl.l3, The most Important of these Is that the reactive species, 
ultimately causing the Irreversible enzyme Inactivation, must be produced by the normal 
catalytic pathway of the enzyme while the lnactivator Is still bound at the active site. 
There are many examples in nature of compounds that function as mechanism-
based lnactlvatorsl.30, · Some therapeutic drugs In use at present are mechanism-based 
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inactlvatorsl.l3. Many enzymes have been targeted for control by mechanism-based 
inactivators1.13. 
Apart from mechanism-based inactivators, the other main category of 
inactivators is affinity labelsl.13, 1.28 (also known as active site directed Irreversible 
Inhibitors). Affinity labels are compounds that contain a reactive functional group, for 
example an a-halo ketone or Isocyanate. and react directly with active site 
nucleophiles. generally via SN2 alkylation or acylation. While useful/n vitro for probing 
enzyme active sites, the major disadvantage of affinity labels Is that they are capable of 
Indiscriminate reactivity within the biological environment, resulting in toxicity and side 
effects. Many cancer chemotherapeutic agents are affinity labels. 
In contrast. mechanism-based inactivators are particularly amenable to the 
design of highly specific,low toxicity drugs. The potential for generating the reactive 
species exclusively within the active site of the target enzyme imparts, in principle, a 
much higher degree of selectivity to mechanism-based inactivators than that exhibited 
by affinity labels. Another advantage of mechanism-based Inactivation is that, In theory, 
only one inactivator molecule is needed per enzyme for Inactivation. Non-specific 
Interactions might occur however, If enzymes other than the target enzyme catalyze the 
production of a reactive species, or If a reactive species escapes from the enzyme 
before reacting. 
SECTION 1.3.2 
ALTERNATE SUBSTRATE INHIBITION 
Alternate substrate lnhibltors1.2D-1.25 function as substrates of the target enzyme; 
however, Instead of chemically reacting with the enzyme, the alternate substrate 
becomes bound so tightly to the active site that further access by natural substrate 
molecules Is prevented. 
Transition state analoguesl.13, 1.27, another class of inhibitor, also bind tightly to the 
enzyme active site. Whereas alternate substrate inhibitors resemble the substrate and 
become covalently bound to the enzyme, transition state analogues are stable 
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compounds wtth a geometry or charge distribution resembling a transition state (or 
intermediate) of the reaction the target enzyme catalyzes. Transition state analogues 
form strong interactions with the active site which may. or may not. be covalent. 
Alternate substrate Inhibitors of serine proteases are simply substrates that form 
very stable acyl enzyme Intermediates ( eg i.03. SCHEME 1.0 1. Section 1.2). so that the 
enzyme remains Inhibited for the life time of the acyl enzyme species. The acyl enzyme 
is a good target for rational drug design due to the broad range of compounds that can 
serve as substrates for serine proteases and form acyl enzyme intermediates. and also 
because a great deal Is known from physical organic chemistry about ester reactivity 
and ways it can be controlledl.30. Disadvantages arise in therapeutic application as a 
consequence of the competitive and reversible nature of alternate substrate inhibition. 
For example. a high inhibitor concentration Is required at the active site and potentially. 
repeated administrations are necessary. 
Protio enollactonesi.2D (1.13), stabilized anhydridesl.21 (i.14 and i.15), 
benzoxazinonesl.22 (1.16) and N-acyl sacharrinsl.23 (1.17) which are alternate substrate 
inhibitors of serine proteases are shown in TABLE i.03. Physostigmine (i.18, TABLE 1.03) is an 
alternate substrate Inhibitor of cholinesterase found in naturel.31, 
The protlo enollactone alternate substrate inhibitors (1.13, TABLE 1.03) of 
chymotrypsin are Identical to the halo enollactone mechanism-based inactivators of 
chymotrypsin (1.06, TABLE 1.02) except that they do not contain a latent reactive group. 
The stability of the acyl enzymes is generally ascribed to an inherently low 
hydrolytic reactivity of the ester link or to an active site conformation that Is unfavourable 
to catalyzed hydrolysis. For example.ln the case of isatolc anhydridel.21 (1.14. TABLE 1.03 
and SCHEME 1.03) the slow hydrolysis of the acyl enzyme (1.19, TABLE 1.03 and SCHEME 1.03) 
Is due to the electron releasing properties of the NH2 group. An Important feature of the 
proposed mechanism of Inhibition (SCHEME 1.03) Is that initially the NH2 group Is masked 
(i.14) and it does not become expressed until the acyl enzyme (i.19) Is formed. 
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TABLE 1.03: Examples of Alternate Substrate Inhibitors of Serine Proteases 
Altemote Substrate Inhibitor Target Enzyme 
Me .... N 
I 
H 
0 
R 
0 
~0 VlN~O 
I 
H 
1.14 
0 R1)( I o 
R2 N~O 
I 
H 
1.15 
chymotrypsin 
chymotrypsin 
chymotrypsin 
pancreatic elpstase 
human leukocyte 
elastase (HLE) 
0-?' ~ 
,N 
0~ ~ 0 "o 
chymotrypsin 
pancreatic elastase 
human leukocyte 
elastase (HLE) 
1.17 
0 
N cholinesterase 
'Me 
i.18 
Acyl Enzyme Species 
0 
R 0Ser195 
0 
~0Ser195 
VlNH2 
1.19 
0 
Me-N.Jl0Ser195 
I 
H 
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SCHEME 1.03: · Alternate Substrate Inhibition of Chymotrypsin by lsatoic Anhydride 
0 
cLOSer195 Co-N/{ H ( 'b 
"-.H+ ! -C~ 
0 
cLOSer195 ~ NH2 
i.19 
Alternate substrate Inhibitors should interact with the enzyme in the manner of a 
normal substrate as shown In Equation 1.02. The rate constant for deacylatlon, kct, Is 
significantly less for the alternate substrate than the natural substrate. 
Equation 1.02 
E = enzyme 
s = alternate substrate 
E.S = Michaelis complex 
E-S = acyl enzyme intermediate 
p 
= product 
Physico chemical terms and enzyme specific Interactions are important in 
determining inhibitionl.22. Potency and stability are desirable for any potential 
therapeutic agent. Potency Is achieved by rapid acylation combined with slow 
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deacylation. Acyl enzyme stability Is obtained by a combination of steric and electronic 
effects. Several alternate substrate inhibitors have been found to form acyl enzymes 
with life times over 10hl.22, The ability to control the duration of inactivation may be useful 
In the In vivo application of these Inhibitors. 
SECTION 1.3.3 
CONFORMATIONALLY RESTRICTED SYSTEMS 
Generally, peptides exist in solution as an equilibrium mixture of conformers. 
Conformational restriction of peptides and amino acid analogues limits the number of 
conformations avallablei.03, 1.32-1.33. Conformationally restricted peptide and amino acid 
analogues; for example, dipeptide lactams, N-methyl amino acids, a.,a.-disubstituted 
amino acids, ~ and r bend mimics and others, have been used extensively to study the 
biologically important preferences of bioactlve peptidesl.34. Although not necessarily 
inhibitors in their own right, the Incorporation of conformationally restricted peptides or 
amino acid analogues Into known inhibitors can be advantageous: Potential benefits of 
conformational restriction in inhibitors Include; Increased metabolic stability due to 
decreased enzymatic degradation; Increased potency due to stabilization of a 
bloactive conformer; and increased specificity due to elimination of conformers which 
inhibit other enzymesi.03, 1.35, 
Considerable use has been made of lactams for achieving conformational 
constraint in bloactlve peptides. For example, the Incorporation of (i.20) into inhibitors of 
renin, an aspartic protease, has afforded compounds which are potent and resistant to 
degradation by chymotrypsinl.36. lnhibiton of renin is a therapeutic strategy for 
controlling hypertensloni.03, 1.37, 
i.20 
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Inhibition of angiotensin converting enzyme (ACE), a metallo protease, Is a viable 
route for treatment of hypertension and congestive heart failure. Studies of five-, six-, 
seven and eight-membered lactams (1.21), as conformationally restricted analogues of 
enalaprllate (1.22), an ACE Inhibitor, allowed determination of 'P (the torsion angle) In the 
bloactlve conformation of enalaprilatel.38. This Information was used to synthesize 
enalaprllate analogues (1.23) of Increased potency, constrained to the optimum 'I' 
valuel.39, 
Ph 
~ 
i. 21 i.22 
Conformationally restricted analogues of chymotrypsin substrates have been 
used to explore the specificity and mechanism of substrate bindingi.OB. 
The alternate substrate inhibitors shown in TABLE 1.03 (Section i.3.2)are essentially 
conformationally locked substrates of serine proteases. The mechanism-based 
inactivators shown in TABLE i.02 (Section i.3.1) represent conformationally locked 
substrates of serine proteases which contain a latent reactive group. 
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SECTION 1.4 
SPECIFICITY IN SERINE PROTEASE INHIBITORS 
A major challenge in producing a therapeutically useful Inhibitor Is to obtain 
specificity. With respect to Inactivation of serine proteases, this demands selective 
inactivation of one enzyme among a group of closely related enzymes. The three-
dimensional structures of serine proteases are very similar and they all employ the same 
catalytic mechanism (Section 1.2) In spite of a diversity of physiological functions. 
Primarily. It Is the primary specificity pocket S1, of the enzyme which determines 
the amino acid residues accepted by the active site and hence the point of cleavage. 
S1 Is a hydrophobic pocket In most serine proteasesi.07, The size and shape of the 
pocket determine substrate specificity. 
The binding site of a proteolytic enzyme for a polypeptide substrate Is 
conveniently defined In terms of a series of subsltesl.40 (SCHEME 1.04). Amino acid 
residues of the substrate Pn ... P3, P2. P1 and P1', P2'· P3' ... Pn' are located In subsites Sn ... S3, 
S2. S1 and s,·, S2'· S3' ... Sn' of the enzyme, respectively. Cleavage occurs between P1 
and Pl'. 
SCHEMEI.04 
N terminus Substrate C terminus 
<~: ___;;__I P_.;.._3 I P_.;.._2 I P~1 I P___;;,_1. I P___;;_2. I P_..;;__3. I _._,.) 
I s3j S2 j S1 I S1' j S2' j S3' I 
Enzyme 
The S1 specificity pocket in chymotrypsin can best accommodate a planar 
aromatic side chain. hence chymotrypsin cleaves peptide bonds on the carboxyl side 
of an aromatic amino acid residue. The s, specificity pocket in trypsin, which cleaves 
on the carboxyl side of arginine and lysine. is very similar to that In chymotrypsin except 
that Serl89js replaced by the acidic amino acid Asp189. Consequently, the basic side 
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chains of lysine and arginine at P1 are stabilized when bound In the S1 pocket. In 
elastase, which cleaves on the carboxyl side of glycine and alanine, the S1 specificity 
pocket Is partially occluded by the side chain of Val216 (Giy In trypsin and chymotrypsin), 
and the bottom Is partly filled by the side chain of Thr226 (Giy In trypsin and chymotrypsin) 
leaving room for binding of Ala and Gly side chains at P1, which are small. 
In the design of specific Inhibitors, the S1 primary specificity pocket Is very 
Important. Specificity considerations were the motivation for the synthesis of the halo 
enollactones (1.24 and 1.25), which are mechanism-based inactivators of 
chymotrypsin1.19. 
0 
II H 
RC-N 
Ph 0 
i.24 
The halo enollactones (i.24 and 1.25) bear a close structural resemblance to 
phenylalanine derivatives which are often good substrates for a-chymotrypsin; 
however, they were prepared in racemic form only. 
Although the S1 specificity pocket Is obviously important In substrate recognition 
and binding, it is not the only binding site. Secondary substrate binding sites may also 
exist and these provide the opportunity for Increasing the binding specificity of a 
synthetic lnactlvator. For some aspartic proteases, the specificity is extended to seven 
(P4-P3') or more amino acids. 
The specificity of affinity labels has been enhanced by attachment of the 
reactive group to an amino acid sequence recognized by the target enzyme1.27. 
As a strategy for Increasing specificity, halo enollactones and protio 
enollactones have been Incorporated into pseudo dlpeptidesl.24 (1.26-1.29). The pseudo 
dipeptide is based on the proline-valine sequences typically seen as the P2-P1 residues 
In elastase substrates. 
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~0 X * i.26 H R c(yo 1.27 H s i.28 Br R 
N X 1.29 Br s 
"Suo-{ 
0 
Whereas the protio enollactones (i.26-i.27) were not effective altE?rnate substrate 
Inhibitors, one of the bromo enollactone diastereolsomers (1.29) was a very effective 
lnactlvator of chymotrypsin and human leukocyte elastase (HLE), but not serine 
proteases of differing specificity. The observed specificity was superior to that found in 
other mono substituted halo enollactones. 
Benefits have also been obtained on peptldyl substitution of 3,1-benzoxazln-4-
ones, alternate substrate Inhibitors of human leukocyte elastase (HLE)L22. Dipeptide-
substituted benzoxazinones (i.31 and i.32) showed a lGO-fold Improvement In the rate 
constant for Inhibition, Kt, compared with pyrrolidlnyl-substltuted benzoxazlnone (i.30), 
and enhanced specificity is also expected. 
R2 0 R1 R2 Ra 
i.30 1-pyrrolidinyl H H 
Ra i.31 Pro-Leu-NH2 H H 
i.32 Pro-Leu-NH 2 Et N~ H 
It should be possible to target different serine proteases with a high degree of 
specificity by incorporation of the same Inhibitor, for example halo enollactone or protlo 
enollactone, Into an ollgopeptlde specific for the target enzyme. 
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SECTION i.5 
RESEARCH DESCRIBED IN THIS THESIS 
This thesis Is concerned with the development of a new class of potential specific 
alternate substrate Inhibitors and mechanism-based lnactivators of chymotrypsin. A 
normal chymotrypsin substrate is represented by (1.33) and the point of cleavage is 
Indicated by the arrow. The proposed new class of mechanism-based inactivcitors and 
alternate substrate inhibitors of chymotrypsin Is illustrated by the bromo enamlno ester 
(i.34) and protio enamino ester (1.35), respectively. 
0 R2 H 0 R3 H 0 ~NAyN~AyN-!-
R1 H 0 I H H 0 R4 
Ph 
i.33 
0 R2 H 0 R3 H 0 ~AyN~AyNJ-
A1 ~ 0 (''\_jN 0 A4 
Ph, ,.)l 
Et02C X 
i.34 X= Br 
1.35 X=H 
The proposed Inhibitors (1.34 and 1.35) have a benzyl group, analogous to the R 
group of phenylalanine, for recognition by chymotrypsin. Other amino acids could also 
be incorporated at this position. The enamlno esters (i.34 and i.35) form part of an 
oligopeptide with the same peptide backbone as a normal chymotrypsin substrate (1.33), 
hence there Is the opportunity for Increased binding specificity. The enamino esters (i.34 
and 1.35) are also conformationally restricted systems. 
The proposed mechanism of chymotrypsin inactivation by bromo enamino ester 
(1.34), (steps a. b, c, SCHEME 1.05) parallels chymotrypsin Inactivation by halo 
enollactones (steps a. b. c. SCHEME 1.02, Section 1.3.1) except that In this case the 
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reactive species is an a.-halo enamlne (1.36, SCHEME 1.05). Alternatively, hydrolysis of the 
a-halo enamlne (1.36) leads to formation of the a.-halo ketone (1.38) (step d. SCHEME 1.05). 
This species Is structurally very similar to known lnactlvators of chymotrypsin (1.40. TABLE 
1.02, Section 1.3.1) and hence Is expected to be alkylated by the nucleophilic active site 
residue. V. to produce the Inactivated enzyme (1.39, step e, SCHEME 1.05). Alternatively, 
hydrolysis of (1.37) may occur to give (1.39) (step f. SCHEME 1.05). 
SCHEME 1.05: Mechanism-Based' Inactivation of Chymotrypsin by Enamlno Ester (1.34) 
y 
1.37 
H20! f 
H 0 
--Y 
i.39 
H 
.JV>N 
e 
i.38 
Introduction 21 
The proposed mechanism of Inhibition of chymotrypsin by protio enamlno ester 
(1.35) is shown In SCHEME 1.06. Formation of a stable acyl enzyme (1.41) (steps a and b, 
SCHEME 1.06) will render (i.35) an effective alternate substrate inhibitor. Hydrolysis of (1.41) 
may occur leading to formation of (i.42) (step c, SCHEME 1.06) which Is structurally very 
similar to known stable acyl enzyme Inhibitors of chymotrypsin (1.43, TABLE 1.03, Section 
i.3.2). 
SCHEME 1.06: Alternate Substrate Inhibition of Chymotrypsin by Protlo Enamino Ester (i.35) 
a 
H 0 
c 
1.42 
H 0 
H 
.J\N'N 
0 
i.41 
A main goal in this work is the development of a generaL versatile synthesis that 
can be used to Introduce CH2Ph and other amino acid R groups into the inhibitor, and 
different amino acids Into the oligopeptide, in a stereo-controlled manner. Thus 
potentially, by judicious choice of substltuents, different serine proteases could be 
targeted with a high degree of selectivity. The proposed inhibitors (1.34 and i.35) have the 
same stereochemistry as natural chymotrypsin substrates (1.33). 
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The synthesis of the target bromo and protio enamino esters (i.34 and i.35) uses 
two new procedures developed during the course of this work. The first of these is the 
bromo lactonization of a keto acid phosphorane, via a modified SCOOPY reaction, to 
form a halo enollactone, and the second Is the Insertion of an amino acid Into an 
enollactone to form an enamino ester. 
Chapter 1 deals with initial development work on bromo and chloro lactonization 
of keto acid phosphoranes. Chapters 2-4 deal with reactions of enollactones and ~-keto 
esters, ultimately leading to the synthesis of target molecules of the type (1.34 and 1.35). 
Chapter 5 deals with trends observed in the mass spectra of keto ester and keto acid 
phosphoranes. 
This thesis represents the first stage in the development of these new classes of 
serine protease inhibitors. Subsequent work will concentrate on replacement of the 
C02Et group with H or Me to give compounds which more closely resemble known 
inhibitors, and development of syntheses of six-membered and larger enamino ester 
Inhibitors. 
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CHAPTER 1 
SYNTHESIS OF HALO 
ENOLLACTONES 
Chapter 1 28 
SECTION 1. 7 
INTRODUCTION 
Halo enollactones are found In many natural products. For example, halo 
enollactones (1.01), which show antimicrobial and antifungal activity, have been isolated 
from the alga Delise a fimbriate 1 .01. 
R=OAc R=OH R=H 
X y X y X y 
Br H Br H Br H 
H Br H Br H Br 
I H I H Br Br 
H I H I 
Cl H Cl H 
H Cl H Cl 
1.01 Br Br Br Br 
The potential for halo enollactones to act as selective, efficient mechanism-based 
inactlvators of serine proteasesl.l3-1.14.1.20 (discussed In detail in the Introduction, Section 
1.3.1) has generated much Interest in the properties of, and synthetic routes to, this class of 
compound. Halo enoHactonization of acetylenic acids 1.02-1.03 (1.02) is the usual method 
of preparation offive- and six-membered halo enollactones (1.03) (SCHEME 1.01). 
SCHEME 1.01 
N-halosucci ni mide 0 
R'~ KHCOa/ Bu4NOH R' CH2Ck/ H20 
( n~ X= Cl, Br, I 
R R= H, Me R 
1.02 R' = H, Ph 1.03 
n = 1, 2 
Six-membered enollactones are more effective Inhibitors than five-membered 
enollactonesl.02-l.04. Six-membered enollactones bind to chymotrypsin, a serine 
protease, with a 20- to 40-fold greater binding affinity, reflecting a better fit in the active site 
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relative to five-membered enol!actones. Further, six-membered enol!actones have a 
1 CJO.. to 20CHold higher activity as mechanism-based lnactlvators of chymotrypsin than five-
membered eno!lactones. This result suggests that the reactive active site nucleophilic 
I 
residue (step c, SCHEME 1.02, in the Introduction) Is more accessible to the electrophllic 
alkylatlng species (the a-halo ketone) derived from six-membered enollactones. 
However, five-membered enollactones are very useful probes for elucidating structure-
activity relationships. 
Other routes which Involve halogenation and/or enol-lactonlzation of acetylenlc 
acids have also been used to prepare five- and six-membered halo enollactones 1.02. 
1.05. Direct halogenation of protio enollactones (1.04) has met with limited success in the 
synthesis of halo enollactones (1.05) 1.02. 1.06 (SCHEME 1.02). This method represents one 
of the few reported syntheses of phthalic-based halo enollactones 1.06, 
SCHEME 1.02 
0 
H 
1.04 
0 0 
R 
R = H or propyl 
Phthalic halo enollactones (eg 1.05, SCHEME 1.02) contain a latent reactive group 
and a hydrophobic aromatic group, comparable to the hydrophobic aromatic residue at 
the cleavage site In natural chymotrypsin substrates, and hence are expected to act as 
mechanism-based lnactlvators of chymotrypsin. 
The above syntheses of halo enollactones tend to lack versatility and often give 
access to only one geometrical isomer. Another disadvantage Is that the precursors are 
often time consuming and synthetically difficult to prepare. 
This chapter describes two new syntheses of halo enollactones (SCHEMES 1.03 and 
1.04). Thus, E- and Z-chloro enollactones (1.11-1.15, SCHEME 1.03) and E- and Z-bromo 
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enollactones (1.17. pathway a. SCHEME 1.04) were prepared via halo enoHactonlzatlon of 
keto acid phosphoranes (1.06-1.10). and E- and Z-bromo enollactones (1.17) were also 
prepared via reaction of 4 ,5-dlchlorophthalic anhydride {1.16) with Ph3P=CBrC02Et 
(pathway b, SCHEME 1.04). 
SCHEME 1.03 
s:~H 
Et02C PPh3 
1.06 
R 
Rs~02H 
Et02C PPh3 
R 
R 
1.07 R=H 
1.08 R=Me 
PPh3 
1.09 R=H 
1.10 R=CI 
S~CI;I 
Et3N 
S~C~/ 
Et3N 
0 0 
C02Et Cl 
1.11 E 1.11 z 
0 :xo 
C02Et Et02C I Cl 
1.12E R=H 1.12Z R=H 
1.13E R=Me 1.13Z R=Me 
0 0 
R R 
R R 
C02Et Cl 
1.14E R=H 1.14Z R=H 
1.15E R = Cl 1.15Z R = Cl 
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SCHEME 1.04 
Cl 
Cl 
0 0 
Cl 
0 
Cl:o:; I o 
Cl ~ 
~ 
Pi'bP=CBrC~Et 
Br 
1.17E 1.17Z 
0 
1.16 
The halo enol-lactonlzation and anhydride/ylide reactions reactions will allow the 
preparation of new potential mechanism-based lnactlvators of chymotrypsin and other 
serine pro teases. With respect to .the target molecule (i.34, discussed in Section 1.5 in the 
Introduction), the reactions represent a means of incorporating latent reactivity. 
By contrast to traditional methods for synthesis of halo enollactones (SCHEMES 1.01 
and 1.02), the new reactions (SCHEMES 1.03 and 1.04) proceed in good yields. The halo 
enol-lactonizotion and anhydride /ylide reactions hove previously been used 1.07-1.08 for 
the synthesis of E- and Z-bromo enollactones (1.18-1.21. SCHEME 1.05) and E- and z-
phthalic-based bromo enollactone (1.21), respectively. 
The halo enol-lactonization (SCHEME 1.03 and pathway a, SCHEME 1.04) and 
anhydrlde/ylide (pathway b, SCHEME 1.04) reactions are related to the SCOOPY reaction 
(le; a ...Substitution plus Carbonyl Qlefinatlon via p-Qxldo Ehosphorous Y.lldes), which Is also 
known as the Schlosser modification 1.09-1.11, and the Wittig anhydride carbonyl olefinotion 
reoctlonl.l2. The SCOOPY reaction and the Wittig anhydride carbonyl olefinatlon reaction 
are extensions of the Wittig reaction. 
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SCHEME 1.05 
, (rtnC02H R-s:0 
Et02C PPh3 
1.06-1.10 
Br2"Et3V 
/n=1 
~iEtaN 
n=1~ 
0 Br~Et3N 
n=2 
0 
C02Et R 
1.18E & 1.18Z 
C02Et 
1.19E & 1.19Z R = H 
1.20E & 1.20Z R =Me 
SECTION 1.2 
WITTIG REACTION 
0 
C02Et 
1.21E & 1.21Z 
The Wittig reaction 1.13, since its discovery In 1953, has become one of the most widely 
used reactions In organic synthesis. The classic Wittig reaction is the reaction of a 
phosphorous ylide with the carbonyl of an aldehyde or ketone (1.22) to form a carbon-
carbon double bond (1.23) (SCHEME 1.06). 
SCHEME 1.06 
0 
R~R' 
1.22 
PhaP=CXY X:( 
R R' 
1.23 
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Phosphorous ylldes1.14, hereafter referred to as ylldes, are molecules In which a 
carbanion is directly attached to a phosphorous atom bearing a high degree of positive 
charge (SCHEME 1.07). 
SCHEME 1.07 
Ylldes are classified as stabilized, semi-stabilized or non-stabilized depending on 
the substituent at the nucleophilic carbon (C-1). Stabilized ylides have strongly 
conjugating substltuents; X (and/or Y) is C02R. CN, S02Ph and tend to form E-alkenes on 
reaction with aldehydes and ketones. Semi-stabilized ylides have mildly conjugating 
substituents; X (and/or Y) Is phenyL allyl. Non-stabilized ylldes lack conjugating 
substituents and generally give rise to Z-alkenes. Yllde reactivity is also dependent on the 
substituents on phosphorous; usually R 1 = R2 = R3 = Ph. 
The Wittig reaction uses mild reaction conditions compatible with labile functional 
groups and allows control of stereochemistry about the double bond. However, the 
reaction mechanism is still under investigation and is far from fully understood 1.13. 
SECTION 1.3 
WITTIG ANHYDRIDE CARBONYL OLEFINATION REACTION 
Synthesis of enollactones (1.26) via reaction of an anhydride (1.24) and stabilized 
yllde (SCHEME 1.08), the so-called, Wittig anhydride carbonyl olefination reaction 1.12, 
represents an important extension of the Wittig reaction. The reaction is a generaL high 
yielding procedure for the synthesis of five-, six- and seven-membered enollactones as 
well as phthalic-based enollactones. The proposed reaction mechanism Is shown in 
SCHEME 1.09. Initial attack on the anhydride by the ylide gives one of two possible betaine 
Intermediates (1.27a and 1.27b). The betaines (1.27a and 1.27b) may then form 
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SCHEME 1.08 
0 
PPha=CHC~Et (r1iiC02H 
-PPhaO {~ R-0 R~0 
Et02C PPh3 Et02:1H 
1.26 1.25 
SCHEME 1.09: Proposed Mechanism of the Wittig Anhydride Carbonyl Olefinatlon Reaction 
0 
R (~0 
0 ~ ~ ~ 0 0 (~ 1.24 (~ 
Rt~o- + R- 0 Et02C~·:o· PhaP=CHC~Et H + 
Et02C PPh3 ~ ~ H PPh3 1.27a R(~~ 1.27b H H 
0 ~ H + ~ 0 {~ Et02C PPh3 {~ 
R- 0 R-0 H~"'f 1.29 Et02C~··p H Et02C PPh3 H PPh3 
1.28a 
<rrnC02H 1.28b 
-PPhaOt -PPhaOt R~0 0 0 
R (~0 (~ Et02C PPh3 
1.25 R- 0 
Et02:iH :Xco2Et 
1.26E 1.26Z 
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oxaphosphetanes (1.28a and 1.28b, respectively). Loss of triphenylphosphine oxide from 
oxaphosphetane (1.28a) yields E-enollactone (1.26E), while loss of triphenylphosphine 
oxide from oxaphosphetane (1.28b) yields Z-enollactone (1.26Z). Altemativelyl the 
betaine Intermediates (1.27a and 1.27b) may ring open to form an unstable phosphonium 
salt 1.15 (1.29) which rapidly lsomerlzes to the more stable I isolable keto acid phosphorane 
( 1.25). Keto acid phosphoranes are synthetic intermediates to enollactones 1.16, 
allenes 1.17 and acetylenes 1.18 I and are also of interest with respect to the extent of n:-
localizatlon and modes of hydrogen-bondingl.l9. 
The factors determining the product ratio of E- and Z-enollactones in the Wittig 
anhydride carbonyl olefination reaction are unclear. The Wittig anhydride carbonyl 
oleflnation reaction of succinic anhydride with Ph3P=CHC02Et gives rise exclusi~ely to the 
E-enollactone. 
SECTION 7.4 
SYNTHESIS OF BROMO ENOLLACTONES VIA REACTION OF 
ANHYDRIDE WITH Ph3P=CBrC02Et 
The Wittig anhydride carbonyl olefination reaction shown in SCHEMES 1.08 and 1.09 
was adapted to allow the synthesis of E- and Z-dichlorophthalic bromo enollactones (1.17E 
and 1.17Z, respectively) by use of the bromo ylide; Ph3P=CBrC02Et (pathway b, SCHEME 
1.04). Thus, dichlorophthalic anhydride (1.16) and Ph3P=CBrC~Et ( 1.1 equivalent), 
dissolved in CH2Cl2, were stirred at 20 oc for 5h to yield the crude E- and Z-dichlorophthalic 
bromo enollactones (1.17E and 1.17Z, respectively), In a ratio of 1 E : 4 Z, by 1 H NMR 
spectroscopy (E/Z assignments are discussed later In Section 1.8). The isomers were 
separated by radial chromatography on silica to give a combined yield of 61%. The 
proposed reaction mechanism (pathway b, SCHEME 1.10) Is analogous to the mechanism 
of the Wittig anhydride carbonyl olefination reaction (SCHEME 1.09). 
The formation of halo enollactone from reaction of Ph3P=CBrC02Et with an 
anhydride proceeds for phthalic- and 4, 5-dlchlorophthalic-anhydrlde, but not for the less 
reactive succinic- and glutaric-anhydrides. 
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SCHEME 1.10: Proposed Mechanism for the Preparation of Bromo Enollactone (1.17) via 
Bromo Enoi-Lactonlzation of the Keto Acid Phosphorane (Pathway a) and from the 
Anhydride/Ph3P=CBrC02Et Reaction (Pathway b): 
Cl 
Cl 
Cl 
Cl 
Cl 
Cl 
0 
1.37a 
0 
0 
+ PPh3 
0 
.. ,,, 0 
I 
PPhs 
c1«0 I o 
Cl ~ 
0 
1 .16 
+ 
PflaP=CBrC~Et 
Cl 
Cl 
Cl 
Cl 
0 
+ PPh3 
PPhs 
Cl 
Cl 
Cl 
Cl 
Cl 
Cl 
0 
0 
+ PPh3 
1.37b 
0 
0 
,,,,, 0 
I 
PPfla 
~PPflaO 
C~Et 
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Thus, although representing a convenient procedure for the synthesis of E- and Z-phthalic-
based bromo enollactones (1.17 and 1.21), the reaction does not appear to be generally 
applicable to the synthesis of succinic- and glutaric-based halo enollactones. Halo ylldes 
are less reactive than Ph3P=CHC02Et due to decreased nucleophlllclty at C-1 , the site of 
reaction. 
SECTION 1.5 
SYNTHESIS OF HALO ENOLLACTONES VIA HALO ENOL-
LACTONIZATION OF KETO ACID PHOSPHORANES 
E- And z-halo enollactones (1.11-1.15, 1.17) were also prepared via the halo enol-
lactonizatlon of keto acid phosphoranes (1.06-1.10) (SCHEME 1.03 and pathway b, SCHEME 
1.04). This method avoids the Initial and presumably slow step of yllde attack on the 
anhydride required for halo enollactone formation in the anhydride/Ph3P=CBrC02Et 
reaction (pathway b, SCHEME 1.10). The reactions required the Independent synthesis of 
the key keto acid phosphoranes C 1.06-1.1 0) via reaction of the appropriate cyclic 
anhydride with Ph3P=CHC02Et (SCHEME 1.11) 1.16. 
SCHEME 1. 11 : Preparation of Keto Acid Phosphoranes 
~~H 
Et02C PPh3 
1.06 
PJlaP=CHC~Et 
R..y'fo 
R 'yo 
0 
R 
R 
1.07 
1.08 
C02H 
0 
PPh3 
R=H 
R=Me 
0 R« I o 
R ~ 
0 
R 
R 
PPh3 
1.09 R=H 
1.10 R=CI 
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The stable keto acid phosphoranes (1.06-1.08) were recrystallized, dissolved In 
CH2CI2 and treated with SCY.2CI2 (1.5 equivalent) and triethylamine (1.5 equivalent), at -78 oc. 
After 30mln at -78 oc, the solutions were allowed to warm to 20 oc. Radial chromatography 
yielded pureE- and Z-chloro enollactones (1.1 L 1.12 and 1.13) In high yield (92%, 73% and 
70%, respectively). TheE and Z Isomers were not separated by radial chromatography In 
this Instance (E/Z assignments are discussed later In Section 1.8). 
Phthalic-based keto acid phosphoranes (1.09-1.10), although observable by lH 
NMR spectroscopy at low temperatures, proved too reactive to Isolate. Therefore, 
solutions of anhydride and Ph3P=CHCCY.2Et In CH2CI2 were stirred at 0 oc for 15mln to allow 
formation of the keto acid phosphoranes (1.09-1.10). At this time, S02CI2 (1.5 equivalent) 
and triethylamine ( 1.5 equivalent) were added and the solution was stirred at 0 oc for 1 h. 
Purification by radial chromatography yielded E- and Z-chloro enollactones (1.14 and 1.15) 
In high yield (62% and 93%, respectively). The E and Z Isomers of the chloro enollactones 
(1.14 and 1.15) were separated by radial chromatography. HoweveL for Z-phthalic chloro 
enollactone (1.14Z) a second chromatographic step was necessary to remove 
unreacted phthalic anhydride (E/Z assignments are discussed later in Section 1.8). 
For the synthesis of bromo enollactone C 1.17) via bromo enol-lactonization of keto 
acid phosphorane (1.1 0), a solution of anhydride and Ph3P=CHC02Et In CH2CI2 was stirred at 
20 oc for 1 Omln at which time Br2 (0. 7 equivalent) and triethylamine were added. After 30mln 
at 
20 oc, the reaction mixture was purified by radial chromatography to yield E- and Z-bromo 
enollactones (1.17E and 1.17Z, respectively) In a combined yield of 44%. The ratio of E-
C 1.17E) and Z- ( 1.17Z) bromo enollactones was the same as that obtained by the direct 
reaction of dichlorophthalic anhydride with Ph3P=CBrC02Et (pathway b, SCHEME 1.10); ie, 1 
E : 4 Z. This Indicates that a common reaction mechanism Is likely for the two reactions, 
with a different method of producing the key halo phosphonium salt intermediate (1.30, 
SCHEME 1.10). The proposed reaction mechanism for the bromo enoHactonization 
reaction and the anhydride/ylide reaction Is shown In SCHEME 1.10. The two methods for 
the synthesis of phthalic promo enollactone (1.21, SCHEME 1.05) also yielded the same E/Z 
Isomer ratio. The mechanism proposed for the chloro enol-lactonization of keto acid 
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phosphoranes (1.06-1.1 0) (SCHEME 1, 12) Is analogous to the mechanism for bromo enol-
lactonization (SCHEME 1.10). 
SCHEME 1.12: Proposed Mechanism for the Synthesis of E- and Z-Chloro Enollactones (1.11-
1.15) via Chloro Enoi-Lactonizatlon of Keto Acid Phosphoranes ( 1.06-1.1 0) 
0 
R(~o 
cl':/ ..::o· 
Et02C PPh:, 
1.38a 
l-PPhaO 
(,rnCO:zH 
R J:o 
Et02C PPh3 
1.06-1.10 
1.38b 
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SECTION 1.6 
SCOOPY REACTION 
The bromo and chloro enol-lactonlzatlon reactions (pathway b, SCHEME 1.10 and 
i 
SCHEME 1.12. respectively) represent extensions of the SCOOPY reaction 1.09-1.11 (pathway 
a, SCHEME 1.13). In the SCOOPY reaction an Initially formed betaine (1.32), derived from an 
aldehyde and a non-stabilized ylide, Is treated with nsuu at low temperature to give a p-
oxido ylide (1.33). Reaction with a second aldehyde (X+ = R2CHO) then gives the allyllc 
alcohol (1.36) stereoselectlvely, via the betaine (1.34) (pathway b, SCHEME 1.13). Halogen 
electrophllesl.09-1.10, for example N-chlorosuccinimlde, Br2 or FCI03, yield the analogous 
vinyl halides (1.35) (pathway a, SCHEME 1.13). The p-oxido ylide route to olefins (1.36) allows 
the joining of three components In one operation, such that the oxygen of the first 
aldehyde Is retained, whereas that of the second aldehyde Is eliminated as 
triphenylphosphine oxide 1.09. 
SCHEME 1.13: SCOOPY Reaction 
R1CHO 
Me 
P".JP=CHMe., R'~fPhs 
o-
1.32 
Me 
R1~x ....,.__a __ 
H X= Br, Cl 
Me 
R'0~hs 
o-
1.35 1.34 
"Buli 
Me 
R1~PPh:J 
ot..r-
1.33 
1.36 
With the chloro aod bromo enoHactonization reactions (SCHEME 1.12 and pathway 
b, SCHEME 1.10, respectively) the p-oxido yllde (1.33) Is by-passed and a betaine (1.31, 
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SCHEME 1.12 and 1.30, SCHEME 1.10) analogous to (1.34) (SCHEME 1. 13) Is produced on 
reaction of a keto acid phosphorane ( 1.06-1.1 0) with either S02C12 or Br2. The normal 
sequence of the SCOOPY reaction Is reversed In that the reaction of the keto acid 
phosphorane (1.06-1.10) promotes enol-lactonlzatlon and hence formation of the p-oxido 
group of (1.38) (SCHEME 1.12) and (1.37) (SCHEME 1.10). Loss of triphenylphosphine oxide 
then occurs to give the chloro enollactones (1.11-1.15, SCHEME 1. 12) and bromo 
enollactones (1.17, SCHEME 1.10), analogous to the vinyl halide (1.35, SCHEME 1.13). In the 
standard SCOOPY reaction the ~-oxido group (1.33, SCHEME 1. 13) Is generated prior to the 
addition of the electrophile. 
SECTION 1.7 
PHOSPHONIUM SALT INTERMEDIATES 
On reaction of the keto acid phosphorane (1.06) with Br2 at 0 oc In CDCI3, the bromo 
phosphonium salt Intermediate (1.39) was detected by 1 H NMR spectroscopy 1.20. 
However, similar attempts to detect the chloro phosphonium salt intermediate (1.40) were 
unsuccessful. The chloro enollactones (1.11) were observed to form directly from the keto 
acid phosphorane (1.06), dissolved In CDCI3 at 0 <>C, immediately upon addition of S02C12. 
c~ 
X~+ 
Et02C PPhs 
1.39 X= Br 
1.40 X= Cl 
A number of different reaction pathways are available to phosphonium salts of the 
type (1.41) (SCHEMES 1.14-1.15) 1.19-1.20. When X isH, Me, BrorCI and n is 1 or 2 the 
phosphonium salt cyclizes to form enollactones (pathway a, SCHEME 1.14). When X isH 
and n is 1 or 2, migration of a proton can occur to give the keto acid phosphorane 
{pathway b, SCHEME 1.14). 
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SCHEME 1.14 
(~C:£ ~Xo 
Et02C PPh3 1.41 
/ b! 
( 
0 
C02Et 
X= H, Me, Br, Cl 
n = 1, 2 
(~C02H 
n 0 
X + 
Et02C PPha 
X=H 
n = 1, 2 
(~C02H 
CH 
II 
c 
II 
Et02c""c'x 
X= Me, Br 
n=3 
Alternatively, enolization followed by the loss of triphenylphosphine oxide occurs to 
yield an allene when cyclization Is not favoured, due to either a long alkyl chain (pathway 
c, SCHEME 1.14) or the absence of a free carboxyl group (SCHEME 1.15). 
SCHEME 1.15 
CH2 II 
c 
II 
Et02C""C'Br 
- PhaPO 
-rt 
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SECTION 7.8 
STRUCTURE ASSIGNMENT OF BROMO AND CHLORO 
ENOLLACTONES 
The structure of the chloro enollactones (1.11-1.15) was assigned by comparison of 
their 1 H and 13c NMR spectra with the 1 H and l3c NMR spectra of the corresponding 
bromo enollactones (1.17-1.21). The structure of the bromo enollactone (1.17Z) was 
determined by single crystal X-ray structure analysis and the perspective view, with 
crystallographic atom labelling, is shown in FIGURE 1.01. 
FIGURE 1.01: Perspective View and Crystallographic Labelling of Z-Bromo Enollactone 
(1.17Z) 
Cl4 
In assigning configuration, the most diagnostic resonances were (H-4)2 and C-5 in 
the succinic-based enollactones (1.11); (H~5)2 and C-6 In the glutaric-based enollactones 
(1.12-1.13); and H-4 and C-3 phthalic-based enollactones (1.14-1.15, 1.17) (TABLE 1.01). The 
ethyl ester in the Z configuration is known to deshield (H-4)2, CH-5)2 and H-4 in succinic-, 
glutaric- and phthalic-based enollactones, respectiveJy1.21. This trend was observed in 
the chloro and bromo enollactones (1.11-1.15, 1.17-1.21, TABLE 1.01). 
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TABLE 1.01: Trends In the 1 H and 13c NMR Spectra of Chloro and Bromo Enollactones 
0 
X y 
3 
4* 1.11 E Cl C~Et 
1.11 Z C~Et Cl 
1.18E Br C~Et 
1.18Z C~Et Br 
R£O 0 R !!!' 0 
16"' R 4* 
X y 
X y R X y R 
1.12E Cl C~Et H 1.14E Cl COzEt H 
1.12Z COzEt Cl H 1.14Z C~Et Cl H 
1.13E Cl C~Et Me 1.15E Cl C~Et Cl 
1.13Z COzEt Cl Me 1.15Z COzEt Cl Cl 
1.19E Br COzEt H 1.17E Br COzEt Cl 
1.19Z C~Et Br H 1.17Z C~Et Br Cl 
1.20E Br C~Et Me 1.21 E Br C~Et H 
1.20Z C~Et Br Me 1.21Z CC>zEt Br H 
Compd E isomero Z isomer o E Isomer Z isomer Ratio Yield 
No. H* H* oCT oCT E/Z 0 (E+Z)%b 
1.11 3.14 3.43 158.5 161.6 86/14 92 
1.18 3.10 3.41 158.9 162.9 70/30 77 
1.12 2.83 3.20 155.4 c 96/4 73 
1.19 2.80 3.16 155.2 161.0 89/11 85 
1.13 2.66 3.05 154.6 c 88/12 70 
1.20 2.65 3.01 154.1 159.7 88/12 85 
1.14 8.49 8.72 149.7 152.9 44/56 62 
1.21 8.70 8.58 149.5 153.7 35/56 55(74)d 
1.15 8.58 8.96 147.8 151.4 23/77 93 
1.17 8.77 8.86 147.7 152.4 20/80 44(6l)d 
a = calculated from 1 H NMR spectrum 
b = Isolated yield after chromatography 
c = 13c NMR spectrum ofminor isomer not recorded 
d =yield of anhydrlde/Ph3P=CBrC02Et reaction 
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However, some ambiguity existed In the phthalic series due to the de shielding 
effect of bromine. The·H-4 resonance of the Z-halo enollactones (1.142, 1.15Z, 1.17Z) was 
downfleld relative to the corresponding E Isomers (1.14E, 1.15E, 1.17E) as expected. The 
exception was phthalic bromo enollactone (1.21). Z-phthallc bromo enollactone (1.21Z), 
the structure of which was confirmed by single crystal X-ray analysis, gave a resonance for 
H-4 (S 8.59) upfleld relative to the corresponding E Isomer (1.21 E) (5 8.80). 
A trend observed for all bromo and chloro enollactones (1.11-1.15, 1.17-1.21) was 
that the ylldene carbon resonances were consistently downfield In the Z Isomers relative to 
the corresponding E Isomers (TABLE 1.01). 
The E-halo enollactone was the major Isomer for the five- and six-membered series 
(1.06-1.10. 1.18-1.20), while the Z-lsomer predominated In the phthalic-based examples 
(1.14-1.15, 1.17, 1.21)(TABLE 1.01). 
SECTION 7.9 
REACTIONS Of CHLORO ENOLLACTONES WITH WATER AND 
METHANOL 
Whereas the bromo enollactones (1.17-1.21) were stable Indefinitely at 20 oc, the 
succinic- and glutaric-based chloro enollactones (1.11-1.13) readily reacted with 
atmospheric H20, over the period of 3 weeks, to form acids (1.42-1.44, SCHEME 1.16). 
The chloro enollactones gave the methyl esters C 1.45-1.47, SCHEME 1.17) after 
contact with silica gel chromatotron plates containing methanol. The methyl esters were 
also formed from the corresponding acids ( 1.42-1.44), on reaction with methanol and p-
toluene sulphonlc acid (PTSA). at 20 oc. 
The proposed mechanism for the formation of the methyl esters (1.45-1.47) from 
chloro enollactones (1.11-1.13) is shown In SCHEME 1.17. An analogous mechanism Is 
proposed for the formation of the corresponding acids (1.42-1.44) from the chloro 
enollactones (1.11-1.13), but with H20 as the nucleophile. 
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SCHEME 1.16 
0 
Et02C Cl 
Et02C 
1.11 1.12R=H 
1.13 R=Me 
l H,O H20l 
I: H~~H I: - C02H -I R I 0 0 0 Q) Q) ~ ~ 
Et02C Cl Et02C 
1.42 1.43 R = H 
1.44 R ~Me 
! MeOH/ H' MeOH/ H'! fi.:e R C02 Me R 0 
Et02C Cl Et02C 
1.45 1.46 R = H 
1.47 R =Me 
SCHEME 1.17 
0 
( 
Et02C Cl Et02C Cl 
1.11-1.13 1.48 
!-w 
(~2Me H+ (~2Me (s;2Me n 0 n 0 ...,. ... n o-p H . 
-
Et02C Cl Et02C Cl Et02C Cl 
1.45-1.47 1.49 
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This mechanism was supported by the finding that reaction of succinic chloro 
enollactone (1.11) with CD30D In the presence of PTSA gave (1.50) (SCHEME 1.18), which 
showed characteristic deuterium (D) NMR signals for the methyl ester and H-2 (TABLE 1.02). 
SCHEME 1.18 
TABLE 1.02 
0 
resonance 
CQ.2CH3 
CHO 
s:~CD3 
Et02C Cl 
1.50 
0 H (1..45) 0 D (1.50) I 
3.69 3.66 
4.87 5.09 
The facile reaction of the chloro enollactones (1.11-1.13) with H20 or methanol 
suggests that their therapeutic potential as mechanism-based lnactivators is very limited. 
The cell environment is aqueous, hence it is unlikely that the chloro enollactones (1.11-1.13) 
would reach their target unchanged. A good mechanism-based lnactivator must be 
stable in the cell environment and react only with the target enzyme. However, the 
reaction chloro enollactones (1.11-1.13) underwent with H20 and methanol (SCHEME 1.16) 
does mimic the initial reaction required for protease mechanism-based Inactivation 
(steps a and b, SCHEME 1.02, Section 1.3. 1 in the Introduction). Hence It is reasonable to 
assume that less reactive halo enollactones, (1.14-1.15, 1.17), will be capable of 
Inactivating the target enzyme via a mechanism-based route. 
The tert-butyl protio enollactone (1.51) underwent an analogous reaction, also 
following contact with silica gel chromatotron plates containing methanoL to give the 
methyl ester (1.52) (SCHEME 1. 19). 
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SCHEME 1.19 
MeOH/W 5t~Me 
tsuo2c H 
1.52 
The acids (1.42-1.44) and methyl esters (1.45-1.47, 1.52) gave similar lH and 13c NMR 
spectra to 3.01 (from Chapter 3). However, as a consequence of the chlral centre at C-2 in 
the acids (1.42-1.44) and methyl esters (1.45-1.47), the resonance arising from CH-4)2 
appeared as a multiplet for ( 1.42-1.44 and 1.45-1.47), whereas H-4 was a triplet for (1.52 and 
3.0 1). The deshlelding effect of Cl relative to H accounts for the significant differences 
between the 1 H and 13c NMR spectra of (1.45-1.47 and 1.42-1.44) (compounds which 
contain Cl at C-2), as compared with the spectra of (1.52 and 3.01) (compounds which 
contain hydrogen at C-2) (TABLE 1.03). 
TABLE 1.03 
H~~Me 
Et02C H 
3.01 
Compd no. o H-2 
1.42 4.88 
1.43 4.87 
1.45 4.79 
1.46 4.78 
1.47 4.81 
1.52 3.40 
3.Ql 3.50 
oC-2 
63.3 
63.2 
63.3 
67.2 
a 
00.6 
51.7 
a 13c NMR spectrum was not recorded 
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Attempts to form the methyl ester (1.45) from the corresponding acid (1.42) by 
methylation with CH2N2 were unsuccessful. A compound, tentatively assigned as the 
alkene (1.53) was Isolated. 
cC.:Me 
4.~ OMe 
Cl I CO,Et. 
1.53 
Assignment of the product to the structure Indicated by (1.53) was based upon 
spectral data. The composition of the product; le, CwH1sCIOs. was consistent with the 
high resolution mass spectrum. The 13c NMR spectrum showed no evidence of a ketone 
or CHCI group; instead there were resonances at B 164.0 and B 104.9 corresponding to the 
carbons of the double bond. Also. there were resonances at o 52.0 and B 56.2 Indicating 
two new OMe groups. The l H NMR spectrum also Indicated the presence of two new 
OMe groups and the absence of the CHCI resonance. As a result, structure (1.53) was 
proposed. The configuration was assigned as E because the (H-4)2 protons (B 3.19) 
resonated at approximately the same chemical shift as the analogous (H-4)2 protons in 
the E-chloro enollactone (1.11E) (8 3.14). The lH and 13c NMR spectra of the product after 
purification by radial chromatography suggested that in addition to (1.53), a small amount 
of another compound (perhaps the Z Isomer of the alkene (1.53)) was present. 
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CHAPTER 2 
SYNTHESIS OF ENAMINO ESTERS VIA 
THE INSERTION REACTION 
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SECTION 2.1 
INTRODUCTION 
Enamino esters are a sub-class of the important group of compounds known as 
ene-lactams. Ene-lactams are found in nature. For example, billprotelns2.0l (2.01-2.03) 
are a family of chromophores consisting of a linear tetrapyrrole covalently bonded to a 
protein. Rings A (2.01-2.03) and D (2.01-2.02) of the billproteins are ene-lactams. 
Protein 
2. 01 R = Et eg phycochromes 
2.02 R = CH=C~ egphytochromes 
Protein 
2.03 eg phycoerythrobilin 
Biliprotelns are found In red algae, cyanobacteria, cryptophytes, mosses and higher 
green plants where they are important In photosynthesis and photomorphogenesls. 
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Pukeleimldes, exemplified by pukelelmide A (2.04), pukeieimide C (2.05) and 
pukeleimide E (2.06), is another naturally occurring class of compound containing an 
ene-lactam unit. 
0 0 0 
N-Me 
I I yo yo 
OMe OMe 
2.04 2.05 
Pukeleimldes have been isolated from strains of the marine blue-green alga, Lyngbya 
maiuscula responsible for the contact dermatitis known as 'swimmer's itch'2.03. 
Ene-lactams, Including cyclic enamino esters, are also versatile synthetic 
intermediates. TABLE 2.01 depicts ene-lactams (2.07-2.12) which have been used as 
intermediates In syntheses of natural products and analogues of natural products (2.03-
2.04, 2.13-2.16)2.03-2.06, 
Another Important application of cyclic acylated enamino esters, which is 
developed In this thesis, is as potential peptide analogue inhibitors of serine proteases 
(discussed in Section /.Sin the Introduction), 
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TABLE 2.01: En amino Esters of Synthetic Importance 
Structure of 
Enamlno Ester Intermediate Target Molecule Tar et Molecule 
chromophore of 2. o 3 
c~ tau blllproteins 
0 
2.08 
0 
N-(C~~C~Me 
Ph 
2.10 
0 
CBzHN,, 
'• 
2.11 
analogues of 
pukelelmlde A 
prostaglandin 
analogue 
gephyrotoxln 
analogue 
2.04 
0 
2.13 
nuOH 
2.14 
0 
R'HN,,c(x •• N C~Na+ 
carbapenam 1 2. 1 5 
analogues 
S(CJ-kkNHR 
corrins (egvitamin 
812) and corrin 
analogues 
2.16 
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Therefore. cyclic enamino esters represent an attractive synthetic target. 
I 
Traditionally, cyclic enamlno esters (2.19 and 2.20) have been prepared from the 
corresponding imide (2.17 and 2.18, respectively) via either a Wittig2.09~2.11 (pathway a, 
SCHEMES 2.01 and 2.02), Reformatsky2.11-2.12 (pathway b. SCHEMES 2.01 and 2.02) or 
Grignard2.11-2.12 reaction (pathway c, SCHEMES 2.01 and 2.02). These reactions suffer 
from low yields. harsh reaction conditions (TABLE 2.02) and undesirable side reactions, 
such as bis adduct formation (for example 2.21), and subsequent Isomerization to 
pyrroles (for example 2.22). 
SCHEME2.0l 
0 
( QNR1 
0 
2.17 
SCHEME2.02 
0 
cGNR1 
0 
2.18 
BrC~C~Et/ Zn 
b 
EtOC = CMgBr/ HCI 
BrC~C~Et/ Zn 
b 
Etoc=cMgBr/ HCI 
0 
QNR1 ( 
CH~ 
2.19 
0 
~NR1 
CH~ 
2.20 
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NC 
2.21 2.22 
Synthesis of enamlno esters via the Wittig, Reformatsky or Grignard reactions has 
essentially been limited to five-membered succinlmlde- and phthalimlde-based 
systems. The synthesis of one example of a six-membered enamlno ester has been 
reported via the Wittig methodology (Entry Sin TABLE 2.02). 
TABLE 2.02: Syntheses of Enamlno Esters via Grignard, Wittig and Reformatsky Reactions 
Pathway SCHEME n Rl R2 Yield% E vs Z Conditions 
a 2.01 1 H Ph 13 " xylene/140 °C/20h 
a 2.01 1 Me Ph 12 E xylene/140 °C/20h 
a 2.01 1 Me C()zEt 32 E melt/130 °C/18h 
a 2.01 1 Ph CN 33 E melt/200 °C/4h 
a 2.01 2 Me C()zEt 11 E melt/200 °C/4h 
a 2.02 - H H 24 * C6H6/80 °C/5h 
a 2.02 - Me Ph 21 56E/44Z xylene/140 °C/20h 
a 2.02 - H C()zEt 33 z melt/140 °C/4.5h 
a 2.02 - H CN 63 z xylene/140 °C/ 24h 
b 2.01 1 H C()zEt 24 88E/l2Z 
b 2.02 - H COzEt 8) z 
b 2.02 - Me C()zEt Cf2 E 
c 2.01 1 Me C()zEt 68 E 
c 2.02 - Me COzEt 52 " 
* E/Z Isomer ratio not reported 
Enamlno esters have also been synthesized via variations of the Wittig and 
Reformotsky reactions discussed above. The Reformatsky reaction of o-cyanobenzolc 
esters (2.23) has been used to synthesize phthalimide-based enamino esters2.13 (2.24) 
(SCHEME 2.03). The analogous Wittig reaction of Ph3P=CHC02Et with cyclic 
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monothiodlcarboximldes (2.25) has been used to synthesize five-, six- and seven-
membered enamlno esters2.14 (2.26) (Scheme 2.04). 
; SCHEME 2.03 
R2 Et sec-Bu 
Yield 30% 50% 
SCHEME2.04 
0 0 
(~NH PhaP=CHC~Et ( 
n = 1-3 
s C02Et 
2.25 2.26 
n 2 3 
Yield 66% 45% 51% 
Six-membered enamino esters (2.28) have also been prepared from imldate 
hydrochlorides2.15 (2.27) (SCHEME 2.05), In low yields, and as for the reactions in SCHEMES 
2.03 and 2.04 the substituent on N is always hydrogen. 
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SCHEME2.05 
HCI ..,. 
MeOH 2Y'r=N~+cr R Cl OMe 
2.27 
1. Meldrum's acid/ Et3N! 
2. EtONa+/ EtOH 
R1 R2 Yield 
H H 10% 
Me H 9% 
R~o 
2 NH 
R CQ,Et Me Me 3% 
2.28 
More recently, cyclic acylated enamino esters (2.30 and 2.32) have been 
prepared from ~-keto esters2.17 (2.29) (SCHEME 2.06) and by treatment of an oxirane (2.31) 
with sodium azide and RNH2.HCI2.16 (SCHEME 2.07). These methods give, at best, modest 
yields and lack generality. The syntheses of enamino esters described In Chapter 3 are 
based on the former reaction (SCHEME 2.06). 
SCHEME2.06 
([j,C~2Me 10 
C02 Me 
2.29 
0 
RN~/ heat 
I n R E vs Z Yield% Conditions 
1 H z f6 8h/l40°C 
1 CH2Ph E 62 1. 18h reflux in toluene I 2. NoH 
l 'Pr E 35 1. l8h reflux in toluene /2. NoH 
1 nsu E 4J 1. 18h reflux in toluene/2. NoH 
1 CH~CHCH2 E 1ft 1. 18h reflux in toluene/2. NoH 
2 CH2Ph E 54 1. 18h reflux in toluene/2. NoH 
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SCHEME2.07 
RN~.HCI 
NaNsf heat 
H20/ EtOH 
0 
R H Me Pr 
Yield 67% 67% 62% 
This chapter describes a new, versatile, high yielding and convenient synthesis of 
succlnimide- and phthallmide-based enamlno esters (SCHEME 2.08). The reaction of an 
enollactone (2.33), readily prepared via Wittig chemistry2.10, with an amine, initially forms 
an isolable keto-amide (2.34) and/or hydroxy lacatm (2.35) intermediate. Subsequent 
elimination of H20 on heating gives the enamino ester (2.36), via an overall insertion 
process. 
SCHEME2.08 
0 
R 2N~or ... 
(R,S)-R2N~.HCI/ 
Et3N 
0 
t 
0 
NH~ 
0 
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As discussed in the Introduction (Section 1.5), enamino esters are potential 
mechanism-based lnactivators and alternate substrate Inhibitors of serine proteases. 
This chapter Is concerned with the synthesis of model enamino esters via the new 
Insertion reaction (SCHEME 2.08) and the establishment of optimum conditions and limits 
for the Insertion reaction before Its application to the synthesis of the target peptide 
analogues (1.34 and i.35, Section 1.5, Introduction). 
SECTION2.2 
KETO-AMIDES AND HYDROXY LACTAMS 
SECTION 2.2. 1 
SYNTHESIS OF KETO-AMIDES AND HYDROXY LACTAMS 
The keto-amides (2.37-2.47) and the hydroxy lactams (2.48-2.50) were prepared 
via the reaction of the appropriate enollactone (2.33a-d), synthesized using standard 
Wittig chemlstry2.10, with a primary amine (SCHEME 2.09). The results are summarized In 
TABLE 2.03. 
The keto-amide (2.37) was obtained In 100% yield, by stirring a CH2CI2 solution of 
succinic enollactone (2.33a) with a solution of NH3 (8 equivalent) In ethanol. After 5h the 
solvent was evaporated under reduced pressure to yield keto-amide (2.37). An identical 
method using succinic enollactone (2.33a) and NH3 (11 equivalent) In ethanoL 
quantitatively gave hydroxy lactam (2.48). 
Keto-amides (2.38-2.41) and hydroxy lactam (2.49) were prepared, also In 100% 
yield, via reaction of the appropriate enollactone (2.33a-2.33b, 2.33d) with methyl-, ethyl-, 
or nbutyl-amlne (1 or 1.8 equivalent) in CH2CI2 at 20 oc for 16h (TABLE 2.03). 
Keto-amides (2.42-2.47) and hydroxy lactam (2.50) were prepared. in yields of 73-
100%, via the reaction of the appropriate enollactone (2.33a-2.33d) with (R.S)-alanine-, 
(R,S)-Ieucine-, (R,S)-phenylalanlne-, or glycine-ethylester hydrochloride, and 
triethylamine, In CH2Ci2ot 20 oc for 16h (TABLE 2.03). 
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SCHEME2.00 
0 
TABLE 2.03 
Compd 
2.37 
2.38 
2.39 
2AO 
2.41 
2.42 
2A3 
2A4 
2..45 
2A6 
2.47 
2.48 
2.49 
2.50 
0 0 
NH~ 
X 
H 
H 
H 
H 
Me 
H 
H 
H 
H 
H 
Me 
H 
2~33a Et H 
2.33b Et Me 
2.33c 1Bu H 
Et02C H 
2.33d 
R2N~or 
(R,S)-R2N~.HCI/ 
Et3N 
R2N~or J {R,S)-R2N~.HCI/ 
Et3N 
Rl 
Et 
Et 
Et 
Et 
Et 
Et 
Et 
Et 
Et 
tsu 
Et 
Et 
0 
C~R1 
2.48 
R2 
H 
Me 
Et 
nsu 
nsu 
(R,S)-CH(Me )C02Et 
0 
C~Et 
2.49 - 2.50 
Yield% Equiv. Amine 
100 8 
100 11 
100 1.8 
100 1 
100 
73 1.3 
(R,S)-CHCCH2CHMe2)C02Et 100 1.3 
(R,S)-CH( CH2Ph)C02Et 97 1.3 
CH2C~Et 88 1.3 
CH2C~Et 87 1 
CH2C~Et 88 1.2 
H 100 11 
nsu 100 1.3 
CH2~Et 79 1.4 
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The hydroxy lactams (2.48-2.50) were Isolated, rather than the corresponding 
keto-amldes, following reaction of succinic enollactone (2.33a) with an excess of NH3 
and after reaction of phthalic enollactone (2.33d) with butylamine and glycine ethylester 
hydrochloride. A stable six-membered ring with Intramolecular hydrogen-bonding 
between the amino H and the carbonyl 0 (SCHEME 2.10) might account for the formation 
of hydroxy lactam (2.48). Formation of the phthalimide-based hydroxy lactams (2.49-
2.50) may be a consequence of the aromatic ring In the corresponding keto-amide ! . 
precursors holding the ketone and amide substltuents In an orientation favourable to 
cycllzatlon. 
SCHEME2.10 
0 
OEt 
2.48 
SECTION 2.2.2 
STRUCTURE ASSIGNMENT OF KETO-AMIDES AND HYDROXY LACTAMS 
The structure of the keto-amides (2.37-2.47) and hydroxy lactams (2.48-2.50) was 
assigned primarily on the basis of lH NMR, 13c NMR and IR spectroscopic and high 
resolution mass spectrometric data. 
KETO-AMIDES (2.37-2.47) 
SCHEME 2. 11 summarizes the l H and 13c NMR assignments for the keto-am Ides 
(2.37-2.47). For keto-amides (2.37-2AO, 2.45-2.46; X= H) the (H-4)2 and (H-5)2 resonances 
appeared as triplets. while for keto-amides with X=Me (2.41 and 2.47) the (H-4)2 protons 
are dlastereotopic and appeared as a multiplet. For the amino acid derived keto-
amldes (2.42-2.44), the diastereotoplc (H-5)2 protons appeared as a multiplet. These 
obseNatlons were used to assign the H-4 and H-5 resonances. 
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SCHEME 2. ll: Range of 1 H (plain text) and 13c (italicized text) NMR data In ppm for keto-
amides (2.37-2.47) 
NB 
* 
c 
2.88-2.93 5 
36.2-39.3 
2.45-2.56 4 
29.1- 30.0 
~0 
4.2 t 1 3 
14 . q u1 
0 
5.27-6.15 br 
NH-R2 
H}X=H: 3.48-3 .. 50 s 
X=Me. 
X CHMe 3.58 q ) 
CHMe 1.35-1.36 s 
Tert-butyl keto-amide (2.46) also fits this pattern except CH-2)2 o 3.41. 
No differentiation was made between the amide and ester carbonyl. 
Arrows denote coupling observed between designated proton resonances. 
The IR and high resolution mass spectra were also consistent with the keto-amide 
structures (2.37-2.47). Further, for keto-amide (2.39) recrystallization was possible and the 
sample thus obtained was determined, by combustion analysis, to have the expected 
% C, Hand N. Combustion analyses were not obtained for keto-am ides (2.37-2.38, 2.40-
2.47) because the corresponding enamino esters readily formed on distillation or 
recrystallization. 
To the best of our knowledge the keto-amldes (2.37-2.47) have not previously 
been Isolated or characterized. However, related keto-amides (2.53 and 2.57) have 
been postulated as reaction Intermediates In the synthesis of imide (2.54) from 
pseudoanhydrlde2.18 (~.51) (SCHEME 2.12) and In the synthesis of hydroxy lactam (2.58) 
from lactone2.19 (2.55) (SCHEME 2.13). · 
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SCHEME 2.12 
SCHEME2.13 
0 
CN 
2.51 
N~Ph 
0 
~NPh 
0 Met;0 
Ph 
2.55 
0 
0 
2.54 
Me~ NMe 
HO Ph 
2.58 
N~Me 
0 
NHPh 
OH 
NC CN 
2.52. 
0 
2.53 
0 Me'¢NHMe 
~ OH 
Ph 
2.56 
t 
0 
Me'¢~HMe 
Ph 
2.57 
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HYDROXY LACTAMS (2.48-2.50) 
The 1 H and 13c NMR data of the hydroxy lactams (2.48-2.50), summarized In 
SCHEME 2.14, were also characteristic. For succlnlmlde-based hydroxy lactam (2.48) an 
Increase In complexity relative to keto-amides (2.37-2.47) was observed for the 
resonances arising from CH2C02Et CH-3)2 and CH-4)2, reflecting the Introduction of a chlral 
centre at C-5. In addition, the NH resonance Integrated for 1 proton whereas in the 
corresponding keto-amide (2.34) the analogous resonance Integrated for 2 protons. 
SCHEME 2. 14: Summary of 1 H (plain text) and 13c (italicized text) NMR Data of Hydroxy 
lactams (2.48-2.50) 
H-4- H-7; 
7.44-7.81 
C-3a- C-7a; 
121.7-146.6 
0 
2.48 
0 
2.49-2.50 
4.23 q 
61.0 
~1.30t 
0 13.9 
0~1.1t 
61 14.0 
The major differences between the lH NMRspectra of the keto-amldes (2.37-2.47) 
and the phthalimide-based hydroxy lactams (2.49-2.50) were the absence of a NH 
resonance and the Increase In complexity of the resonances for NCH2 (2x 1 H multiplets In 
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(2.49) and ABq In (2.50)) and CH2C02Et CABq) , reflecting the Introduction of a chlral centre 
atC-3. 
The most characteristic resonances In the l3c NMR spectra were those arising 
i 
from C-OH; C-Sin the succinlmide-based hydroxy lactam (2.48) and C-3 In the 
phthalimlde-based hydroxy lactams (2.49-2.50), at o 86.4, 88.3 and 87.9, respectively and 
those arising from CH2C02Et at o 45.1, 41.5, 40.4, respectively. The 13c NMR spectra also 
Indicated that (2.48-2.50), unlike the keto-amides (2.37-2.47), did not contain a ketone 
functionality because a resonance was not observed at o -200. 
The IR and high resolution mass spectra were also consistent with the hydroxy 
lactam structures (2.48-2.50). 
Hydroxy lactams are known compounds. For example, hydroxy lactam (2.58) 
has been prepared from reaction of PhMgBr with an imlde2.19 (2.59) (SCHEME 2. 15) and 
from lactone (2.55) and NH2Me 2.19 (SCHEME 2.13). 
SCHEME2.15 
0 
Me0 
~NMe 
0 
2.59 
0 
PhMgBr Me~~ 
_ _..,.._ .. S<NMe 
HO Ph 
2.58 
The Reformatsky reaction of phthalimide (2.60) with bromo acetic acid ethylester 
was used to prepare the hydroxy Jactam (2.61), which dehydrated to the corresponding 
enamlno ester (2.62) on heating2.12 (SCHEME 2.16). 
SCHEME2.16 
0 
~NH _zn_...,_ ~ BrC~C~Et 
0 
2.60 
0 
2.61 C02Et 
0 
heat ~NH 
-~0 
CHC02Et 
2.62 
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SECTION2.3 
ENAMINO ESTERS 
SECTION 2.3. 1 
SYNTHESIS OF ENAMINO ESTERS VIA THE INSERTION REACTION 
The enamino esters (2.63-2.75) were prepared via three different methods, the 
results of which are summarized in TABLE 2.04: 
Method A : Keto-amide (2.37-2.47) or hydroxy lactam (2.48-2.50) and p-toluene 
sulphonlc acid (PTSA) were refluxed in 1. 2-dlchloroethane for 3-43h, with azeotroplc 
removal of H20. The solution was washed with H20 to remove PTSA, dried (MgS04) and 
evaporation of the solvent under reduced pressure yielded enamino ester (2.63-2.75) 
which was purified by recrystallization or distillation. In the case of the methyl enamino 
esters (2.67, 2.73) purification was achieved by radial chromatography. 
Method B : As for Method A except that the solvent was benzene. 
Method C : A 1, 2-dichloroethane solution of enollactone (2.33a) and methyl-, 
ethyl-, or nbutyl-amine, containing activated 4A sieves, was heated at 65 oc for 3-4 days. 
The solution was filtered to remove the sieves and the solvent was evaporated under 
reduced pressure to yield the enamino ester which was purified by recrystallization or 
distillation. 
Problems were encountered in the synthesis of tert-butyl enamino ester (2.72) due 
to acid catalyzed hydrolysis of the tert-butyl group. Pure enamino ester (2.72) was 
obtained following radial chromatography of the corresponding keto-amide (2.46); 
however, the yield was low; 23%. 
Method C represents a direct one step synthesis of enamino esters from 
enollactones and amlnes. However, Method C was not generally applicable. For 
example; attempted syntheses of enamino esters (2.67 and 2.75) via Method C led to the 
Isolation of the keto-amide (2.41) and hydroxy lactam (2.49), respectively, even after 
heating for 6 days. Sill)ilar1y, when keto-amides (2.42-2.47) and hydroxy I act am (2.50) 
were subjected to the conditions of Method C little or no enamino ester formation 
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occurred. Method A was the most applicable and consistently gave the best yields. 
Method B was more applicable than Method C, but Method C gave superior yields 
(TABLE 2.04). 
TABLE 2.04: Synthesis of Enamino Esters (2.63-2.75) 
0 
Compd X Rl R2 
2.63 H Et H 
2.64 H Et Me 
2.65 H Et Et 
2.66 H Et nsu 
2.67 Me Et nsu 
2.68 H Et (R,S)-CH(Me)C02Et 
0 
H 
2.74 - 2. 75 
Cycnzn. Time 
Method 
* c 3days 
B 2h 
c 4days 
B 3h 
c 3days 
c 3days 
c 6days 
A 101 
B 4h 
A 24h 
2.69 H Et (R,S)-CHCCH2CHMe2)C02Et A 201 
2.70 H Et (R ,S)-CH(CH2Ph)C02Et A 24h 
B 6h 
2.71 H Et CH2C~Et B 2h 
2.72 H tBu CH2~Et v N/A 
2.73 Me Et CH2C~Et A lOh 
B 6h 
2.74 nau A 3h 
B 3h 
2.75 CH2C~Et A 3h 
*Method C conditions with hydroxy lactam (2.48). 
Yield% E/Z 
83 5/95 
13 5/95 
93 100/0 
71 100/0 
71 95/5 
100 95/5 
100 100/0 
ff) 84/16 
23% 82/18 
84 100/0 
84 100/0 
86 100/0 
23 100/0 
83 100/0 
23 100/0 
57 74/26 
15 86/14 
76 86/14 
23 95/5 
~ 60/40 
v Enamino ester (2.72) formed from keto-amide (2.46) during radial chromatography. 
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In general. the yields of enamlno esters, synthesized via Methods A and C, were 
superior to yields of enamino esters synthesized via other literature routes (Section 2. 7). 
For comparison, the NH3-derived enamlno ester (2.63) has been obtained via the p-keto 
ester (SCHEME 2.06), Wittig (pathway a, SCHEME 2.01) and Reformatsky (pathway b, 
SCHEME 2.01) reactions In yields of 67%2.16, 32%2.11 and 21%2.11, respectively. Using the 
Insertion reaction the NH3-derived enamlno ester (2.63) was synthesized In 83% yield. 
Also, the methylamine-derived enamlno ester (2.64) which was prepared via the p-keto 
ester reaction in 67% yield2.16, was formed in 93% yield via the Insertion reaction. 
SECTION 2.3.2 
CHARACTERIZATION OF ENAMINO ESTERS 
STRUCTURE ASSIGNMENT 
The NH3- and methylamine-derived enamino esters (2.63 and 2.64, respectively) 
prepared In the current study were Identical by lH NMR, l3c NMR and IR spectroscopy, 
high resolution mass spectrometry and melting point to enamino esters (2.63 and 2.64) 
reported in the llterature2.16. 2.11. The remaining compounds (2.65-2.75) were assigned 
as enamlno esters on the basis of lH NMR, 13c NMR and IR spectroscopy, high resolution 
mass spectrometry and combustion analysis results consistent with known enamlno 
esters2.11-2.12, 2.16-2.17. The chemical shifts of key 1 H and 13c NMR resonances of 
enamlno esters (2.63-2.75) are summarized in TABLE 2.05. 
E/Z CONFIGURATION 
The E Isomer was obtained as the major isomer in all examples studied CT ABLE 
2.04) except In the case of the NH3-derived enamlno ester (2.63) (discussed later). 1 H 
NMR spectroscopy was used to assign the E/Z configuration of the cyclic enamino 
esters (2.63-2.75). The most diagnostic resonances were (H-4)2 and =CH for the 
succlnlmlde-based enamino esters (2.63-2.73) and H-4 and =CH for the phthallmlde-
based enamino esters (2.74-2.75) (TABLE 2.05). 
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TABLE 2.05: Characteristic lH and 13c NMR data of Enamlno Esters (2.63-2.75) 
Succlnlmlde-Based Enamlno Esters 
Compd. + o (H-3)2, m 8 (H-4)2, m 8 =CH, tor J (Hz)=CH 8=CH or ac-s 
Confign =CMe, t or=CMe =CMe 
2.63 E * 5.30 2.0 
2.63Z 2.52 2.87 5.00 1.5 00.2 157.4 
2.64E 2.57 3.24 5.19 1.9 91.6 161.1 
2.65E 2.55 3.23 5.23 1.9 91.2 159.5 
2.65 z * 5.02 1.5 
2.66E 2.55 3.23 5.21 1.9 91.2 159.8 
2.66 z * 5.02 1.5 
2.67E 2.47 3.13 2.06 1.2 101.4 153.1 
2.67Z 2.51 2.64 1.91 1.1 101.2 143.8 
2.68E 2.59 3.28 5.10 2.0 92.4 157.8 
2.69E 2.60 3.27 5.10 1.9 92.8 157.9 
2.70E 2.46 3.13 5.11 1.9 92.7 158.0 
2.71 E 2.64 3.31 5.05 2.0 92.1 159.0 
2.72E 2.62 3.28 4.98 2.0 94.0 157.7 
2.73E 2.56 3.22 1.97 1.4 101.9 152.7 
2.73Z 2.59 2.77 1.89 1.0 101.6 146.1 
* Insufficient amount of the minor Isomer present to obtain all 
lH and 13c 1\MR fP6Chd data 
Phthallmlde-Based Enamlno Esters 
Compd BH-4 o=CH o=C B C-3 
2.74E 9.06 5.71 98.2 148.0 
2.74Z <9.06 5.88 93.8 143.9 
2.75E 9.10 5.54 98.7 147.7 
2.75Z 7.86-7.89 5.92 94.6 144.4 
The ethyl ester (or tert-butyl ester) in the E configuration ls known to deshleld (H-4)2 
In succlnlmlde-based enamlno esters2.17 and H-4 In phthalimlde-based enamlno 
esters2.11. Therefore, the major Isomer of the succlnimlde- and phthalimide-based 
enamlno esters (2.67, 2;73 and 2.74-2.75, respectively) was assigned theE configuration on 
the basis of the downtleld shift of (H-4)2 and H-4, respectively, relative to the 
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corresponding z Isomer. For the methyl enamino esters (2.67, 2.73) the assignment was 
confirmed by the observation of an n.O.e. between NCH2 and =CCH3 for the E isomer and 
an n.O.e. between (H-4)2 and =CCH3 for the Z isomer. 
It has been reported for enol-y-lactones that =He of the E isomer (2.76E) resonates 
at lower field and shows a larger coupling constant, J0 c, relative to the corresponding Z 
isomer2.20 (2.762) (SCHEME 2.17). 
SCHEME 2.17 
J = 1.2-1.4Hz; X == Me 
J = 1.9-2.0Hz; X = H 
0 
2.76E 
H 0 
H 
2.63E- 2.73E 
Jao = 0.8Hz 
J = 1.0-1.1Hz; X= Me 
J = 1.5Hz; X = H 
0 
R 
2.76Z 
0 
2.63Z 
2.65Z- 2.67Z 
2.73Z 
The same trend was observed in the methyl enamino esters (2.67, 2.73); the =CCH3 
resonance was downfield for the E isomer (2.67E and 2.73E) and showed a larger coupling 
constant relative to the corresponding Z isomer (2.672 and 2.732, respectively). The 
assignment of configuration to protio enamino esters (2.63, 2.65-2.66) for which lH NMR 
data was obtained for both isomers. was therefore based on a comparison of =CH 
resonances. Assignment of the major isomer of (2.63) as the Z isomer was confirmed by 
the downfield position of NH. consistent with hydrogen-bonding (SCHEME 2.18). relative to 
the E isomer. 
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The remaining enamino esters (2.64, 2.68-2.72) were assigned theE configuration 
on the basis of the chemical shifts for the (Hw4)2 resonances, which reflected the 
deshlelding effect of C02Et, and the =CH coupling constants; J= 1.9-2.0Hz, which were 
identical to the analogous coupling constants of E enamlno esters (2.63, 2.65-2.66) (TABLE 
2.05). 
SCHEME2.18 
0 
OEt 
2.63 
In contrast to the succinimlde-based enamino esters (2.63-2.73), the resonance 
arising from =CH was up field In the E Isomer relative to the corresponding Z Isomer for 
phthallmide-based enamlno esters (2.74·2.75) (TABLE 2.05). This is consistent wtth the 
trend obseNed in literature enamlno esters (2.77-2.79, TABLE 2.06). 
TABLE 2.06 
0 o=CH o=CH 
Rl R2 E isomer Z isomer 
2.77 CO):t H 5.80 6.14 
2.78 CO):t Me 5.30 5.57 
H 2.79 CHO Me 5.94 6.12 
A trend obseNed In the 13c NMR spectra of E- and Z-enamlno esters (2.67, 2.73 
and 2.74-2.75) was that the carbons of the double bond, C::::C, were downfield In the E 
Isomer relative to the corresponding Z isomer CT ABLE 2.05). This is analogous to the trend 
obseNed In the 13c NMR spectra of chloro and bromo enollactones (1.11-1.15, 1.17-1.21) 
In which the double bond carbons were consistently downfield In the Z Isomers relative to 
the corresponding E isomers (Section 1.8, Chapter 1). 
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The enamlno esters synthesized via the insertion reaction showed the same 
trends in configuration (TABLE 2.05) as enamlno esters synthesized via literature 
routes2.09-2. 12. 2.14. 2.16-2.17. The z Isomer predominated In the NH3-derlved enamlno 
esters (2.63), possibly due to Intramolecular hydrogen-bonding between NH and the 
ester carbonyl (SCHEME 2. 18). Generally, exclusively the E Isomer was formed in the 
succinic-derived protlo enamlno esters (2.64-2.66, 2.68-2.72). Exceptions arose with 
enamlno ester formation via Method C, when less than 5% of the Z Isomer was observed 
for (2.64-2.65), reflecting the mild conditions of this method. In the phthalimlde-based 
enamino esters (2.74-2.75) and methyl enamlno esters (2.67, 2.73), theE isomer 
predominated, but a significant amount of the Z Isomer also formed. It was possible to 
separate E and Z Isomers of the methyl enamino esters (2.67, 2.73) by radial 
chromatography and the E Isomer of the phthalimide-based enamlno ester (2.74) was 
isolated by recrystallization. For the phthalimlde-based enamlno ester (2.75) the ratio of E 
and Z Isomers changed on heating at 60 oc for 3h, with PTSA In CDCI3, from 6 E : 4 z to 7 E : 3 
Z. as determined by 1 H NMR spectroscopy. 
SECTION 2.4 
SIDE PRODUCTS OF THE INSERTION REACTION TO METHYL 
ENAMINO ESTERS 
With the exception of the methyl enamlno esters (2.67, 2.73), the enamino esters 
(2.63-2.75) were formed cleanly (as seen by the 1H and 13c NMR spectra). Purification of 
the glycine-derived methyl enamlno ester (2.73) by radial chromatography also led to 
Isolation of a compound which was assigned as the endocyclic Isomer (2.80). 
Assignment was based on the 1 H and 13c NMR spectra and the results of 1 H NMR 
decoupling experiments (the couplings observed are Indicated by the arrows). The 
endocyclic Isomer (2.80) was present, by lH NMR spectroscopy, as a 1 : 1 mixture of 
dlastereoisomers. After 3 days at 20 oc one dlastereolsomer gave rise toE- and Z-
enamlno esters (2.73) .. 
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2.80 R = CH2C~Et 
2.81 R= 0 Bu 
An analogous compound (2.81) present In the 1 H NMR spectrum of the nbutyl 
enamlno ester (2.67) before radial chromatography was not isolated. 
The endocyclic isomers (2.80 and 2.81) may form from the E- and Z-enamino 
esters (2.73 and 2.67, respectively) (pathway b, SCHEME 2.19) or from the hydroxy lactams 
(2.82 and 2.83, respectively), via (2.84) and (2.85) (pathway a, SCHEME 2.19). A related 
reaction was observed for another class of enamlno esters whereby the reaction 
occurred from the enamino esters (discussed later in this chapter; Section 2.7.1). 
SCHEME 2.19 
0 ~ 
Me 
2.82 R = CH 2CO;zEt 
2.83 R= 0 Bu ~ 
0 
Me C~Et ~ 0 
2.84 R=CH2C~Et~ 
2.85 R="Bu 
1 ~ b 
Me 
0 
2.80 R=CH2C~Et 
Me C~Et 
2. 73 R = CH 2C~Et 
2.67 R= nsu 
2.81 R= 08u 
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SECTION2.5 
MECHANISM OF THE INSERTION REACTION 
The proposed mechanism of the Insertion reaction is shown In SCHEME 2.20. 
SCHEME2.20 
HO 
) C~R1 
w 2.35 
NHf12 
o-
NHf12 
X 
2.86 
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Initial attack at the enollactone (2.33) carbonyl by the amine leads, via a 
resonance stabilized Intermediate (2.86), to the keto-amide (2.34), which was isolated in 
the succlnimlde-based series (2.37-2.47, TABLE 2.03, Section 2.2.1). The keto-amide then 
cycllzes to the hydroxy lactam (2.35), which was Isolated In the phthallmide-based series 
and In the NH3-derived series (2.49-2.50, TABLE 2.03, Section 2.2. 7). Loss of H20 from the 
hydroxy lactam (2.35) results In the formation of E- and Z-enamlno esters (2.63-2.75). 
Evidence for this mechanism comes from the isolation and characterization of 
keto-amldes and hydroxy lactams (2.37-2.47 and 2.48-2.50, respectively, TABLE 2.03, 
Section 2.2.1) which were shown to be precursors of enamino esters. Also, the NH3-
derlved keto-amide (2.37) formed the corresponding hydroxy lactam (2.48) on standing, 
which indicates that keto-amides are likely precursors of hydroxy lactams. Further, the 
proposed mechanism (SCHEME 2.20) requires protonation of the hydroxyl group for 
enamino ester formation which is consistent with the reaction conditions used. 
OTHER MECHANISMS 
A competing mechanism (SCHEME 2.21) for the formation of enamino esters, 
involving Michael addition of the amine to the enollactone must also be considered. 
Whereas the mechanism depicted in SCHEME 2.20 leads to the Isolation of keto-amide 
(2.34) and/or hydroxy lactam (2.35) Intermediates, the mechanism depicted In SCHEME 
2.21 Is expected to lead to the isolation of Imine (2.88) and/or enamine (2.89) 
intermediates. However, the spectral data of the keto-amide and hydroxy lactam 
Intermediates (2.37-2.47 and 2.48-2.50. respectively, SCHEME 2.09) were Inconsistent with 
the presence of Imine (2.88) and/or enamine (2.89). For example, the 13c NMR spectra 
did not contain signals at ll 145-160 or at o 125-160 which are characteristic of imlne2.21 and 
enamlne2 ·22 carbons, respectively. Also, the enamine (2.89) and possibly also the imine 
(2.88) would be expected to exhibit E/Z Isomerism and this was not observed In the 1 H or 
13c NMR spectra. The enamine (2.89) can also be discounted as an Intermediate 
Isolated during the Insertion reaction on the basis of 1 H NMR integrals. An NH resonance 
was not observed In the lH NMR spectra of hydroxy lactams (2.49-2.50). When X=H, the 
enamlne (2.89) contains an olefinic proton; however, the 1 H NMR spectrum of neither the 
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keto--amldes (2.37·2.47) or the hydroxy lactams (2.48·2.50) contained a resonance 
attributable to an olefinic proton. 
Therefore, It Is highly unlikely that the mechanism depleted In SCHEME 2.21 
operates In competition with the mechanism depleted In SCHEME 2.20 for the synthesis of 
enamino esters (2.63-2.75) from enollactones and amlnes. 
SCHEME 2.21 
0 
r"'W 
OH 
NH~ 
X 
2.89 
H 
X 
2.89 
-W 
-~-~so+ 
~w 
~NH~ 
X 
H 
0 
OH 
NR2 H+ 
:.::Y 
X HC~R1 
2.88 
H 
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OTHER POSSIBLE PRODUCTS 
It Is conceivable that the keto-amide (2.34), as well as giving rise to enamino 
esters, might give rise to the imine (2.91) or the endocycllc compound (2.92) as shown In 
' ' 
pathways a and b, respectively, of SCHEME 2.22. However, the crude lH and l3c NMR 
spectra Indicated that the enamlno esters (2.63-2.75) were the sole reaction products 
(with the exception of the methyl enamino esters (2.67, 2.73) discussed earlier in Section 
2.4). Hence It Is unlikely that either of the pathways depleted in SCHEME 2.22 operates. 
SCHEME2.22 
NR2 NR2 
-~0 
0 ;/ C02R1 X 
2.90 
~ 0 0 X -~0 
The Imine (2.91) might be expected to exhibit E/Z isomerism at both the imine and 
alkene, which was not observed in the lH and 13c NMR spectra of the enamlno esters 
(2.63-2.75). Also, the 13c NMR spectra did not have resonances characteristic of the 
imine carbon2.21. 
The lH NMR spectra of the methyl enamino esters (2.67, 2.73) did not contain 
resonances attributable to the olefinic and CHMe protons of the endocyclic Isomer 
(2.92). Also, the phthalimide-based enamino esters (2.74-2.75) are unable to exist as 
endocyclic isomers. 
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SECTION2.6 
EXTENSION OF THE PEPTIDE CHAIN IN THE C DIRECTION 
The ultimate goal of this work was to develop the insertion reaction for the 
synthesis of peptide analogue inhibitors of serine proteases (1.34 and 1.35, Section 1.5, 
Introduction) The Insertion reaction allows for the extension of the peptide chain in the C 
direction. Serine protease substrate recognition Is Influenced by Interactions between 
the enzyme and residues removed from the primary binding amino acid residue CS1). 
Therefore, the Incorporation of a potential inhibitor Into a small peptide Is a strategy for 
Increasing specificity towards a target enzyme. Enamino esters (2.68-2.73, 2.75) extend In 
the C direction by one amino acid residue. C direction extension by two amino acid 
residues, which would provide an additional binding site, is discussed In this section. 
Gly-gly enamlno ester (2.93) was synthesized via 2 routes; directly by Insertion of 
glycylglyclne ethylester into the enollactone (2.33a) (pathway a, SCHEME 2.23) and also 
by the stepwise addition of glycine residues (pathway b, SCHEME 2.23). 
SCHEME2.23 
0 
Gly-OtBu.HCI/ Et3N 
b 
Et02C 
2.33a 
a !Giy-gly-OEt.HCI/ 
Et3N/ heat 
0 
2.93 
Gly-OEt. HCI/ 
Et3N/ DCC 
0 
2.94 
lPTSN heat 
0 
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The better method, with a yield of 79%, was the direct reaction whereby enollactone 
(2.33a), glycylglyclne ethylester hydrochloride (1.8 equivalent) and triethylamine (1.8 
equivalent) In l, 2-dlchloroethane were refluxed for 16h, with azeotroplc removal of H20, 
to yield crude enamino ester (2.93) which was purified by radial chromatography. 
Enamlno ester (2.93) was assigned the E configuration on the basis of the chemical shift of 
the (H-4)2 resonance; ~ 3.32, which Indicated deshleldlng by C02Et and the =CH coupling 
constant; J=2.0Hz (cf Section 2.3.2). 
The stepwise addition of glycine units to the enollactone (2.33a) gave the 
enamlno ester (2.93) In a yield of 47% (SCHEME 2.23). In the first step of this 3 step reaction, 
' 
the keto-amide (2.94) was isolated after reaction of enollactone (2.33a). glycine tert-
butylester hydrochloride ( 1.5 equivalent) and triethylamine ( 1.5 equivalent), at 20 oc. The 
keto-amide (2. 94) was refluxed for 5h, with azeotropic removal of H20, in 1, 2-
dichloroethane containing PTSA, to yield the deprotected enamino ester (2.95). From 
the chemical shift of the (H-4)2 protons; S 3.30 and the coupling constant of =CH; J= 1.8Hz. 
enamino ester (2.95) was assigned the E configuration (cf Section 2.3.2). Other enamlno 
esters (2.63-2.75) prepared via this method were washed with H20 to remove the PTSA 
(Section 2.3.1); however. enamino ester (2.95) was significantly soluble in H20. hence it 
was used without purification. Thus, enamino ester (2.95) was dissolved in CH2CI2. treated 
with DCC CL3-dlcyclohexylcarbodllmide), glycine ethylester hydrochloride (1.1 
equivalent) and triethylamine (1. 1 equivalent) and the resulting mixture was stirred at 20 oc 
for 16h. Work-up gave the crudE? enamino ester (2.93) contaminated with some DCC and 
DCC by-products. Purification by radial chromatography yielded pure E-enamino ester 
(2.93). 
Enamino ester (2.95) was also prepared directly via the reaction of enollactone 
(2.33a) with glycine (SCHEME 2.23, pathway c). However, due to the Insolubility of glycine 
In organic solvents. It was necessary to perform the reaction In CH2CI2 (5ml)/DMF 
(5ml)/H20 (3mL). After stirring at 20 oc for 44h, the solution was heated at reflux 
temperature and the solvent was allowed to evaporate. The residue contained, by lH 
NMR spectroscopy, E-e.namino ester (2.95) contaminated with DMF. As expected, the 
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corresponding keto-amide precursor was not Isolated. This Illustrates that the Insertion 
reaction may be performed with amino acids as well as esters of amino acids. 
SECTION 2.7 
(AITEMPTED) SYNTHESES OF HALO ENAMINO ESTERS 
' Enamino esters (1.34) which are potential mechanism-based lnactivators of serine 
proteases, contain a latent reactive group; an a-halo Imine (Section 1.5, Introduction). 
This section examines attempts to prepare enamino esters (2.36) with potential latent 
reactivity. 
0 
Et02C X 
2.36 X = Br, Cl 
SECnON2.7.1 
SYNTHESIS OF SUCCINIMIDE-BASED CHLORO ENAMINO ESTERS 
SCHEME 2.24 summarizes the reactions used to prepare enamino ester (2.98). 
Chloro enollactone (1.11), glycine ethylester hydrochloride (1.3 equivalent) and 
triethylamine (1.3 equivalent) were stirred for 3h in ethyl acetate. The solvent was 
evaporated under reduced pressure and a 1 H NMR spectrum of the residue indicated 
that keto-amide (2.96) and hydroxy lactam (2.97) were present in a ratio of 9 : 1, 
respectively. Ethyl acetate was added to the residue, the mixture was filtered to remove 
triethylamine hydrochloride and the solvent was evaporated under reduced pressure to 
yield a mixture of keto-amide (2.96) and hydroxy lactam (2.97) in a ratio of 3 : 1, 
respectively, by lH NMR spectroscopy. 
The keto-amides (2.37-2A7, TABLE 2.03) were normally isolated rather than the 
corresponding hydroxy lactams in the succinimide-based series (Section 2.2. 1). 
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Isolation of hydroxy lactam (2.97) may be attributable to the electronegative chlorine 
making the ketone carbon of the keto-amide (2.96) more electrophlilc and therefore 
more susceptible to reaction with the amide nitrogen and/or to the "gem-dimethyl 
effect" (also known as the "Thorpe-Ingold effect")2.23, 
SCHEME2.24 
0 
2.99 
0 
Et02C Cl 
H 
N...--C02Et 
0 
1.11 ! Gly-OEt.HCI/ Et3N 
0 
C02Et 
2.97 
4-DM~ 
acetic a~h~dri~ 0 
0 
0 
H 
2.101 
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The chloro keto-amide (2.96) formed more readily than the corresponding protlo 
and methyl keto-amldes (2.37-2.47, TABLE 2.03, Section 2.2.1). The more electronegative 
chlorine Is likely to stabilize the negative charge of the keto-amide precursor (2.86), thus 
making formation of keto-amide (2.96) more facile. 
0 
Et02C X 
2.86 X= Cl 
The hydroxy lactam (2.97), which contains 2 chiral centres, was found, by 1H NMR 
spectroscopy, to be present as a mixture of 2 diastereoisomers. Due to overlapping 
signals tt was not possible to estimate the ratio of diastereoisomers. 
Dehydration of (2.96/2.97) was effected via heating with PTSA in 1, 2-
dichloroethane, containing activated 4A sieves, at 70 "C for 6.5 days. The mixture was 
filtered and purification by radial chromatography yielded E- and Z-chloro enamino 
esters (2.98) In a 1 : 1 ratio by lH NMR spectroscopy. The Z Isomer (2.98Z) was assigned 
on the basis of a downfleld shift of 0.35ppm for (H-4)2 relative to the E isomer (2.98E). The 
assignment was supported by the 1 H NMR spectrum of the E- and z-chloro enollactones 
(1.11) In which (H-4)2 resonated at a similar chemical shift to (H-4)2 In the E- and Z-
enamlno ester (2.98), respectively (TABLE 2.07). 
In the 13c NMR spectrum of the chloro enamino esters, the C-5 resonance was 
downfield in the Z isomer (2.98Z) relative to theE isomer (2.98E). This trend was also 
obseNed in the 13c NMR spectra of chloro and bromo enollactones (Section 1.8, 
Chapter 1) and is analogous to the trend obseNed for protio and methyl enamino esters 
(2.67, 2.73, 2.74-2.75, Section 2.3.2). 
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TABLE 2.07: o (H-4)2 and o C-5 in E-and Z-Chloro Enamino Esters and Enollactones 
0 
R2 
Compd. & Rl R2 X o CH-4)2 oC-6 
Confign. 
2.98E Cl C~Et NCH2C~Et 3.00 150.2 
2.98Z ~Et Cl NCH2C~Et 3.35 152.3 
1.11 E Cl C~Et 0 3.14 158.5 
1.11 z C~Et Cl 0 3.43 161.5 
The yield of E- and Z-enamino esters (2.98) was very low; 26%, due to a 
competing pathway, Involving a retro-Ciaisen type reaction leading to formation of the 
Imide (2.99, SCHEME 2.24 and SCHEME 2.25). The melting point and spectral data of the 
Imide (2.99) were Identical to the melting point and spectral data previously reported2.24 
for the Imide (2.99). 
SCHEME2.25 
0 0 
~N ..,C02Et L...n _J + CH:,CICO.,Et 
0 
2.99 
The retro-Cialsen type reaction was not observed for any of the previously 
discussed methyl or protio keto-amldes or hydroxy lactams (2.63-2.75, Section 2.2.1 and 
2.94, Section 2.6). Again, chlorine is better able to stabilize the negative charge of the 
leaving group, thus making imide (2.99) formation more favourable for the chloro hydroxy 
lactam (2.97) (SCHEME 2.25). 
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Imide (2. 99) formation was effectively blocked by first making the acetate (2.1 00) 
of the hydroxy lactam (2.97) (SCHEME 2.24). This was achieved by stirring (2.96/2.97), 
acetic anhydride (2 equivalent), triethylamine (2 equivalent) and 4-dlmethyl amino 
pyridine (4-DMAP) (1.5 equivalent) In CH2CI2 for 2.5h. 1 H NMR spectroscopy indicated the 
acetate (2.100) was present as a mixture of two diastereolsomers, In a ratio of 3 : 2. The 
acetate (2.100) was heated at 65 oc In benzene for 90min to eliminate acetic acid. 
Evaporation of the solvent under reduced pressure yielded E- and Z-enamino esters 
(2.98); 44% E: 56% Z by lH NMR spectroscopy, In a much Improved yield of 78%. 
However, the E- and Z-chloro enamlno esters (2.98) were unstable. On heating 
and/or In the presence of acid, E- and Z-chloro enamlno esters (2.98) eliminated HCl to 
give theE and Z Isomers of (2.101) (SCHEME 2.24). For example, attempted distillation of 
the enamlno esters (2.98), formed via the acetate route, led to complete conversion to 
the elimination product (2.101). The elimination product (2.101) also formed from chloro 
enamino esters (2.98) during radial chromatography on silica. 
The elimination product (2.1 01) was prepared by refluxing a 1, 2-dlchloroethane 
solution of (2.96/2.97) and PTSA for 3h with azeotroplc removal of H20. The yield of 
elimination product (2.101) after purification by radial chromatography was relatively low; 
39%, due to the competing retro-Cialsen type reaction to imide (2.99). 
The proposed mechanism for formation of the elimination product (2.101), shown 
In SCHEME 2.26, Is similar to that leading to formation of the methyl endocycllc isomers 
(2.80-2.81, SCHEME 2.19, Section 2.4); however, for the chloro enamino esters (2.98) 
subsequent elimination of HCI was possible. 
SCHEME2.26 
0 0 0 
-HCI 
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Heating a 1: 1 CDCI3 solution of E- and Z-chloro enamino esters (2.98), at 55 oc, 
showed that the E-enamino ester (2.98E) formed the elimination product (2.1 01) more 
rapidly than the Z-isomer (2.98Z). After 15m in all of the E Isomer (2.98E) had been 
converted to the elimination product (2.1 01), whereas It took 45min for the z-enamino 
ester (2.98Z) to be completely converted to elimination product (2.101). The reason for 
the more rapid reaction of E-enamino ester (2.98E) to elimination product (2.101) Is 
unknown. 
The structure of the elimination product (2.101) was established from the spectral 
data. The mass spectrum was consistent with the absence of Cl and the accurate mass 
was consistent with the expected mass of elimination product (2.101). The lH and 13c 
NMR spectra Indicated that the basic enamino ester structure oH2.98) was intact and that 
E and Z isomers were present. Major changes involved the introduction of three olefinic 
protons and the positions of these in the structure was determined by the respective 
chemical shifts and the results of 1 H NMR de coupling experiments. 
Assignment of configuration to the isomers of the elimination product (2.101) was 
based upon lH NMR spectroscopy (SCHEME 2.27) (cf Section 2.3.2). TheE isomer (2.101E) 
showed the characteristic downfield shift of H-4 relative to the Z Isomer (2.101Z) due to the 
deshieldlng effect of C02Et. The Z isomer (2.101Z) showed a downfield shift for NCH2 
relative to the E Isomer (2.10 1 E), also reflecting the deshielding effect of C02Et. Further, as 
expected, the olefinic proton, =CHC02Et; of theE isomer (2.101E) exhibited a greater 
degree of coupling to H-3 than the corresponding olefinic proton of the Z Isomer (2.1 0 lZ). 
SCHEME2.27 
0 0 
Et02C H 5.44 d J=1Hz 5.44 s H C02Et 
2.101 E 2.101 z 
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SECTION 2.7.2 
ATTEMPTED SYNTHESIS OF GLUTARIMIDE-BASED CHLORO ENAMINO ESTERS 
The keto-amide (2.103) was Isolated, in 84% yield, from the reaction of chloro 
enollactone (1.12) with glycine ethylester hydrochloride (1.4 equivalent) and triethylamine 
(1.4 equivalent) at 20 oc (SCHEME 2.28). 
SCHEME2.28 
0 
2.104 
Gly-OEt. HCI/ 
Et3N 
0 
2.105 
The keto-amide (2.103) was refluxed in 1, 2-dichloroethane containing PTSA for 6h, with 
azeotroplc removal of H20. to give the endocyclic Isomer (2.104). Radial 
chromatography gave a fraction containing the endocyclic isomer (2.104) (38%) and 
another fraction containing a mixture of unreacted keto-amide (2.103) (10%) and imide 
(2.105) (8%). Imide (2.105) was formed by the competing retro-Cialsen type reaction, 
which was also observed in the chloro succinic series (SCHEME 2.24, Section 2.7.1). The 
presence of the Imide (2.105), a known compound2.24, was implied In the 1 H NMR 
spectrum by a triplet at 8 2.53 arising from 2x COCH2 and a singlet at 8 4.51 arising from 
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The 1 H NMR spectrum of the main product was consistent with endocycllc 
enamino ester (2.104) rather than the corresponding exocycllc enamlno ester (2.1 06); a 
singlet at o 4.971ndlcated the CHCI resonance, a triplet at o 5.621ndicated the =CH 
resonance, and the Introduction of a chiral centre was reflected by the presence of 
diastereotopic protons. It was not surprising that the endocycllc enamino ester (2.104) 
formed In preference to the corresponding exocycllc enamino ester (2.1 06) because 
six-membered rings are known to be thermodynamically more stable with an 
endocyclic, rather than on exocyclic, double bond2.25, 
SECTION 2. 7.3 
ATIEMPTED SYNTHESES OF PHTHALIMIDE-BASED HALO ENAMINO ESTERS 
Attempts at forming phthalimlde-based halo enamlno esters (2.107-2.109), via 
reaction of phthalimlde-based halo enollactones (1.17, 1.15 and 1.14, respectively) with 
glycine ethylester were unsuccessful. lmides (2.110. SCHEME 2.29 and 2.111, pathway a 
SCHEME 2.30, respectively), which presumably arose from the retro-Ciaisen type reaction 
discussed earlier (Section 2.7.1), were the only identified products. 
SCHEME2.29 
Cl 
Cl 
R 
R 
0 
Et02C . X 
1.15 X= Cl 
1.17 X= Br 
0 
X 
Gly-OEt.HCI/ 
Et3N/ heat 
X R 
2.107 Br Cl 
2.108 Cl Cl 
2.109 Cl H 
0 
Cl« COEt I N_/ 2 
Cl ~ 
0 
2.110 
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SCHEME2.30 
0 
0 ex; a 
0 
2.112 
a 
Gly-OEt. HCI/ 
Et3N/ heat 
b 
Gly-OEt. HCI/ Et3N 
0 
o:;N_/C02EI 
0 
2.111 
-1-1,0 tPTSN heat 
0 
~~----co2Et 
Vco2H 
2.113 
Imide formation occurred more readily than for the chloro succinic and glutaric 
series (Sections 2.7.1 and 2.7.2). The succinimide- and glutarlmlde-based imldes (2.99 
and 2.105, respectively) formed when the keto-amide (and hydroxy lactam) (2.96/2.97, 
2.103) were heated, whereas the phthalimlde-based lmldes (2.110 and 2.111) were 
observed after the 20 oc reaction of phthalic enollactones C 1.15, 1.17 and 1.21) with glycine 
ethylester hydrochloride ( 1.3-1.4 equivalent) and triethylamine ( 1.3-1.4 equivalent) In 
CH2Ci2 or ethyl acetate. The relative amounts of lmldes (2.110 and 2.111) Increased on 
heating the mixtures in 1, 2-dlchloroethane with PTSA. After radial chromatography of the 
reaction mixture arising from bromo enollactone (1.17), imide (2.110) was obtained In a 
yield of 49%. The Imide (2.110) was identified by comparison of its spectral data with that 
of the known2.24 imide (2.111). No other fractions contained compounds which were 
identified. 
lmldes (2.110 and 2.111), present In the reaction mixtures arising from enollactones 
(1.15 and 1.21, respectively), were not isolated. However, imide (2.111) was prepared 
Independently, In an overall yield of 48%, via dehydration of the keto-amide (2.113) 
formed from the reaction of phthalic anhydride (2.112) with glycine ethylester (pathway b, 
. ' 
SCHEME 2.30). Dehydration of the keto-amide (2.113) required refluxing with PTSA in l, 2-
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dichloroethane, with azeotroplc removal of H20, for 8 days. The imide (2.111) was 
identified by comparison of Its melting point and spectral data with literature values2.24. 
Further attempts were made to obtain bromo enamlno ester (2.107) from the 
corresponding bromo enollactorle (1.17) using the method that successfully blocked 
Imide formation In the succlnimide-based series (Section 2.7.1). Thus a mixture 
containing enollactone (1.17), glycine ethylester hydrochloride (1.3 equivalent) and 
triethylamine (1.3 equivalent), In ethyl acetate, was stirred at 20 "C for 50min. Acetic 
anhydride (2 equivalent), triethylamine (2 equivalent) and 4-DMAP (1.5 equivalent) were 
added and the resulting mixture was stirred for 2h. The 1 H NMR spectrum of the residue, 
obtained after work-up, contained the Imide (2.110) and other unidentified compounds. 
Three separate portions of the residue were heated under different conditions; at 
70 "C In C6D6 for 1 day, at reflux in toluene for 16h, and at 180 "C at 1 mm for 2h. The only 
species Identified by 1 H NMR spectroscopy, even after purification of the latter two 
residues by radial chromatography, was the Imide (2.110). 
Therefore, phthallmlde-based halo enamino esters· (2.1 07-2.1 09) were not able to 
be synthesized via the Insertion reaction. Instead, the reactions led to formation of the 
lmides (2.110-2.111) and several unidentified compounds. lmldes are potentially useful 
compounds with respect to enzyme lnhibltion2.26. 
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SECT/ON2.8 
SYNTHESIS OF A KEY SYNTHETIC INTERMEDIATE OF 
PROSTAGLANDIN ANALOGUES USING THE INSERTION REACTION 
As mentioned at the beginning of this chapter, enamlno esters are a sub-class of 
the group of compounds known as ene-lactams. The ene-lactam (2.09) Is a key 
synthetic intermediate of prostaglandin analogues (TABLE 2.01, Section 2. 1). Ene-lactam 
(2.09) has been prepared, In a yield of 54%, via the 5 step sequence shown In SCHEME 
2.312.05. (Since no yield was reported for the reduction reaction, the overall yield may 
have been less than 54%.) 
SCHEME2.31 
CC0:2Me N0:2 PhC:::CH/ POCI3 (70%) 
0 Yield not reported 
0 
Ph 
I Et3N/ CIC~Et 
+ (90%) 
Ph 
I(CH 2)aC~Me/ 
NaH/ DMF/ 50°C/ 24h 
(87%) 
Ph 
Ph 
I KOH 
+{98%) 
C~H 
Ph 
0 
2.09 
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Using the Insertion reaction ene-lactam (2.09) was synthesized, In the Improved 
yield of 75%, via the 3 step sequence outlined in SCHEME 2.32. 
SCHEME2.32 
2.114 
0 
Ph 
0 
0 
II 
P~P=CHCPh 
heat 
0 
Ph 
2.115 
MeO.,C ( C 1-!,)s N 1-1,. H CV J Et3N 
NH- {C~)sC~Me 
0 
2.116 
PTSAI heat! 
0 
0 
NH- (C~)6C~Me 
OH 
0 
Ph 
2.117 
N- (C~)sC~Me 
Ph 
2.09 
The appropriate enollactone (2.115) was prepared In a yield of 99% via standard 
Wittig chemistry .. However, it was necessary to reflux the CH2CI2 solution of succinic 
anhydride (2.114) and Ph3P=CHCOPh (2.3 equivalent) for a total of 5 months. The reaction 
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was not accelerated by the higher boiling point solvents toluene and CHCI3. The 
enollactone (2.115), which was purified by column chromatography, was assigned the E 
configuration on the basis of the chemical shift of (H-4)2; o 3.64 and the =CH coupling 
constant of J=2.1Hz (cf Section 2.3.2). 
Reaction of enollactone (2.115) with heptanoic methylester hydrochloride (1 .3 
equivalent) and triethylamine (1.3 equivalent) In CH2CI:2 gave, In a yield of 93%, a mixture 
of the keto-amide (2.116) and the corresponding enol-amide (2.117), In a ratio of 1:4, 
respectively. by 1 H NMR spectroscopy. 
The enol form (2.117) predominated over the keto form (2.116). due to stabilization 
by double bond conjugation with the phenyl group. The keto-amides (2.37-2.47, TABLE 
2.03, Section 2.2.1) do not have the phenyl substituent and existed entirely In the keto form 
(Section 2.2. 7). 
It is likely that the geometry about the enol double bond Is Z due to the potential for 
intramolecular hydrogen bond formation between the hydroxyl and the carbonyl 
(SCHEME 2.33). 
SCHEME2.33 
0 
Ph 
0 
2.116 
0 
NH-(CH2)6C02Me 
0-H 
Ph 
2.117 
The chemical shift of CH-3)2; o 2.85. which does not Indicate deshleldlng by COPh. 
supports the assignment of the Z configuration to the enol amide (2.117). The chemical 
shift of =CH (o 6.21) for the enol-amide (2.117) and <H-2)2 (o 4.17) for the keto-amide (2.116) 
compares well with analogous chemical shifts reported for the keto and enol forms of 
(2.118 and 2.119)2.26, . 
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H .. 
0 0 o" 'o 
~ Ph 0 4.5 Ph PhyPh 
H 
2.118 ss.s 
H .. 
0 0 o' ·a 
I 
OEt __.._ OEt 
F F 
H 
ss.s 
The IR spectrum also provided evidence for the enol-amide (2.117); a carbonyl 
stretch, observed at 1720-1730cm·l for other keto-am ides (2.38-2.39, 2.44-2.45, 2.47, Table 
2.03, Section 2.2.1) was absent from the IR spectrum of (2.117). 
The keto-amide/enol-amide mixture (2.116/2.117) in 1, 2-dichloroethane 
containing PTSA was refluxed, with azeotroplc removal of H20, for 43h to give the ene-
lactam (2.09) in a yield of 81%. Ene-lactam (2.09) was assigned the E configuration on the 
basis of the chemical shift of the (H-4)2 resonance: 8 3.44, and the =CH coupling constant 
of J= 1.8Hz (cf Section 2.3.2). 
Ene-lactam (2.09) synthesized via the alternative literature route (SCHEME 2.31) was 
deplcted2.05 as having the Z configuration. This Is unlikely because acylated enamino 
esters (for example 2.64-2.75) have been found to exist in the E configuration (Section 
2.3.2). Also, the method for the synthesis of the ene-lactam (2.09, SCHEME 2.31) required 
heating at 50 oc for 24h; conditions known to promote the conversion of z isomers to E 
isomers (Section 2.3). The melting point and spectral data for ene-lactam (2.09) 
synthesized via the routes outlined in SCHEMES 2.31 and 2.32 were identical. Thus, the 
Insertion reaction was applied, with better results, to the synthesis of an ene-Jactam which 
represents a key synthetic Intermediate of prostaglandin analogues2.05 (2.13, TABLE 2.01, 
Section 2. 1). 
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SECTION 3.1 
INTRODUCTION 
Protio and bromo cyclic acylated enamino esters are potential alternate 
substrate and mechanism-based inhibitors, respectively, of serine proteases (Section ;.s, 
Introduction). This chapter describes the synthesis of protlo and bromo cyclic acylated 
enamino esters (2.66, 2.71, 3.02-3.03, SCHEME 3.01) from the reaction of ~-keto ester (3.01) 
with glycine ethyl ester hydrochloride or butylamine. via lsolable enamine Intermediates. 
Protio enamlno esters (2.66 and 2.71) have been prepared via the insertion reaction 
(Sections 2.2-2.3, Chapter 2). 
SCHEME 3.01 
0 
cr~Me X R ... "Bu 2.66 H 
2. 71 H CH2C02Et 
3.02 Br nsu 
C02Et X 3.03 Br C~C~Et 
3.01 
A related procedure has been reported3.0l in which ~-keto ester (2.29) Is refluxed 
with various amlnes In toluene for 18h. The mixture is then treated with NoH to yield the E-
enamino esters (2.30) (SCHEME 2.06, Section 2.1, Chapter 2). In this case, an intermediate 
species was not isolated. 
Also in this chapter, the ~-keto ester route and insertion reaction are extended to 
the synthesis of the 3-substltuted enamino ester (3.04). which has the potential for peptide 
chain extension in the N and C directions. Incorporation of enamino esters into an 
appropriate ollgopeptlde Is a strategy for enhancing recognition by a target enzyme. 
CBzHN.,, 
H 
0 
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SECTION 3.2 
SYNTHESIS Of PROTIO AND BROMO ENAMINO ESTERS 
SECTION 3.2. 1 
PREPARATION OF ~-KETO ESTER 
~-Keto ester (3.01), the starting compound for the synthesis of enamlno esters 
(2.66, 2.71, 3.02, 3.03, SCHEME 3.01), was prepared from acid chloride3.02 (3.05) according 
to the procedure reported by Oikawa et aJ3.03 (SCHEME 3.02). A CH2CI2 solution of acid 
chloride (1.1 equivalent) and pyridine (2 equivalent) was treated with Meldrum's acid (2,2-
dimethyl-1 ,3-dioxane-4 ,6-dione) at 0 oc for 1 h and then at 20 oc for 1 h, to give the acyl 
Meldrum's acid (3.06). Acyl Meldrum's acid (3.06) was refluxed in ethanol for 2h to give p-
keto ester (3.01) which was used subsequently without purification. 
SCHEME3.02 
(C02Me 
COCI 
3.05 
Meldrum's 
acid/ EtOH/ heat 
pyridine 0 0 
3.01 
SECTION 3.2.2 
PREPARATION AND CHARACTERIZATION OF ENAMINES 
Protlo enamlnes (3.07 and 3.08, SCHEMES 3.03 and 3.04, respectively) were 
prepared by refiuxlng, with azeotroplc removal of H20, a benzene solution of the p-keto 
ester (3.01) with butylamine (2 equivalent), or glycine ethylester hydrochloride (2 
equivalent) and triethylamine (2 equivalent). After 90mln the solvent was evaporated 
and the crude enamlnes (3.07 and 3.08) were purified by radial chromatography. 
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SCHEME3.03 
crc:e BuN~/ C02 Me C02Me heat 
:iNH-0Bu ~NH-"Bu 
C02Et Et02C H H C02Et 
3.01 3.07E 3.07Z 
NBS/ ooc 
0 
N-nBu C02 Me C02 Me 
s:NH-nBu ~NH-"Bu 
Br C02Et Et02C Br 
3.09E 3.09Z 
NaH 
0 0 
0 0 
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SCHEME3.04 
3.01 3.08E 
0 
3.1 DE 
0 
0 
C02 Me 
NH C02Et ~ 
H C02Et 
3.08Z 
NBS/ ooc 
NaH 
3.10Z 
0 
0 
C02Et 
2.101 z 
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Bromo enamines (3.09 and 3.10, SCHEMES 3.03 and 3.04. respectively) were 
prepared from the corresponding protlo enamines (3.07 and 3.08, respectively),ln 100% 
and 96% yield, respectively, by treatment with NBS (N-bromosuccinlmide) 0 equivalent) 
at 0 oc for 15mln In THF. 
The lH NMR spectra of enamines (3.07-3.10) Indicated that E and Z Isomers were 
present. The broad NH resonances at o 4. 72, 5.31, 5.51 and 6.07 were attributed to the 
minor Isomer of enamlnes (3.07, 3.08, 3.09 and 3.10, respectively). The Integrals of the NH 
resonances allowed estimation of the E/Z ratio for enamlnes (3.07-3.10) (TABLE 3.01). 
Doubling of other resonances In the lH and l3c NMR spectra of enamines (3.07-3.10) also 
indicated the presence of the minor Isomer. 
The chemical shift of the NH resonance in the major Isomer of enamlnes (3.07-3.10) 
was Indicative of hydrogen-bonding between NH and C02Et (SCHEME 3.05 and TABLE 
3.01). Therefore, the major Isomer was assigned the Z configuration for the protlo 
enamlnes (3.07 and 3.08), and theE configuration for bromo enamlnes (3.09 and 3.10), on 
the basis of the downfield position of the NH resonance relative to the corresponding 
minor Isomer <TABLE 3.01). 
TABLE 3.01 
Enamine R X oNH 
3.07 nsu H 8.58 
3.0S CH2C~Et H 8.89 
3.09 nBu Br 9.28 
3.10 CH2C~Et Br 9.59 
SCHEME3.05 
(Confign) 
(Z) 
(Z) 
(E) 
(E) 
l> NH 
. 
4.72 
5.31 
5.51 
6.07 
3.07 z 
3.08 z 
3.09 E 
3.10 E 
(Con n) E/Z 
(E) 22/78 
(E) 28/72 
(Z) 83/17 
(Z) 75/25 
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The spectral data of (3.07-3.10) were consistent with the proposed enamine 
structure. Resonances at~ 4.44 and 4.55 In the 1 H NMR spectrum of Z-protio enamines 
(3.07Z and 3.08Z, respectively) were characteristic of the olefinic enamine proton. 
Medium to strong absorptions at 1610-1675cm·l in theIR spectra of compounds (3.07-3.10) 
are characteristic of enamlnes3.04. The olefinic enamine carbon, C-1, of the major 
Isomer (3.07Z. 3.08Z. 3.09E and 3.10E) resonated at o 80.5. 83.5, 76.9 and 79.5, respectively, 
which Is within the range typically observed for C-1 of enamines; o 79-1313.04. The 
resonances observed for C-2 of the major Isomer (3.07Z. 3.08Z. 3.09E and 3.10E); () > 160, 
were downfield of the resonances typically observed for C-2; () 124-1563.04. However, the 
accurate masses of enamlnes (3.07-3.10) were consistent with the calculated masses. 
SECTION 3.2.3 
SYNTHESIS AND CHARACTERIZATION OF ENAMINO ESTERS 
Enamino esters (2.66. 3.02, SCHEME 3.03 and 2.71. 3.03, SCHEME 3.04) were prepared 
from the appropriate enamine (3.07, 3.09, 3.08 and 3.10, respectively) on treatment with 
NoH (1 equivalent) at 20 oc for 18h. in THF. 
Protio enamino esters (2.66 and 2.71) were identicaL by lH NMR spectroscopy, to 
enamino esters (2.66 and 2.71) prepared via the Insertion reaction (Sections 2.2 and 2.3. 
Chapter 2). Exclusively theE isomer formed; In yields of 40% and 27%. respectively, from 
the ~-keto ester (3.01). Enamino esters (2.66 and 2.71) were synthesized in superior yields 
from enollactones. via the Insertion reaction; 100% and 73%, respectively (Sections 2.2 
and 2.3. Chapter 2). Another disadvantage of the P-keto ester route is that p-keto esters 
are less convenient to prepare than enollactones. 
The structure of bromo enamlno esters (3.02 and 3.03) was confirmed by 
comparison of their spectral data with that of related enamino esters; In particular the 
chloro enamino esters (2.98) synthesized via the insertion reaction (Section 2.7. 1. Chapter 
2). The configuration of the bromo enamino esters (3.02 and 3.03) was assigned on the 
basis of 1 H NMR spectr<?scopy. The CH-4)2 resonance was downfield in the Z isomers 
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(3.02Z and 3.03Z) relative to the corresponding E isomers (3.02E and 3.03E, respectively), 
reflecting the deshlelding effect of C02Et. 
ELIMINATION PRODUCT 
Bromo enamlno esters (3.02 and 3.03, SCHEMES 3.03 and 3.04, respectively), like the 
chloro enamino ester (2.98, Section 2.7. 1. Chapter 2), were unstable. The residue 
obtained from the reaction of the glycine-derived bromo enamine (3.10) with NoH, 
contained, by lH NMR spectroscopy, 85% bromo enamino ester (3.03E and 3.03Z) (In a 
ratio of 1 E: 4 Z) and 15% elimination product (2.101E and 2.101Z) (In a ratio of 3 E: 2 Z). 
When this residue was subjected to preparative tic on silica, theE- and Z-bromo 
enamlno esters (3.03E and 3.03Z, respectively) were separated. However, the fraction 
containing the E Isomer (3.03E) was contaminated with elimination product (2.1 01 E and 
2.101Z); 30% (3.08E) and 70% (2.101E and 2.101Z), by lH NMR spectroscopy. The 
elimination product (2.1 01 E and 2.101 Z) was also obtained from the corresponding chloro 
enamlno ester (2.98) (Section 2.7. 1. Chapter 2). This reaction may represent a convenient 
preparation of this class of compound. 
The residue obtained from the reaction of the butylamine-derived bromo 
enamine (3.09) with NoH, contained. by 1 H NMR spectroscopy, 30% bromo enamino 
ester (3.02E and 3.02Z) (In a ratio of 7 E : 3 Z) and 700k elimination product (3.11 E and 3.11 Z) 
(in a ratio of 7 E : 3 Z). Complete conversion to elimination product (3.11 E and 3.11Z) was 
achieved when the residue was dissolved In CCI4 containing p-toluene sulphonlc acid 
(PTSA) and heated at 60 oc for 5 days. Purification by radial chromatography yielded 
elimination product (3.11 E and 3.11Z, respectively) in a ratio of 9 E : 1 Z, by 1 H NMR 
spectroscopy. The E Isomer of the elimination product (3.11 E) was assigned on the basis 
of the downfleld shift of H-4 and the larger coupling constant of =CH relative to the Z 
isomer (3.11Z). 
A reduced reaction time of 2h. rather than 18h, for the butylamine-derived bromo 
enamlne (3.09)/NaH reaction gave, by 1H NMR spectroscopy, 80% bromo enamino 
ester (3.02E and 3.02Z) (in a ratio of 7.5 E: 2.5 Z) and 20% elimination product (3.11E and 
3.11Z) (In a ratio of 7.5 E: 2.5 Z). Purification by radial chromatography allowed separation 
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of E- and Z-bromo enamlno esters (3.02E and 3.02Z, respectively); however, the fraction 
containing the E Isomer (3.026E) was also contaminated with elimination product (3.11 E 
and 3.11Z); 4QOk (3.02): 60% (3.11), by lH NMR spectroscopy. 
SECTION3.3 
SYNTHESIS OF AN ENAMINO ESTER WITH THE POTENTIAl FOR 
PEPTIDE CHAIN EXTENSION IN THE N DIRECTION 
Enamino ester (3.04) (SCHEME 3.06), which has the potential for peptide chain 
extension In the N and C directions, was synthesized via the enamine route (pathway a, 
SCHEME 3.06) and the Insertion reaction (pathway b, SCHEME 3.06). The starting 
compound for both syntheses was the acid chloride (3.14), which was prepared from the 
reaction of the corresponding acid (3.13) with oxalyl chloride (10 equivalent) and DMF in 
CH2CI2. The acid (3.13) was synthesized according to the procedure reported by Scholtz 
and Bartleft3.05 whereby (S)-benzyloxycarbonyl CCBz) aspartic acid (3.12), 
paraformaldehyde (2 equivalent) and PTSA (0.06 equivalent), In benzene, were refluxed 
for lh wtth azeotroplc removal of H20. The oxazolldlnone (3.13) effectively protects the 
non R group acid of (S)-CBz aspartic acid (3.12) and allows subsequent reactions to 
occur at the unprotected acid. 
SECTION 3.3. 1 
SYNTHESIS OF ENAMINO ESTER (3.04) FROM p-KETO ESTER 
~-Keto ester (3.15) was prepared from the acid chloride (3.14), in a yield of 75%, 
using the procedure3.03 used to prepare p-keto ester (3.01, SCHEME 3.02, Section 3.2. 7). 
I 
Thus, acid chloride (3.14) (1.1 equivalent), pyridine (2 equivalent) and Meldrum's acid, 
dissolved in CH2CI2, were stirred at 0 oc for 1 h then 20 oc for 1 h (SCHEME 3.06). The solvent 
was evaporated under reduced pressure and the residue was refluxed with ethanol for 2h 
to give the crude ~-keto ester (3.15) which was purified by radial chromatography. 
Chapter 3 1 07 
SCHEME3.06 
ro 
,...N·>¢· 0 CBz ' 
H 
(C~O),/ PTSA/ heat CBzNH~~C02H 
C02H 3.12 
ro 4~~:·,:d:co2H 
,...N·{·· 0 CBz 
H 
1. Meldrum's acid/ pyrid~ COCI "'-bp P~haPP=CHC~Et 
2. EtOH/heat /a 3.14 b ~ 
ro csz-:~o 
Et02C 
3.15 
! Gly-OEt. HCI/ Et3N/ heat 
r:)=o) C02Et csz-:~ -~NHJ 
Et02C 
3.16 
~150°C/ 1mm 
CBzHN.,, 
H 
Et02C 
0 
3.04 
PTSA/he~ 
CBzHN,,, 
H 
0 
3.20 
ro 
CBz-N.,,, 
H 
PPh3 
Et02C 
3.17 
NaOH/ heat! 
H OH 
Et02C 
3.18 
heati 
CBzHN,,, 
H 
Et02C 
3.19 
0 
/Giy-OEt. HCI/ 
/ Et3N 
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~-Keto ester (3.15), glycine ethylester hydrochloride (1.5 equivalent) and 
triethylamine (1.5 equivalent) were refluxed in benzene for 90min, with azeotropic 
removal of H20. The mixture was cooled to 20 oc, filtered and evaporation of the solvent 
under reduced pressure yielded a residue which was used without further purification. By 
. 1 
analogy to the simpler systems (Section 3.2.2) the compound present at this stage ought 
to be the enamlne (3.16). However, the 1H NMR spectrum of the residue was complex 
and was not able to be assigned, which suggested that a mixture of E- and Z-enamines 
(3.16) and possibly also the corresponding E- and Z-imines (3.21) had formed (SCHEME 
3.07). 
SCHEME3.07 
0 
[ x>=O.I C02Et 
CBz- H':: -~NH_/ :::;::=~ 
Et02C 
3.16 
0 r~ C02Et CBz-N •• ,. . N.J 
H ~ 
Et02C 
3.21 
It Is unlikely that the residue was predominantly the product of an undesirable side 
reaction because, on heating at 150 oc at lmm Hg for 2h, the target enamino ester (3.04 
SCHEME 3.06) was formed relatively cleanly. Purification by radial chromatography 
yielded the enamino ester (3.04) in an overall yield of 42% from the acid chloride (3.14). 
Mechanistically, the formation of enamino ester (3.04) from the enamlne (3.16), on 
heating, Involves 2 steps; formation of the 5-membered enamino ester ring via attack of 
the enamine N on the oxazolidinone carbonyl (step a, SCHEME 3.08) and loss of the 
formaldehyde protecting group (step b, SCHEME 3.08). 
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SCHEME3.08 
1-t ro~ H N~l/) COEt CBz~ H~·-~N!...../ 2 
Et02C 
3.16 H 
~ H' '----F6 0 
CBz""~··· 
CBzHN.,, 
H 
0 
For the simpler systems (Section 3.2.3) the enamlno esters (2.66, 3.02, SCHEME 3.03 
and 2.71, 3.03, SCHEME 3.04) were prepared from the corresponding enamines (3.07,3.09 
and 3.08, 3.10, respectively) via reaction with NaH, because this method was used for the 
preparation of related enamlno esters3.0l. Enamlno ester (3.04); however, was prepared 
from the enamlne/lmlne (3.16/3.21) via heating under reduced pressure; conditions 
similar to those reported3.06 for the preparation of the related 3-substltuted enamlno ester 
(3.24) from P-keto ester (3.23) (SCHEME 3.09). The enamlno esters (2.66, 3.02, SCHEME 3.03 
and 2.71, 3.03, SCHEME 3.04) were not Isolated following heating, at reduced pressure, of 
the enamlnes (3.07, 3.09 and 3.08, 3.10, respectively). 
SCHEME3.09 
CBzHN,,, 
H 
0 
1. DMBNf-k/ 
toluene/ heat 
2. 150-160°C/ 
1h/20mm 
DMB = 2,4-dimethoxybenzyl 
CBzHN,,, 
H 
0 
N-DMB 
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The 1 H and l3c NMR spectra of the en amino ester (3.04) Indicated a single Isomer 
which was assigned theE configuration because the CH-4)2 resonances were in a 
characteristic downfleld position reflecting the deshleldlng effect of the C02Et group (cf 
Section 2.3.2, Chapter 2). The chemical shifts of CH-4)2 were similar to the chemical shifts 
of (H-4)2 in related enollactones and enamino esters (3.24E. 3.25E, 3.26E, 3.27Z) of the same 
relative configuration (TABLE 3.02). 
TABLE 3.02 
CBzHN,,, 
H 
0 
Compd Rl X o (H-4)0 o (H-4)b 
Ester group (R 1) is trans relative to X 
3.04E C0:2Et H NC~C0:2Et 3.04 3.77 
3.24E C0:2CH2Ph H NCH2DMB 2.80-3.21 3.96-4.43 
3.25E C0:2CH2Ph H NH 3.04 3.77 
3.26E C0:2Et H 0 3.25 3.88 
3.27Z C0:2Et Br 0 3.27 3.86 
Ester group (R2) Is cis relative to X 
3.25Z H C0:2CH2Ph NH 2.80 3.26 
3.27E Br C0:2Et 0 3.08 3.48 
DMB = 2.4-dimethoxybenzyl 
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SECTION 3.3.2 
SYNTHESIS OF ENAMINO ESTER (3.04) VIA THE INSERTION REACTION 
Enamlno ester (3.04) was also prepared via the Insertion reaction (pathway b, 
SCHEME 3.06), which Is discussed in Chapter 2. Synthesis of the enollactone (3.19) via 
anhydride Wittig chemistry was not practical. The anhydride precursor (3.28) Is difficult to 
make and Its reaction with Ph3P=CHC02Et gives rise to th~ undesired reglolsomer3·07 (3.29) 
(SCHEME 3.10). 
SCHEME3.10 
0 
CBzH~ 
H '--no 
0 
3.28 
Et02C 
CBzHN •• , 
PhaP=CHC0:2Et H 
0 
3.29 
Therefore, the required enollactone (3.19) was prepared via the reaction 
sequence depleted In pathway b of SCHEME 3.063.07. Acid chloride (3.14) and 
Ph3P=CHC02Et (2 equivalent) were dissolved in CH2Cl2 and stirred at 0 oc for 1 h and then 
20 oc for 4h. The solvent was evaporated under reduced pressure and the crude 
oxazolidinone (3.17) was purified by radial chromatography. 
Selective hydrolysis was achieved when the oxazolidinone (3.17), dissolved In 
methanol, was treated with lN NaOH (10 equivalent). After 4h at 20 oc, the solution was 
acidified with lN HCI, the solvent was evaporated under reduced pressure and the free 
acid (3.18) was extracted from the residue with ethyl acetate. The acid (3.18) was 
dissolved In CHCI3 and refluxed for 48h. Radial chromatography led to the isolation of 
enollactone (3.19) In an overall yield of 66% from the acid chloride (3.14). It was 
necessary to perform the radial chromatography as rapidly as possible, because the 
enollactone (3.19) was unstable on silica. 
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Keto-amide (3.20) was obtained following reaction of enollactone (3. 19), glycine 
ethylester hydrochloride (1.2 equivalent) and triethylamine ( 1.2 equivalent) In CH2CI2 at 
20 oc for 16h. The target E-enamlno ester (3.04) was obtained from the keto-amide (3.20) 
on refluxlng with PTSA In 1 , 2-dichloroethane, with azeotroplc removal of H20, for 4h. 
Overall, the enamlno ester (3.04) was synthesized in a yield of 33% from the acid chloride 
(3.14) via the Insertion route (pathway b, SCHEME 3.06). The P-keto ester route (pathway a, 
SCHEME 3.05) represented a higher yielding route (42%) with one less transformation. 
SECTION 3.3.3 
OPTICAL ACTIVITY OF ENAMINO ESTER (3.04) 
The chlral centre of the starting compound (S)-CBz aspartic acid (3.12) should not 
be racemized by any of the reactions depleted In SCHEME 3.06. Therefore, enamino 
ester (3.04) Is expected to be optically active, whether synthesized via the p-keto ester 
(pathway a) or Insertion (pathway b) route. The specific rotation of enamlno ester (3.04) 
was measured to be (a)o20 = -13° (c 0.35; CH2C12). More evidence that the reactions do 
not racemlze the chlral centre is discussed in Chapter 4 (Section 4.5.3). 
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CHAPTER 4 
SYNTHESIS OF THE TARGET 3,3-
DISUBSTITUTED ENAMINO ESTERS 
VIA THE INSERTION REACTION AND 
FROM p-KETO ESTER 
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SECTION4.1 
INTRODUCTION 
This chapter describes the synthesis of 3,3-dlsubstituted bromo enamino esters 
(4.01 E and 4.01Z) and 3.3-dlsubstltuted protlo enamlno esters (4.02-4.07) (TABLE 4.01). The 
bromo enamlno esters (4.01 E and 4.0 lZ) are key Intermediates for the target molecule 
(1.34) and represent a new class of potential mechanism-based lnactlvators of 
chymotrypsin (Section 1.5, Introduction). The protio enamlno esters (4.02-4.07) are key 
Intermediates to the target molecule (i.35) and represent a new class of potential 
alternate substrate Inhibitors of chymotrypsin (Section 1.5, Introduction). 
TABLE 4.01 
0 R2 0 R3 0 -yllNAy~.0':-iNAy~y-
R1 H 0 I 0 R4 
Ph 
Et02C X 
I Compd 
i.34 X= Br 
i.35 X= H 
0 
CBzNH 
4.01E CH2C~Et Br C~Et 
4.01Z CH2C~Et C~Et Br 
4.02 O:l2C~Et C~Et H 
I 
4.03 CH2CONHCH2C~Et C~Et H 
tl04 CH2C~tau C~Et H 
4.05 . CH2C02H C~Et H 
tl06 (S)-CH(Me)C02Et C~Et H 
tl07 nsu C~Et H 
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The 3,3-dlsubstltuted enamlno esters (4.01-4.07), unlike the enamlno esters 
described In Chapters 2 and 3, contain an amino acid R group; namely the benzyl group 
of phenylalanine, at position 3 which Is required for recognition by the target enzyme. 
Methodology developed largely by Seebach and coworkers for the asymmetric 
synthesis of ex ,cx-disubstituted amino acids4.0l was extended to allow the Introduction of 
the benzyl group, with stereo-controL into the potential inhibitors (4.01-4.07). The 
methodology developed In the current work should enable the Introduction of any amino 
acid at position 3. 
SECTION4.2 
BENZVLOXYCARBONYL (CBz) AND BENZOYL OXAZOLIDINONES 
SECTION 4.2. 1 
SYNTHESIS OF CBz OXAZOLIDINONES 
SYNTHESIS OF 4-SUBSTITUTED CBz OXAZOLIDINONE (4.11) 
Synthesis of the oxazolldinone precursors to enamino esters (4.01-4.07, TABLE 4.01) 
Is summarized In SCHEMES 4.01 and 4.02. The key oxazolldlnone (4.11) was prepared via 
the procedure reported by Seebach et al4.02 (pathway a, SCHEME 4.01) and also via the 
procedure reported by Karady et at4.03 (pathway b. SCHEME 4.01). The former method 
(pathway a, SCHEME 4.01) Involved treatment of the Schiff base salt (4.09) of (S)-
phenylalanlne (4.08), In CH2CI2. with benzyl chloroformate (1 equivalent) and the resulting 
mixture was stirred at -20 oc for 1 day and at 4 oc for 3 days. The tatter method (pathway b, 
SCHEME 4.01) involved treatment of (S)-CBz phenylalanine (4.10), In 1,1, Hrlchloroethane, 
with benzaldehyde (2 equivalent) and p-toluene sulphonlc acid (PTSA) (1 equivalent). 
The solution was refluxed for 18h with azeotroplc removal of H20. A lH NMR spectrum of 
the crude oxazolldinone (4.11) revealed the presence of less than 5% of the trans epimer 
(4.12) in the case of pathway a and 50% of the trans epimer (4.12) for pathway b (cis/trans 
assignment is discussed later In Section 4.2.3). The desired cis oxazolidinone (4.11) was 
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separated from Its eplmer (4.12) by silica column chromatography and recrystallization In 
an overall yield of 47% for pathway a, SCHEME 4.01 and 21% for pathway b, SCHEME 4.01. 
SCHEME4.01 
H2~)<C~H 
f H 
Ph 
4.08 
a 
NaOH/ 
PhCHO 
Ph'--Nyc~Na+ 
... , ......... , 
I H 
Ph 
4.09 
a!CBzCI 
Ph, Ph~ 
CBzNXC0.2H 
f H 
''rO I 0 PT~A/ .,. ,.N ~0 + ,.N ~0 CBz X CBz X 
Ph PhCHO ,,, H •'' H I I 
Ph Ph 
. 4.10 4.11 . 4.12 
SYNTHESIS OF 4.4-DISUBSTITUTED CBz OXAZOLIDINONES 
The synthesis of 4,4-disubstltuted CBz oxazolidinones Is summarized In SCHEME 
4.02. Oxazolidlnone (4.11) was alkylated, with high degree of dlastereoselectivlty, using 
the method pioneered by Seebach 4.01; a THF solution of oxazolidinone (4.11), at -78 oc, 
was treated with a l M THF solution of lithium hexamethyldlsllazlde (LIHMDS) (1. 1 
equivalent) and the resulting solution was stirred at -78 oc for 7mln. The alkylating agent, 
BrCH2C02CHPh2 or BrCH2COC(PPh3)C02Et, was added and the solution was stirred at -7 8 
oc for 2h, and subsequently at 20 oc for 16h. The crude oxazolidinones (4.14 and 4.15) 
contained less than 5% of the minor (2S.4R)-eplmer (4.16 and 4.17, respectively), by 1 H 
NMR spectroscopy. Phosphorane oxazolidinone (4.15) was obtained In a yield of 26% 
after radial chromatography. The crude benzhydryl oxazolldlnone (4.14), which was 
obtained quantitatively, was subsequently used without further purification. 
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SCHEME4.02 
Ph,,~lo liHMDS/ 
~ -78°C 
CBz~Nx O 
f"' H 
Ph 
4.11 
BrC~C~CHP~ 
Ph~ ~.,0 
csz~~~o 
Ph OCHPh2 
4.14 
TFNo•c! 
Ph, 
~.,0 
csz~Nf~o 
Ph OH 
4.18 
!CDI 
4.20 
4.13 
I 
I 
I 
I 
I 
I 
I 
I 
Ph t 
"·ro CBz~~~o 
Ph 
4.16 R = CH 2C~CHP~ 
4.17 R = CH2C-CC02Et II II 
0 PPh3 
DMF/ 
oxalyl chloride 
Et02C 
4.15 
t Ph,P=CHCQ,Et 
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The formation of the 4.4-disubstituted oxazolidinones (4.14 and 4.15) from 
oxazolidinone (4.11) proceeds via the unstable planar enolate (4.13). The chlral centre of 
the enolate controls the stereochemical outcome of the alkylation reaction. The 
alkylating group approaches from the sterlcally least hindered face of the enolate; le 
opposite the phenyl group. The configuration at this centre was dictated by the chiral 
centre In (S)-phenylalanlne (4.08) or (S)-CBz phenylalanine (4.10). Overall the 
stereochemical outcome of the sequence Is described as self reproduction of chirality 
because the formation of oxazolidinones (4.14 and 4.15) proceeded with retention of 
configuration (assignment of configuration is discussed later in Section 4.2.3). 
The Seebach alkylation reaction has been carried out with oxazolidlnones 
derived from most amino acids and with a number of alkylating agents and bases; for 
example, UHMDS, LOA and LiN(Et)2 4.01. The alkylation using the phosphorane 
BrCH2COC(PPh3)C02Et represents a new example of this existing important strategy. 
The benzhydryl group was removed on treatment of benzhydryl oxazolidinone 
(4.14) with TFA (trifluoroacetlc acid) (20 equivalent), at 0 oc. The acid (4.18) was purified 
by recrystallization, to give a final yield of 32%. Attempts to purify the acid (4.18) by 
extraction Into NaHC03 led to emulsification. 
The acid (4.18) was dissolved in CH2Cl2, cooled to 0 oc and treated with oxalyl 
chloride (5 equivalent) and a catalytic quantity of DMF to give the acid chloride (4.19), In a 
yield of 100%. 
Treatment of the acid chloride (4.19) with Ph3P=CHC02Et (2 equivalent), In CH2CI2. 
at 0 oc for 1.5h and at 20 oc for 4.5h, followed by radial chromatography, quantitatively 
gave the phosphorane (4.15). Therefore, although requiring three additional steps, the 
phosphorane (4.15) was prepared In superior yield and purity, by 1 H NMR spectroscopy, 
via this method, rather than via alkylation of the oxazolidlnone (4.11) with 
BrCH2COCCPPh3)C02Et. 
The phosphorane (4.15) prepared via both routes was present as a 1 : 1 mixture, 
by lH NMR spectroscopy, of two conformers. The related benzoyl phosphorane (4.26, 
SCHEME 4.04) was present as a single Isomer by lH and 13c NMR spectroscopy. 
Therefore, it is likely that the conformational Isomerism observed for CBz-phosphorane 
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(4.15) arises due to restricted rotation about the CBz group. The 1 H NMR spectra of CBz 
phosphorane (4.15) and benzoyl phosphorane (4.26) are shown; Spectrum 4.01 and 4.02, 
respectively. Resonances in the lH NMR spectrum of CB,z phosphorane (4.15) (Spectrum 
4.01) are doubled; for example there are two resolved triplets (Inset) arising from the 
methyl groups, whereas the spectrum of benzoyl phosphorane (4.26) (Spectrum 4.02) has 
I 
one triplet (Inset). The lH and 13c NMR spectra of the related phosphorane (3.18) 
I 
Indicated a single Isomer; however, the lH NMR resonances were broad. The lH NMR 
spectrum of CBz-phosphorane (4.15) In d6-DMSO, heated to 85 "'C. Indicated that a single 
conformer was present. The 1 H NMR spectra of CBz phosphorane In d6-o'MSO at 23 oc 
and 85 oc are shown; Spectrum 4.03 and 4.04, respectively. Again, doubling of 
resonances is evident In the 1 H NMR spectrum of CBz phosphorane (4.15) at 85 oc 
(Spectrum 4.03); for example there are two overlapping triplets (inset) arising from the 
methyl groups, whereas at 23 oc (Spectrum 4.04) there Is one triplet (Inset). 
Ph)-O 
Ph N y .. , 
0 
ro 
CBz-N,,, 
H 
PPh3 
On treatment with carbonyl dilmldazole (CDI) (1.2 equivalent) In THF, the acid (4.18) 
was converted into the corresponding lmidazole4.04 (4.20) which, without isolation, was 
treated with magnesium dlethyl malonate 4.05 (l equivalent) to give the ~-keto ester (4.21) 
In a yield of 65%, offer chromatography. 
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1 ppm 
Spectrum 4.02 
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Spectrum 4.03 
Spectrum 4.04 
I 
I 
J IJ 
____ ./ 
f"i"'fi 1 ifl'f ,, ,., ..... , .. , 
0.82 0. 76 ppm 
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SECTION 4.2.2 
SYNTHESIS OF BENZOYL OXAZOLIDINONES 
The analogous oxazolldlnones derived from benzoyl oxazolldinone (4.22) were 
prepared using the general methods described above, In some cases with minor 
modifications (SCHEMES 4.03 and 4.04). 
SYNTHESIS OF 4-SUBSTITUTED OXAZOLIDINONE (4.22) 
Reaction of the Schiff base salt (4.09) of (S)-phenylalanine (4.08) with 
benzoylchlorlde (l equivalent) at -20 oc for 1 day and at 4 oc for 4 days gave a mixture 
containing, by 1H NMR spectroscopy, 70% trans oxazolldlnone (4.22) and 30% cis 
oxazolidinone (4.23) (cis/trans assignment Is discussed later In Section 4.2.3). The trans 
oxazolldlnone (4.22) was purified by recrystallization, In a yield of 25%. 
SCHEME4.03 
H2~}(C~H 
I H 
Ph 
4.08 
NaOH/ 
PhCHO 
SYNTHESIS OF 4,4-DISUBSTITUTED OXAZOLIDINONES 
The synthesis of 4,4-disubstituted benzoyl oxazolidinones is summarized in 
SCHEME 4.04. The enoiate (4.24) was prepared by treatment of the oxazolldinone (4.22), 
dissolved in THF at -78 °9, with UHMDS (SCHEME 4.04). Alkylation of the enolate (4.24, 
SCHEME 4.04) with BrCH2C02CHPh2 gave a mixture, used subsequently without further 
purification, which contained, by 1H NMR spectroscopy, 67% of the desired benzhydryl 
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oxazolldinone (4.25), 22% BrCH2C02CHPh2 and 11% of a compound tentatively assigned 
as the dimer (4.33, discussed later In Section 4.3). lH NMR spectroscopy revealed that 
less than 5% of the minor dlastereolsomer (4.27) had formed. Hence, overall the 
reactions leading to formation of oxazolldlnone (4.25) proceeded with inversion of 
configuration. 
Ph 
Ph )-x:O 0 YN... ,H 
0 N 
Ph Ph Fo 
Ph 
4.33 
Alkylation of the enolate (4.24) with BrCH2COCCPPh3)C02Et gave a mixture which 
contained, by lH NMR spectroscopy, 15% of the phosphorane oxazolidinone (4.26), 70% 
recovered BrCH2COC(PPh3)C02Et and 15% of the dimer (4.33, discussed later in Section 
4.3). Again, less than 5% of the minor dlastereoisomer (4.28) was observed by 1 H NMR 
spectroscopy. Purification of phosphorane oxazolldinone (4.26) was not achieved by 
silica or dlol chromatography. However, benzoyl phosphorane (4.26) was prepared In 
superior yield and purity from the acid (4.29) via reaction with oxalyl chloride and DMF 
followed by Ph3P=CHC02Et (SCHEME 4.04). The acid (4.29) was prepared via treatment of 
benzhydryl oxazolldlnone (4.25) with TFA, and purified by an acid/base extraction 
followed by recrystallization. 
Benzoyl ~-keto ester (4.32) was prepared from the acid (4.29), in a yield of 91%, via 
reaction with carbonyl dlimldazole4.04 CCDI) followed by magnesium diethyl 
malonate4.05, In contrast, benzoyl ~-keto ester (4.32) was also prepared, In 21% yield, via 
reaction of the acid (4.29) with oxalyl chloride and DMF followed by Meldrum's acid (2,2-
dlmethyl-1 .3-dioxane-4,6-dlone) and pyridine, then finally treatment with ethanol4.07 
(SCHEME 4.04). It is likely that the simpler ~-keto esters (3.01, 3.14) prepared via the 
Meldrum's acid route (Chapter 3, Sections 3.2.1 and 3.2.3), could have been better 
prepared via reaction _of the appropriate acid with carbonyl dlimidazole CCDI) and 
magnesium diethyl malonate. 
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SCHEME4.04 
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SECTION 4.2.3 
ASSIGNMENT OF R/S CONFIGURATION TO THE OXAZOLIDINONES 
The benzoyl oxazolidlnone (4.22, SCHEMES 4.03 and 4.04) was assigned the trans 
configuration on the basis of melting point and IR, 1 H NMR and 13c NMR data Identical to 
that reported4.06 (4.22). Assignment of the trans configuration was confirmed by the 
observation of an n.O.e. between H-2 and CH2Ph. 
literature4.06 assignment of the trans configuration to (4.22) was based on 
comparison of the chemical shifts of the protons at H-2 and H-4 with the corresponding 
chemical shifts of cis and trans 2-(tert-butyl) oxazolldinones4.02. 4.08 (4.34 and 4.35, 
respectively) The H-2 and H-4 resonances, summarized In TABLE 4.02, are downfield In 
the trans Isomer (4.35) relative to the corresponding cis isomer (4.34). 
TABLE 4.02 
4.34 
CIS 
Compd 
R 4.34 · o H-2 
Me a 6.13 
CHMe2 b '5.95 
CH2CH2SMe c 6.10 
(CH2)4NHC02tBu d 6.05 
4.23 * 
4.11 6.45 
8 H-4 
4.07 
4.29 
4.20 
3.88 
4.92 
4.66 
~p PhyN~O 
II R' H 0 
4.35 
TRANS 
Compd 
4.35 8 H-2 
a 6.25 
b 6.14 
c 6.21 
d 6.16 
4.22 5.83 
4.12 * 
* Sample :of Insufficient purity to assign o H-2 
oH-4 
4.37 
4.29 
4.52 
4.33-4.46 
5.2 
4.71 
Chapter 4 127 
CBz oxazolidlnone (4.11) was assigned the cis configuration on the basis of IR and 
13c NMR data identical to that reported4.03. There Is some ambiguity regarding the 
configuration because, while the text reports that the cis Isomer (4.11) was obtained from 
($)-phenylalanine, the figures depict (R)-phenylalanine giving rise to the corresponding 
cis isomer4·03. The configuration of the cis oxazolidinone (4.11) was reportedly 
confirmed by single crystal X-ray structure analysis4.03. The atom coordinates of the X-
ray analysis were obtained from the Cambridge crystallographic data base; however, 
due to anomalies in the hydrogen coordinates, the configuration was not able to be 
unambiguously determined. 
On the basis of the upfield position of the H-4 resonance in the major isomer 
relative the minor Isomer, the major isomer was tentatively assigned the cis configuration 
(4.11) <TABLE 4.02). An n.O.e. was not observed between H-2 and H-4 or C4CH2Ph. 
The configuration of 4,4-disubstituted benzoyl oxazolldinones (4.25-4.26, 4.29-4.32, 
SCHEME 4.04) was confirmed by the observation of an n.O.e. between H-2 and CH2Ph in 
the acid (4.29). This confirmed that the electrophilic alkylatlons had occurred from the 
least sterically hindered face of the enolate (4.24). 
The configuration of the 4.4-dlsubstituted CBz oxazolidlnones (4.14-4.15,4.18-4.21, 
i 
SCHEME 4.02) was confirmed by the observation of an n.O.e. between H-2 and C4CH2CO 
In the p-keto ester (4.21). In all reported alkylations4.01 the electrophile attacked the least 
sterically hindered face of the enoiate. Therefore I it is likely that the oxazolidinone (4.11) I 
a precursor of the alkylated (2S,4R)-oxazolldinones (4.14-4.15,4.18-4.21, SCHEME 4.02). has 
the cis configuration. 
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SECTION 4.2.4 
TRENDS IN THE lH NMR/ 13c NMR AND HIGH RESOLUTION MASS SPECTRA 
OF OXAZOLIDINONES 
The lH and lJc NMR spectral data of oxazolldinones (4.11, 4.14-4.15, 4.18-4.19, 4.21-
4.22, 4.25-4.26, 4.30, 4.32, SCHEMES 4.01-4.04) and of literature oxazolidinones4.02-4.03 (4.36-
4.39) are summarized In TABLE 4.03. 13c NMR resonances for C-2, C-4, C4CH2Ph, C-3, PhCN 
and PhCH20CN appeared at characteristic chemical shifts for all examples. In the 1 H 
NMR spectra, H-2 characteristically resonated at o 5.29-6.51. In the alkylated 
oxazolldlnones (4.14-4.15, 4.18-4.19, 4.21, 4.25-4.26', 4.30, 4.32) C4CH2Ph and C4CH2R 
appeared as AB quartets with J= 13Hz and J= 18Hz, respectively. In the CBz oxazolidinones 
(4.11, 4.14-4.15, 4.18-4.19, 4.21) OCH2Ph also appeared as an AB quartet, typically with 
J=12Hz. 
Ph'-/2~p 3 5 
CBz'N) O 
Me'' 
Ph 
4.36 
CBz""N O 
( Me 
Ph 
4.37 
:::) 
Ph((~~'~ 0 
......... ' OH 
o I 
Ph Ph 
4.39 
The mass spectra of the oxazolldinones (4.11, 4.14-4.15, 4.18-4.19, 4.21-4.22, 4.25-
4.26, 4.30, 4.32, SCHEM.ES 4.01-4.04) characteristically showed a large signaL often the base 
peak, at M-91 corresponding to M-CH2Ph. 
Chapter 4 129 
...... 
w 
0 
TABLE 4.03: Characteristic lH and 13c NMR Resonances of Oxazolidinones 
C4CH2?h (ABq) C4CH2R (ABq) 
No. C-2 C-4 C'40-l2 CON oH-2 oHa oHb JAB Hz oHa oHb JAB Hz 
4.11 82.2 58.3 36.6 153.9 6 . .45 3.19-3.43* N/A 
4.14 13c NMR not recorded 5.95 3.25 3.56 13.2 3.19 3.89 17.4 
4.15e 89.4 65.2 41.9 151.7 5.29 3.27 3.67 13.4 3.51 4.761 18.0 
and and and and and and and 
89.5 65.7 42.7 152.2 5.33 3.29 3.46 13.2 3.59 4.69 18.6 
4.18 00.6 65.0 38.9 152.2 6.30 3.25 3.87 13.5 3.13 3.57 18.1 
4.19 13c NMR not recorded 6.30 3.20 3.50 13.2 3.61 4.37 19.1 
4.21 00.4 64.3 41.7 152.2 6.38 3.20 3.52 13.2 3.28 4.10 18.8 
4.22 91.3 57.8 34.9 169.3 5.83 3.4* N/A 
4.25 13c NMR not recorded 6.13 3.41 4.02 13.3 3.34 4.16 17.6 
4.26 00.7 67.7 42.9 169.0 6.06 3.41 4.12 13.5 4.05 4.59 18.5 
4.29 91.7 66.1 38.7 170.3 6 . .45 3.42 4.04 13.4 3.26 4.14 18.0 
4.30 13c NMR not recorded 6.39 3.38 3.98 13.4 3.76 4.65 19.1 
4.32 91.6 65.4 42.3 170.0 6.49 3.37 3.99 13.4 3.41 4.39 19.0 
4.36 88.5 61.7 41.8 153.2 1 H NMR not reported 
4.37 85.1 64.9 40.9 151.7 1 H NMR not reported 
4.38 91.6 66.2 39.1 169.8 6.51 3.71 ABq 13.5 3.61 ABq 17.5 
4.39 89.9 69.4 39.3 165.1 6.12 3.11 ABq 14 N/A 
* 1 H NMR resonance overlapped with other resonances 
• 1 H and 13c NMR resonances are given for both conformers 
OCH2Ph (ABq) 
oHa oHb JAB Hz 
5.05 5.16 12.1 
4.66 5.(12 12.7 
4.74 5.00 12.2 
and 
5.21 5.29 12.2 
4.82 5.11 12.2 
4.84 5.10 12.2 
4.79 5.05 12.2 
SECTION4.3 
BENZOYL DIMER 
Formation of the compound, tentatively assigned as the dimer (4.33), competed 
with electrophilic alkylation of the benzoyl enolate (4.24, SCHEME 4.04) by BrCH2C02CHPh2 
or BrCH2COC(PPh3)C02Et. For the more sterlcally hindered electrophile; 
BrCH2COCCPPh3)C02Et. the reaction leading to formation of the dlmer (4.33) was more 
favoured (Section 4.2.2). 
4.33 
Dimer (4.33) was also prepared, In 62% yield after chromatography, when LiHMDS 
(1.1 equivalent) and oxazolidinone (4.22) were dissolved in THF and stirred at -78 oc for 2h 
followed by 20 oc for 16h. 
The dlmer (4.33) Is likely to form via a mechanism lnvolylng self condensation of 
oxazolidlnone (4.22). Other examples of self condensation of oxazolldinones have been 
reported4.09. 
The structure of the dlmer (4.33) was determined primarily by 1 H and 13c NMR 
spectroscopy. The 13c NMR spectrum of the dlmer (4.33) showed resonances at o 90.7, 
7 4.6 and 38.1 which are characteristic of C-2, C-4 and CH2Ph. respectively (TABLE 4.03) and 
therefore reflect that (4.33) Is an oxazolidinone. This was supported by the 1 H NMR 
spectrum which had resonances at o 4. 72 (s, 1 H) and 3.61, 4.46 (ABq. JAa= 13.9Hz) which are 
characteristic of H-2 and CH2Ph. respectively (TABLE 4.03). The remaining fragment was 
determined as containing two aromatic groups (from the lH and/or 13c NMR spectra). 
NH (from the 1 H NMR spectrum), a carbonyl group (from the l3c NMR spectrum) and a 
. ' 
methine proton (from the 1 H and 13c NMR spectra). Consideration of the chemical shifts 
and the connectivity of the oxazolldlnone (4.22) from which the fragment Is derived led to 
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proposal of the dlmer (4.33). The lH and 13c NMR assignments were supported by an 
NMR proton~carbon heteronuclear correlation experiment. The mass spectrum, IR 
spectrum and combustion analysis were also consistent with the proposed structure 
(4.33). The absolute stereochemistry about C4C*HPh Is unknown. An X-ray crystal 
structure analysis, planned for the future, will unambiguously determine the structure of 
the compound (4.33). 
SECTION4.4 
SYNTHESIS OF THE TARGET ENAMINO ESTERS 
The target enamlno esters (4.01-4.06, SCHEMES 4.05 and 4.07) were synthesized 
from CBz phosphorane oxazolldlnone (4.15) via the insertion reaction (discussed In detail 
In Chapter 2) and the target enamlno esters (4.02 and 4.07, SCHEME 4.08) were synthesized 
from CBz ~-keto ester oxazo!idlnone (4.21) via the enamlne route (discussed In detail in 
Chapter 3). The benzoyl oxazolidinones (4.25 and 4.29, SCHEME 4.02) were not used to 
prepare the corresponding benzoyl enamino esters. 
SECTION 4.4. 1 
SYNTHESIS OF TARGET PROTIO AND BROMO ENAMINO ESTERS VIA THE 
INSERTION REACTION 
Hydrolysis of the phosphorane oxazolidlnone (4.15), dissolved In a mixture of THF 
and methanol, by reflux with 3.33N LIOH (103 equivalent) for 4h (SCHEME 4.05) gave the keto 
acid phosphorane (4.40) quantitatively. The related phosphorane oxazolidlnone (3.18) 
was hydrolyzed by the less harsh conditions of treatment with 1 N NaOH (1 0 equivalent) at 
20 oc for 4h, In methanol4.1 o (Section 3.3.2, Chapter 3). The keto acid phosphorane (4.40) 
was relatively unstable and was used subsequently without further purification. However. 
methylation with CH2N2, followed by radial chromatography, gave the corresponding 
methyl ester (4.41) which was fully characterized. The acid (4.40) and methyl ester (4.41) 
existed as single conformers, unlike the oxazolldinone (4.15, Section 4.2.1). 
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4.42Z 
\ 
Gly-OEt.HCI/ I 
Et 3N 
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4.43 
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The keto acid phosphorane (4.40) was refluxed In THF for 6h to give the protlo 
enollactone (4.43) which was lsol,ated In a yield of 73% following radial chromatography 
(SCHEME 4.05). The corresponding E- and Z-bromo enollactones (4.42E and 4.42Z, 
respectively) were formed via bromo enoHactonlzatlon of the keto acid phosphorane 
(4.40) (SCHEME 4.05). Halo enol-lactonlzatlon of keto-acid phosphoranes Is discussed In 
detail in Chapter 1. Thus, a CH2CI2 solution of the acid (4.40), Br2 (1 equivalent) and 
triethylamine (1 equivalent) was stirred at 0 oc for 20m in and at 20 oc for 30mln. The solvent 
was evaporated under reduced pressure to give a residue which contained, by 1 H NMR 
spectroscopy, E and z isomers in a ratio of 46% E (4.42E): 54% z (4.42Z). The isomers were 
separated by radial chromatography to give a combined yield of 68%. 
The protio enollactone (4.43) and bromo enollactone (4.42E or 4.42Z) were 
dissolved in CH2CI2 and stirred for 16h at 20 oc with glycine ethylester hydrochloride (2-3 
equivalent) and triethylamine (2-3 equivalent) to yield the corresponding acylated amino 
alcohols (4.45 and 4.44, respectively, SCHEME 4.05). For the less substituted succinimlde 
series discussed In Chapters 2 and 3, the acyclic keto-amide intermediate (for example 
2.36, SCHEME 2.08, Section 2.1, Chapter 2) was Isolated. In th.e case of (4.44) and (4.45) 
Increased substitution promotes cycllzation via the "gem-dimethyl effect" (also known 
as the ''Thorpe-Ingold effect")4.11 and consequently the acylated amino alcohols (4.44 
and 4.45) were isolated as the reaction intermediates. Protio hydroxy lactam (4.45) 
contains 2 chlral centres and was observed, by 1 H NMR spectroscopy, to exist as a 
mixture of 2 diastereoisomers In a ratio of 9 : 1. Bromo hydroxy lactam (4.44) contains 3 
chlral centres and was observed by lH NMR spectroscopy to exist as a complex mixture 
of dlastereolsomers. 
The protio enamino ester (4.02) and bromo enamino esters (4.01E and 4.01Z) were 
formed when the protio (4.45) and bromo (4.44) acylated amino alcohols, respectively, 
were dissolved In 1, 2-dichloroethane, containing PTSA, and refluxed for 3-3.5h with 
azeotropic removal of H20. The crude enamlno esters were purified by radial 
chromatography to give E-protlo enamlno ester (4.02) in a yield of 68% and an 
inseparable mixture of E- and Z-bromo enamino esters (4.01E and 4.01Z, respectively) In a 
combined yield of65% and In the ratio of 15% E (4.01E): 85% z (4.01Z), by lH NMR 
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spectroscopy. The bromo enamlno esters (4.01) were prepared In Identical yield and 
Isomer ratio from reaction of glycine ethyl ester with E~bromo enollactone (4.42E) and Z-
bromo enollactone (4.42Z). This observation Is consistent with the Insertion reaction 
mechanism shown In SCHEME 2.20 (Section 2.5, Chapter 2). The corresponding Imide 
(4.46, SCHEME 4.06) was Isolated from the crude bromo enamino ester reaction mixture In 
13% yield. It Is likely that the Imide (4.46) forms from the hydroxy Iactam (4.44) via a retro-
Clalsen type reaction as discussed In Section 2.7. Chapter 2 and summarized In SCHEME 
4.06. We expect that the yield of bromo enamlno esters (4.01E and 4.01Z) could be 
elevated by acetate formation with 4-DMAP (discussed in Section 2. 7. 1, Chapter 2). 
SCHEME4.06 
0 
CBzNH 0 
-------- ···'' N_/ 2 
PTSAI heat CBzNH~ CO Et 
I 
Ph 
0 
4.46 
The 3.3-disubstituted bromo enamino esters (4.01E and 4.01Z) were stable, unlike 
the less substituted bromo and chloro enamino esters (Sections 2.7.1-2.7.2, Chapter 2 and 
Section 3.2.3, Chapter 3), because the competing elimination reaction was blocked by 
3 ,3-dlsubstitution. 
The protio enollactone (4.43) and bromo enollactones (4.42E and 4.42Z) from 
which the bromo and protio enamino esters (4.01 and 4.02, respectively) were derived, 
may be inhibitors of chymotrypsin in their own right (Section 1.3. 1 and 1.3.2, Introduction); . 
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SECTION 4.4.2 
SYNTHESIS OF OTHER PROTIO ENAMINO ESTERS VIA THE 
INSERTION REACTION 
Synthesis of the target enamlno esters (4.03-4.06) Is summarized In SCHEME 4.07. 
The protio enollactone (4.43). glycylglyclne ethylester hydrochloride (5.4 equivalent) and 
triethylamine (5.4 equivalent) In 1. 2-dichloroethane were refluxed for 44h with azeotropic 
removal of H20. PTSA was added and the mixture was refluxed for a further 4h with 
azeotropic removal of H20. Purification by radial chromatography gave E-enamino 
ester (4.03) In a yield of 64%. 
E-enamlno ester (4.03) was also prepared, In the reduced yield of 51%, via the 
stepwise addition of glycine units. This demonstrates the feasibility of incorporating an 
Inhibitor Into an ollgopeptlde specific for the target enzyme. Reaction of protlo 
enollactone (4.43) with tert-butyl glycine ethylester hydrochloride (2 equivalent) and 
triethylamine (2 equivalent) In CH2CI2 at 20 oc gave the corresponding hydroxy lactam 
(4.47) as a mixture of dlastereoisomers In the ratio of 9 : 1. by 1 H NMR spectroscopy. 
The hydroxy lactam (4.47) was dissolved in l, 2-dlchloroethane containing PTSA 
and refluxed for 3h, with azeotropic removal of H20, to give the tert-butyl E-enamlno ester 
(4.04). More PTSA was added to tert-butyl E-enamlno ester (4.04), dissolved In benzene, 
and the solution was refluxed. with azeotropic removal of H20. for 3h to yield the 
deprotected E-enamlno ester (4.05). Finally, E-enamino ester (4.05). DCC (1 ,3-
dicyclohexylcarbodilmlde) (1 equivalent), glycine ethylester hydrochloride (1.1 
equivalent) and triethylamine ( 1. 1 equivalent) In CH2CI2 were stirred at 20 oc for 16h to form 
crude E-enamlno ester (4.03) which was purified by radial chromatography. 
Protlo enollactone (4.43), (S)-alanine methylester hydrochloride (15 equivalent) 
and triethylamine (15 equivalent), in 1, 2-dichloroethane, were refluxed for 43h with 
azeotroplc removal of H20 to give crude E-enamlno ester (4.06) which was isolated in a 
yield of 78% following radial chromatography. The reaction with (S)-alanlne methylester 
demonstrates that the Insertion reaction Is generally applicable to Incorporation of 
different amino acids into 3,3-disubstituted enollactones. E-enamino ester (4.06) was also 
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of value In assessing the optical purity of the products of the Insertion reaction (discussed 
later In Section 4.5.3). 
SCHEME4.07 
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SECTION 4.4.3 
SYNTHESIS OF TARGET PROTIO ENAMINO ESTERS FROM 
(3-KETO ESTER 
In contrast to the simpler systems described in Chapter 3 (Sections 3.2-3.3), the 
corresponding enamlne (4A8, SCHEME 4.08) or Imine was not detected, by lH NMR 
spectroscopy, following reflux (2-18h) of a 1, 2-dlchloroethane or benzene solution of p-
keto ester (4.21) with glycine ethylester hydrochloride (2-20 equivalent) and triethylamine 
(2-20 equivalent). 
SCHEME4.08 
,,. ( 
Ph 
Et02C 
4.21 
Gly~~~:~~x Ets/ 
CBzNH 
Gly-OEtl TiCI4 
CBzNH 
0 
Et02C 
4.4.8 
0 
NH~ 'c~Et 
N_/C~Et 
N-"Bu 
TiCl4 has been used as a Lewis acid catalyst in cases when formation of 
enamines has proven difficult4.12. TiCI4 also removes H20 formed in the reaction as Ti02. 
Therefore, TiCI4 (0.5 equivalent) was added top-keto ester (4.21) and butylamine (4 
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equivalent) In toluene, at 0 oc, and after warming to 20 oc the solution was refluxed for 18h. 
The residue was purified by preparative tic on silica to give E-enamino ester (4.07) in 6% 
yield (SCHEME 4.08). 
Similarly, E-enamlno ester (4.02) was prepared via the TICI4 mediated reaction of 
~-keto ester (4.21) with glycine ethylester (10 equivalent) In ether and toluene (SCHEME 
4.08). Purification by preparative tic on silica gave E-enamino ester (4.02) In 12% yield. 
Although not Isolated, the enamlnes (for example 4.48, SCHEME 4.08) or corresponding 
imlnes are the likely precursors of the enamino esters (4.02 and 4.07). The yields of 
enamino esters (4.02 and 4.07) were very low, hence the more viable synthesis of the 
target enamino esters Is by the insertion reaction discussed previously (Sections 4.4.1-
4.4.2). 
SECTION4.5 
CHARACTERIZATION OF TARGET ENAMINO ESTERS 
SECTION 4.5. 7 
ASSIGNMENT OF E/Z CONFIGURATION TO ENOLLACTONES 
AND ENAMINO ESTERS 
The configuration of the enollactones (4.42-4.43) and enamlno esters (4.01-4.07) 
was assigned on the basis of 1H NMR spectroscopy. For the bromo enollactones (4.42), 
the Z Isomer (4.42Z) was assigned on the basis of a downfield shift of the (H-4)2 
resonance, relative to theE isomer (4.42E), which reflects the deshielding effect of C02Et 
<TABLE 4.03). The deshielding effect of C02Et was also used to assign E/Z configuration to 
the enollactones and enamino esters discussed In Chapters 1 and 2-3, respectively. 
Other differences between the 1 H NMR spectra of E- and Z-bromo enollactones were 
that the (H-4)2 protons appeared as an AB quartet in the z isomer (4.42Z) and as a 
multiplet in the E isomer (4.42E), and OCH2CH3 appeared as a multiplet In the Z Isomer 
(4.42Z) and as a quartet in the E isomer (4.42E). 
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The ylidene carbon, C-5, resonance was downfleld In the Z Isomer (4.42Z); o 159.7, 
relative to theE Isomer (4.42E); o 155.3, which Is consistent with the trend observed in the 
simpler chloro and bromo enollactones (Section 7.8, Chapter 1). 
The major bromo enamlno ester was assigned the Z configuration (4.01Z) due to 
the similarity of its 1H NMR spectrum to that of Z-bromo enollactone (4.42Z). For the z-
bromo enamlno ester (4.01Z), the resonance arising from (H-4)2 was at a similar chemical 
shift to CH-4)2 In the Z-bromo enollactone (4.42Z) which again reflected the deshlelding 
effect of C02Et (TABLE 4.03). Also, the multiplicity of the (H-4)2 and OCH2CH3 resonances 
of the major bromo enamlno ester (4.01Z) were the same as In Z-bromo enollactone 
(4.42Z); namely, an AB quartet and multiplet respectively. 
TABLE 4.03 
0 
CBzNH 
H or Br 
Compd E VS Z o (H-4)0 o (H-4)b JAB (Hz) 
4.01Z z 3.42 3.92 17.3 
4.02 E 3.38 3.89 18.6 
4.()3 E 3.37 3.79 19.1 
4.()4 E 3.37 3.82-4.31* 17.6 
4.0S E 3.37 3.84 18.6 
4.D6 E 3.37 3.71 18.6 
41J7 E 3.55* 3.80 18.8 
4.43 E 3.50 3.82 19.1 
4.42Z z 3.49 3.80 19.1 
No E vs Z o (H-4)2 
4.42E E 3.37m 
* 1 H NMR resonance overlapped with other resonances 
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The remaining protio enollactone (4.44) and protio enamino esters (4.02-4.07) were 
assigned the E configuration because the chemical shift of the (H·4)2 resonances 
indicated deshielding by C02Et (TABLE 4.03). In the protio enollactone and enamlno 
esters (4.43,4.02-4.07), the (H-4)2 resonances were AB quartets at approximately the 
same chemical shifts as the AB quartet of (H-4)21n the Z-bromo enollactone (4.42Z) and 
Z-bromo enamino ester (4.01Z), which have the same relative configuration (TABLE 4.03). 
Also, for the simpler succlnimlde-based protio enollactones and acylated enamino 
esters (Section 2.3.2, Chapter 2) the E isomer was invariably favoured. 
SECTION 4.5.2 
TRENDS IN THE lH NMR, 13c NMR AND HIGH RESOLUTION MASS SPECTRA 
OF ENOLLACTONES AND ENAMINO ESTERS 
TABLE 4.041ists characteristic lH and l3c NMR resonances of enollactones (4.42-
4.43) and enamlno esters (4.01-4.07). Key 13c NMR resonances of enamlno ester (4.02) 
were able to be assigned following an NMR proton-carbon heteronuclear correlation 
experiment, and by analogy, characteristic resonances in the .13c NMR spectra of 
enollactones (4.42-4.43) and enamino esters (4.0 1, 4.03, 4.06-4.07) were also assigned. 
Thus, the range of resonances observed for C-4, CH2Ph, C-3, OCH2Ph, =CH and NCH2 
(where applicable) was 5 36.9-40.3,42.2-42.5, 59.1-60.4, 67.1-67.7, 92.9-98.7 and 41.4-44.9, 
respectively (TABLE 4.04). 
In the lH NMR spectra of enollactones (4.42-4.43) and enamlno esters (4.01-4.07) 
the C3CH2Ph and (H-4)2 resonances were distinguishable on the basis of the upfleld 
position of C3-CH2Ph relative to CH-4)2. Also, the gemlnal coupling constants of the 
' C3CH2Ph AB quartets; J= 13.Q-13.2Hz, was considerably smaller than the gemlnal coupling 
constants of the (H-4)2 AB quartets; J= 17.3-19.1 Hz (TABLES 4.02 and 4.03). 
For enamino ester (4.02) the 1 H - 13c NMR correlation experiment showed that the 
lH NMR resonance at a 4.99 was coupled to the 13c NMR resonance at a 92.9 
characteristic of =CH, whereas the 1 H NMR resonance at o 5.27 did not show coupling to 
any 13c NMR resonances. Hence the resonances at o 4.99 and o 5.27 were assigned to 
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TABLE 4.04: Characteristic lH and 13c NMR Resonances of Enamino Esters and Enollactones 
o 13c NMR o lH NMR 
No. C-4 NCH2 C4CH2 C-3 OCHth =CH =CH Cs) NH (S) C4CH2Ph NCH2 OCH2f'h 
4.01Z 40.3 44.9 42.5 59.1 67.2 98.7 5.08* 5.29 3.04/3.09 ABq 4.76/4.83 ABq 5.08 m* 
J=13.2Hz J=18.4Hz 
4.02 36.9 41.9 42.5 59.3 67.1 92.9 4.99 5.27 3.05m 4.09/4.43 ABq 5.01/5.10 ABq 
J=17.6Hz J=l1.8Hz 
4.03 36.9 41.4 42.2 59.1 or 67.7 92.9 5.11 5.42 2.97/3.11 ABq 3.65/4.67 ABq 5.02s 
59.8 J=13.2Hz J=17.1Hz 
4.04 lSc NMR spectrum was not recorded 5.29 5.38 3.05m 3.82-4.31 m* 5.08m 
4.05 13c NMR spectrum was not recorded 5.06 5.38 3.01/3.07 ABq 4.23/4.36 ABq 5.03/5.07 ABq 
J=13.2Hz J=17.5Hz J=l2.2Hz 
4.06 37.0 N/A 42.5 59.1 or 67.1 93.7 5.01* 5.27 2.98/3.07 ABq N/A 5.01 m* 
59.7 J=l3.2Hz 
4.07 13c NMR spectrum was not recorded 4.98 5.27 2.98/3.03 ABq 3.35 m* 5.05/5.08 ABq 
J=l3.0Hz J=l2.0Hz 
4A2E 40.2 N/A 42.5 59.9 67.7 94.6 N/A 5.40 3.03/3. 15 ABq N/A 5.11 m 
J=13.2Hz 
4.42Z 39.1 N/A 42.5 ffl.4 67.7 90.7 N/A 5.40 2.98/3.14 ABq N/A 5.09m 
J=13.2Hz 
4.43 37.3 N/A 42.5 59.5 67.7 97.9 5.34 5.46 2.99/3.14 ABq N/A 5.10m 
J=l3.2Hz 
" 1 H NMR resonance overtopped with other resonances 
=CHand NH, respectively. From this result, NH was assigned as downfield relative to =CH 
for all protio enollactones and enamlno esters (4.43, 4.02-4.07). 
The mass spectra of the enamlno esters, like that of oxazolldinones (4.11, 4.14-4.15, 
4.18-4.19, 4.21-4.22, 4.25-4.26, 4.30, 4.32, Section 4.2.4), characteristically showed a large 
signal, often the base peak, at M-91 corresponding to M-CH2Ph. 
The endocycllc Isomer (4.49) was discounted as the product of the Insertion 
reaction between bromo enollactone (4.42) and glycine ethylester because 1 H NMR 
resonances characteristic of the olefinic proton and CHBr were not obseNed. Instead 
resonances were obseNed at o 3.42 and 3.92, consistent with (H-4)0 and (H-4)b of the 
enamlno ester (4.01). The 1 H and 13c NMR spectra of (4.02-4.07) showed the same 
characteristic resonances as those of the bromo enamlno ester (4.01), hence, by 
analogy, (4.02-4.07) were assigned as enamlno esters rather than the corresponding 
endocycllc Isomers (4.50). Further, enamlno ester (4.02) was prepared via the Insertion 
reaction and the enamlne route, which Is unlikely to give rise to the endocyclic Isomer. 
0 
CBzNH 
X 
4.49 X= Br R = CH2C~Et 
4.50 X=H 
SECTION 4.5.3 
OPTICAL ACTIVITY OF ENAMINO ESTERS 
It was expected that the sequence of reactions (SCHEMES 4.01, 4.03-5) leading to 
the enamlno esters (4.01-4.07) would not cause racemization at the chlral centre(s). The 
(a)o20 values of the enamino esters (4.01-4.07), enollactones (4.42-4.43) and 
oxazolidlnones (SCHEMES 4.01-4.04) showed the compounds to be optically active. 
In the 13c NMR spectrum of enamlno ester (4.06), derived from enollactone (4.43) 
and (S)-alanine methyl ester hydrochloride, less than 5% of another diastereolsomer was 
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observed. Therefore.lt Is very unlikely that racemization had occurred at C-3 in enamlno 
ester (4.06) or In Its precursors. By analogy, the other enamlno esters (4.01-4.05 and 3.16, 
Chapter 3) prepared via the same general method are assumed to be optically pure. In 
the future we expect to confirm the stereochemistry and configuration of the enamlno 
esters (4.01-4.07) by single crystal X-ray structure analysis. 
SECTJON4.6 
PRELIMINARY TESTING OF ENAMINO ESTERS AND ENOLLACTONES 
A colorimetric-based assay was used to measure the inhibition of a-
chymotrypsin by enamlno esters and enollactones (2.71, 3.04, 4.01-4.03, 4.06, 4.42-4.43). 
The % Inhibition for solutions of enamino esters and enollactones was measured, for a 
fixed time IntervaL relative to a control containing a-chymotrypsin and substrate (namely 
N-succinyl alanine 4-nltroanilide). The results of the assay are summarized in TABLE 4.05. 
TABLE 4.05 
0 
H 
H H 
2. 71 ,3.04 4. 02-4.03,4.0 6, 4.43 
Compd X concn* %1 
(mmoi/L) 
2.71 H 7.8x1Q·4 0 
3.04 CBzNH 4.9x1Q-4 0 
4.01 NCti2C0:2Et 3.5xl0·4 2) 
4.02 NCti2C0:2Et 4.0xlo-4 0 
4.03 NCt12CONHCH2C0:2Et 3.6xlo-4 5 
4.06 (S)-NCH(Me )C02Et 3.9x1Q·4 0 
4.42£ 0 4.5xl0·4 15 
4.422 0 4.5xlo-4 5 
4.43 0 4.9xlo-4 10 
%1 = % Inhibition * all 2x1Q-4mg/mL 
0 
Br 
4.01,4.42 
concn" 
(mmoi/L) 
7.8x1Q·l 
4.9x1Q·l 
3.5xlo-1 
4.0x1Q·l 
3.6xlo-l 
3.9xlo-l 
4.5x1Q·l 
4.5xl0-1 
4.9x1Q·l 
%1 
5 
25 
4) 
4) 
4) 
BJ 
4) 
35 
25 
.., 
all2xlo-1mg/mL 
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Bromo enamino ester (4.01), E-bromo enollactone (4.42E) and protio enollactone 
(4.43) showed significant Inhibition of a-chymotrypsin at concentrations of 2x w-4 mg/ml. 
The results of the a-chymotrypsin assay (TABLE 4.05) for 2x1o-1 mg/ml solutions of 
enamlno esters and enollactones (2.71, 3.04, 4.02, 4.03, 4.06 and 4.43), designed as 
alternate substrate Inhibitors of chymotrypsin, show some Interesting trends. 
Enamino ester (2.71) gave negligible Inhibition whereas (3.04) gave 25% Inhibition 
which Indicates that extension of the peptide chain In the N direction Is a viable strategy 
for optimizing Interaction with the target enzyme and thereby Increasing inhibition. 
Similarly, enamlno esters extended in the C direction by 1 or 2 amino acid residues; (4.02, 
4.03 and 4.06), were more effective inhibitors than the enollactone (4.43). In this study 
attempts were not made to Incorporate the potential inhibitors Into the optimum 
oligopeptide. 
The greater degree of inhibition exhibited by phenylalanine analogues (4.02, 4.03 
and 4.06) compared with enamino esters (2.71 and 3.04) illustrates the importance of the 
aromatic residue at S1 for chymotrypsin inhibition. 
The alanine-derived enamlno ester (4.06) exhibited a greater degree of inhibition 
than the corresponding glycine and glyclglycine derived enamino esters (4.02 and 4.03, 
respectively) which Indicates that Inhibition can be enhanced by Incorporation of the 
Inhibitor Into a peptide which has optimum Interactions with the target enzyme. 
Bromo enamlno ester and enollactones (4.01, 4.42E and 4.42Z) were designed as 
mechanism-based inactivators of a-chymotrypsin and at concentrations of 2xlo-1 
mg/mL showed 35-40% Inhibition. The E-bromo enollactone (4.42E) was a marginally 
better Inhibitor than Z-bromo enollactone. Unlike the protio enamino esters (4.01, 4.43) 
there was little difference between the bromo enamlno esters (4.01) and bromo 
enollactones (4.42E and 4.42Z) with respect to Inhibition. 
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SECTION4.7 
CONCLUSION AND FUTURE WORK 
A new general route to enamino esters, Involving reaction of enollactones and 
amlnes, has been developed and used to synthesize a new class of potential 
mechanism-based lnactlvators and alternate substrate Inhibitors of chymotrypsin. The 
potential inhibitors are optically pure, having the same configuration as natural enzyme 
peptide substrates. The inhibitor Is incorporated into a small peptide, which may be 
varied, and contains a CH2Ph residue for recognition by chymotrypsin. The potential 
mechanism-based inactivators contain a latent reactive group which was incorporated 
via a new reaction involving halo enoHactonlzation of keto-acid phosphoranes. 
Another route to enamlno esters by reaction of p-keto esters with amlnes was also 
developed. 
The two syntheses of enamino esters are versatile and in the future will be 
adapted to incorporate the inhibitor Into different peptides so that the maximum 
enzyme-Inhibitor Interaction is achieved. Also, different recognition groups will be used 
so that other protease enzymes are targeted. 
Use will be made of Me or H, instead of C02Et, as the ylidene substituent, to obtain 
systems which more closely resemble the natural substrate. Further, methods for 
removal of the CBz group and subsequent addition of amino acid residues to the N 
terminus will be investigated. A preliminary result showed that the CBz group was 
removed from enamino ester (4.05) upon refluxing in l, 2-dichloroethane for 5h with PTSA 
( 1.6 equivalent). 
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CHAPTER 5 
NMR SPECTROSCOPY AND 
MASS SPECTROMETRY OF 
KETO ACID AND KETO ESTER 
PHOSPHO RANES 
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SECTION 5. 7 
INTRODUCTION 
The work presented In Chapter 4 has shown benzyl oxycarbonyl (CBz) keto acid 
phosphorane (4.40) to be an important synthetic intermediate to bromo enoilactones 
(4.42) and protio enoilactones (for example 4.43) (SCHEME 5.01). In Chapter 1 extensive 
use was made of keto acid phosphoranes as synthetic Intermediates to bromo and 
chloro enollactones (See Chapter 1 for more detail). Keto acid phosphoranes are also 
synthetic intermediates to allenesS.Ol (for example 5.02) and acetylenes5.02 (for 
example 5.03) (SCHEME 5.02). 
SCHEME5.01 
0 
CBzNH 
SCHEME5.02 
H OH 
Csz-N 
~-~ ( 
Ph PPh3 
Et02C 
Br I 4.40 
r~ 0 CBzNH 
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Another application of keto acid phosphoranes Is In the study of keto acid 
hydrogen-bonding patterns5.03. 
A detailed study of the NMR spectroscopy and. In particular, the high resolution 
mass spectrometry of keto acid and keto ester phosphoranes (4.15. 4.26, 4.40-4.41, TABLE 
5.01), Introduced In Chapter 4, was undertaken. To provide further examples of this class 
of compound the tbutyl keto acid and keto ester phosphoranes (5.04-5.06, TABLE 5.01) 
were also prepared and studied. 
TABLE 5.01 
0 0 
2 II II R ocl(c,R1 
PPh3 
No R1 R2 
CH 9H2Ph 
4.15 ~NCBz Et 
0 0 ).-_Ph 
4.26 
CH CH2Ph 
Et 1"'NCOPh 
o 0 .).-.Ph 
QH2Ph 
4.40 CH2'j-NHCBz Et 
C02H 
CH yH2Ph 
4.41 27-NHCBz Et 
C02 Me 
5.04 (CH2hC02CHPh2 tau 
5.05 (CH2bC02H tau 
5.06 (CH2bC02Me tau 
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SECT/ON5.2 
SYNTHESIS OF KETO ACID AND KETO ESTER PHOSPHORANES 
Keto acid phosphoranes (4.15 and 4.26, TABLE 5.01) were prepared via reaction of 
the appropriate acid chloride with Ph3P=CHC02Et and also by alkylation of the 
appropriate oxazolldlnone with BrCH2COC(PPh3)C02Et. Phosphorane (4.15) existed as a 
1 : 1 mixture of conformers, by lH NMR. Keto ester phosphorane (4.40, TABLE 5.01) was 
prepared by selective hydrolysis of oxazolldinone (4.15) and. on treatment with CH2N2. 
gave the methyl ester (4.41. TABLE 5.01). More detail on the synthesis of phosphoranes 
(4.15, 4.26 and 4.40-4.41) Is given in Chapter 4 (Sections 4.2 and 4.4. 1, respectively). 
The synthesis of keto acid and keto ester phosphoranes (5.04-5.06) Is summarized 
In SCHEME 5.03. 
SCHEME5.03 
~ oxalyl chloride/ DMF 0 CI~C02CHPh2 
5.08 
HO~C02CHPh2 
5.07 
0 
Go 
0 
5.09 
~ PhsP=CHC~ Bu 
0 
'Bu02C~C02CHPh2 
PPh3 
5.04 
~TFA 
0 
'Bu02C~C02H 
PPh3 
5.05 
!C~N2 
0 
'Bu02C~C02Me 
PPh3 
5.06 
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Benzhydryl phosphorane (5.04) was prepared. in 91% yield after radial 
chromatography. via reaction of Ph3P=CHC02tsu (2 equivalent) with 
Ph2CH02C(CH2)2COCI (5.08) In benzene. Benzhydryl ester phosphorane (5.04) was also 
prepared. In the reduced yield of 27%, via the above method with Ph3P=CHC02tsu (1 
equivalent) and lpr2NEt ( 1 equivalent). 
Deprotectlon of benzhydryl phosphorane (5.04), with TFA (trifluoroacetic acid), 
quantitatively gave the keto acid phosphorane (5.05). Keto acid phosphorane (5.05) 
was also preppred from the reaction of succinic anhydride (5.09) with Ph3P=CHC02tsu, In 
CH2CI2. The crude residue contained, by lH NMR spectroscopy, 46% keto acid 
phosphorane (5.05) : 27% succinic anhydride (5.09) : 27% Ph3P=CHC02tsu. Without further 
purification the residue was dissolved in THF and treated with an excess of CH2N2 to give 
the methyl ester phosphorane (5.06), which was Isolated In a yield of 41% following radial 
chromatography. Methyl ester phosphorane (5.06) was also prepared, In 51% yield, 
from the reaction of Me02C(CH2)2COCI (5.10) with Ph3P=CHC02tBu (2 equivalent) in 
benzene. 
SECTION 5.3 
13C and 31p NMR SPECTROSCOPY OF KETO ACID AND KETO 
ESTER PHOSPHORANES 
Traditionally, keto ester and keto acid phosphoranes have been Identified on the 
basis of lH, l3c and 3lp NMR spectroscopyS.04. The l3c and 31p NMR data of keto acid 
and keto ester phosphoranes (4.15, 4.26, 4.40-4.41, 5.04-5.06) were typical of that of 
previously studied phosphorous compounds5.04. Characteristic 13c NMR resonances of 
keto acid and keto ester phosphoranes (4.15, 4.26. 4.4D-4.4L 5.04~5.06), assigned by 
comparison of the chemical shifts and 13c- 31p coupling constants with those of reported 
phosphorous compounds5.04, are shown In TABLE 5.02. The broad band decoupled 3lp 
NMR spectra showed that the phosphorous atom in keto acid and keto ester 
phosphoranes (4.15. 4.26, 4.40-4.41, 5.04-5.06) also resonated In· a characteristic chemical 
shift range; 5 17-19 (downfield relative to 85% H3P04) <TABLE 5.02). 
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TABLE 5.02: Characteristic Resonances In the 13c and 31p NMR Spectra of Phosphoranes 
(4,15 1 4,261 4.40-4.41, 5,04-5,06) 
Characteristic 13c NMR resonances o doublet ( J in Hz) 3lp 0 
No. CH2CO C=PPh3 C02R CH2CO Ipso ortho meta para p 
4.15., 46.0 71.1 167.3 192.1 125.6 133.2 128.6 131.6 18.1 
(7.6) (109.3) (14.1) (6.0) (93.7) (10.1) (12.6) (2.5) 
and and and and and and 
48.0 71.2 167.5 192.2 125.9 133.2 
(7.1) (110.8) (14.5) (5.1) {93.1) (9.6) 
4.26 45.9 70.8 167.4 192.9 125.3 133.4 128.5 131.7 18.3 
(7.1) (110.6) (14.4) (4.6) (93.2) (10.0) (12.6) (2.9) 
41.5 If 166.6 192.8 124.4 133.1 128.8 132.4 18.6 4.40 
(6.1) (13.1) (4.0) (93.7) (10.0) (13.1) (2.1) 
4.41 45.6 71.8 167.6 193.1 126.3 132.2 127.9 131.6 18.0 
(6.1) (110.8) (15.1) (4.0) {93.7) {10.0) (14.1) (3.0) 
5.o4 35.2 70.5 167.3 194.6 127.1 133.0 128.4 131.4 17.7 
(7.6) (109.5) (13.7) (4.3) (93.6) (9.7) (12.7) (2.9) 
5.0S 33.6 73.8 166.6 196.5 125.5 133.0 128.8 132.1 17.3 
(7.3) {107.6) (12.4) (3.7) (93.7) (10.1) (12.5) (3.0) 
35.4 * 167.4 194.9 127.2 133.0 128.5 131.4 17.2 5.Q6 
(7.3) (13.8) (4.5) (93.1) (9.8) (12. 1) (3.0) 
Y Keto acid phosphorane (4.15) existed as a 1 : 1 mixture of conformers (Section 4.2. 1, 
* 
Chapter 4) and data Is given for both conformers 
Insufficient sample to obtain C=PPh3 
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SECTION5.4 
FAB MASS SPECTROMETRY OF KETO ACID AND KETO ESTER 
PHOSPHORANES 
Fast atom bombardment CFAB) mass spectra of the keto acid and keto ester 
phosphoranes (4.15. 4.26. 4.40--4.41. 5.04-5.06) were also characteristic. TABLE 5.021ists the 
relative abundance of positive Ions obseNed In the FAB mass spectra of phosphoranes 
(4.15. 4.26. 4.40-4.4 1. 5.04-5.06). 
TABLE 5.02 Relative Abundance of Positive Ions in FAB Mass Spectra of the Keto Acid 
and Keto Ester Phosphoranes (4.15, 4.26. 4.40--4.41, 5.04-5.06) 
No m/z (relative intensity. %) 
4.15 776 (38), 730 (35). 390 (35), 375 (80).303 (100). 279 (32). 262 (51), 201 (51), 183 (80)0 
4.26 746 (81). 700 (56), 390 (65), 375 (89). 303 (100). 279 (26). 262 (63). 201 (38), 183 (56). 
165 (45)0 
4AO 688 (45).642 (20), 612 (21). 508 (31).390 (41).375 (71). 349 (25). 303 (100). 279 (39), 
262 (53).225 (20).201 (38). 183 (65)0 
4.41 702 (86). 656 (22). 390 (64),375 (71),303 (100), 279 (21), 262 (43), 201 (22), 183 (38)0 
5.04 643 (10). 569 (8),403 (15).347 (30), 303 (30), 279 (7). 262 (8),201 (34). 183 (15), 167 
(100), 152 (l2)b 
5.0S 477 (41), 403 (54), 377 (58).347 (45), 321 (99), 303 (82). 279 (29).262 (24), 201 (21), 
183 (58), 152 (lOO)b 
5.06 491 (41).417 (57),403 (11). 347 (56), 303 (100),279 (26),262 (15), 201 (18). 183 (32), 
152 (16)b 
a Spectra run in nitrobenzyl alcohol 
b Spectra run in "magic bullet" (ie 1 dithioerythrltol : 5 dlthlothreitol) 
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All spectra showed the protonated molecular ion (MH)+ and a common 
fragmentation pattem. Fragment Ions occurred at (MH-74)+ for tbutyl phosphoranes 
(5.04-5.06), which corresponds to loss tbutanot and at (MH-46)+ for ethyl phosphoranes 
(4.15,4.26,4.40-4.41) which corresponds to loss of ethanol. Loss of Rl resulted in fragment 
Ions at m/z 403 for tbutyl phosphoranes (5.04-5.06) and at m/z 375 for ethyl phosphoranes 
(4.15 I 4.26 A.4o-4.41). Characteristic fragment Ions were also observed at m/z 303 
(C2QH160P)~ 279 (C1sH160P), 262 CC1aH1sP) and 20l CC12H100P) for ethyl and tbutyl 
phosphoranes (4.15, 4.26, 4.4o-4.41, 5.04-5.06). 
FAB mass spectra of seven other keto acid and keto ester phosphoraness.os 
(5.11-5.17, TABLE 5.03), each with R2=Et also showed the protonated molecular ion (MH)+ 
and the same fragmentation pattern as phosphoranes (4.15,4.26,4.40-4.41, 5.04-5.06); 
namely, signals at m/z 375 (loss of Rl), 303,279,262,201 and (MH-46)+. The fragmentation 
pattem of the phosphoranes (4.15 I 4.26 I 4.40-4.41 I 5.04-5.06, 5.11-5.17), summarized In 
SCHEME 5.04, was supported by the results of metastable decompositions for 
phosphoranes (5.12, 5.15-5.16) and high resolution results. 
TABLE 5.03 
No R1 R2 
5.11 (CH2)2C02H Et 
5.12 (CH2bC02H Et 
5.13 (CH2)4C02H Et 
5.14 CHBr(CH2)sC02H Et 
5.15 CH2C02 Me Et 
5.16 (CH2bC02CHPh2 Et 
5.17 (CH2)4C02Me Et 
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SCHEME 5.04: FAB Positive lon Fragmentation Pathway for Keto Acid and Keto Ester 
Phosphoranes (4.15, 4.26, 4.4Q-4.41 , 5.04-5.06) 
/ 
o ol+ 
2 II II 
2 
R OCI(C 
R = Et m/z 375 PPh
3 
R2 = 1Bu m/z 403 \ 
m/z 279 
* 
0 0 l + 
''!( c 1 R 
PPh3 
[MH - EtOH]+ 
[MH - tBuOH]+ 
~Ph2P=or 
mlz 201 
Ph3 Pl + 
m/z262 
Bold lettering designates high resolution result 
*Verified by metastable transitions for phosphoranes (5.12, 5.15 and 5.16) 
Representative mass spectra; of phosphoranes (4.26) and (5.06), are shown; 
Spectrum 5.01 and Spectrum 5.02, respectively. 
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Spectrum 5.01 
m/z 
Spectrum 5.02 
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In the literature, mass spectral data of phosphoranes Is limited to positive and 
negative ion electron Impact (EI) mass spectrometry of simple trlphenyl 
phosphoranes5.06-5.o7. It is reported5.07 that 0 alkyl cleavage to give the species (5.18), 
followed by loss of R lc=C=O gives rise to the ion observed at m/z 2781n the El spectra of 
simple trlphenylphosphoranes (SCHEME 5.05). The formation of (5.18) was substantiated 
by the observation of a metastable peak. The protonated version of the fragment ion 
m/z 2781s observed In the FAB mass spectra of keto acid and keto ester phosphoranes 
(4.15.4.26, 4.41,5.04-5.06) at m/z 279, and It is probably formed from the protonated 
molecular ion (MH)+ via the same mechanism. 
SCHEME5.05 
PflaP=CR1 C~Et 
(R1 = H or Me) 
-OEf 
* 
*Verified by a metastable transition 
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SECT/ON5.5 
CONCLUSION 
Keto acid and keto ester phosphoranes are Important as synthetic Intermediates 
to enollactones, allenes and acetylenes and also In the study of keto acid hydrogen-
bonding patterns. The resonances obseNed In the 31p and 13c NMR spectra of keto 
acid and keto ester phosphoranes (4.15, 4.26, 4..40--4.41, 5.04-5.06) occurred at 
characteristic chemical shifts and the 13c- 31p coupling constants In the 13c NMR 
spectra were also diagnostic. The FAB mass spectra of phosphoranes (4.15, 4.26, 4.40-
4.41, 5.04-5.06) showed the protonated molecular ion and a common fragmentation 
pattern; fragment ions were observed corresponding to (MH-46)+ and at m/z 375,303,279, 
262,201 and for the tbutyl phosphoranes (5.04-5.06), and corresponding to (MH-76)+ and at 
m/z 403,303,279,262,201 for ethyl phosphoranes (4.15,4.26, 4.40.4.41). Hence, on the basis 
of the fragmentation pattern observed in FAB mass spectrometry, It is possible to Identify 
keto acid and keto ester phosphoranes. 
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EXPERIMENTAL 
Experimental 161 
GENERAL METHODS 
Melting points less than 200 oc were measured using a Reichert micro heating 
stage and are uncorrected. Melting points greater than 200 oc were measured using an 
I 
Electrothermal melting point Apparatus and are uncorrected. 
Infrared spectra were measured using a Pye Unlearn SP3-300 (denoted in the text as IR) or 
Perkin Elmer 1600 FTIR (denoted in the text as FTIR) Spectrophotometer. and were 
referenced on the polystyrene 1603cm-l absorbance. 
Nuclear Magnetic Resonance CNMR) spectra were obtained on a Varian XL 300 
Spectrometer operating at 300 MHz for lH NMR, 75.5 MHz for 13CNMR and 121.5 MHz for 
3lp NMR. lH NMR spectra run in CDCI3 used atrimethylsilane internal standard. and 3lp 
NMR used an external phosphoric acid reference. 1 H NMR Is reported as ppm 
(multiplicity, coupling constant(s) in Hz. assignment). 
Mass spectra were obtained using a Kratos MS80RFA magnetic sector double 
focusing mass spectrometer. 
ORD spectra were recorded using a JASCO J-20C Recording Spectropolarimeter 
and are reported as±<> (concentration in g/lOOmL; solvent). 
Preparative Chromatography was carried out using a Chromatotron (Harrison 
Research Inc.); a centrifugally accelerated radial thin layer chromatograph, using glass 
plates coated with silica gel (P.F. 254 60) of 1 mm, 2mm or 4mm thickness. Visualisation of 
non-coloured compounds was achieved using an ultraviolet lamp. 
Solvents and chemicals. where necessary. were purified by standard 
techniquesE.Ol. 
All reactions were carried out under a dry N2 atmosphere. Following reaction the 
solvent was evaporated under reduced pressure (Buehl Rotary Evaporator. 20mm), 
unless otherwise stated. 
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SECTION E. 7 
CHAPTER 1 EXPERIMENTAL 
SECnON E. 1.1 
PREPARATION OF CHLORO AND BROMO ENOLLACTONES (1. 11-1. 15, 1.17) 
General Method for the Preparation of Chiaro Enollactones 0 .1 1-1.13): 
A solution of the keto acid phosphoraneE.02 (1.06-1.08) (stated amount, 1 equiv) In CH2CI2, 
was cooled to -78 oc and S02CI2 (1.5equlv), followed by triethylamine (1.5equlv) were 
added. The solution was stirred at -78 oc for 30min and was then allowed to warm to 20 oc. 
The solvent was evaporated and the residue was purified by radial chromatography on 
a 2mm silica gel chromatotron plate, eluting with the stated solvent system. 
CE>- and CZ>-5-cb/oroethoxycorbonylmetbylldene-2-tetrohydrofuranone 0.11E and 1.1 JZ): 
0 0 
C02Et Cl 
1.11 E 
General method with phosphorane (1.06) (370mg, 0.83mmol), S02CI2 OOOJ.tL 1.24mmol) 
and triethylamine ( 163J.tL 1.24mmol) in CH2CI2 (20ml). Elution with 55% petroleum 
ether/45% ethyl acetate gave an inseparable mixture of E- and Z-chloro enollactones 
(1.11E and 1.11Z, respectively) (86% E: 14% Z, by lH NMR) as an oil (156mg, 92%): IR (film) 
1840, 1720 and 1650cm-l; lH NMR (CDCI3) E isomer (1.11E) from mixture 8 1.35 (t, J=7.2Hz, 
OCH2CH3), 2.78 (m, (H-3)2), 3.14 (m, (H-4)2), 4.32 (q, J=7.2Hz, OCH2CH3), Z Isomer (1.11Z) 
from mixture o 1.36 (t, J=7.1Hz, OCH2CH3), 2.83 (m, (H-3)2), 3.43 (m, (H-4)2).4.30 (q, J;::;7.1Hz, 
OCH2CH3); 13c NMR (CDCI3) E lsomer(1.11E) from mixture 8 14.01. 25.48, 27.07,61.96, 104.14, 
158.50, 160.88, 173.27, Z isomer (1.11Z) from mixture 8 14.03, 26.48, 27.32, 61.88, 101.40, 161.58, 
162.87, 172.32. HRMS (M) Found 204.0190 (Calcd for CaH935CI04 204.0 190). Anal. Calcd for 
C8H9CI04: C 46.96; H 4.43; Cl17 .33. Found: C 46.36; H 4.32; Cll7 .30. 
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(£)- and (ZJ-6-cb/oroethoxycarbony/methylldeoe-2-tetrabydro.Qyrooe 0 .12E and 1. 12Z): 
Et0
2
5(0 
1.12Z 
General method with phosphorane (1.07) (100mg, 0.22mmol), S02CI2 (26J.tL 0.32mmol) and 
triethylamine (43J.tL 0.32mmol) In CH2CI2 (4mL). Elution with 85% petroleum ether/15%. 
ethyl acetate gave an Inseparable mixture of E- and Z-chloro enollactones (1.12E and 
1.12Z, respectively) (96% E : 4% Z, by 1 H NMR) as an oil (35mg, 73%): IR (oujol) 1790, 1720 
and 1620cm-1; lH NMR (CDCI3) E Isomer (1.12E) from mixture o 1.35Ct.J=7.1Hz, OCH2CH3), 
2.00 (quln,J=6.7Hz, (H-4)2), 2.65 (t, J=6.7Hz, (H-3)2), 2.83 (t, J=6.7Hz, (H-5)2),4.31 (q, J=7.1Hz, 
OCH2CH3), Z isomer (1.12Z) from mixture o 1.35 (t, J=7.2Hz, OCH2CH3), 1.97 (quia, J=6.6Hz, (H-
4)2), 2.72 (t, J=6.6Hz, (H-3)2), 3.20 (t, J=6.6Hz, (H-5)2), 4.28 (q, J=7.2Hz, OCH2CH3); 13c NMR 
CCDCI3) E lsomer(1.12E) from mixture o 14.13, 17.15, 25.51,30.08,62.20, 108.57, 155.42, 161.60, 
165.39; HRMS (M) Found 218.0348 (Calcd for C9H 1135CI04 218.0346). 
(£)- and CZ>-6-ch/oroethoxycarbonylmethy/ldeoe-4.4-dlmethyt-2-tetrabydrooyrooe 0 .13E 
and 1.13Z>: 
0 
General method with phosphorane (1 .08) (100mg, 0.20mmol), S02CI2 (25f..lL 0.31 mmol) and 
triethylamine (40f..lL, 0.31mmol) In CH2CI2 (4mL). Elution with 65% petroleum ether/35% 
ethyl acetate gave an Inseparable mixture of E- and Z-chloro enollactones (1.13E and 
1.13Z, respectively) (88% E: 12% Z, by lH NMR) as an oil (35mg, 70%): lH NMR (CDCI3) E 
Isomer (1.13E)from mixture o 1.13 (s, C(CH3)2), 1.35 (t, J=7.1Hz, OCH2CH3), 2.49 (m, (H-3)2), 
2.66 (m, (H-5)2), 4.32 (q, J=7.1Hz, OCH2CH3), Z isomer from mixture (1.13Z) o 1.10 (s, CCCH3)2), 
1.36 (t, J=7.1Hz, OCH2CH3), 2.54 (m, (H-3)2), 3.05 (m, (H-5)2), 4.28 (q, J=7.1Hz, OCH2CH3); 13c 
NMR CCDCI3) E isomer (1.13E)from mixture o 14.06, 27.96,29.74,38.95,43.53,62.12, 108.91, 
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154.58, 161.56, 165.06; HRMS (M) Found 248.0646 (Calcd for CnH1s37CI04 248.0630), Found 
246.0659 (CalcdforC11H1535co4 246.0660). 
General Method for the Preparation of Phthalic-Based Chloro Enollactones 
0.14-1.15); 
Ph3P=CHC02EtE.OJ (l.lequiv) was added to a stirred solution of anhydride (stated amount, 
1 equlv), In CH2CI2 (8ml). at 0 oc. After 15m In S02CI2 (1.5equiv), followed by triethylamine 
( 1.5equlv), were added and the solution was stirred for 1 h at 0 oc. The solvent was 
evaporated and a 1 H NMR spectrum of the crude mixture allowed estimation of the E/Z 
Isomer ratio. The products were purified by radial chromatography using a 2mm silica 
gel chromatotron plate, eluting with the stated solvent system. 
(£)- and {Z)-3-cbloroethoxycarbooy/methylidene pbthalide (]I 14E and 1 I 14Z); 
General method with Ph3P=CHC02Et (18lmg, 0.52mmol), phthalic anhydride (69mg, 
0.47mmoD, S02CI2 (56J.tL 0. 70mmol) and triethylamine (93J.tl, 0. 70mmol) in CH2C12 (8ml) 
gave E- and Z- chloro enollactones (1.14E and 1.14Z, respectively) (44% E: 56% Z, by lH 
NMR). Elution with 56% petroleum ether/44% CH2CI2 gave Z-chloro enollactone (1.14Z) 
as a white solid (42mg, 35%) (Another radial chromatographic step, eluting with 75% 
petroleum ether/25% ethyl acetate, was necessary to remove unreacted phthalic 
anhydride): mp 114-115 oc (petroleum ether, colourless crystals); IR (KBr) 1800, 1720, 1620 
and 1590cm-l; lH NMR CCDCI3) o 1.44 (t.J=7.1Hz,OCH2CH3),4.43 (q,J:::7.1Hz,OCH2CH3), 7.68 
(dt, J= 1.0, 7.5Hz, H-5), 7.80 (dt, J= 1.3, 8.1Hz, H-6), 7.99 (td, J= 1.0. 7.5Hz, H-7), 8.72 (td, J=0.8, 
8.1Hz,H-4); 13cNMR(CDCI3)l> 14.08,62.79, 108.07, 125.88, 126.15, 127.22, 132.05, 135.39, 135.71. 
152.93, 162.65, 164.44; HRMS (M) Found 254.0151 (Calcd for C12H937CI04 254.0160), Found 
252.0187 (CalcdforC12H935CI04 252.0190). Anal. CalcdforC12H9CI04: C 57.05; H 3.59; Cl 
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14.03. Found: C 56. 90; H 3.50; Cl 14.52. Further elution gave E-chloro enollactone (1.14E) as 
a white solid (32mg, 27%): mp 137-139 oc (petroleum ether, colourless crystals); IR (KBr) 
1790, 1720 and 1630cm-1; lH NMR (CDCI3) o 1.43 (t, J=7.1Hz. OCH2CH3).4.43 (q,J=7.1Hz, 
OCH2CH3), 7.73 (dt, J= 1.0, 7.5Hz, H-5), 7.85 (dt, J= 1.3, 7.7Hz. H--6), 8.04 (td, J= 1.0, 7.6Hz, H-7), 
8.49(td,J=0.8,8.0Hz,H-4); 13cNMR(CDCI3)o 14.17,62.93, 108.31, 125.72, 126.24, 126.65, 132.29, 
135.22, 137.46, 149.67, 161.48, 164.77; HRMS(M)Found254.0190(Calcdforc12H937cro4 
254.0160), Found 252.0186 (Calcd for C12H935CI04 252.0190). Anal. Calcd for C12H9CI04: C 
57.05; H3.59; Cll4.03. Found: C56.90; H3.51; Cl14.32. 
(f)- and (l)-3-chloroetboxycarbonyfmetby/jdene 5,6-dicbloroohtha/lde 0.15E and J.JSZ>: 
General method with Ph3P=CHC02Et ( 181 mg. 0.52mmol), 4 ,5-dichlorophthalic anhydride 
(102mg, 0.47mmol), S02CI2 (56J.tl, 0.70mmol) and triethylamine (93f.ll, 0.70mmol) In CH2C12 
(8ml) gave E- and Z-chloro enollactones (1.15E and 1.15Z, respectively) (23% E: 77% Z, by 
1 H NMR): Elution with 60% CH2CI2/40% petroleum ether gave Z-chloro enollactone 
(1.15Z) as a white solid (109mg, 72%): mp 147-149 oc (petroleum ether, colourless crystals); 
IR(KBr) 1810, 1720and 162Qcm·l; 1HNMRCCDCI3)o 1.44(t.J=7.1Hz.OCH2CHJ),4.44{q, 
J=7.1Hz, OCH2CH3), 8.04 (s, H-7),8.96 (s, H-4); 13c NMR CCDCI3) o 14.04,63.17, 109.73, 125.54, 
127.11, 129.31, 134.47, 137.21, 140.63, 151.41, 162.26, 162.35; HRMS(M)Found321.9359(Calcd 
forC12H737cr35c1:204 321.9381), Found 319.9418 (ColcdforC12H73scr3o4 319.9411). Anal. 
Calcd for C12H7CI304: C 44.82; H 2.19; Cl33.08. Found: C 44.75; H 2.05; Cl33.30. Further 
elution gave E-chloro enollactone (1.15E) as a white solid (32mg,21%): mp 171-173 oc 
(petroleum ether); IR (KBr) 1800, 1720 and 1630cm-1; 1H NMR (CDCI3) o 1.42 (t, J=7.1Hz, 
OCH2CH3), 4.43 (q, J=7.1Hz, OCH2CH3), 8.09 (s, H-7), 8.58 (s, H-4); 13c NMR (CDCI3) o 14.11, 
63.20, 109.68, 125.05, 127.60, 128.09, 136.28, 137.57, 140.49, 147.80, 160.89, 162.62; HRMS (M) 
Found 321.9394 (Calcd forC12H737cr3SC1204 321.938l),Found 319.9411 (Calcd for 
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C12Hr>cb04319.94ll). Anal.CalcdforC12H7CI304: C44.82; H2.19; Cl33.08. Found: C 
44.53; H 1.98; Cl33.68. 
Pre.paratlon of Ethyl (f)- and (l>-bromo-(5.6-dlch/oro-3-oxo-1.3-dlhydrolsobenzoturan-1-
yUdene>acetate 0 .1 ZE and l.JZZ>: 
0 7 0 
4 4 
Et02C Br 
1.17Z 
METHOD A: Ph3P=CBrC02EtE.04 (538mg, 1.26mmoL 1.1 equiv) was added to a stirred 
solution of 4,5-dichlorophthallc anhydride (1.16) (246mg, 1.13mmoL 1equlv), dissolved In 
CH2CI2 (20ml), at 20 oc. After 5h at 20 oc, the solvent was evaporated and a 1 H NMR 
spectrum of the crude product revealed an isomer ratio of 20% E : 80% Z. by 1 H NMR. 
Purification by radial chromatography using a 2mm silica gel chromatotron plate, eluting 
with 50% CH2CI2/S00k petroleum ether gave Z-enollactone (1.17Z) as a white solid 
(194mg,47%): mp 165-166 oc (petroleum ether); lH NMR CCDCI3) o 1.44 (t,J=7.1Hz, 
OCH2CH3).4.43 (q, J=7.1Hz. OCH2CH3), 8.02 (s. H-4), 8.86 (s, H-7); 13c NMR (CDCI3) o 14.1, 
63.3,99.0, 125.9, 127.2, 128.3, 129.1. 137.2, 140.7, 152.4, 162.4, 162.7; Anal. Calcdfor 
C12H7BrCI204: C 39.4; H 1.9. Found: C 39.4; H 1.9. Further elution gave E-enollactone 
(1.1ZE) as a white solid (58mg, 14%): mp 154-155 oc (petroleum ether); IR (KBr) 1810, 1720 
and 1620cm-1; 1HNMR(CDCI3)o 1.41 (t.J=7.1Hz,OCH2CH3),4.42(q,J=7.1Hz,OCH2CH3).8.08 
(s,H-4),8.77(s,H-7); 13CNMR(CDCI3)o 14.1,63.3,98.7, 125.5, 127.6, 127.9, 136.2, 137.5, 140.2, 
147.7, 161.3, 162.4; HRMS (CI, M+ 1) Found 364.8980 (Calcd for C12Ha79sr35Ci204 364.8983). 
METHOD B: Ph3P"'CHC02EtE.03 (80mg. 0.23mmol, lequiv) and 4,5-dichlorophthalic 
anhydride (1.16) (50mg, 0.23mmol. 1equiv) were stirred In CH2CI2 (lOmL) at 20 oc for 10min. 
Triethylamine (32!lL 0.23mmol, 1equlv), followed by Br2 (8!lL 0.16mmol, 0.7equiv), were 
added and the solution· was stirred for a further 30min at 20 oc. The solvent was 
evaporated and a 1 H NMR spectrum of the crude product revealed an isomer ratio of 
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20% E : 80% z. Purification by radial chromatography using a 2mm silica gel 
chromatotron plate, eluting with 50% CH2CI2/S00k petroleum ether gave Z-enollactone 
(1.17Z) (2lmg, 36%) and E-bromo enollactone (1.17E) C5mg, 8%): lH NMR (CDCI3) as 
given above. 
Crystal Data for of Ethyl Z-bromo-(4.5-dichloro-3-oxe=J ;3-djhydrojso-benzofuran-
J -ylldene)acetote C1 .lZZ). 
C12H7BrCI204, colourless, crystallized from petroleum ether, crystal dimensions 
0.14x 0.03 x0.04 mm, space group P}, a= 6.272(2), b= 7.682(5), c= 14.661(6) A, a= 
92.98(4), p = 100.46(3), r= 113.36(4)0 , V= 631.7(6) A3,z = 2, F(OOO) = 360. Using 2.4° (I)-SCans 
at scan rate of 7.32° min-1, 1650 unique reflections were collected In the range of 4 < 28 < 
45° and 772 of these having I > 3cr(l) were used in the structural analysis. 
Data were recorded at 160 K on a Nicolet R3m four circle diffractometer using Mo 
- Ka radiation. Cell parameters were determined by least squares refinement of 24 
accurately centred reflections. Crystal stability was monitored by recording check 
reflections and no significant variations were observed. Data were corrected for 
Lorentz-polarization effects and for absorption. 
Direct methods revealed the position of the non-hydrogen atoms and the 
structure was refined by blocked-cascade least-squares techniques. Hydrogen atoms 
were Inserted at calculated positions using a riding model with thermal parameters equal 
to 1.2 U of their carrier atoms. The refinement converged with R = 0.065 and Rw = 0.073 and 
a maximum least-squares shift/error of 0.001. The final difference fourier map showed no 
significant features. All programs used In the data collection and structure solution are 
contained In the SHELXTL (Version 4.1) package. 
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TABLE E.O 1: Atomic Coordinates (x 1o4) and isotropic Thermal Parameters cA2x 103) for (1.17Z) 
" Atom X v z Ueq 
Br 46:l) (4) 8255 (3) 1147 (2) 16 (1)* 
Cl(5) 
-2135 (10) 12825 (8) 3898 (4) 31 (3)* 
Cl(4) -30SQ (9) 15166 (7) 2276 (4) 25 (3)" 
C(l) 1721 (33) 12314 (27) 530 (14) 14 (5) 
C(2) 624 (33) 12597 (28) 1319 (13) 16(5) 
C(3) 
-623 (31) 13724 (26) 13(£) (13) 14 (5) 
C(4) 
-1472 (34) 13757 (28) 2167 (13) 17 (5) 
C(5) 
-1139 (35) 127:!D (29) 2887 (14) 18(5) 
C(6) f.B (35) 11528 (29) 2786 (14) 20(5) 
C(7) 956 (32) 11508 (27) 1980 (13) 14 (5) 
C(8) 2300 (35) 10448 (29) 1628 (15) 23(5) 
C(9) 3163 (31) 9192 (26) 1949 (13) 11 (4) 
C(lO) 3076 (35) 8533 (29) 2875 (14) 18 (5) 
C(ll) 4314 (36) 6615 (31) 39:1} (14) 28(6) 
C(12) 65W (38) 7786 (32) 4556 (15) 38(6) 
0(1) 1891 (23) 13051 (19) -167 (9) 24 (7)* 
0(2) 2644 (22) 11025 (17) 761 (9) 17 (6)" 
0(3) 4205 (24) 7374 (21) 3015 (9) 26 (7)* 
0(4) 2182 (26) 8997 (22) 34f.B (10) 37 (8)" 
*Equivalent isotropic U defined as one third of the trace of the 
orthogonalized un tensor 
TABLE E.02: Bond lengths CA) for (1.17Z). 
Br-C (9) 1.891 (22) CI(5)-C(5) 1. 7')fJ (23) 
CI(4)-C(4) 1.756 (26) Cl (1)-C (2) 1.496(32) 
c (1)-Q (1) 1.195 (25) c (1)-0 (2) 1.359 (28) 
C(2)-Q(3) 1.384 (34) C (2)-C (7) 1.353 (30) 
c (4)-0(5) 1.391 (30) C (3)-C (4) 1.386 (30) 
c (7)-G (8) 1.520 (35) C (5)-C (6) 1.413 (37) 
C(8)-G(9) 1.344(34) C (6)-C (7) 1.40) (31) 
C(8)-0(2) 1.393 (26) c (9)-C (10) 1.477 (28) 
c (10)-0(3) 1.343 (31) c (10)-0 (4) 1.214 (30) 
c (11)-0 (12) 1.469 (25) c (11)-0 (3) 1.464 (26) 
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TABLE E.03: Bond angles (0) for (1.17Z). 
C (2)-C (l )-0 (1) 130.4(23) C (2)-C ( l)..Q (2) 106.2 (17) 
0 (1)-C (l)-0 (2) 123.4 (21) C ( l)-C (2)-C (3) 126.0(19) 
C (l )-C (2)-C (7) 109.3 (21) C (3)-G (2)-C (7) 124.7 (21) 
Cl (4)-C (4)-C (5) 118.7 (17) C (2)-G (3)-C (4) 115.3 (20) 
Cl (5)-C (5)-C (4) 122.6(20) Cl (4)-C (4)-C (3) 118.2 (17) 
C (4)-C (5)-C (6) 118.9 (20) C (3)-G (4)-C (5) 123.1 (23) 
C (5)-C (6)-C (7) 118.4 (20) Cl (5)-C (5)-C (6) 118.5 (16) 
C (2)-C (7)-C (6) 119.5(23) C (2)-G (7)-C (8) 106.8 (19) 
C (6)-C (7)-C (8) 133.7 (20) C (7)-G (8)-C (9) 135.9 (20) 
C (7)-C (8)-0 (2) 105.6(18) C (9)-C (8)..() (2) 118.5 (21) 
Br-C (9)-C (8) 116.5 (16) Br-C (9)-C (10) 118.5 (17) 
C (8)-C (9)-C (10) 124.9(21) C (9)-C (10)-0 (3) 110.9 (20) 
c (9)-G (10)..() (4) 125.9 (23) 0 (3)-C (10)-0 (4) 123.1 (20) 
C (l )-0 (2)-C (8) 112.3 (17) C (12)-C (11)-0 (3) 110.1 (16) 
C (10)-0 (3)-C (11) 117.9 (18) 
TABLE E.04: Anisotropic Thermal Parameters cA2x103) for (1.17Z). 
un 
Br 15 (1) 21 (1) 17 (1) 2 (l) 6(1) 11 (l) 
Cl(5) 39(4) 36 (4) 27(4) 5 (3) 14 (3) 22(3) 
Cl(4) 23(3) 'E (4) 30(4) 1(3) 10(3) 16 (3) 
0(1) 29(9) 3) (9) 27(9) 12(7) 9(7) 24(8) 
0(2) 24(8) 4 (8) 23(8) 1(6) 7 (6) 5(7) 
0(3) 28(9) 47 (10) 24(9) 22(8) 20(7) 28 (8) 
0(4) 42 (10) If) (11) 27(9) 6(8) 13 (8) 24(9) 
The anisotropic temperature factor exponent takes the form: 
-2n2 (h2a*2U11 + ... + 2hka*b*U12) 
TABLE E.05: Hydrogen Coordinates (x1o4) and Temperature Factors cA2x103) for (1.17Z). 
Atom X y z u 
H (3) -898 14426 862 21 
H (6) 248 10744 3256 25 
H (11A) 3037 6641 4177 37 
H (llB) 4152 5320 3&Y> 37 
H (12A) ti:E/:; . 7286 5142 47 
H (12B) 6763 <;082 4658 41 
H (12C) 7876 7758 4288 41 
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SECTION E. 1.2 
REACTION OF CHLORO ENOLLACTONES WITH WATER AND METHANOL: 
General Method for the Formation of Acids CJ .42-1 .44): 
The succinic- and glutaric- chloro enollactones (1.11-1.13) reacted with atmospheric 
H20, over 3 weeks at 20 oc, to form acids (1.42-1.44), used subsequently without 
purification, which existed as oils. 
7 -Ethyl 2-chloro-3-hexandloate <1.42>: 
6 
5~C~H 
4 0 
3 
H 2 
Et02C Cl 1 
IR (film) 3000 and 1740cm-l; lH NMR (CDCI3) o 1.32 (t.J=7.1Hz, CH3), 2.71 (t,J=6.5Hz, (H-5)2), 
3.05 (m, (H-4)2),4.30 (q,J=7.1Hz, OCH2), 4.88 (s, H-2); 13c NMR (CDCI3) o 13.82, 27.74, 33.43, 
60.91.63.29. 164.77, 177.80, 197.53; HRMS (M) Found 222.0287 (CalcdforCaHn35CIOs 
222.0295). 
1-Ethyl 2-cbloro-3-heotandloqte Cl .43): 
6 7 
C~H 
0 
IR (film) 3000 and 17 40cm-1; 1 H NMR (CDCI3H> 1.32 (t, J= 7.1 Hz, CH3), 1. 97 ( quin, J= 7. 1Hz, (H-
5)2), 2.43 (t. J=7.2Hz, (H-6)2), 2.83 (m, CH-4)2), 4.30 (q, J=7.1Hz. OCH:i), 4.79 (s, H-2); 13C NMR 
(CDCIJ) o 13.93, 18.33, 32.37, 37 .61, 60. 78, 63.25, 164.95, 178.31. 198.38; HRMS (M)Found 238.0439 
(Calcd forC9Hl337CIOs 238.0422), Found 236.0447 (Calcd for C9H1335CIOs 236.0452). 
The dimethyl glutaric chloro enollactone (1.14) also underwent this reaction. 
Experimental 171 
General Method for the Formation of Methyl Esters 0 .45-1 .47. 1 .52): 
The succinic- and glutaric- chloro enollactones (1.11-1.13), the corresponding acids 
(1.42-1 .44) and protio enollactoneE.05 (1.51) reacted, at 20 oc, with traces of methanol and 
acid (for example; on silica gel chromatotron plates) to form the corresponding methyl 
esters (1 .45-1.47, 1 .52, respectively). Purification by radial chromatography using silica 
gel chromatotron plates, eluting with the stated solvent system yielded the methyl esters 
(1 .45-1.47, 1.52) as oils. 
1-Ethy/6-m~tby/2-cb/oro-3-oxohexandioate 0.45>: 
Eluted with 85% petroleum ether/15% ethyl acetate; IR (film) 1740cm-1; lH NMR CCDCI3) o 
1.33 (t, J=7.1Hz, CH2CH3), 2.67 Ct J=6.5Hz. (H-5)2), 3.04 (m, (H-4)2), 3.69 {s, OCH3), 4.31 (q, 
J=7.1Hz,OCH:it4.87 (s, H-2); 13c NMR (CDCI3) o 13.88, 27.79, 33.74.51.92.60.97, 63.20. 164.80, 
172.38. 197.67; HRMS (M) Found 238.0384 (Calcd for C9H1337CIOs 238.0422), Found 236.0450 
(Calcd for ~Hla35cJOs 236.0452). Anal. Calcd for C9H13CIOs: C 45.68; H 5.54. Found: C 
45.68; H 5.63. 
7 -Ethyl 1-m ethyl 2-cb/oro-3-oxohe.ptandloate C 1 .46): 
6 7 
C~Me 
0 
Eluted with 90% CH2CI2/10% ethyl acetate; IR (film) 1730 and 164Qcm-l; lH NMR (CDCIJ) o 
1.32 (tJ=7.1Hz. CH2CH3), 1.96 (quln, J=7.2Hz, CH-5)2), 2.37 (t J=7.2Hz. (H-6)2), 2.81 (m, (H-4)2). 
3.68 (s, H-2). 4.29 (q, J=7. i Hz, OCH2), 4.78 (s, OCH3); l3c NMR CCDCia) o 13.89, 18.60, 32.51, 
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37.75,51.6 L 60.77, 63.17, 164.92, 173.26, 198.40; HRMS (M) Found 250.0616 (Calcdfor 
C10H1s3Sc10s 250.0630). 
1-Etbyl 7-metby/ 2-chloro-5.5-dlmefhy/-3-oxoheptandloate C 1.47): 
Me 
6 7 
C~Me 
0 
Eluted with 70% CH2Cf2/30% petroleum ether; FTIR (film) 1734cm·1; 1 H NMR CCDCI3) o 1.11 
(s, C(CH3)2), 1.32 (t, J=7.2Hz, CH2CH3),2.46 CABq, JAs=14.9Hz, lH, (H-6)0 }, 2.50 (ABq, 
JAs=14.9Hz, lH, (H·6)b), 2.84 (ABq, JAs=l8.0Hz, 1H, (H-4)0 ), 2.90 (ABq, JAs= 18.0Hz, 1H, (H-
4)b), 3.65 (s, OCH3}, 4.30 (q, J=7.2Hz, OCH2), 4.81 (s, H-2): HRMS (M) Found 278.9903 (Calcd 
for C12H1935CIOs 278.9903). 
6-Methy/ Htert-buty/) 3-oxobexqndioate (1.52): 
Eluted with 80% petroleum ether/20% ethyl acetate; bp 115-125 oc (lmm, colourless oil); 
IR (film) 1750 and 1730cm-1; lH NMR (CDCI3Hi 1.48 (s, CCCH3)3),2.62 (t,J=6.6Hz, CH-5)2),2.87 
(t, J=6.6Hz, (H-4)2), 3.40 (s, (H-2)2), 3.68 (s, OCH3); 13C NMR (CDCI3) 6 27.68, 27.97,37.35,50.60, 
51.84, 82.10, 166.21, 172.87,201.41; HRMS CM) Found 230.1122 (Calcd forCnH1aOs 230.1154). 
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Reaction of chloro enollactone 0.1 D with C~OD: 
Chloro enollactone (1.11) (6mg, 0.029mmol) and a catalytic quantity of p-toluene 
sulphonlc acid (PlSA) were dissolved In CD30D (0. 7ml). After 24h, when all the 
enollactone had been converted to acid (1.50), the sample was filtered to remove PTSA 
and the solvent was evaporated: 2H NMR CCHCI3) o 3.66 (0CD3). 5.09 (COCO. 
Preparation of 7-Etby/6-metby/ <E>-2-ch/oro-3-methoxyhex-2-enedjoate C1.53): 
6 
5 
C0.2Me 
OMe 
1 
Cl C0.2Et 
Succinic-derived acid (1.42) (15mg, 0.07mmol. 1equiv) was dissolved in ether (2ml) and 
an excess of freshly distilled CH2N2 in ether was added. The excess CH2N2 was allowed 
to evaporate and the residue was purified by radial chromatography using a 1 mm silica 
gel chromatotron plate. eluting with 95% CH2CI2/6% ethyl acetate to yield an oil which Is 
tentatively assigned as the alkene (1.53) (6mg, 36%): IR (film) 1740, 1670 and 1590cm-l; lH 
NMR (CDCI3) o 1.33 Ct. J=7.1Hz. CH2CH3),2.59 (m. (H-5)2), 3.19 (m. CH-4)2),3.71 (s, OCH3),3.87 
(s, OCH3).4.25 (q, J=7.1Hz, OCH2); 13c NMR (CDCI3) S 14.16,24.10,31.6 1,51.95,56.24,61.56. 
104.93. 164.01. 166.21. 172.32; HRMS (M) Found 252.057 4 (Calcd for CwH 1537 CI05 252.0600), 
Found 250.0602 (Calcd for CwH 1535CI05 250.0630). 
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SECTION E.2 
CHAPTER 2 EXPERIMENTAL 
SECTION E.2. 1 
PREPARATION OF KETO-AMIDES AND HYDROXY LACTAMS (2.37-2.50) 
Preparation of Ethy/5-carbarooy/-3-oxooentanoate (2.37>: 
0 
N~ 
0 
Ammonia (0.5ml of 22.5mg/mL solution in ethanol, 0.66mmol, 8equlv) was added to 
enollactoneE.05 (2.33a) (15mg. 0.08mmol. lequlv) in CH2CI2 (3ml) and the solution was 
stirred at 20 oc for 5h. The solvent was evaporated to yield keto-amide (2.37) as an oiL 
which was used In subsequent steps without further purification: Yield 17mg, quant; 1 H 
NMR (CDCI3) S 1.28 (t.J=7.1Hz. CH3), 2.53 (t,J=6.5Hz. (H-4)2), 2.92 (t, J=6.5Hz. CH-5)2), 3.50 Cs. CH-
2)2),4.20 (q,J=7.2Hz, OCH2), 5.50 (bs, NH2); 13C NMR (CDCfa) S 14.13,29.05. 37.79,49.17.61.42. 
167.06. 173.84. 201.88; HRMS (M) Found 187.0842 (Calcd for CsH13N04 187.0845). 
Preparation of C5R.S> 5-CEthoxycarbony/roetby0-5-hydroxy-2-oyrrolidinone C2.48): 
C~Et 
Ammonia (0.7ml of 22.5mg/ml solution In ethanol, 0.91mmol. llequlv) was added to 
enollactoneE.OS (2.33a) (15mg, 0.88mmol, lequiv) and the solution was stirred at 20 oc for 
5h. The solvent was evaporated to yield the hydroxy lactam (2A8) as an oil. which was 
used In subsequent steps without further purification: Yield 17mg. quant; IR (film) 3400 and 
1700cm-1: lH NMR (CDCI3) o 1.30 (t, J=7.2Hz, CH3), 2.11 Cm. lH). 2.28 (m, lH), 2.34 (m, 1H),2.60 
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(m, 1H),2.75 (ABq,JAs=17.0Hz, lH, CH0C~Et),2.93 (ABq. JAs=17.0Hz, lH,CHbC~Et),4.23 (q, 
J=7.2Hz, OCH:z),6.tiJ (bs, NH); 13c NMR (CDCI3) S 13.93, 29.19,34.t/J,45.09, tiJ.95,86.36, 170.55, 
177 .82; HRMS (M) Found 187.0848 (Calcd for CaH13N04 187 .0845). 
General Method for the Preparation of Amine-Derived Keto-Amldes C2.38-2.4D and 
Hydroxy Lactam (2.492: 
The Indicated amine (stated amount) was added to the appropriate enollactoneE.O&E.06 
(2.33a-b, 2.33d) (lequiv) dissolved In CH2CI2 or 1, 2-dichloroethane and the solution was 
stirred for 16h at 20 oc. The solvent was evaporated at 20mm and finally at 1 mm to 
quantitatively yield the keto-amide (2.38-2.41) or hydroxy lactam (2.49). which was used In 
subsequent steps without further purification. 
Ethyl 5-CN-metbylcacbamoyf)-3-oxapentanoqte <2.38): 
NH-Me 
0 
General method with enollactone (2.33a) (20mg, 0.12mmol) and methylamine (53J.LL of 
3.91M solution in 1. 2-dlchloroethane, 0.22mmol, 1.8equiv),ln 1, 2-dlchloroethane (5ml): 
Yield 25mg, white solid, quant; IR (KBr) 3350, 1750, 1720, 1650and 1570cm-1; lH NMR (CDCIJ) 
o 1.28 (t, J=7.1Hz, CH2CH3), 2.47 Ct. J=6.5Hz, (H-4)2); 2.79 (d. J=4.8Hz, NCH3),2.92 (t, J=6.5Hz, CH-
5)2), 3.50 (s, (H-2)2), 4.20 (q, J=7.1Hz, OCH:z), 5.69 (bs, NH); 13c NMR CCDCI3) o 14.04, 26.33, 
29.63,38.05,49.17,61.40, 167.10, 172.01,202.17; HRMS (M) Found 201.10CI6 (Calcd for C9l11sN04 
201.1002). 
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Ethyl 5-(N-ethy/carbamoy0-3-oxapentanoate <2.39): 
0 
NH-Et 
0 
General method with enollactone (2.33a) (10mg, 0.06mmol) and ethylamlne (57J.tl of 
1.53M solution In CH2CI2, O.llmmol, 1.8equlv), In CH2C12 (5ml): Yield 13mg, white solid, 
quant; IR (KBr) 3425,3325, 1755, 1730, 1660 and 1560cm-1; lH NMR (CDCI;Y 8 1.13 (t, J=7.2Hz, 
NCH~H3), 1.28 (t, J= 7.2Hz, OCH2CH3), 2.45 (t, J=6.5Hz, (H-4)2), 2. 91 (t, J=6.5Hz, (H-5)2), 3.27 
(m, NCH2), 3.50 (s, (H-2)2), 4.20 (q, J=7.2Hz, OCH:i), 5.27 (bs, NH); 13C NMR (CDCI3) 8 13.94, 
14.58,29.65, 34.32,37.96,49.09, 61.26, 167.05, 171.17, 202.10; HRMS (M) Found 215.1158 (Calcd 
forC10H17N04 215.1158). 
Ethyl 5-(N-( 1-butyl>-carbamoyl)-3-oxopentaooqte <2.40): 
General method with enollactone (2.33a) (50mg, 0.29mmol) and butylamine (30J.tL 
0.29mmol, 1equlv), in CH2Ci2 (5mL): Yield 83mg, white solid, quant; IR (KBr) 3300, 1775, 1720, 
1650 and 1560cm-1; 1 H NMR (CDCI3) o 0. 92 Ct, J= 7 .2Hz, CH2CH2CH3), 1.28 (t, J= 7. 1Hz, 
OCH~H3), 1.35 (m, NCH2CH2CH2), 1.47 (m, NCH2CH2), 2.46 (t, J=6.5Hz, (H-4)2), 2.91 (t, 
J=6.5Hz, (H-5)2), 3.22 (m, NCH:i), 3.50 (s, (H-2)2),4.20 (q, J=7.1Hz, OCH2), 5.57 Cbs, NH); 13c 
NMR (CDCIJ) 0 13.64, 14.01 I 19.95, 29.80, 31.54,38.05, 39.30,49.16,61.33, 167.07, 171.24, 202.08; 
HRMS CM) Found 243.1470 (Calcd for C12H21N04 243.1471). 
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Ethyl C2R.S2 2-methy/5-CN-0-butyV-carbamoy0-3-oxopeotanoate (2.4D: 
General method with methyl enollactone (2.33b) (30mg, 0.16mmol) and butylamine 07t..tl, 
0.16mmol, lequlv), In CH2C12 (5ml): Yield 43mg, oil, quant; IR (film) 3325, 1750, 1725, 1660 
and 1565cm-l; lH NMR(CDCI3) S 0.91 Ct.J=7.2Hz,CH2CH2CH3), 1.27 (t,J=7.1Hz,OCH2CH3), 
1.32 (m, NCH2CH2CH:z). 1.35 (d, J=7.2Hz. CHCH3), 1.47 (m, NCH2CH:z), 2.45 (m, (H-4)2), 2.91 Ct. 
J=6;5Hz, (H-5)2), 3.22 (m, NCH:z). 3.58 (q,J=7.2Hz, CHCH3).4.19 (q,J=7.1Hz. OCH:z).5.75 (bs, 
NH); 13c NMR(CDCI3) S 12.72. 13.67, 14.03, 19.98,29.96.31.59,36.71.39.32,52.74.61.37. 170.47, 
171.38, 205.28; HRMS(M) Found 257.1620 (CalcdforC13H23N04 257.1628). 
2-Butyl C3R.$) 3-ethoxycorbooylmethyl-3-hydroxyisoindolone (2.492: 
0 
C~Et 
General method with phthalic enollactone (2.33d) (100mg, 0.52mmol) and butylamine 
(6/3f.tL 0.67mmol. 1.3equiv), In CH2CI2 (15ml): Yield 170mg, white solid, quant; IR (KBr) 3350, 
1750, 1680and 1630cm-l; lH NMR (CDCIJ) o 0.93 (t.J=7.3Hz, CH2CH2CH3), 1.08 (t, J=7.2Hz, 
OCH2CH3), 1.36 (sextet. J=7.4Hz. NCH2CH2CH2), 1.62 (m. NCH2CH2), 2.99 (ABq. JAB= 15.7Hz, 
1H. COH-CH0 ), 3.13 (ABq.JAa=15.7Hz. 1H. COH-CHb). 3.20 (m, 1H. NCHa), 3.51 (m, 1H. NCHb), 
4.09 (q,J=7.2Hz, OCH2), 7.44 (m, (Ph)l), 7.53 (m (Ph)2). 7.65 (dt, J= 1.0, 7.4Hz, (Ph)l); 13c NMR 
(CDCis)o 13.76, 13.84,20.57,31.17,38.96.41.50,61.13,88.33, 121.72, 123.15.129.66,131.13132.11. 
146.32, 167.28, 169.78; HRMS CM) Found 291.1473 (Calcd forC16H21N04 291.1471). 
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General Method tor the Preparation of Amino Acid-Derived Keto-Amldes <2.42-2.47> and 
Hydroxy Lactam C2.5ID: 
The Indicated amino-acid ethylester hydrochloride (stated amount) and triethylamine 
(stated amount) were added to the appropriate enollactoneE.05-E.06 (2.33a-d) ( 1 equlv) 
dissolved In CH2C12 and the mixture was stirred for 16h at 20 oc, during which time 
homogeneity was achieved. The solution was transferred to a separating funnel and 
washed with water (10ml). The organic layer was dried (MgS04) and the solvent 
evaporated at 20mm and finally at 1 rom to yield the keto-amide (2.42-2.47) or hydroxy 
lactam (2.50), which was used in subsequent steps without further purification. 
Ethyl C6'R,S) 5-CN-0 -ethoxycarbony/ethyDcarbamoyD-3-oxooentanoate C2.42): 
0 
/C~Et 
NH~ 
o Me 
General method with enollactone (2.33a) (80mg, 0.47mmol), (R,S)-alanine ethylester 
hydrochlorideE.07 (94mg, 0.61 mmoL 1.3equlv) and triethylamine (81 J.!L 0.61 mmoL 
1.3equiv), in CH2C~ (8ml): Yield 99mg, white solid, 73%; IR (KBr) 3325, 1760, 1720, 1650 and 
1560cm-1; lH NMR (CDCIJ) li 1.28 (t, J=7.1Hz, OCH2CHa), 1.28 Ct. J=7.2Hz, OCH2CHa), 1.39 (d, 
J=7.2Hz CHCHa). 2.53 (t, J=6.5Hz, (H-4)2), 2.91 (m, CH-5)2), 3.50 (s, (H-2)2), 4.20 (q, J=7.2Hz, 
OCH2), 4.20 (q, J=7.1Hz, OCH2), 4.53 (m, CHCH3), 6.15 (bd, J=6.8Hz, NH); 13C NMR (CDCI3) 8 
14.09, 14.11, 18.46,29.65,37.78,48.23,49.26,61.42,61.50, 167.07, 170.86, 173.01,201.77; HRMS(M) 
Found 287.1376 (Calcd forC13H21N06 287.1369). 
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Ethyl (6 'R.S> 5-CN-f 1-ethoxycarbooyl-3-methy/butyncawamoy0-3-oxQPentanoate <2.43): 
General method with enollactone (2.33a) (80mg, 0.47mmol), (R.S)-Ieuclne ethylester 
hydrochlorldeE.07 ( 120mg. 0.61 mmot. 1 .3equlv) and triethylamine (81 J.LL, 0.61 mmol. 
1.3equlv), In CH2CI2 (8ml): Yield 164mg, white solid. quant; IR (film) 3350, 1750, 1660and 
lSSOcm-1; lH NMR (CDCI3) o 0.93 (d,J=1.5Hz. CHCH3), 0.95 (d,J=1.5Hz,CHCH3), 1.28 Ct. 
J=7.1Hz. OCH2CH3), 1.28 CtJ=7.1Hz. OCH2CH3), 1.60 (m.3H. NCHCH2CH), 2.53 (tJ=6.3Hz (H-
4)2), 2.91 (m. (H-5)2), 3.49 (s, CH-2)2).4.18 (q, J=7.1Hz, OCH2),4.19 (q, J=7.1Hz, OCH2).4.58 (m, 
NCH). 5.96 (bd,J=7.6Hz. NH); 13C NMR (CDC!J) o 14.05~ 14.09~21.97, 22.72. 24.80,29.6 L 37.81. 
41.65,49.19,50.86,61.27, 61.37, 167.05, 171.12, 172.99, 201.70; HRMS (M) Found 329.1837 (Calcd 
for C1t>H21N06 329.1839). 
Ethyl (6 'R,S) 5-CN-C 1-ethoxycarbonyt-2-ohenvfethyl)carbamovo-3-oxopentanoate C2.442: 
0 
-cC~Et NH 0 Ph 
General method with enollactone (2.33a) (80mg. 0.47mmol). CR.S)-phenylalanine 
ethylester hydrochlorideE.07 (140mg. 0.61mmol. 1.3equiv) and triethylamine (81J.tL 
0.61mmoL 1.3equlv)~ In CH2CI2 (8mL): Yield 165mg, white solid. 97%; IR (KBr) 3340, 1740~ 
1720, 1655 and 1530cm-l; lH NMR CCDCI3) 3 1.24 (t, J=7.1Hz. CH3), 1.28 Ct. J=7.1Hz. CH3), 2.49 
(dt I J= 1.7 I 6.6Hz~ (H-4)2)~ 2.88 (m. (H-5)2), 3.11 (dd, J=2.2. 5.8Hz, CH2Ph). 3.48 (s. (H-2)2) ,4. 17 
(ql J=7.1Hz. OCH2),4.20 (q. J=7. 1Hz, OCH2). 4.82 (m, NCH). 6.03 (bd, J=7.2Hz. NH), 7.12 (m. 
(Ph)v~ 7.27 (m. (Ph)3); 13c NMR (CDCI3) o 14.05. 14.05.29.55. 37.66. 37.89~49.19. 53.21. 61.36. 
61.44~ 127.02, 128.46. 129.33. 135.84, 167.03. 170.84,171.41.201.58; HRMS(M)Found363.1681 
(Calcd for C19H2sN06 363.1683). 
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Ethyl 5-CN-0 -ethoxvcarbony/methyl>carbamoy0-3-oxopentanoate (2.45): 
0 
.... c~Et 
NH__..,. 
0 
General method with enollactone (2.33a) (47mg, 0.28mmol), glycine ethylester 
hydrochloride (50mg, 0.36mmot 1.3equlv) and triethylamine (47J.ll, 0.36mmot 1.3equlv), In 
CH2CI2 (5mL): Yield 66mg, white solid, 88%; mp 66.5-68.5 oc (ethyl acetate/petroleum 
ether, white crystals); IR (KBr) 3325, 1760, 1720, 1660 and 1560cm-l; lH NMR (CDCfs) S 1.26 Ct. 
J=7.1Hz, CH3), 1.29 (t, J=7.1Hz, CH3), 2.56 (t, J=6.5Hz CH-4)2), 2.92 (t, J=6.5Hz. (H-5)2), 3.50 (s, (H· 
2)2),4.01 (d,J=5.2Hz, NCH:i),4.20 (q,J=7. 1Hz, OCH:i),4.22 (q, J=7.1Hz, OCH:i),6.11 (bs, NH); 
13CNMR(CDCI3)S 13.94, 13.99,29.27,37.69,41.32,49.07,61.26,61.30, 166.99, 169.80, 171.60, 
201.80; HRMS (M) Found 273.1214 (Calcd for C12H19N06 273.1213). Anal. Calcd for 
C12H1~6: C 52.74; H 7.01; N 5.13. Found: C 52.59; H 7.01; N 5.01. 
Tart-butyl 5-(N-0-ethoxycarbony/methyOcqrbamoy/)-3-oxoQentanoqte <2.462: 
0 
.... c~Et 
NH_/ 
0 
General method with tert-butyl enollactone (2.33c) (150mg, 0.76mmol), glycine ethylester 
hydrochloride (106mg, 0.76mmoL 1equlv) and triethylamine (98J.1L 0.76mmoL lequlv), in 
CH2CI2C6ml): Yield 199mg,yellowoll,87%; IR(film)3350, 1735,1715, 1660and 1540cm-1; lH 
NMR (CDCI3) S 1.29 (t, J=7.2Hz. OCH2CH3), 1.47 {s, C{CH3)3), 2.55 Ct. J=6.5Hz, {H-4)2), 2.91 Ct. 
J=6.5Hz, (H-5)2), 3.41 (s, CH-2)2), 4.01 (d. J=5.2Hz, NCH:i), 4.22 (q, J=7.2Hz, OCH:i), 6.13 (bs, NH); 
l3CNMR (CDCI3) S 13.83, 27.65, 29.07,37.52,41.14,50.16,61.04,81.64, 166.17, 169.71, 171.77, 
202.17; HRMS (M-18) Found 283.1422 (Calcd for C14H21N05 283.1420). 
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Ethyl C2R.S> 2-methyl 5-CN-0 -etboxycarbonylmefhyOcarbamoy0-3-oxooentanoate 
0 
.... c~Et 
NH--' 
0 
Me 
General method with methyl e.nollactone (2.33b) (85mg, 0.46mmol), glycine ethylester 
hydrochloride (79mg, 0.57mmot 1.2equiv) and triethylamine 05~-tl. 0.57mmot 1.2equlv), in 
CH2C120ml): Yield l16mg,colourlessoil.88%; IR(film)3375, 1750,1730, 1660and 1550cm-l; 
lH NMR CCDCI3) o 1.27 (t, J=7.1Hz, OCH2CH3), 1.29 Ct. J=7.2Hz, OCH2CH3), 1.36 (d,J=7.1Hz, 
CHCH3), 2.55 (m, (H·4)2), 2.93 (t,J=6.4Hz, (H·5)2), 3.58 (q, J=7.2Hz, CHCH3), 4.01 (d,J=5.2Hz, 
NCH:i), 4.19 (q, J=7.1Hz, OCH:i), 4.22 (q, J=7.2Hz, OCH:i), 6.11 Cbs, NH); 13C NMR CCDCI3) o 
12.55, 13.87, 13.92,29.29,36.23,41.24,52.56,61.21, 169.78, 170.31. 171.70,204.86; HRMSCM) 
Found 287.1366 (Calcd for C13H21N06 287.1369). 
C3R .S> 2-ethoxycarbonylmethy/-3-ethoxycqrbooylmeth yl-3-h ydroxyisoindolone (2.502: 
0 
_/C~Et 
N 
C~Et 
General method with phthalic enollactone (2.33d) (lOOmg, 0.52mmol), glycine ethylester 
hydrochloride (109mg, 0.78mmoL 1.5equlv) and triethylamine (102~-tL 0.78mmol, 1.5equiv), 
in CH2CI2 (5ml): Yield 131mg, colourless oil, 79%; IR (film) 3400, 1750, 1720 and 1630cm-l; lH 
NMR CCDCI3) o 1.06 Ct. J=7.1Hz, CH3), 1.31 Ct. J=7.2Hz, CH3), 3.07 CABq, JAB= 15.3Hz, lH, COH-
CH0), 3.14 CABq.JAs=15.3Hz, 1H, COH-CHb).4.00 (q, J=7.2Hz, OCH:i},4.16 (ABq. JAs=17.9Hz, 
1H, NCH0), 4.23 (q, J=7.1Hz, OCH:i}. 4.53 (ABq. JAs=17.9Hz, 1H. NCHb), 7.52 (m, (Ph)l), 7.62 (m, 
(Ph)2), 7.81 (dt, J= 1.0, 7.4Hz, (Ph)1); 13c NMR (CDCIJ)() 13.71. 13.98, 40.35,41.78,60.86, 61.66, 
87.92, 122.13, 123.37, 129.71, 130.14, 132.59, 146.55, 167.22, 168.84, 170.19; HRMS (M) Found 
321.1208 (Calcd for C16H19N06 321.1213). 
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SECTION E.2.2 
PREPARATION OF ENAMINO ESTERS (2.63-2.75) 
General Methods tor the Preparation of Enamlno Esters (2.63-2.75): 
GENERAL METHOD A: The appropriate keto-amide or hydroxy lactam (2.37-2.50) (stated 
amount, lequlv) and a catalytic quantity of PTSA, dissolved in 1. 2-dlchloroethane, were 
refluxed with azeotropic removal of H20 for the Indicated time. The solution was cooled 
to 20 oc, washed with H20 (15mL), dried (MgS04) and the solvent evaporated to yield the 
enamlno ester (2.63-2.75). 
GENERAL METHOD 8: As for General Method A except that the solvent used was 
benzene. 
GENERAL METHOD C: The appropriate enollactoneE.OS (2.33a) or keto-amide (2.37) 
(stated amount, 1 equiv) and the indicated amine (stated amount) were dissolved In 1, 2-
dichloroethane. Activated 4A molecular sieves were added and the solution was stirred 
at 65 oc for 3 days, then was filtered and the solvent was evaporated to yield the enamino 
ester (2.63-2.66). 
(l)-5-Etboxycarbony/methylldene-2-pyrro/idinoneElJli C2.63Z): 
0 
C~Et 
General method C with hydroxy lactam (2.48) ( 12mg, 0.064mmol) In 1, 2-dlchloroethane 
(5mL): Yield 9mg, white solid, 83%; mp 79-81 oc (ethanoi/H20) (LitE.08 79-80 °C); IR (KBr) 
3280, 1760.1735, 1685, 1630 and 1610cm-1; lH NMR (CDCf3Hi 1.28 Ct. J=7.1Hz, CH3), 2.52 (m, (H-
3)2),2.87 (m, (H-4)2).4.17 (q, J=7.1 Hz, OCH2), 5.00 Ct. J= 1.5Hz, =CH), 9.88 (bs, NH); 13c NMR 
(CDCI3) o 14.35, 26.04, 27.71. 59.90. 90.20, 157.4 L 168.11, 177.36; HRMS (M)Found 169.0739 
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(Calcd for CaH11N03 169.0739). lH NMR (CDCI3) also showed the presence of less than 5% 
of the E Isomer: o 5.30 (t, J:::::2.0Hz~ =CH). 
General method B with keto~amlde (2.37) (17mg, 0.091 mmol) and a catalytic quantity of 
PTSA, In benzene (15ml), and a reflux time of 2h gave comparable results: Yield 2mg, oil, 
13%; 1 H NMR (CDCI3) as given above. 
l~Methyl CE>-5-ethoxycarbooytmethylidene~2-pyrrolldinoneflll C2.64): 
0 
General method C with enollactoneE.OS (2.33a) (20mg, 0.12mmol) and methylamine (52j.tL 
of 3. 91 M solution in 1, 2-dlchloroethane, 0. 20m mol. l. 7 equiv) I In l, 2-dlchloroethane (5ml), 
and with heating for 4 days: Yield 20mg, white solid, 93%; 1 H NMR (CDCI3) o 1.29 (t J=7.1 Hz, 
CH2CHJ), 2.57 (m, CH-3)2), 3.00 (s, NCH3),3.24 (m, (H-4)2), 4.17 (q,J=7.1Hz, OCH:V~ 5.19 (t, 
J= 1. 9Hz, =CH). 
l~Ethy/ CE>-5-ethoxycarbooy/metbyllc:Jene-2-pvrro/Jdioone <2.65): 
0 
General method B with keto-amide (2.39) (67mg, 0.29mmol) and a catalytic quantity of 
PTSA, In benzene ( 15ml), and a reflux time of 3h: Yield 41 mg, white solid I 71 %; mp 158-159 
°C; IR(KBr) 1745, 1715and 1630cm-l; lHNMRCCDCf3)o l.l6CtJ=7.2Hz,NCH2CH3), 1.30(t,. 
J=7.1Hz, OCH2CH3),2.55 (m, (H-3)2),3.23 (m, (H-4)2),3.58 (q,J=7.2Hz~ NCH;V,4.17 (q, J=7.1Hz, 
OCH2), 5.23 (t, J= 1.9Hz, =CH); 13c NMR (CDCI3) o 11.63, 14.39, 24.68, 27.98, 35.23,59.48, 91.21, 
159.50, 167.33, 176.61; HRMS (M) Found 197.1054 (Calcd for C10H1sN03 197.1053). Anal. 
CalcdforC1d-11sN03: C60.90; H7.67; N7.10. Found: C60.65; H7.77; N6.63. 
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General method C with eno!lactone (2.33a) (50mg, 0.29mmol) and ethylamlne (0.25J.tL 
0.3Bmmol, 1.3equlv). In 1. 2-dichloroethane (l0ml) gave comparable results: Yield 41mg, 
white solid, 71%; lH NMR CCDCI3) as given above. lH NMR (CDCI3) also showed the 
presence of less than 5% of the Z Isomer: o 5.02 (t, J= 1.5Hz, =CH). 
1-Buty/ CE>-5-ethoxycarbonylmethylidene-2-pyrrolldinone (2.66): 
General method C with enollactone (2.33a) (50mg. 0.29mmol) and butylamine (39J.tL 
0.38mmot 1.3equlv) In 1, 2-dlchloroethane (1 Oml): Yield 65mg, oiL 100%; bp 175 "C (1 mm); 
IR (film) 1750, 1715 and 1630cm-l; lH NMR (CDCI3) o 0.94 (t.J=7.3Hz, CH2CH~H3), 1.30 (t, 
J=7.1Hz, OCH2CH3), 1.32 (m, NCH2CH2CH2), 1.54 (m, NCH2CH2), 2.55 (m, (H-3)2), 3.23 (m, (H-
4)2), 3.51 (t.J=7.6Hz. NCH2).4.17 (q, J=7.1Hz, OCH2), 5.21 (t, J=l.9Hz, =CH); 13c NMR (CDCI3) o 
13.56, 14.33, 20.06,24.62,27.84,28.30, 40.23,59.40, 91.22, 159.83, 167.26, 176.79; HRMS (M) Found 
225.1368 (Calcd for C12H19N03 225.1366). Anal. Calcd for C12H19N03: C 63.98; H 8.50; N 
6.22. Found: C 63. 73; H 8.36; N 6.37. 1 H NMR (CDCIJ) also showed the presence of less 
than 5% of the Z Isomer: o 5.02 (t, J= 1.5Hz, =CH), which was converted to the E Isomer upon 
heating for a further 3 days. 
1-Butyl (£)-and (Z2-5-0-ethoxycgrbony/ethyl/dene>-2-Qyrrol/dinone C2.67E and 2.67Z): 
0' 0 
Me C~Et 
2.67Z 
General method A with keto-amide (2.41) (112mg, 0.44mmol) and a catalytic quantity of 
PTSA, In 1, 2-dlchloroethane (15ml), and a reflux time of 1 Oh gave a mixture containing E-
and Z-enamlno esters (2.67E and 2.67Z, respectively) in the ratio of 84% E: 16% z. by 1H 
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NMR. Purification by radial chromatography using a 1 mm silica gel chromatotron plate, 
eluting with 75% petroleum ether/25% ethyl acetate gave E-enamlno ester (2.67E) as an 
oil: 51mg,50%; unstable to distillation; IR (film) 1740. 1710 and 162Qcm-1; lH NMR (CDCIJ) o 
0.94(t.J=7.3Hz,CH2CH2CH3). 1.31 (t,J=7.1Hz.OCH2CH3). 1.31 (m,NCH2CH2CH2), 1.55(m, 
NCH2CH2). 2.06 (t, J= 1.2Hz. =CCH3), 2.47 (m, (H-3)2), 3.13 (m, (H-4)2), 3.78 (t, J=7.7Hz, NCH2), 
4.19(q,J=7.1Hz,OCH2); 13cNMR(CDCI3)o 13.48, 13.70,14.351 19.84,27.96,28.68,30.76,42.63, 
60.17. 101.44, 153.1 L 169.25, 178.56; HRMS (M) Found 239.1521 (Calcd for C13H21N03 
239.1522). Further elution gave z-enamlno ester (2.611:) as an oil: lOmg, 9%; IR (film) 1740, 
1710 and 1630cm-l; 1 H NMR (CDCIJ) o 0.88 (t, J= 7 .2Hz, CH2CH2CH3) I 1.23 <m~ NCH2CH2CH2) I 
1.32 (t.J=7.2Hz. OCH2CH3). 1.35 (m. NCH2CH2), 1.91 (t, J=1.1Hz, =CCH3), 2.51 (m, (H-3)2), 2.64 
(m, (H-4)2),3.73 (t. J=7.5Hz. NCH2),4.21 (q, J=7.2Hz. OCH2); 13C NMR (CDCI3) o 13.76. 14.26, 
16.46. 19.94, 25.36, 28.13, 28.49. 41.47, 60.68, 101.23, 143.84. 168.73. 177.40; HRMS (M) Found 
239.1524 (Calcd for C13H21N03 239.1522). 
General method B with keto-amide (2.41) ( 42mg. 0. 16m mol) and a catalytic quantity of 
PTSA, In benzene (10mL). and a reflux time of 4h gave. after radial chromatography: 
9mg, oil, 23% (82% E (2.67E): 18% Z (2.67Z), by lH NMR); lH NMR (CDCI3) as given above. 
2-Butyt (f)- and CZ>-3-etboxycarbonylmefbylldene-isolndotone <2.74E and 2.74E): 
4 
0 
C~Et 
2.74Z 
General method A with hydroxy lactam (2.49) (150mg. 0.51mmol) and a catalytic quantity 
of PTSA, In 1, 2-dlchloroethane (15ml). and a reflux time of 3h gave a mixture of E- and Z-
enamlno esters (2.74E and 2.74Z, respectively) (86% E: 24% z. by lH NMR): Yield 134mg. 
oiL 76%. TheE isomer (2.74E) was Isolated by crystallization (ethanoi/H20): mp 72-73 °C; 
IR (KBr) 1725 and 1635cm-1; lH NMR (CDCI3) o 0.97 (t, J=7.3Hz, CH2CH2CH3), 1.37 (t, J=7.1Hz, 
OCH2CH3), 1.39 (m, NCH2CH2CH2), 1.65 (m, NCH2CH2). 3.79 (t, J=7.4Hz, NCH2).4.29 (q, 
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J=7.1Hz, OCH2), 5.71 (s, =CH), 7.57 (dt, J= 1.1, 7 .4Hz, H-4), 7.65 (dt, J= 1.4, 7 .6Hz, H-5), 7.85 (dd, 
J=0.9, 6.3Hz, H·3), 9.06 (d, J=7.8Hz, H-4); 13C NMR (CDCIJ) o 13.60, 14.23. 20.01, 29.77, 39.18, 
60.34, 98.21. 122.85, 127.82, 129.92, 130.95, 132.85. 133.66, 148.04, 165.88, 167.07; HRMS (M) Found 
273.1370(ColcdforC16H19N03273.1366). Anai.Ca!cdforC16H19N03: C70.31; H7.01; N 
5.12. Found: C 70.26; H 7 .18; N 5.17. Z Isomer (2.74Z) (from mixture): 1 H NMR (CDCI3) o 5.88 
(s,=CH); l3CNMR(CDCia)o 13.76, 19.71,30.93,41.84,60.44,93.84, 119.77, 123.38, 128.10, 130.59, 
132.31, 137.75, 143.86, 164.71, 168.56. 
General method B with hydroxy lactam (2.49) (14mg, 0.048mmo!) and a catalytic quantity 
of PTSA. in benzene (15ml), and a reflux time of 3h gave a mixture of E and Z Isomers 
(2.74E and 2.74Z, respectively) (95% E: 5% Z by lH NMR): Yield 9mg, oil, 23%; lH NMR 
(CDCI3) as given above. 
C 1 'R.S> CE>-1-0-Etboxycarbony/eth-l-yl)-5-ethoxycarbony/metby/ldene-2-pyrroUdinone 
0 
General method A with keto-amide (2.42) (82mg, 0.29mmol) and a catalytic quantity of 
PTSA, In 1, 2-dichloroethane (15ml), and a reflux time of 24h: Yield 65mg, oil, 84%; bp 120 
°C(1mm); IR(film) 1740, 1710and 1630cm-l; lH NMR(CDCI3)o 1.25(t,J=7.1Hz,CH2CH3), 1.27 
(t, J=7.1Hz, CH2CH3), 1.52 (d, J=7.3Hz, NCHCHJ),2.59 (t,J=7.5Hz, (H-3)2), 3.28 (m. (H-4)2),4.15 
(q, J= 7.1 Hz, =CHCD2CH2), 4.21 (m, NCHC02CH:iL 4.89 (q, J=7 .3Hz, NCH), 5.10 (t, J=2.0Hz, =CH); 
13C NMR (CDCia) o 13.10, 13.98, 14.29, 24.65,27.60,49.18,59.50,61.77, 92.43, 157.76, 166.93, 
169.14, 176.17; HRMS (M)Found 269.1261 (Calcd forC13H19NOs 269.1264). AnaL Calcd for 
C13H19N05: C 57.98; H 7.11; N 5.20. Found: C 57.86; H 6.85; N 5.20. 
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( 1 'R.S> CE>-1-0 -Etboxycarbonyl-4-methy(pent-2-yl>-5-etboxycarbony/methy/ldene-2-
PY«Oildloone <2.69): 
General Method A with keto-amide (2.43) (155mg, 0.47 mmol) and a catalytic quantity of 
PTSA. In 1, 2-dlchloroethane (15mL), and a reflux time of 20h: Yield 95mg, oil, 84%; bp 155 
°C (lmm); IR (film) 1750, 1715 and 1630cm-1; lH NMR (CDCij) o 0.92 (d, J=4.6Hz, CHCH3),0.94 
(d, J=4.5Hz, CHCH3), 1.24 (t, J=7.0Hz, CH2CH3), 1.27 (t, J=7.2Hz, CH2CH3), 1.46 (m, CH(CHa)2), 
1.95 (t J=7.2Hz, NCHCH2), 2.60 (m, (H-3)2), 3.27 (m, CH-4)2), 4.14 (q, J=7.2Hz, =CHC02CH2), 4.21 
(m, NCHC02CH2), 4.97 (t, J=7.5Hz, NCH), 5.10 (t, J= 1.9Hz, =CH); 13C NMR (CDC!3) o 13.96, 14.24, 
21.54, 22.84,24.48, 25.18,27.56,35.77,52.05,59.47,61.67, 92.83, 157.94, 166.93, 169.17, 176.54; 
HRMS (M) Found 311.1736 (Calcd for C16H2sN05 311.1734). Anal. Calcd for C16H2sNOs: C 
61.72; H 8.09; N 4.50. Found C 61.61; H 8.23; N 4.65. 
( l'R.S> CE>-l-0-Ethoxycarbooyl-2-pheoyleth-1-yD-5-ethoxycarbonylmethylideoe-2-
QY«Oiidlnone (2.70): 
General method A with keto-amide (2.44) (165mg, 0.45mmol) and a cata!ytlc quantity of 
PTSA, In 1, 2-dlchloroethane (15mL), and a reflux time of 24h: Yield 140mg, oil, 86%; bp 200 
°C(lmm); IR(film) 1745, 1710and 1630cm-l; lHNMR(CDCia)o 1.26(t.J=7.1Hz,CHJ), 1.28(t, 
J=7.1Hz, CH3), 2.29 (m, lH, (H-3)0 ), 2.46 (m, lH, (H-3)b), 3.13 (m, (H-4)2), 3.29 (dd, J=10.8, 
14.2Hz, lH, CH0 Ph), 3.45 (dd, J=5.5, 14.1Hz, 1H, CHbPh), 4.15 (q, J=7.1Hz, =CHC02CH2),4.25 
(m, NCHC02CH2), 5.09 (t, J=8.0Hz, NCH), 5.11 Ct. J= 1.9Hz, =CH), 7.13 {m, (Ph)2), 7.24 (m, (Ph)a); 
13c NMR (CDCJa) o 13.95, 14.24,24.40,27.17, 32.90,54.88,59.45,61.86,92.69, 126.85, 128.32, 
128.81, 136.17, 158.02, 166.85, 168.36, 176.18; HRMS (M) Found 345.1579 (Calcd forC19H2aN05 
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345.1577). Anai.CalcdforC19H23NOs: C66.07; H6.71; N4.06. Found: C65.99; H6.76; N 
4.23. 
General Method B with keto-amide (2.44) (18mg, 0.050mmol) and a catalytic quantity of 
PTSA, in benzene (15ml), and a reflux time of 6h gave comparable results: Yield 4mg, oil, 
23%; lH NMR (CDCI3) as given above. 
CE>-1 Ethoxycarbonylmethyl-5-ethoxycarbonylmetby/jdene-2-Qyrro/ldinone C2 .71 ): 
General method B with keto-amide (2.45) (40mg, 0.15mmol) and a catalytic quantity of 
PTSA, In benzene (15ml), and a reflux time of 2h: Yield 31 mg, white solid, 83%; mp 111-112 
oc (ethyl acetate/petroleum ether, colourless crystals); IR (KBr) 1760, 1720 and l660cm-l; 
1H NMR CCDCI3) o 1.28 (t J=7. 1Hz, CH3), 1.29 (t, J=7.1Hz, CH3), 2.64 (m, (H-3)2), 3.31 (m, (H-
4)2),4.16 (q, J=7. 1Hz, OCH2),4.23 (q, J=7.1Hz, OCH2),4.28 (s, NCH2), 5.05 (t, J=2.0Hz, =CH); 13C 
NMR (CDCI3) o 14.05, 14.35, 24.74, 27.76,41.69, 59.65,61.92, 92.10, 158.97, 166.49, 166.89, 176.47; 
HRMS (M) Found 255.1112 (Calcd forC12H17NOs 255.1107). Anal. Calcd for C12H17NOs: C 
56.46; H 6.71; N 5.49. Found: C 56.56; H 6.85; N 5.26. 
{E>-1-Ethoxycarbonylmethyi-5-Ctert-butoxycarbonyDmethylldene-2-pyrrolldlnone <2.72): 
Keto-amide (2.46) (33mg, 0. 11 mmol) was absorbed onto a 1 mm silica gel chromatotron 
plate. Elution with a gradient of ethyl acetate (5-30%) In petroleum ether yielded 
enamlno ester(2.72) as a white solid (7mg, 23%): mp 98-99.5 °C; IR (KBr) 1760, 1740, 1710 
and 1640cm-1; lH NMR CCDCI3) o 1.30 Ct J=7.1Hz, CH2CH3), 1.48 (s, C(CH3)3), 2.62 (m, (H-3)2), 
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3.28 (m, (H-4)2). 4.23 (q, J=7.1Hz. OCH2).4.26 (s. NCH2), 4.98 (t,J=2.0Hz, =CH); 13c NMR 
CCDCis)o 14.02,24.62,27.77.28.30,41.65,61.84, 79.78,94.04, 157.74, 166.33, 166.60, 176.44; HRMS 
CM) Found 283.1415 (CalcdforC14H21NOs 283.1420). Anal. Calcd forC14H21NOs: C 59.35; H 
7.47; N 4.94. Found: C 58.97; H 7.42; N 5.06. 
(f)- and fl>-l-Etboxycarbony/metbyl-5-( 1-ethoxycarbony/ethylfdene>-2-oyrroUdloone 
<2.Z3E and 2.Z3Z) and f5R.S> and f5'R.S> 5-CEtboxycarbonyleth-l-y/)-1-
etboxycarbony/metby/-Dyrrolld-3-en-2-one <2.802: 
0 0 
C~Et 
2.73Z 
0 
Me 
2.80 
General method A with keto-amide (2.47) (116mg, 0.40mmol) and a catalytic quantity of 
PTSA, In L 2-dichloroethane (15ml), and a reflux time of lOh yielded E- and z-enamlno 
esters (2.Z3E and 2.73Z, respectively) in the ratio 74% E: 26% Z, by lH NMR. Purification by 
radial chromatography using a 1mm silica gel chromatotron plate. eluting with 80% 
petroleum ether/20% ethyl acetate gave E-enamino ester (2.Z3E) as an oil: 46mg, 42%; 
unstable to distillation; IR (film) 1750, 1710 and 1630cm·l; lH NMR CCDCI3) o 1.29(t.J=7.1Hz, 
CH2CH3), 1.30 (t. J=7.1 Hz. CH2CH3), 1.97 Ct. J= 1.4Hz, =CCH3), 2.56 (m, (H-3)2), 3.22 (m, CH-4)2), 
4.18 (q, J=7.1Hz. OCH2). 4.24 (q, J=7.1Hz. OCH2),4.57 (s, NCH2); 13c NMR (CDCI3) o 13.29, 
14.09, 14.32,27.89.28.28.45.07.60.27,61.80, 101.93, 152.68, 168.21. 168.80, 178.37; HRMS(M) 
Found 269.1265 (Calcd for C13H19N05 269.1264). Further elution gave Z-enamino ester 
(2.73Z)asanoil: 16mg,15%; IR(film) 1750, 1710and 163Qcm·l; lHNMR(CDCI3)o 1.26(L 
J=7.1 Hz, CH2CH3), 1.28 (t, J=7.1Hz, CH2CH3), 1.89 Ct. J= l.OHz, =CCH3), 2.59 (m, (H-3)2), 2.77 (m, 
(H-4)2), 4.16 (q, J=7.1Hz, OCH2), 4.17 (q, J=7.1Hz, OCH2), 4.56 (s, NCH2); l3C NMR (CDCI3) o 
14.10, 14.20, 16.11,25.98,27.69,44.70,60.66,61.27, 101.61.146.14, 167.89, 168.16, 177.76; HRMS 
(M) Found 269.1266 (Calcd for C13H19NOs 269.1264). Further elution gave the endocycllc 
isomer (2.80) as 1 : 1 mixture of two diastereoisomers: 8mg, oiL 7%; 1 H NMR (CDCI3) o Q.26 
(d, J=7.3Hz, CHCH3), 1.14 (d. J=7.1Hz. CHCH3), 1.22 Ct. J=7.2Hz, CH2CH3), 1.29 (m, 9H, 3x 
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CH2CH3) • .2..86 (m, CHCH3), 2.94 (m, CHCH3),.3..Z2 (ABq.JAa= 17.9Hz, lH, NCH0 ),3.74 (ABq, 
JAB=18.0Hz, lH, NCHa).4.07-4.25 (m,8H.4x OCH2).~ (ABq.JAB= 17.9Hz, lH. NCHb), 4.71 
(ABq,JAa=18.0Hz, lH, NCHb).41.2 (m, H-5),4.77 (m, H-5),6.25 (m, 2H, 2x H-3), 7.10 (dd,J=1.8, 
6.0Hz, H-4) .ill (dd, J= 1.6, 6.1 Hz. H-4); HRMS (M) Found 269.1258 (Calcd for C13H19NOs 
269.1290). Over 3 days at 20 <>C the relative proportion of one diastereolsomer (the one for 
which the lH ~ values are underlined above) increased as the other began to form E- and 
z-enamlno esters (2.73E and 2.73Z, respectively): 13c NMR (CDCI3) major 
dlastereolsomer of (2.80) ~ 10.49, 14.11, 14.17,39.19.41.65,61.24,61.50,63.38, 128.10, 146.63, 
168.85, 171.94, 173.21. 
General method B with keto-amide (2.47) (71 mg. 0.25mmoD and a catalytic quantity of 
PTSA. In benzene (15mL), and a reflux time of 6h gave E- and Z-enamlno esters (2.73E and 
2.73Z, respectively) In the ratio 86% E: 14% z. by lH NMR. Purification by radial 
chromatography as above gave E- and Z-enamino esters (2.73E and 2.73Z, respectively): 
15mg, oil, 15%; lH NMR (CDCI3) as given above, and endocycllc Isomer (2.80) as a 1 : 1 
mixture of dlastereolsomers: 30mg, oil. 45<ro; lH NMR (CDCia) as given above. 
CE>- and (l)-2-etboxycarbonylmethy/-3-etboxycarbonyJmethyl/dene-lsolndolooe C2.75E 
and2.75Zl: 
4 
0 
CQ,zEt 
2.75Z 
General method A with hydroxy lactam (2.50) (134mg, 0.42mmol) and a catalytic quantity 
of PTSA,In l, 2-dichloroethane (15ml), and a reflux time of 3h gave a mixture of E- and Z-
enamino esters (2.75E and 2.75Z. respectively) (60% E: 40% z. by lH NMR): Yield 114mg, 
white solid, 90%. On recrystallization (ethanoi/H20) the Isomer ratio changed to 45°k E: 
55% Z by 1 H NMR: IR (KBr) 1750, 1730 and 165Qcm·1; 1 H NMR (CDCf3) E Isomer (2.75E) from 
mixture o 1.29 (t, J=7.1Hz, CH3), 1.35 Ct. J=7.1Hz, CH3), 4.25 (q,J=7.1Hz. OCH2),4.27 (q, J=7.1Hz, 
OCH2), 4.56 (s, NCH2), 5.54 (s, =CH), 7.61 (dt, J=l. L 7.4Hz, H-6), 7.70 (dt, J= 1.4, 7.7Hz, H-5), 7.89 
Experimental 191 
(dd, J=0.9, 6.7Hz, H-7), 9.10 (d, J=7.8Hz, H-4); Z lsomer(2.75Z)from mixture o 1.28 Ct.J=7.1Hz. 
CH3), 1.31 Ct. J=7.1Hz, CH3).4, 19 (q,J=7.1Hz, OCH2).4.21 (q, J=7.1Hz, OCH2),5.15 (s, NCH2), 
5.92 (s, =CH), 7.56-7.73 and 7.86-7.89 (m, 4H, H-4, H-5, H-6 and H-7); 13c NMR (CDCI3) E Isomer 
(2.75E) from mixture o 13.97, 14. 16.41.00,60.44,61.75, 98.68, 123.27, 128.14. 129.44, 131.21. 133.35, 
133.74, 147.71, 165.45, 167.16. 168.74,Z lsomer(2.75Z) from mixture o 14.05, 14.08,44.39,60.21. 
61.11 I 94.56, 120.14, 123.76, 127.43, 130.90. 132.84, 137.72, 144.44, 164.83, 166.73, 168.23; HRMS (M) 
Found 303.1116 (Calcd for C16H17NOs 303.1107). Anal. Calcd for C16HuNOs: C 63.36; H 5.65; 
N 4.62. Found: C 63.36; H 5.65; N 4.7 4. 
Isomerization of Z-Enamjno Ester <2.75Z>: E- and Z-enamino esters (2.75E and 2.75Z, 
respectively) (4mg) from above (le; 60% E: 40% Z) and PTSA (1 crystal) were dissolved In 
CDCI3 (0. 7ml) and heated at 60 °C. After 3h the Isomer ratio was 70% E : 30% Z, by 1 H NMR, 
and this ratio had not changed after heating for a further 20h. 
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SECTION £.2.3 
EXTENSION OF THE PEPTIDE CHAIN 
Preparation of (£)-5-Ethoxycarbonylmefhylldene-1-(N-ethoxycarbonylmefhyl)-
carbamoy/methyl-2-pyrrolidlnone <2.93): 
METHOD A: Glycylglyclne ethylester hydrochloride (69mg, 0.35mmol. 1.8equiv) and 
triethylamine (46Jtl, 0.35mmot 1.8equlv) were added to enollactoneE.05 (2.33a) (33mg, 
0.19mmol, lequiv), dissolved In 1, 2-dlchloroethane (30mL), and the mixture was refluxed 
for 16h with azeotroplc removal of H20. The solvent was evaporated and purification of 
the residue by radial chromatography using a lmm silica gel chromatotron plate. eluting 
with 50% ethyl acetate/50% CH2CI2 yielded enamino ester (2.93) as a white solid (48mg, 
79%): mp 131-133 <>C (ethyl acetate/petroleum ether); FTIR (KBr) 3298, 1763. 1742, 1705, 
1664, 1619and 156Qcm·l; lHNMRCCDCI3)o 1.27 (t,J=7.1Hz,CH3), l.29(t,J=7.1Hz.CH3),2.66 
(m, (H-3)2), 3.32 (m, (H-4)2), 4.03 (d. J=4.9Hz, NHCH:z), 4.15 (q, J=7.1Hz, OCH:z), 4.23 (q, 
J=7.1Hz. OCH:z), 4.25 (s, NCH:z), 5.25 (t,J=2.0Hz, =CH), 6.27 Cbs, NH); l3c NMR (CDCI3) o 14.06, 
14.32, 24.73, 27.80,41.38, 43.68, 59.68, 61.7 L 92.90. 158.75, 165.72, 166.96, 169.38, 176.97; HRMS 
(M) Found 312.1319 (Calcd for C14H20N:206 312.1321). Anal. Calcd for C14H2oN:206: C 53.84; 
H 6.45; N 8.97. Found: C 53.70; H 6.42; N 8.72. 
METHOD B: DCC (1.3-dicyclohexylcarbodiimlde) (40mg, 0.19mmol. lequiv). glycine 
ethylester hydrochloride (30mg. 0.21 mmol. 1.1 equlv) and triethylamine (28JtL 0.21 mmol. 
1. 1 equiv) were added to enamlno ester (2. 95) (0. 19m mot 1 equiv) dissolved in CH2CI2 
(5mL) and the mixture was stirred at 20 oc for 16h. The resulting solution was washed with 
H20 (5ml), dried CMgS04) and the solvent evaporated. Purification by radial 
chromatography uslng.a lmm silica gel chromatotron plate. eluting with 50% ethyl 
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acetate /50% CH2CI2 yielded enamlno ester (2. 93) (28mg, 40%) as a white solid; 1 H NMR 
(CDCI3) as given above. 
Preparation of CE>-l-Garboxymetbyl-5-etboxycarbooylmethylldene-2-pyrroUdinone 
!2..2.5k 
METHOD A: General method A for the preparation of enamlno esters (See page 183) with 
keto-amide (2.94) (59mg, 0.20mmol) and a catalytic quantity of PTSA, In 1. 2-
dlchloroethane (15ml), and a reflux time of 5h. The acid (2.95) Is significantly soluble in 
H20, hence after refluxing, the solvent was evaporated and the solid thus obtained was 
used in subsequent steps without further purification: FTIR (KBr) 17 34, 1702 and 1619cm-l; 
lH NMR (CDCI3) o 1.29 (t, J=7.1Hz, CH3), 2.65 (m. (H-3)2). 3.30 (m. (H-4)2).4.17 (q, J=7.1Hz. 
OCHl), 4.34 (s. NCH:l). 5.11 (t, J= 1.8Hz. ==CH); 13c NMR (CDCIJ) o 14.33, 24.78. 27.76, 41.36, 60.00, 
92.43, 158.91, 167.23, 170.38, 176.87; HRMS (M) Found 227.0790 (Calcd for C10H13NOs 
227.0794). 
METHOD B: EnollactoneE.OS (2.33a) (20mg, 0.12mmol. lequiv) and glycine (llmg. 
0.14mmol. 1.2equlv), dissolved in a mixture of CH2CI2 (5ml), DMF (5ml) and H20 (3ml), 
were stirred at 20 oc for 44h. The solvent was evaporated by boiling at atmospheric 
pressure and finally at 1 mm to give an oil (33mg) which contained enamlno ester (2.95) 
and residual DMF: lH NMR (CDCI3) as given above. This sample was not used 
subsequently. 
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Preparation of Ethyl 5-CN-Cl-tert-butoxycarbony/methyOcarbamoy/)-3-oxopentanoate 
5 
4 
0 
NH--....C~tsu 
0 
General method for the preparation of amino acid-derived keto-amides (See page 179) 
with enollactone (2.33a) (35mg, 0.2lmmoL lequiv), glycine tert-butylester hydrochloride 
(51 mg, 0.31 mmot 1.5equlv) and triethylamine (41 J.tl, 0.31 mmot 1.5equlv), in CH2Ci2 (15ml): 
Yield 63mg, white solid, quant; FTIR (KBr) 3276, 1736, 1713, 1665, 1642 and 1563cm-1; lH NMR 
(CDCI3) o 1.28 (t, J=7.1Hz, CH3), 1.47 (s, CCCH3)3), 2.55 (t,J=6.6Hz, CH-4)2), 2.92 (t, J=6.6Hz, CH-
5)2),3.50 (s, (H-2)2), 3.92 (d, J~.9Hz, NCH2), 4.20 (q, J=7.1Hz, OCH2), 6.09 (bs, NH); 13C NMR 
(CDClJ)o 13.98,27.91,29.34,37.71.42.01,49.13,61.31,82.14, 167.01, 168.98, 171.39,201.85; HRMS 
(M-18) 283.1420 cealed for C14H21NOs 283.1420). 
Experimental 195 
SECTION £.2.4 
PREPARATION OF SUCCINIMIDE-BASED CHLORO ENAMINO ESTERS 
Preoarat/on of Ethyl C2R.S> 2-cbtoro-5-CN-0-etboxYcarbony/metbyDcarbamoy/)-3-
oxopentanoate (2.96) and C5R and/or S> and (5'R and/or S> 
ChtoroCethoXYcarbonyt>methyl-l-etboxycarboay/methyl-5-bydroxy-2-pyrrolldinone 
C~Et 
2.97 
Glycine ethylester hydrochloride (27mg, 0.19mmol. 1.3equiv) and triethylamine (25J.tL, 
0. 19mmol. 1.3equiv) were added to enollactone (1.11) (30mg, 0. 15m mol, 1 equlv), 
dissolved in ethyl acetate (3mL), and the mixture was stirred for 3h. The solvent was 
evaporated to give on oil which contained, by 1 H NMR. keto-amide (2.96) and hydroxy 
lactam (2.97) in the ratio 9: l, respectively: lH NMR (CDCI3) keto-amide (2.96) from 
mixture~ 1.29 (t, J=7.1Hz, CH3), 1.32 (t, J=7.1Hz, CH3), 2.60 (t, J=6.5Hz, (H-5)2), 3.07 (m, (H-4)2), 
4.02 (d, J=5.2Hz, NHCH:z), 4.22 (q, J=7.1Hz, OCH:z),4.30 (q, J=7.1Hz, OCH:z), 4.90 (s, CHCI), 6.10 
(bs, NH). Ethyl acetate (3mL) was added to the residue, the mixture was filtered and the 
solvent was evaporated to give an oil (47mg, quant) which contained, by lH NMR, keto-
amide (2.96) and hydroxy lactam (2.97) in the ratio 3: 7, respectively. Hydroxy lactam 
(2.97) was present as a mixture of diastereolsomers, by 1 H NMR. 1 H NMR (CDCI3) hydroxy 
lactam (2. 97)from mixture ~ 1.26-1.40 (m, CH3), 2.17, 2.48, 2.68 and 2.89 (m, H-3 and H-4), 3.71 
(ABq, JAB= 18.1Hz, 1H, NCH0 ),4.13 (ABq, JAa=17.8Hz, lH, NCH0 ), 4.2Q-4.32 (m, OCH:z),4.38 (S, 
CHCI),4.50 (ABq. JAs= 17.8Hz, lH, NCHb),4.53 (s, CHCI), 4.68 (ABq. JAs= 18. 1Hz, lH, NCHb). 
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Preparation of(£>- and (ZJ-5-Ch/oroethoxycarbooy/mefby/ldene-1-
ethoxycarbooylmethy/-2-pyrrolldlnone C2.98E and 2.98Z) and 1-Ethoxycarbooy/methy/ 
oyrroUdlne-2.5-dloneUO C2.99l: 
0 
C~Et 
2.98E 2.99 
METHOD A: Keto-amide- hydroxy lactam mixture (2.96/2.97) (32mg, O.lOmmol) and a 
catalytic quantity of PTSA were dissolved In l, 2-dlchloroethane (10ml). Some activated 
4A ·molecular sieves were added and the mixture was stirred at 70 oc for 6.5 days. The 
mixture was cooled to 20 <>c, filtered and the solvent evaporated. Purification by radial 
chromatography using a lmm silica gel chromatotron plate, eluting with 72% petroleum 
ether/22% ethyl acetate/6% CH2CI2 yielded E-enamino ester (2.98E) as an oil (4mg, 13%): 
IR (film) 3435, 17 40, 1720 and 1640cm-l; 1 H NMR (CDCI3) o 1.27 (t I J==7 .2Hz, CH3), 1.32 (t I 
J=7.2Hz, CHJ), 2.64 (m, (H-3)2), 3.00 (m, (H-4)2}, 4.19 (q, J=7.2Hz, OCH2), 4.22 (q, J=7.2Hz, 
OCH2),4.68 (s, NCH2); 13c NMR (CDC(J)O 14.06, 14.00, 27.19, 28.19, 45.22, 61.46, 61.94, 99.73, 
150.21, 162.81, 167.75, 177.79; HRMS (M) Found 291.0702 (Calcd forC12H1637CINOs 291.0688), 
Found 289.0718 (Calcd for C12H16 35CIN0s 289.0718). Further elution gave Z-enamlno ester 
(2.98Z)asanoll(4mg, 13%): IR(film)3465, 1740, 1690and l59Qcm·l; lHNMR(CDCI3)o 1.29 
(t, J=7.1Hz, CH3), 1.33 (t, J=7.1Hz, CH3), 2.64 (m, (H-3)2), 3.35 (m, (H-4)2), 4.24 (q, J=7.1Hz, 
OCH2), 4.25 (q, J=7.1 Hz, OCH2), 4.86 (s, NCH2); 13C NMR (CDCIJ) o 14.11, 14.22, 27.76, 27.76, 
44.63, 61.46, 61.80,97.22, 152.26, 163.95, 167.92, 177.42; HRMS (M) Found 291.0640 (Calcdfor 
C12H1637ciNOs 291.0688), Found 289.0714 (Calcd for C12H1635CINOs 289.0718). Further 
elution gave imldeE.lO (2.99) as an oil (llmg, 57%): mp 65-68 oc (ethyl acetate/petroleum 
ether, white crystals)(LitE.lO 68 °C); IR (KBr) 1740 and 1710cm·l; lH NMR (CDCI3) o 1.29 (t, 
J=7.1Hz, CH3), 2.81 (s, 4H, 2x NCOCH2), 4.22 (q, J=7.1Hz, OCH2), 4.25 (s, NCH2); 13c NMR 
(CDCJ:3) o 14.06, 28.23, 39.56, 61.95, 166.67, 176.29; HRMS (M) Found 185.0686 (Calcd for 
CaH11N04l85.0688). Anai.CalcdforCaHnN04: C51.89; H5.99; N7.56. Found: C51.77; H 
5.87; N 7 .55. 
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METHOD B: 
0 
C~Et 
2.100 
Acetic anhydride (36J.tl, 0.38mmol, 2equlv) and triethylamine (50J.tL 0.38mmol, 2equlv) 
were added to keto-amide- hydroxy lactam mixture (2.96/2.97) (58mg, 0.19mmol, 
lequlv) and 4-DMAP (35mg, 0.28mmol, 1.5equlv), dissolved In CH2CI2 (6ml), and the 
mixture was stirred for 2.5h. The solvent was evaporated and the residue was dissolved 
In benzene (lOmL), washed successively with O.lN HCI (4x lOmL) and 0.2N NaOH (4x lOmL), 
dried (MgS04) and the solvent was evaporated to yield acetate (2.100) (43mg, oiL 65%), 
as a 3: 2 mixture of two dlastereolsomers, by lH NMR. This oil was used In subsequent 
steps without further purification: IR (film) 1750, 1725, 1635 and 1595cm-l; lH NMR (CDCI3) 
both dlastereolsomers o 1.25-1.36 (m, 12H, 4x CH3), 2.01 (s, major dlastereolsomer, 
COCH3),2.06 (s, COCH3), 2.40-2.52 (m,4H, 2x (H-3)2), 2.74-2.98 (m,4H, 2x(H-4)2), 3.82-4.32 (m, 
12H,4xOCH2and 2x NCH2),4.88 (s, major, CHCD, 5.00 (s,CHCD; 13c NMR CCDCI3) o 13.87, 
13.96, 14.05, 21.57, 21.69, 26.69, 27.88, 28.44, 28.61,41.80,42.52, 56.67,58.38,61.43,61.49,62.61, 
62.76,96.04,96.91, 165.91, 165.77, 166.00, 167.87, 167.97, 168.93, 169.53, 176.39, 176.52; HRMS(M-
60) Found 291.0699 (Calcd for C12H1637CJNOs 291.0688), Found 289.0715 (Calcd for 
C12H1635clNOs 289.0718). 
Acetate (2.100) (40mg, 0.11 mmol) was dissolved In benzene (5ml) and heated at 
65 oc for 90min. The solvent was evaporated to give an oil (25mg) which contained, by 1 H 
NMR, 85% E- and Z-enamlno esters (2.98E and 2.98Z, respectively) (In the ratio of 56% Z: 
44% E) and the elimination product (2.101) (15%). On distillation (145-160 oc, lmm) theE-
and Z-enamlno esters (2.98E and 2.98Z, respectively) formed the elimination product 
(2.101). 
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Preparation of (£)- and (Z2-l-Etboxycarbonylmetbyl 5-etboxycqrbonylroetby/ldene 
pyrrolld-3-en-2-one <2.101E and 2.10JZ): 
0 
CD.2Et 
2.101 z 
METHOD A: Keto-amide- hydroxy lactam mixture (2.96/2.97) (llmg, 0.036mmol) 
and a catalytic quantity of PTSA were dissolved In 1, 2-dlchloroethane (7ml) and 
refluxed, with azeotroplc removal of H20. for 3h. Purification by radial chromatography 
using a 1mm silica gel chromatotron plate, eluting with 95% CH2CI2/6% ethyl acetate 
gave an oil which contained E and Z Isomers of the elimination product (2.101E and 2.101Z, 
respectively) in the ratio of 59% E: 41% Z, by lH NMR (3.5mg, 39%): lH NMR CCDCI3) E 
i 
Isomer (2.101 E) from mixture 8 1.28 Ct J=7.2Hz, CH3), 1.32 Ct J=7.2Hz, CHJ),4.19 (q, J=7.2Hz, 
OCH2). 4.22 (q, J=7.2Hz, OCH2), 4.35 (s, NCH2), 5.44 (d. J= l.OHz, =CH), 6.40 (dd, J= 1.5. 6.0Hz. H· 
3), 8.21 (d. J=6.0Hz. H-4); Z Isomer (2.101Z) from mixture o 1.27 (t, J=7.2Hz, CHa). 1.28 (t, 
J=7.2Hz, CHa).4.17 (q, J=7.2Hz, OCH2). 4.24 (q, J=7.2Hz, OCH2), 4.94 (s, NCH2). 5.44 (s, =CH), 
6.36 (d, J=5.7Hz. H-3), 6.99 (d, J=5. 7Hz. H-4); 13c NMR (CDCI3) E Isomer (2.101 E) from mixture o 
14.09,14.24,40.56,60.74,61.88,99.69, 126.73, 136.43, 150.48, 165.24, 167.34, 169.79; HRMS(M) 
Found 253.0953 (Calcd for C12H1sNOs 253.0951). 
METHOD B: E- and Z-chloro enamino esters (2.98E and 2.98Z, respectively) (2mg) 
present In the ratio of 1 E : 1 Z, dissolved In CDCI3 (0. 7mL) containing PTSA ( 1 crystal), were 
heated at 55 oc and the reaction was monitored by lH NMR. After 15mln all theE Isomer 
(2.98E) had been converted to the elimination products (2.101 E and 2.101Z) and after 45min 
all the Z Isomer (2.98Z) had been converted to the elimination products (2.101E and 2.101Z) 
to give an Isomer ratio of 80% E: 20% Z. respectively. by lH NMR. 
METHOD C: The elimination products (2.101 E and 2.101Z) formed from chloro 
enamlno esters (2.98E and 2.98Z) on silica gel chromatotron plates during radial 
chromatography. The extent of conversion and the E/Z.lsomer ratio varied depending 
on the time spent on the silica. 
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SECTION E.2.5 
ATIEMPTED PREPARATION OF GLUTARIMIDE-BASED 
CHLORO ENAMINO .ESTERS 
Ethyl (2R.S> 2~chtoro-6-CN-C l-ethoxycarbony/methyl>carbamoy{)-3-oxohexanoate 
(2.103): 
5 
4 
0 
N............._C~Et 
OH 
General method for the preparation of amino acid derived keto-amides (See page 179) 
with enollactone (1. 12) (38mg, 0.17mmol, lequlv), glycine ethylester hydrochloride (34mg, 
0.24mmoL 1.4equlv) and triethylamine (32J.tl, 0.24mmoL 1.4equlv), In CH2CI2 (5ml): Yield 
47mg, pale yellow oll,84%; IR (film) 3350, 1760, 1670, and 1550cm-l; lH NMR (CDCIJ) o l.29(t, 
J=7.1Hz, CH3), 1.32 (t, J=7.1Hz, CH3), 2.01 (m, (H-5)2), 2.30 (t, J=7.3Hz, (H-6)2), 2.84 (dt, J= 1.5, 
6.8Hz, (H-4)2).4.02 (d, J=5.2Hz, NCH2).4.22 (q,J=7.1Hz, OCH2),4.29 (q, J=7.1Hz, OCH2),4.81 (s, 
CHCD,6.01 (bs, NH); 13c NMR (CDCI3) o 13.86, 14.06, 19.23,34.38,37.83,41.26,60.71, 61.44,63.11, 
165.04, 169.93, 172.26, 198.72; HRMS (M) Found 323.0952 (Calcd for C13H2037CIN06 323.0950), 
Found 321.0984 (Calcd for C13H2o3SciN06 321.0980). 
C6'R.S> 6~chloro(efhoxycarbonyDmethyl~ 1 ~efboxycarbony/methyl~ojperld-5~en-6-one 
(2.104): 
No 
't'N .......,-C~Et 
0 
2.105 
General method A for the preparation of enamino esters (See page 183) with keto-amide 
(2.103) (30mg, 0.093mmol) and a catalytic quantity of PTSA, in 1, 2-dichloroethane (lOmL), 
and reflux time of 6h. Purification by radial chromatography using a 1 mm silica gel 
chromatotron plate, eluting with 60% petroleum ether/40% ethyl acetate gave the 
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endocycllc isomer (2.104) as an oil: Yield lOmg, 38%; bp 155 oc (lmm); IR (film) 3385, 1750, 
1685 and 1615cm-1; lH NMR (CDCIJ) a 1.28 (t.J=7.1Hz, CH3), 1.31 (t.J=7.1Hz, CH3),2.39 (m, (H-
.4)2), 2.56 (t, J=7 .4Hz, (H-3)2>. 4.20 (q, J= 7.1 Hz, CH2CD2CH2CH3), 4.27 (m, CHCiC02CH2), 4.41 
(ABq, JAs= 18.0Hz, lH, NCH0 ),4.61 (ABq, JAB= 18.0Hz, lH. NCHb). 4.97 (s. CHCI), 5.62 (t.J=4.9Hz. 
H-5); l3CNMR(CDCIJ)a 13.92, 14.08,19.51.30.60,43.59,56.79,61.42,63.20, 113.16, 135.36, 166.50, 
168.76, 170.98; HRMS (M) Found 305.0845 (Calcd for C13H1s37ciNOs 305.0844); Found 
303.0857 (Calcd for C13H1s35CIN05 303.087 4). Anal. Calcd for C13H1sCINOs: C 51.41; H 5.97; 
N 4.61. Found: C 51.11; H 5.97; N 4.71. Further elution gave a fraction (4mg) containing 
recovered keto-amide (2.103) and lmldeE.lO (2.105) In a ratio of 5:4, by lH NMR. 
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SECTION £.2.6 
ATTEMPTED PREPARATION OF PHTHALIMIDE-BASED 
HALO ENAMINO ESTERS 
Reaction with E-dichlorophthalic bromo enollgctone Cl.JZE): 
Preoaratlon of 2-Ethoxycarbony/methy/-5.6-dlchloro-/solndollne-l .3-dlooe C2. 11 Q): 
0 
Cl«7 C~Et 
6 I 1 N_/ 
5~ 3 
Cl 4 
0 
2.110 
Glycine ethylester hydrochloride (24mg, 0.17mmol, 1.3equiv) and triethylamine (23tJ..L 
0.17mmot 1.3equiv) were added to E-dichlorophthalic bromo enollactone (1.17E) (50mg, 
0.14mmol, lequlv), dissolved In CH2C12 (lOmL). The mixture was stirred at 20 oc for 16h, 
washed with H20 ( 1 Oml) and the solvent evaporated to give an intractable mixture 
(67mg, oil). 
This oil (67rog) and a catalytic quantity of PTSA were dissolved in 1, 2-
dichloroethane (lOroL) and activated 4A molecular sieves were added. The mixture 
was stirred at 70 oc for 6 days. The solvent was evaporated and the residue was purified 
by radial chromatography using a 1 rom silica gel chromatotron plate, eluting with a 
gradient of CH2CI2 (45-800k) In petroleum ether to give Imide (2.110) as a white solid (20mg, 
49%): mp 118-120 oc (petroleum ether. white crystals): IR (KBr) 1760 and 1720cm-1; 1 H 
NMR (CDCI3) o 1.29 (t J=7.1Hz, CH3).4.23 (q, J=7.1Hz, OCH2).4.42 (s, NCH2), 7.97 (s, (Ph)2); 
13c NMR (CDCIJ) o 14.09, 39.24,62.09, 125.72, 131.10, 139.28, 165.52, 166.79; HRMS (M) Found 
302.9879 CCalcd for C12H937 C13SCIN04 302.9880). Anal. Calcd for C121-f9Cf2N04: C 47 .71; H 
3.00; N 4.64. Found: C 48.01; H 2.99; N 4.63. 
Reaction wtth E-djchlorophthalic chloro enollgctone 0 .158: 
Glycine ethylester hydrochloride (12mg, 0.087mmol, 1.4equlv) and triethylamine Cl2f.!.L, 
0.087mmol, 1.4equiv) were added to E-dlchlorophthalic chloro enollactone (1.15E), 
dissolved In ethyl acetate (5rol). The mixture was stirred at 20 oc for 16h, filtered and the 
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solvent was evaporated to give an Intractable mixture (21 mg. oil) which contained some 
Imide (2.110), by lH NMR: lH NMR (CDCI3) as given above. 
Reaction with Z-pbthallc chloro enollactone CJ.14Z): 
Glycine ethylester hydrochloride (7mg, 0.050mmol, 1.4equiv) and triethylamine {17J.tl, 
0.050mmol, 1.4equiv) were added to Z-phthalic chloro enollactone (1.14Z) (9mg, 
0.036mmoL lequiv), dissolved in ethyl acetate (3ml). The mixture was stirred at 20 oc for 
16h, tittered and the solvent was evaporated to give an Intractable mixture (11 mg. oil). 
This oil ( 11 mg) and a catalytic amount of PTSA were dissolved in 1, 2-dichloroethane 
(5ml) and refluxed, with azeotroplc removal of H20, for 3h. The solvent was evaporated 
to give an Intractable mixture which contained some imldeE.l O (2.111), by 1 H NMR (See 
below for data). 
Preparation of 2-Etboxycarbooylmetby/ isoindollne-1 .3-dioneUO <2. 111 ): 
2.113 
Glycine ethylester hydrochloride (1 04mg, 0. 7 4mmol. 1. 1 equlv) and triethylamine (98J.tL 
0.74mmol, l.lequlv) were added to phthalic anhydride (2.112) (100mg,0.68mmol, lequiv), 
dissolved in ethyl acetate (15ml). The mixture was stirred at 20 oc for 16h. tittered and the 
solvent was evaporated to give acid-amide (2.113) as an oil (171mg, quant): IR (film) 
3360, 1720 and 1650cm-l; lH NMR (CDCIJ)(> 1.31 Ct. J=7.2Hz, CH3).4.25 (d, J=4.6Hz, NHCH:l), 
4.25 (q, J=7.2Hz, OCH:l), 6.77 (bt, J=4.6Hz, NH). 7.57 (m, (Ph)3), 8.06 (m, (Ph)l); 13c NMR 
CCDCI;Y o 13.87.41.79,61.36, 127.85, 129.20, 129.82, 130.67, 131.96. 136.59, 168.92, 169.67, 170.41; 
HRMS (M-18) Found 233.0693 (Calcd for C12H11N04 233.0688). 
Acid-amide (2.113) (ll4mg. 0.45mmol) and a catalytic quantity of PTSA were 
'dissolved In l, 2-dlchloroethane (20ml) and refluxed, with azeotropic removal of H20. for 
8 days. The solvent was evaporated and the residue was purified by radial 
chromatography using a lmm silica gel chromatotron plate, eluting wtth a gradient of 
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ethyl acetate (0-50%) In CH2CI2. lmldeE.lO (2.111) was obtained as a white solid (50mg, 
48%): mp 112-114 oc (petroleum ether, white crystals) (utE.lO 114-115 °C): IR (KBr) 1750 and 
1730cm-1; lH NMR (CDCI3) o 1.28 (t, J=7.1Hz, CHJ),4.23 (q, J=7.1Hz, OCHi>-4.43 (s, NCH:z), 
7.75 (m, (Ph)2), 7.89 (m, (Ph)2); 13c NMR CCDCI3) o 14.03, 38.87,61.82. 123.52, 131.95, 134.15, 
167.17. 167.40; HRMS (M) Found 233.0692 (CalcdforC12H11N04 233.0688). Anal. Calcdfor 
C12H11N04: C 61.80; H 4.75; N 6.01. Found: C62.07; H 4.69; N 6.01. 
More Reactions with Dlchlorophthallc Bromo Enollactone CJ .17): 
Glycine ethylester hydrochloride (11lmg, 0.79mmoL 1.3equiv) and triethylamine 
(105j.tL 0.79mmol, 1.3equiv) were added toE- and Z-dlchlorophthallc bromo enollactones 
(1.17E and 1.17Z) (223mg, 0.61 mmol. 1 equlv) I dissolved In ethyl acetate (8ml) I and the 
mixture was stirred at 20 oc. After 50 min 4-DMAP ( 112mg, 0. 91 mmol I 1.5equiv) I 
triethylamine (161f.1L 1.22mmoL 2equiv) and acetic anhydride (115f.1L, 1.22mmol, 2equlv) 
were added and the mixture was stirred for 2h~ then filtered. The filtrate was diluted with 
ethyl acetate (15ml)~ washed with 10% citric acid solution (20ml) and H20 (2x 20ml), 
dried (MgS04) and the solvent evaporated to give an Intractable mixture (176mgl oil) 
which contained some Imide (2.110): lH NMR CCDCI3) as given above. 
Oil (5mg) was dissolved in C6D6 (0. 7ml) and heated at 70 oc. After 1 day the 
composition, by 1 H NMR, bad not changed. 
011 (20mg) was dissolved In toluene (5ml) and refluxed for 16h. At this stage the 
composition, by 1 H NMR~ bad changed very little. Purification by radial 
chromatography, using a lmm silica gel cbromatotron plate, eluting with a gradient of 
ethyl acetate (5-100%) In petroleum ether gave a series of Intractable fractions. 
Oil C 151 mg) was heated at 180 oc at 1 mm for 2h. Purification by radial 
chromatography, using a lmm silica gel chromatotron plate, eluting with a gradient of 
ethyl acetate (5-1 00%) In petroleum ether gave a series of intractable fractions. 
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SECTION E.2.7 
A SYNTHETIC INTERMEDIATE OF PROSTAGLANDIN ANALOGUES 
Pr<marafion of CE)-5-(2-oxo-2-pheny/ethylldene>-2-tetrahydrofuranooe C2. 1 1 5): 
0 
Succinic anhydlide (0.84g,0.0084mol, 1equlv) and Ph3P=CHCOPhE.ll (4.77g,0.013mol, 
1.5equlv) were dissolved In CH2CI2 (80ml) and refluxed for 3 months, at which time more 
Ph3P=CHCOPh (1.84g, 0.0048moL 0.6equiv) was added and the reflux continued. After 
another month, more Ph3P=CHCOPh (0.65g, 0.00 17mol, 0.2equlv) was added and the reflux 
continued for one month more. The solvent was evaporated and the residue was 
purified by silica column chromatography, eluting with CH2CI2 to give enollactone (2.115) 
as a beige solid (1.68g, 99%): mp 156-159 oc (CH2CI2/petroleum ether, cream crystals); 
FTIR (KBr) 1802, 1696 and 1668cm-l; lH NMR (d6-acetone) 8 2.99 (m, CH-3)2), 3.64 (m, (H-4)2), 
7.06 (t, J=2.1Hz, =CH), 7.65 (m, (Ph)2), 7.73 (m, (Ph)l), 8.13 (m, (Ph)2); 13c NMR (d6-acetone) 
325.77,27.77,99.51, 127.94, 128.87, 132.78, 139.07, 171.18, 174.43, 189.59; HRMS(M)Found 
202.0632 CCalcdforC12H1003202.0630). Anal. CalcdforC12H1003: C 71.28; H 4.98. Found: 
C 71.08; H 5.12. 
PrElQaratlon of Methyl (£)- and m-((4-bydroxy-6-oxobex-4-eooyl)am/nolh<mtanoate 
<2. 1172 and the corresoondlna keto-amide <2. J 16): 
Ph 
0 
0 
NH- (C~)sC~Me 
0 
2.1 ~ 6 
0 
NH- (C~)sC~Me 
0-H 
. 
• 
• 
.&0 
6 
Ph 
2.117 
General method for the preparation of amino acid-derived keto-amides (See page 179) 
with enollactone (2.115) (lOOmg, 0.50mmol. lequiv), heptanoic methylester 
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hydrochlorideE.12 (126mg, 0.64mmoL 1.3equiv) and triethylamine (85J..LL 0.64mmoL 
1.3equlv) in CH2CI2 (lOmL) gave a mixture of the enol-amide (2.117) and corresponding 
keto-amide (2.116) In the ratio of 4: l, respectively, by lH NMR: Yield 166mg, white solid, 
93%; FTIR CKBr) 3299,1737, 1634 and 1568cm-1; lH NMR (CDCI3) enol-amide (1.117) from 
mixture~ 1.31 (m,4H, NCH2CH2CH~H2), 1.49 Cm. NCH2CH2), 1.00 (m, CH2CH2C02CHa), 2.28 
(t J=7.5Hz, CH2C~CH3), 2.54 (t, J=6.9Hz CH-2)2), 2.85 (t, J=6.9Hz, (H-3)2), 3.24 (m, NCH:z), 3.66 
(s, CH3),5.70 (bs, NH), 6.21 (s, =CH), 7.47 (m, (Ph)3), 7.86 (m, (Ph)2); lH NMR (CDCI3) keto-
amide (1.116) from mixture o 4. 17 (s, CH2COPh); HRMS (M) Found 361. 1899 (Calcd for 
C2QH27N05 361. 1889). 
{E)-1-Metboxycarbooylbexyl-5-(2-oxo-2-pbenyletbyUdeoe)-2-oyrrolidinonef.ll C2.09): 
Ph 
0 
General method A for the preparation of enamino esters (See page 183) with enol-amide 
(2.117) - keto-amide (2.116) mixture (t:JJmg, 0.17mmol) and a catalytic quantity of PTSA, in 
l, 2-dlchloroethane (lOmL), and reflux time of 43h: Yield 46mg, oll,81%; mp 62-63 oc 
(ether/petroleum ether); 1 H NMR (CDCI3) o 1.39 (m, 4H. NCH2CH2CH2CH:z), 1.65 (m, 4H, 
NCH2CH2CH2CH2CH2) I 2.32 (t I J=7 .4Hz, CH2C~CH3), 2.61 (m, (H-3)2), 3.44 (m, (H-4)2), 3.64 (t, 
J=7.6Hz, NCH:z), 3.66 (s, CH3), 6.36 (t, J= 1.8Hz, =CH), 7.50 (m, (Ph)a), 7.90 (m, (Ph)2); 13c NMR 
(CDCG) o24.68, 26.08, 26.34,26.62, 27.89, 28.67, 33.85, 40.58, 51.48, 96.10, 127.52, 128.50, 131.96, 
139.92, 161.96, 174.01, 177.39, 189.80; HRMS (M) Found 343.1779 (Calcd for C2oH2sN04 
343.1784). 
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SECTION E.3 
CHAPTER 3 EXPERIMENTAL 
SECTION £.3. 1 
PREPARATION OF {3-KETO ESTER (3.01) 
Preparation of l-Ethy/6-roethy/3-oxobexandloateLH (3.0D: 
6 
5S(C~Me 
4 0 
3 
2 1 
C~Et 
3.01 
To a solution of recently recrystallized Meldrum's acid (2,2-dimethyl-1,3-dloxane-4.6-
dlone) (1.97g, 0.014mol, 1.03equiv) dissolved in CHzCiz (5ml) and cooled to 0 oc. dry 
pyridine (2.69mL, 0.033moL 2.5equiv) was added over lOmin. To this solution, acid 
chlorideE.15 (3.05) (2.00g, 0.013moL lequiv) dissolved In CHzCI2 (4ml) was added over 
105min and the resulting solution, after stirring at 0 oc for 60min and at 20 oc for 50mln, was 
poured Into 2N HCI (8ml) containing crushed Ice. The organic layer was removed and 
the aqueous layer was extracted with CHzCiz (2x 2ml). The combined CHzCiz extracts 
were washed with 2N HCI (2x 2ml), saturated aqueous NaCI solution (3ml), dried (MgS04) 
and the solvent was evaporated to give Meldrum's acid compound (3.06) as a brown 
solid ( 1. 95g, 58%), which was used subsequently without further purification: 1 H NMR 
CCDCIJ) o 1.75 (s, C(CHJ)z), 2.75 (t, J=6.8Hz, CH2COzCH3), 3.45 (t, J=6.8Hz, CH2CH2COzCH3), 
3.71 (s, OCH3). 
Meldrum's acid compound (3.06) (1. 95g, 0.0076mol) was dissolved In ethanol 
(40ml) and refluxed for 2.5h. The s~lvent was evaporated to yield p-keto esterE.14 (3.01), 
which was used subsequently without purification, as an oil (1.49g, 95%): 1 H NMR (CDCI3) 
o 1.29 (t, J=6.9Hz, CHzCHJ), 2.63 (t, J=6.5Hz. (H-5)2), 2.88 (t, J=6.5Hz, (H-4)2), 3.50 (s, (H-2)2), 3.69 
(s, OCH3)A.21 (q, J=6.9Hz, OCH2CH3); 13c NMR (CDCI3) o 13.82, 27.44, 37.16.48.99,51.68, 
61.28, 166.99, 172.83, 201.13. 
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SECTION £.3.2 
PREPARATION OF ENAMINES (3.07-3.10) 
General Method for the Preparation of Protio Enamlnes (3.07 and 3.08): 
Glycine ethylester hydrochloride (1.4equlv) and triethylamine (1.4equiv), or butylamine 
(2equlv) were/was added top-keto ester (3.01) (stated amount, lequlv), dissolved in 
benzene, and the mixture was refluxed with azeotroplc removal of H20 for 90mln. The 
solvent was evaporated and the crude enamine (3.08. 3.07. respectively) was purified by 
radial chromatography using a 4mm silica gel chromatotron plate, eluting with the stated 
solvent system. 
1-Ethyl. 6-roethy/ CE2- and (l}-3-CN-butylamino)-2-hexenedloate <3.07E and 3.07Z): 
s 
C02 Me 
: NH-nBu 
' 
2 
Et02C H 
3.07E 
s 
C02Me ~ NH-0 Bu 
1 
H C02Et 
3.07Z 
General method with p-keto ester (3.01) (100mg, 4.94mmol) and butylamine (l.OmL. 
9.87mmoL 2equiv).ln benzene (80mL). Elution with 87% petroleum ether/13% ethyl 
acetate yielded E- and Z-enamlnes (3.07E and 3.07Z, respectively) in the ratio 22% E: 78% 
Z,bylHNMR: 420mg,oi1,47%; FTIR(film)3389,3282,319L 1740,1685, l654andl608cm-l; lH 
NMR (CDCI3) Z Isomer (3.07Z) from mixture 5 0.96 (t, J=7.3Hz, CH2CH2CH3), 1.27 (t, J=7.1Hz, 
OCH2CH3), 1.40 (m, NCH2CH2CH;V. 1.56 (m, NCH2CH;V. 2.56 (s, 4H, (H-4)2 and (H-5)2), 3.23 (q, 
J=6.5Hz, NCH;V. 3.73 (s, OCH3), 4.11 (q, J=7.1Hz, OCH;V. 4.44 (s, =CH). 8.58 (bs, NH); 13c NMR 
(CDCi3) Z isomer (3.07Z) from mixture o 13.41. 14.26, 19.67. 26.69, 31.66, 32.15.42.03, 51.46,57.98, 
80.51. 163.23,170.42, 172.13; HRMS(M)Found257.1634(CalcdforC13H23N04257.1637). 1H 
NMR (CDCIJ) indicated the presence of the E Isomer (3.07E): o 4. 72 (bs. NH). 
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7-Ethy/, 6-methy/ (£)-and CZ2-3-CN-ethoxycarbonytmethy/qmlno>-2-hexenedloate C3.08E 
and 3.08Z>: 
6 
:~~~C~Et ;lC~Et 
3.08Z 
General method with p-keto ester (3.01) (500mg, 2.47mmol), glycine ethylester 
hydrochloride (500mg, 3.58mmol. 1.4equlv) and triethylamine (1.0mL, 9.87mmol. 2equlv), 
In benzene (40mL). Elution with 80% petroleum ether/20% ethyl acetate yielded E- and Z-
enamlnes (3.08E and 3.08Z, respectively) In the ratio 28% E: 72% Z, by lH NMR: 319mg, oil, 
45%; FTIR (film) 3388,3291, 1741, 1688, 1657 and 1605cm·l; lH NMR (CDCI3) Z Isomer (3.08Z) 
from mixtureS 1.25 (t, J=7.1Hz, CH2CH3), 1.29 (t, J=7.1Hz, CH2CH3), 2.52 (m,4H, (H-4)2 and (H-
5)2), 3.70 (s, OCHJ),4.01 (d, J=6.1Hz, NCHit 4.11 (q, J=7.1Hz, OCH:z), 4.23 (q,J=7.1Hz, OCH:z), 
4.55 (s, =CH), 8.89 (bt, NH); 13c NMR Z Isomer (3.08Z) from mixture (CDCI3) S 14.07, 14.45, 
26.63,31.73,44.34, 51.84, 58.64,61.50, 83.49, 162.13, 169.66, 170.32, 172.35; HRMS (M) Found 
287.1367 (Calcd for C13H21N06 287.1369). lH NMR CCDCIJ) indicated the presence of theE 
Isomer (3.08E): s 5.31 Cbs, NH). 
General Method for the Preparation of Bromo Enamlnes (3.09 and 3.102: 
NBS (N-bromosucclnlmlde) (lequlv), which bad been purified by recrystallizationE.Ol, was 
added to enamine (3.07, 3.08) (stated amount, lequiv) dissolved in THF (20mL), at 0 oc, 
and the solution was stirred at 0 oc for 15mln. The solvent was evaporated and CCI4 C3mL) 
was added. The mixture was filtered and the solvent was evaporated to yield enamlne 
(3.09,3.10, respectively) as an oil, which was used in subsequent steps without further 
purification. 
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1-Ethy/. 6-methy/ (f)- and (ZJ-2-b,romo-3-(N-butylamjoo)-2-hexened/oate (3.09E and 
3.09Z): 
6 
C02 Me 
: NH-"Bu 
1 
Br C02Et 
3.09E 
General method with enamlne (3.07) (95mg, 0.36mmol) and NBS (63mg, 0.35mmot 
1equlv), In THF (20ml), gave E- and Z-enamlnes (3.09E and 3.09Z, respectively) In the ratio 
83% E: 17% Z, by lH NMR: Yield 119mg, quant; FTIR (film) 3374,3252,3146, 1740, 1670, 1634 
and 1588cm·l; 1 H NMR CCDCI3) E Isomer (3.09E) from mixture o 0. 94 Ct, J= 7 .3Hz, CH2CH2CH3), 
1.31 (t, J=7.0Hz, OCH2CHJ), 1.42 (m, NCHzCH2CH:i), 1.58 (m, NCH2CH:i), 2.59 (m, (H-5)2), 2.93 
(m, (H-4)2), 3.28 (m, NCH2), 3.72 (s, OCH3), 4.17 (q, J=7.0Hz, OCH2). 9.28 (bs, NH); 13C NMR 
(CDCI3) E isomer(3.09E) from mixture o 13.72, 14.46, 19.94, 27.47, 30.82,32.45,43.83,51.98, 60.49, 
76.86, 162.39, 167.73, 172.34; HRMS (M) Found 337.0713 (Calcd forC13H228lBrN04 337.0713), 
Found 335.0735 (Calcd tor C13H2279BrN04 335.0733). 1 H NMR (CDCI3) indicated the 
presence of the Z Isomer (3.09Z): o 5.51 (bs, NH). 
1-Ethyl. 6-methyl (f)- and (l2-2-bromo-3-(N-ethoxycarbooy/metbytamloo)-2-
hexenedioate C3.10E and 3.10Z): 
General method with enamine (3.08) (92mg, 0.32mmol) and NBS (57mg, 0.32mmol, 
lequiv), in THF (20mL), gave a mixture of E- and Z-enamines (3.10E and 3.10Z, 
respectively) In the ratio 75% E: 25% Z, by 1H NMR: Yield 113mg, 96%; FTIR (film) 3357, 
3263, 1740, 1641 and 1583cm·l; lH NMR CCDCI3) E lsomer(3.10E) from mixture o 1.30 Ct 
J=7.1Hz, CHzCH3), 1.32 (t, J=7.1Hz, CH2CH3), 2.62 (m, (H-5)2), 2.83 (m, (H-4)2), 3.71 (s, OCH3), 
4.10 (d, J=5.9Hz. NCH2), 4.20(q, J=7.1Hz, OCH:i>, 4.24 (q, J=7.1Hz, OCH2), 9.59 (bt, NH); 13C 
NMR (CDCI3) E Isomer (3.10E) from mixture o 14.05, 14.31, 27.53,30.63, 45.49, 51.91, 60.76, 61.69, 
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79.47, 161.00, 167.29, 169.39, 172.28; HRMS(M)Found367.0454CCalcdforC13H2081BrN06 
367.0455), Found 365.0496 (Calcd for C13H2079BrN06 365.0474). lH NMR CCDCI3) Indicated 
the presence of the Z Isomer (3.1 OZ): o 6.07 (bs, NH). 
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SECTION E.3.3 
PREPARATION OF ENAMINO ESTERS (2.66, 2.71, 3.02-3.03) 
General Method tor the Preparation of Enamino Esters C2.66. 2.71 . 3.02-3.03): 
The appropriate enamlne (3.07,3.09, 3.08, 3.10) (stated amount, lequlv), dissolved In THF 
(3ml), was added to NoH (1 equlv) and the solution was stirred at 20 oc for 18h. The solvent 
was evaporated, CH2CI2 (3ml) was added, the mixture was filtered and the solvent was 
evaporated to give the enamlno ester (2.66. 2.71, 3.02-3.03, respectively) as an oil. 
1-Buty/ CE>-5-ethoxycarbonylmetbylldene-2-pyrrolldinone (2.66): 
General method with enamlne (3.07) (50mg, 0.19mmol) and NoH (5mg),ln THF (3mL): 
Yield 37mg, 85%; 1H NMR (CDCI3) as given earlier (Chapter 2 Experimental). No Z Isomer 
was observed. 
(f)-l-Ethoxycarbooy/methyl-5-etboxycarbooylmetbylidene-2-oycro/ldjoone C2.71): 
General method with enamlne (3.08) (70mg, 0.24mmol) and NaH (6mg), In THF (3ml): 
Yield 37mg,59%; lH NMR (CDCI3) as given earlier (Chapter 2 Experimental). 
1-Buty/ (f)- and CZ>-5-bromoethoxvcarbooy/metbyUdene-2-pyrrolldinone (3.02): 
0 0 
Br C~Et 
3.02E 
General method with enamlne (3.09) (33mg, 0.098mmol) and NaH (2mg), In THF (3ml), and 
a reaction time of 2h gave an oil (16mg) which contained, by lH NMR, a mixture of E- and 
Z-bromo enamlno esters (3.02E and 3.02Z, respectively) (SO% of mixture; 75% E: 25% Z) 
and elimination products (3.11E and 3.11Z) (20% of mixture; 75% E : 25% Z). Purification by 
radial chromatography using a lmm silica gel chromatotron plate, elutlf1g with 87% 
petroleum ether/10% ethyl acetate/3% CH2CI2 gave an oil (5mg) which contained, by 
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lH NMR. a mixture of elimination products (3.11 E and 3.11Z) (60% of mixture; 73% E : 27% l:J 
and E-bromo enamino ester (3.02E) (40% of mixture): 1 H NMR (CDCI3) E-bromo enamlno 
ester (3.02E) from mixture o 0.89 (t, J=7.2Hz. CH2CH2CHJ), 1.26 (m. NCH2CH2CH:z), 1.35 (t 
J=7.2Hz, OCH2CH3), 1.60 (m, NCH2CH:z), 2.55 (m, CH-3)2),2.84 (m, (H-4)2),3.77 (t, J=7.6Hz, 
NCH2),4.27 (q, J=7.2Hz, OCH:z); See below for data of elimination products (3.11E and 
3.11Z). Further elution gave Z-brom,o enamlno ester (3.02Z) (3mg, 10%): 1 H NMR (CDCI3) 3 
0.94 (f.J=7.3Hz, CH2CH2CH3), 1.33 (m, NCH2CH2CH:z), 1.34 (t,J=7.1Hz, OCH2CH3), 1.57 (m, 
NCH2CH:z), 2.53 (m, (H-3)2), 3.25 (m, (H-4):2), 4.09 (t, J=7.8Hz, NCH:z), 4.25 (q, J=7.1Hz, OCH2). 
Preparation of 1-Butyl CE2- and CZ>-5-etboxycarbony/methyUdene pyrroUd-3-en-2-one 
(3.11 E and 3.11 Z); 
0 0 
General method with enamine (3.09) (51 mg. 0.15mmol) and NoH (4mg), In THF (3ml). 
gave a residue (35mg) which contained, by 1 H NMR, elimination products (3.11 E and 
3.11Z) (70% of mixture; 70% E: 30% l:), and E- and Z-bromo enamino esters (3.02E and 
3.02Z, respectively) (30% of mixture; 70% E : 30% Z). This mixture was dissolved in CCI4 
(15ml), containing a catalytic quantity of PTSA, and the solution was heated at 60 oc for 5 
days. Purification by radial chromatography using a lmm silica gel chromatotron plate, 
eluting with BOOk petroleum ether/20% ethyl acetate yielded E and Z Isomers of the 
elimination product (3.11 E and 3.11 Z, respectively) In the ratio 90% E : 10% z. by 1 H NMR: 
Yield 14mg,41%; FTIR(film) 1708.1635and 1560cm-l; lHNMRCCDC13)Eisomer(3.11E)from 
mixture 30.94 Ct. J=7.3Hz, CH~H2CH3), 1.32 (m, NCH2CH~H:z), 1.34 (t, J=7.1Hz, OCH2CH3), 
1.55 (m, NCH2CH2),3.58 (t,J=7.4Hz. NCH2),4.25 (q,J=7.1Hz. OCH2).5.54 (d,J= l.7Hz, =CH),6.30 
(dd, J= 1.7, 6.0Hz, H-3), 8.13 (d, J=6.0Hz, H-4); Z isomer (3.112) from mixture o 5.35 (s, =CH), 
6.27 (d. J=5.8Hz. H-3), 6.88 (d. J=5.8Hz, H-4); 13c NMR CCDCI3) E Isomer (3.11E) from mixture o 
13.67, 14.26, 20.02, 30.35 •. 39.06, 60.59, 99.10, 126.88, 135.45, 151.07, 165.67, 170.29; HRMS (M) 
Found 223.1210 (CalcdforC12H17N03 223.1208). 
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CE>~ and CZ>-5~Bromoetboxycarbony/metbylldene-1-ethoxycarbony/methy/-2-
pyrroUdinone <3.03E and 3.03Z): 
0 0 
General method with enamine (3.1 0) C50mg, 0. 14m mol) and NaH (3mg), In TI-IF (3mL), 
gave an oil (39mg) which contained, by 1 H NMR, a mixture of elimination product (2.1 01) 
(15% of mixture; .60% E: 40% Z) and E- and Z-bromo enamlno esters (3.03E and 3.03Z, 
respectively) (85% of mixture; 84% Z : 16% E). Some of this mixture (7mg) was purified by 
preparative tic on silica, eluting with BOOk CH2CI2/l6% petroleum ether/5% ethyl acetate 
to give a fraction (2mg. oil) containing. by 1 H NMR. a mixture of elimination products 
(2. 101E and 2. 101Z) (700k of mixture; 43% E: 57% Z) and E- bromo enamlno ester (3.03E) 
(30% of mixture): lH NMR (CDCI:y E-bromo enamino ester (3.03E) from mixture 8 2.64 Cm. 
(H-3)2). 2.97 (m. (H-4)2). 4.61 (s, NCH:l); see page 199 for data of elimination products 
(2.101E and 2.101Z) (Chapter 2 Experimental). Another fraction (l mg, oil) contained z-
bromo enamino ester(3.03Z): lH NMR (CDC~:}) o 1.30 Ct. J=7.1Hz. CH3), 1.33 Ct. J=7.1Hz, CH3), 
2.63 (m, CH-3)2), 3.36 (m, (H-4)2),4.24 (q, J=7.1Hz. OCH:z), 4.24 (q, J=7.1Hz, OCH:z). 4.91 (s, 
NCH2); HRMS (M) Found 335.0190 (Calcd for C12H168lBrNOs 335.0193), Found 333.0177 
CCalcdforC12H1679BrNOs 333.0212). 
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SECTION £.3.4 
PREPARATION OF ENAMINO ESTER (3.04) WITH THE POTENTIAL FOR PEPTIDE 
CHAIN EXTENSION IN THE N AND C DIRECTIONS 
Preparation of C4S> 3-beozyloxycarbonyl-4-cblorotormy[methy/-1 .3-oxazolldln-5-ooe 
The banzyloxycarbonyl (CBz) acldE.l6 (3.13) (1.89g, 6.77mmol. lequiv) was dissolved In 
CH2CI2 (50ml) and the solution was cooled to 0 <>C. Freshly distilled oxalyl chloride (8.6mL 
98.6mmot 15aqulv) and a catalytic quantity of DMF ware added. The mixture was stirred 
at 0 <>C for 2h and at 20 <>C for 16h. The solvent was evaporated, mora CH2CI2 (2ml) was 
added and evaporated (repeated 3 times). Final traces of oxalyl chloride were 
removed at lmm to yield acid chloride (3.14) as a beige solid (2.02g, 100%) which was 
used In subsequent steps without further purification: 1 H NMR CCDCI3) o 3.55 CABq. 
JAs= 17.2Hz, lH, CH0 COCO, 3.86 (bm, lH, CHbCOCO. 4.33 (m, H-4), 5.17 CABq. JAs= 12.7Hz, lH, 
CH0 Ph), 5.23 (ABq.JAs=12.7Hz, lH, CHbPh), 5.34 (m, 1H, (H-2)0 ), 5.50 (bs, lH, (H-2)b), 7.37 (m, 
CPh)s). 
ENAMINE ROUTE TO ENAMINO ESTER (3.04) 
Preparation of (4$) 3-Benzyloxycarbony/-4-(3-ethoxvcarbony/-2-QXOQropyf)-1 ,3-
oxazo//din-5-one (3.15): 
'f}=~_ csz-NH.,~ ~o 
Et02C 
Pyridine (53~.tL 0.65mmol. 2equiv) and Meldrum's acid (47mg, 0.33mmol, lequiv) were 
added to acid chloride (3.14) (l07mg. 0.36mmol, 1.1 equlv), dissolved in CH2CI2 (5ml), at 0 
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°C. The solution was stirred at 0 oc for 1 h, then at 20 oc for 1 h. The solvent was evaporated 
to give an oil (207mg), used subsequently without further purification, containing acylated 
Meldrum's acid: lH NMR (CDCis) o 1.72 (s, CCCH3)2), 3.04 (m. lH, C4CH0 ), 3.36 (bm, lH, 
C4CHb), 4.34 (bs, H-4), 5.18 (m, CH2Ph), 5.32 (bs, 1H, (H-2)0 ), 5.53 Cbs, 1H. (H-2)b), 7.36 (m, 
(Ph)s). 
Acylated Meldrum's acid (assumed 0.33mmol) was dissolved In ethanol (10ml) 
and refluxed for 2h. The solvent was evaporated. Purification by radial chromatography 
using a 1mm silica gel chromatotron plate, eluting with 80% CH2CI2/20% ethyl acetate 
gave oxazolldinone (3.15) as an oil (86mg, 75%), which was used in subsequent steps 
without further purification: lH NMR (CDC's) o 1.26 (t, J=7.2Hz, CH3), 3.21 (m, 1H, C4CH0 ). 3.44 
(s. CH2C~Et), 3.65 (bm, 1H. C4CHb).4.18 (q, J=7.2Hz, OCH:z). 4.30 (s, H-4), 5.19 (s, CH2Ph), 
5.38 (d. J=3.0Hz, 1H, (H-2)0 ), 5.51 (s, lH, (H-2)b). 7.36 (m, (Ph)s); 13c NMR (CDCI3) o 13.87, 
42.24.48.54,50.60,61.53.67.77,78.21, 128.14, 128.48, 128.57, 135.22, 152.46.166.18, 171.66, 199.95; 
HRMS (M) Found 349.1165 (Calcd for C17H19N07 349.1161). 
Preparation ofenaroine (3.16)/lm/ne C3.2D: 
0 
f .)=o, CO,Et csz-: .. -~ NHJ 
Et02C 
3.16 
ro 
CBz-N • .)= O .. N.,v/C~Et 
H·-~ 
Et02C 
3.21 
Glycine ethylester hydrochloride (65mg, 0.47mmot 1.5equiv) and triethylamine (621JL 
0.47mmol, l.5equiv) were added to ~-keto ester(3. 15) (109mg, 0.31mmol. lequiv), 
dissolved In benzene (24ml), and the mixture was refluxed, with azeotroplc removal of 
H20. for 90min. The mixture was filtered and the solvent was evaporated to yield an oil 
(116mg, 86%) which was used in subsequent steps with further purification: lH NMR 
CCDCI3) shown below (Spectrum E.Ol). HRMS (M) Found 434.1689 (Calcd for C21H26N20s 
434.1694). 
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Spectrum E.Ol 
i\ 1~ ,.,/\, . 11 j \l.....__,__ __ --./ JtJ (.JJt . ./i · V,J0\uV!,\.l)~JL._._).\.~ __ j) l 
?.s ?.e s.s s.e s.s s.e 4.5 -4.e ::~.s ::1.0 z.s a.e 1.s PP• 
Preoaratjoo of (3$) CE)-3-Benzyloxycarbony/amjoo-7-etboxycarbonytroetby/-5-
etboxycarbooy/roetbyljdjoe-2-oyrrolldjoone (3.04): 
Enamine (3.16)/imine (3.21) (51mg, 0.12mmol) was heated at 150 oc, at 1mm, for 1h. 
Purification by radial chromatography using a 1mm silica gel chromatotron plate, eluting 
with 80% CH2CI2/20% ethyl acetate gave enamino ester (3.04) as an oil (31 mg, 65%): FTIR 
(film)3350, 1801,1714, 1632and 1530cm-l; lHNMR(CDCIJH> 1.28(tJ=7.1Hz,CH3), L29(t, 
J=7.1Hz, CH3), 3.11 (dd, J=6.9, 19.0Hz, 1H, (H-3)0 ), 3.91 (dd, J=9.7, 19.0Hz, 1H, (H-3)b),4.12-4.26 
(m,6H, 2x CH2CH3 and NCH2), 4.43 (m, H-4), 5.12 (m,3H, CH2Ph and =CH), 5.39 (bs, NH), 7.35 
(m, (Ph)s); l3c NMR (CDCIJ) o 14.07, 14.36,32.85,42.11,50.06,59.92,62.12,67.39, 93.50, 128.19, 
128.33, 128.58, 128.64, 154.84, 155.78, 166.27, 166.49, 173.74; HRMS (M) Found LUJ4.1577 (Calcd 
for C2d"l24~07 LUJ4.1583); (a.)o20 = -13° (c 0.35; CH2CIV. 
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INSERTION ROUTE TO ENAMINO ESTER (3.04) 
Preparation of (4$) 3-benzy/oxycarbonyl-4-(3-ethoxycarbony/-2-oxo-3-
tr[pbeoy/phosohorany/ldeDYIPrOQy/)-1 .3-oxazolfdio-5-oo~ <3. 1 7): 
Acid chloride (3.14) (107mg, 0.36mmol, lequiv) was dissolved in CH2CI2 (50ml) and 
cooled to 0 oc. Ph3P=CHC02EtE.03 (251 mg, 0. 72mmoL 2equlv) was added and the solution 
was stirred at 0 oc for 30mln and at 20 oc for 30m ln. The solvent was evaporated and the 
residue was purified by radial chromatography using a 2mm silica gel chromototron 
plate, eluting with 55% ethyl ocetate/45% petroleum ether to give phosphorone (3.17) as 
a colourless solid (187mg, 84%), which was used subsequently without further purification: 
lH NMR (CDCI3) () 0.73 (bt, CH3), 3.39 CABq. JAB= 17.5Hz, lH, C4CHa), 3.77 (q, J=7.1Hz, 
OCH2CH3), 4.20-4.32 (m, 3H, C4CHb, H-4 and (H-2)a), 5.16 (m, CH2Ph), 5.31 (ABq. JAB= 12.0Hz, 
lH, (H·2)b), 7.49 (m, (Ph)2o)· 
Prru;>aratlon of 7-Ethy/ (5SJ 5-benzytoxycarbonylamlno-3-oxo-2-
trioheoylpbospboranylidenehexqndloateEJ.l (3.18): 
0 
NH--.C~Et 
0 
1 N NaOH (1.5ml, 1.5mmol, 6equiv) was added to a stirred solution of phosphorane (3.17) 
(l50mg, 0.25mmol), In methanol (3ml), at 20 °C. After 4h the solution was acidified to pH 3 
with 1 N HCL the solvent was evaporated and the residue was extracted ~ith ethyl acetate 
(2x 5ml). The combln!9d ethyl acetate extracts were dried CMgS04) and the solvent was 
evaporated to yield acid (3.18) as a colourless solid (145mg, quont): lH NMR (CDCI3) o 
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0.67 (t, J=7.1Hz, CH3), 3.13 (m, 1H, (H-4)0 ),3.73 (m, OCH:2CH3),4.02 (m, lH, (H-4)b),4.55 (m, H-
5),5.11 (m, OCH2Ph),5.94 (d, J=6.5Hz, NH), 7.29-7.69 (m, (Ph)2Q). 
Preparation of (4$) Ethyl CE>-3-benzyloxycarbony/amloo-5=ethoxycarbonylmethvfldene-
2-tetrahydroturononeE.Jl {3. 19): 
0 
Acid (3.18) (30mg, 0.05mmol) was dissolved In CHCI3 (5ml) and refluxed for 48h. The 
solvent was evaporated and the residue was purified by radial chromatography using a 
lmm silica gel chromatotron plate, eluting with 85% CH2CI2/15% ethyl acetate to give E-
enollactone (3.19) as a colourless oil (12mg, 78%): lH NMR (CDCI3) o 1.28 (t.J=7.2Hz, CH3), 
3.25 (dd, J=7A 18.5Hz, lH, (H-4)a), 3.89 (dd,J= 10.5, 18.5Hz, lH, (H-4)b), 4.18 (q, J=7.2Hz. 
OCH2CH3), 4.~6 (bq, J=9.4Hz, H-3), 5.13 (m. OCH2Ph), 5.56 (bs, NH),5.74 (s, =CH), 7.35 (m, 
(Ph)s). 
PreParation of Ethyl C5S2 5-benzy/oxycarbony/amino-5-CN-0-
ethoxycarbony!methyf)carbamoyD-3-oxopeotqnoqte (3.20): 
CBzHN ••• 
H 
0 
NH--.C~Et 
0 
Glycine ethylester hydrochloride (9mg. 0.068mmol. 1.2equiv) and triethylamine (9J!L, 
0.068mmol. 1.2equlv) were added to enollactone (3. 19) (18mg, 0.056mmol. lequiv), 
dissolved In CH2CI2 (5ml), and the mixture was stirred at 20 oc for l6h. The solution was 
washed with H20 (5ml), dried (MgS04) and the solvent evaporated to yield keto-amide 
(3.20) as a pale yellow oil (15mg. 63%) which was used in subsequent steps without further 
purification: FTIR (film) 3344, 1720 and 1530cm·l; lH NMR (CDCI3) o 1.26 (t.J=7.1Hz, CHJ), 1.27 
(t, J=7.1Hz, CH3), 2.95 (dd, J=6.0, 18.0Hz. lH. (H-4)0 ), 3.29 (dd. J=4.0, 18.0Hz, lH. CH-4)b), 3.50 (s, 
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(H-2)2),3.98 (dd, J= 1.8,5.4Hz, NHCH.2),4.18 (q, J=7.1Hz, CH2CH3),4.20 (q,J=7.1Hz, CH2CH3), 
4.66 (m, H-5), 5.13 (s, CH2Ph), 5.94 (d, J=8.4Hz, CBzNH), 6.97 (bs, NHCH2), 7.36 (m, (Ph)s); 13c 
NMR CCD03) S 14.03, 14.09,41.50,44.00,49.37,50.86,61.53,61.58,67.37, 128.14, 128.30, 128.57, 
135.90, 156.13, 166.70, 169.29, 170.66, 202.26; HRMS (M) Found 422. 1693 (Calcd for C20H26N20s 
422.1689). 
Preparation of C3S> CEJ-3-Benytoxycarbony/amlno-1-etboxycarbonytmethyl-5-
ethoxycarbony/metby/idene-2-pyrrolldinone C3.04): 
Keto-amide (3.20) (15mg, 0.036mmol) and PTSA (5mg) dissolved In 1. 2-dichloroethane 
(6ml) were refluxed, with azeotropic removal of H20. for 4h. The solution was cooled to 
20 oc, washed with H20 (2ml), dried CMgS04) and the solvent evaporated to yield 
enamlno ester (3. 16) as a yellow oil (11 mg. 78%): lH NMR CCDCI3) as given above. 
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SECTION E.4 
CHAPTER 4 EXPERIMENTAL 
SECTION £.4. 7 
PREPARATION OF CBz OXAZOLIDINONES (4.11, 4.14-4.15, 4.18-4.19, 4.21) 
&eparat/on of C2RAS2-4-Benz:yl-3-benzytoxycarbony/-2-phenyf.. 7.3-oxazoUdlo-5-oo#w-).8. 
Ph)2 0 
CBz"N~O 
( H 
Ph 
4.12 
METHOD AE.19: The Schiff base sattE.l9-E.20 (4.09) of (S)-phenylalanlne (0.121mo!), in 
CH2CI2 (500ml), was cooled to -20 oc and benzyl chloroforrnate (17.0ml, 0.121mo!) was 
added. The mixture was stirred at -20 oc for 12h and then at 4 oc for 3 days. The solvent 
was evaporated and the residue partitioned between ethyl acetate (500ml) and 
aqueous 5% NaHC03 solution (500ml). The organic layer was extracted, washed with 
aqueous 5% KHS04 solution (500ml) and H20 (500ml), dried (Na2S04) and the solvent 
was evaporated to yield an oil which contained, by lH NMR, 95% cis oxazolidinone (4.11) 
and 5% trans oxazolidinone (4.12). Purification by silica column chromatography, eluting 
with 80% petroleum ether/20% ethyl acetate yielded cis oxazolidinone (4.11) as a white 
solid (22.06g, 47%): mp 124-128 oc (ethyl acetate/petroleum ether) (UtE.l8 mp 109-112 <>C); 
lH NMR (CDC~:)) o 3.19-3.43 (bm, C4CH2Ph),4.66 (dd,J=4.0, 5.9Hz, H-4),5.05 (ABq, JAa=l2.1Hz, 
lH, OCH0 Ph), 5.16 (ABq, JAs=12.1Hz, 1H, OCHbPh), 6.45 (bs, H-2), 7.06-7.33 (m, (Ph)ls); 13c 
NMR(CDCI3)o36.38,58.13,67.76,89.10, 126.55, 127.10, 127.98, 128.11, 128.27, 128.39, 128.58, 
129.16, 130.14, 135.13, 136.12, 153.74, 170.90; (a)o20=+40°(C 1.0; CH2CIV. Selected lHNMR 
data tor the trans oxazolidinone (4.12); (CDCI3) o 3.11 (m, CH2Ph), 4. 71 (m, H-4). 
METHOD BE.18: (S)-CBz phenylalanine (4.10) (lO.Og, 0.033moL lequiv), benzaldehyde 
(6.8mL 0.067moL 2equiv) and PTSA (6.36g, 0.033mol. 1equlv) dissolved in 1, 1.1-
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trichloroethane (135ml) were refluxed, with azeotroplc removal of H20. for 18h to give 
crude cis and trans oxazolldlnones (4.11 and 4.12, respectively) In the ratio of 1 : 1, by lH 
NMR. Cis oxazolldlnone (4.11) was purified as above: Yield 21%; mp and lH NMR 
(CDCI3) as given above. 
Preoaratlon of C2RAS> 4-Beozy/-3-benzy/oxycarbonyl-4-
(d/phenylmethexycarbooytmetbyf)-2-pheny/-1 .3-oxazoUd/n-5-one (4. 14): 
Ph~ ~,r::- 0 
t2 1 
N3 5 CBz- 4 
OCHP~ 
Oxazolldinone (4.11) (7.85g, 0.020mol1equiv) was dissolved in THF (200ml) and the 
solution was cooled to -78 °C. lithium hexamethyldlsllazlde (UHMDS) (22.3ml of 1M 
solution In THF, 0.022mol, 1.1 equlv) was added and the solution was stirred, at -78 oc for 
7min. BrCH2C02CHPh2E.21 (6.43g, 0.0211 mol, 1.04equiv) was added and the resulting 
yellow solution was stirred at -78 oc for2h and was then allowed to warm to 20 oc over 16h. 
The THF was evaporated and the residue partitioned between saturated aqueous NH4CI 
solution (100ml) and ether (100ml). The aqueous layer was separated and extracted 
with ether (2x 100ml). The combined ether extracts were dried (Na2S04) and 
evaporated to give the crude oxazolldinone (4.14) as a yellow oil (12.3g, quant) which 
was used In subsequent steps without further purification: lH NMR (CDCI3) o 3.19 (ABq, 
JAs=l7.4Hz, lH, CH0 C02CHPh2),3.25 CABq, JAs=13.2Hz, lH, C4CH0 Ph), 3.56 CABq. JAs=l3.2Hz, 
lH, C4CHbPh),3.89 CABq,JAs=l7.4Hz, lH, CHbC~CHPh2),4.66 (ABq. JAs= 12.7Hz, lH, 
OCHaPh), 5.02 CABq, JAB= 12.7Hz, lH, OCHbPh),5.95 (s, H-2), 5.99 (d, J=7.3Hz, (Ph)2), 6.61 (d, 
J=7.3Hz, (Ph)2), 6.91 (s, CHPh2), 6.93 (m, (Ph)2), 7.07-7.36 (m, (Ph)l9). lH NMR Indicated the 
presence of< 5% of the 2RAR oxazolldinone (4.16). 
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Prf!U)arat/on of C2R.4S> 4-Benzy/-3-benzy/oxycarbonyl-4-carboxymethy/-2-phenyl-1.3-
oxazolldin-5-ooe (4. 18): 
Ph, 
.... ,r:::-0 
't;)=o 
CBz-~,."'---{o 
Ph OH 
The benzhydryl oxazolidinone (4.14) (0.020mol, 1equiv) was dissolved in CH2CI2 (500ml) 
and the solution was cooled to 0 °C. TFA (tritluoroacetic acid) (31 mL 0.406mol, 20equlv) 
was added and the solution was stirred at 0 oc for 2h, then was diluted to 1 L with CH2CI2 and 
washed with H20 (3x ll). (Attempted purification by extraction into aqueous 5% NaHC03 
solution produced an emulsion.) The organic Ioyer was dried CMgS04) and the solvent 
evaporated to yield acid (4. 18) as a yellow oil which was crystallized from ethyl 
acetate/petroleum ether (2.85g, white crystals, 32%): mp 181-185 °C; FTIR (KBr) 3415, 1794, 
1738 and 1674cm-1; lH NMR (CDCf3) B 3.13 CABq. JAB= 18.1Hz, 1H, CH0C~H),3.25 (ABq. 
JAs=13.5Hz, 1H. C4CHaPh). 3.57 (ABq.JAs=13.5Hz, lH, C4CHbPh), 3.87 (ABq. JAB=18.1Hz, lH, 
CHbC~H).4.82 CABq. JAs=l2.2Hz, 1H,OCH0 Ph),5.11 CABq,JAs=12.2Hz, lH, OCHbPh),6.13 (d, 
J=7.3Hz, (Ph)2),6.30 (s. H-2), 6.68 (d, J=7.4Hz, (Ph)2),6.96-7.41 (m, (Ph)n); 13c NMR CCDCI3) o 
38.85.41.85,65.00,67.45,90.56, 127.71.127.96, 128.21. 129.13, 129.35, 130.82. 134.65, 135.16. 135.40, 
152.24, 172.72, 174.75; HRMS (M)Found 445.1539 (Calcd for C26H23N06 445.1525). Anal. 
Calcd for C26H23N06: C 70.1 0; H 5.20; N 3.14. Found: C 69.36; H 5.42; N 3. 12. 
freparot/on of C2RAS> 4-Benzyl-3-benz.Y/oxycarbony/-4-ch/oroformylmetbyl-2-pbenyt-1.3-
oxazo//din-5-one (4' J 9): 
Ph, 
.. , 0 /21 
N3 5 csz- 4 
,. 
(~ 
Ph Cl 
The acid (4.18) (402mg, 0.90mmoL lequiv) was dissolved In CH2CI2 (32ml) and the solution 
was cooled to 0 oc. Freshly distilled oxalyl chloride (0.39mL 4.51 mmol. 5equlv) and a 
catalytic quantity of DMF were added. The mixture was stirred at 0 oc for 2h and at 20 oc 
for 16h. The solvent was evaporated, more CH2CI2 (2ml) was added and evaporated 
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(repeated 3 times). Final traces of oxalyl chloride were removed at 1 mm to yield acid 
chloride (4.19) as a beige solid (418mg, 1 00%), which was used in subsequent steps 
without further purification: 1 H NMR CCDCI3) o 3.20 CABq, JAB= 13.2Hz, 1 H, C4CH0 Ph), 3.51 
CABq,JAs=13.2Hz, 1H,C4CHbPh), 3.61 (ABq, JAs=l9.1Hz, lH, CHaCOCI),4.37 CABq, 
JAs= 19.1Hz, lH, CHbCOCI),4.84 CABq, JAB= 12.2Hz, lH, OCHaPh), 5.10 CABq, JAB= 12.2Hz, 1 H, 
OCHbPh), 6.12 (d, J=7.3Hz, (Ph)2), 6.30 (s, H-2),6.72 (d, J=7.8Hz, (Ph)2), 7.01 (m, (Ph)4), 7.23 (m, 
CPh)5), 7.37 (m, (Ph)2). 
PrEZParaflon of C2R.4S> 4-Benzy/-3-beozy/oxycarbooyl-4-{3-etboxycarbooy/-2-oxo-3-
tripheoy/,Qbosohoraoy/ldeoy/prooy0-2-pbeoy/-l .3-oxqzolidin-5-ooe (4. 1 5): 
METHOD A: Acid chloride (4.19) (412mg, 0.89mmol, 1 equlv) was dissolved In CH2CI2 
(32ml) and cooled to 0 "C. Ph3P=CHC02EtE.OO (619mg, 1.78mmol, 2equlv) was added and 
the solution was stirred at 0 "C for 1.5h and at 20 "C for 4.5h. The solvent was evaporated 
and the residue was purified by radial chromatography using a 4mm silica gel 
chromatotron plate, eluting with 55% petroleum ether/45% ethyl acetate to give 
oxazolidinone (4.15) as a 1 : 1 mixture of 2 dlastereolsomers (colourless solid, quant): mp 
209-211 "C (ethyl acetate/petroleum ether, 691mg, colourless crystals); FTIR (KBr) 1790, 
1710, 1666 and 1559cm-l; lH NMR (CDCI3) o 0.70 (t, J=7.1Hz, CH3), 0.77 Ct. J=7.1Hz, CH3), 3.27 
(ABq. JAs= 13.4Hz, lH, C4CH0 Ph), 3.29 (ABq, JAB= 13.2Hz, lH, C4CH0 Ph), 3.46 CABq. JAs= l3.2Hz 
,1H, C4CHbPh),3.51 CABq. JAs=18.0Hz, lH, C4CH0 C0),3.59 CABq,JAB=l8.6Hz, lH, C4CH0 CO), 
3.67 CABq, JAs= l3.4Hz, lH, C4CHbPh),3.78 (m, 4H, 2x OCH2CH3), 4.69 CABq. JAB= 18.6Hz, lH, 
C4CHbC0),4.74 (ABq. JAB=l2.2Hz, lH, OCH0 Ph), 4.76 (ABq.JAs=18.0Hz, lH, C4CHbC0),5.09 
(ABq. JAs= 12.2Hz, lH, OCHbPh), 5.21 CABq. JAs=l2.2Hz, lH, OCH0 Ph), 5.29 (s, H-2), 5.29 (ABq. 
JAs=l2.2Hz, lH, OCHbPh),5.33 (s, H-2), 5.86 (d, J=7.4Hz, (Ph)2), 6.01 (d, J=7.3Hz, (Ph)2), 6.57 (d, 
J=7.4Hz, (Ph)2), 6.92 (q, J=7.6Hz, (Ph)4), 7.10-7.67 (m, (Ph)4o); 31p NMR (CDCI3) o 18.1; 13c 
NMR CCDCI3) o 13.75, 41.93,42.74,45.95 (d,J=7.6Hz),48.01 (d,J=7.1Hz), 58.28,58.54,65.22, 65.72, 
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66.63, 67 .24, 71.08 (d, J= 109.3Hz), 71.24 (d, J= 11 0.8Hz), 89.35, 89.50, 125.56 (d, J=93. 7Hz), 125.89 
(d,J=93.1Hz), 126.88, 127.01, 127.33, 127.51, 127.62, 127.79, 127.91, 127.97, 128.25, 128.45(d, 
J=l2.CHz), 128.60, 128.62(d,J=12.6Hz), 128.64, 128.70, 129.08, 130.80, 131.63(d,J=2.5Hz), 133.15 
(d,J=lO.lHz), 133.20 (d,J=9.6Hz). 135.40, 135.65. 135.71. 135.98, 136.02, 136.46, 151.69, 152.23, 
167.33(d,J=14.1Hz), 167.45(d,J=l4.1Hz), 173.96, 174.13,192.14(d,J=6.0Hz), 192.22(d,J=5.1Hz); 
HRMS (FAB, M+ 1) Found 776.2776 (Calcd for C4aH43N07P 776.2777); (a)o2° = -4 (c 1.5; 
CH2CI:i). Anal. Calcd for C4aH42N07P: C 7 4.31; H 5.46; N 1.81. Found: C 7 4.08; H 5.36; N 
1.79. 
METHOD B: Oxazolidinone (4.11) (100mg, 0.26mmol, 1equlv) was dissolved in THF (10ml) 
and cooled to -78 oc. UHMDS (0.28mL 0.28mmot 1.1 equiv) was added and the resulting 
yellow solution was stirred at -78 oc for 7min. BrCH2COC(PPh3)C02Et (127mg, 0.27mmot 
1.05equiv) was added and the solution was stirred at -78 oc for 2h and was then allowed to 
warm to 20 oc over 16h. The THF was evaporated and the residue partitioned between 
saturated aqueous NH4CI solution (lOmL) and CH2CI2 (10mL). The aqueous layer was 
separated and extracted with CH2CI2 (2x lOmL). The combined CH2CI2 extracts were 
dried CMgS04) and evaporated. Further purification by radial chromatography using a 
2mm silica gel chromatotron plate, eluting with 55% petroleum ether/45% ethyl acetate 
yielded oxazolldinone (4.15) as a,whlte solid (52mg, 26%): lH NMR (CDCI3) as given 
above. 
Preparation ofBrCH.zCOCCPPh~.zEt;. 
A procedure similar to that reported was usedE.22. Freshly distilled bromo acetyl 
bromide (lOQ .. tL l.l5mmol. lequlv) was added to Ph3P=CHCD2Et (800mg,2.30mmol, 
2equiv) dissolved In CH2CI2 (12mL) and cooled to 0 oc. The solution was stirred at 0 oc for 
1 h. then 20 oc for 4.5h. The solvent was evaporated and the residue was purified by radial 
chromatography using a 4mm silica gel chromatotron plate eluting with 95% CH2CI2/S% 
ethyl acetate to yield BrCH2COC(PPh3)C02Et as a pale pink solid (l08mg, 20%). 
BrCH2COCCPPh3)C02Et was purified further by recrystallization from ethyl 
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acetate/petroleum ether: lH NMR (CDCI3) o 0.67 Ct J=7.1Hz, CH3), 3.75 (q, J=7.1Hz, OCH2), 
4.56 (s, CH2Br), 7.43-7.57 (m, (Ph)9), 7.64-7.71 (m, (Ph)(>). 
High Temperature lH NMR for <2R.4$) 4-Benzyl-3-benzyloxycarbonyl-4-<3-
ethoxycarbonyl-2-oxo-3-triphenylphosphoranylldenylpropyD-2-phenyl-1.3-oxazolldlo-5-
one C4.J5): 
lH NMR (d6-DMSO, 23 °C) o 0.65 (t,J=6.8Hz, CHJ),0.67 (t, J=6.8Hz, CH3), 3.19-3.58 (m, 
6H, 2xC4CH2Ph and 2x C4CH0 CO), 3.73 (m,4H, 2x OCH~H3), 4.78 (ABq, JAs= 17.6Hz, lH, 
C4CHbC0), 4.81 CABq. JAB= 18.0Hz, lH. C4CHbC0), 4.96 CABq, JAB= 12.7Hz, 1H, OCH0 Pb),5.20 
(ABq. JAs= 12.7Hz, lH, OCHbPh).5.20 (S, H-2), 5.22 (s, H-2), 5.30 (ABq, JAB= 12.2Hz, lH. 
OCH0 Ph), 5.34 CABq.JAs= l2.2Hz. lH, OCHbPh),5.93 (d. J=7.3Hz. (Ph)2), 6.00 (d. J=7.8Hz. 
(Ph)2),6.66 (d. J=6.8Hz, (Ph)2), 7.03-7.76 (m, (Ph)44). 
lH NMR (d6-DMSO. 85 °C) o 0.77 Ct. J=7.3Hz, CH3), 3.26 CABq. JAs= 13.2Hz. lH, 
C4CH0 Ph), 3.37 CABq. JAB= 17.6Hz, lH, C4CH0 CO), 3.53 (ABq, JAB= 13.2Hz, lH, C4CHbPh), 3.77 
Cm. OCH2CH3),4,74 CABq,JAs=l7.6Hz. 1H,C4CHbC0),5.18 (m, OCH2Ph),5.43 (s, H-2),6.16 (d, 
J=7.3Hz. (Ph)2), 7.10 (m, (Ph)4), 7.37 (m. (Ph)6). 7.68 (m. (Ph)13). 
Preparat/onU.J. of C2R.4S) 4-Benzyf-3-benzytoxycarbonyt-4-(3-ethoxvcarbooy/-2-
oxooropy0-2-pheoy/-1.3-oxozoUd/o-5-one (4.2U: 
Ph, 
'''r::- 0 
I 2 1 
N3 5 csz- 4 
.~ 
.... ~ 
I 
Ph 
Carbonyl dilmidazole (CDI) (175mg, 1.08mmot 1.2equlv) was added to acid (4. 18) (400mg, 
0.90mmol, lequlv) In THF (40ml). After stirring at 20 "C for 2h, freshly prepared magnesium 
diethyi malonate (257mg, 0.90mmol. lequiv) was added and the mixture was stirred at 20 
oc for 19h. The mixture was concentrated to 5ml, diluted with ethyl acetate (35ml) and 
washed with H20 (40rnL), 5% aqueous KHS04 solution (40ml), 5% aqueous NaHC03 
solution (40ml) and 10% aqueous NaCI solution (40ml). The organic layer was dried 
(Na2S04) and the solvent evaporated. Purification by radial chromatography using a 
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2mm silica gel chromatotron plate, eluting with 75% petroleum ether/25% ethyl acetate 
yielded ~-keto ester (4.21) as a yellow oil (300mg, 65%): mp 118-121 oc (ethyl 
acetate/petroleum ether, colourless crystals); FTIR (film) 1791 and 1714cm-1; lH NMR 
(CDCI:3) o 1.31 (t. J=7.1Hz, CH3),3.20 (ABq. JAs=l3.2Hz, 1H, C4CH0 Ph), 3.28 (ABq, JAB= 18.6Hz, 
1H, C4CHaC0),3.46 (s, COCH2CO), 3.52 CABq, JAa= 13.2Hz, lH, C4CHbPh), 4.10 CABq. 
JAs= 18.8Hz, lH, C4CHbC0), 4.23 (q, J=7.1Hz, CH2CH3), 4.79 CABq. JAs= 12.2Hz, lH, OCHaPh), 
5.05 (ABq. JAs= 12.2Hz, lH, OCHbPh), 6.14 (d, J=7.8Hz, (Ph)2), 6.38 (s, H-2), 6.69 (d, J=7.3Hz, 
(Ph)2),6.97 (m, (Ph)2), 7.08 (m, (Ph)2), 7.22 (m, (Ph)s), 7.36 (m, (Ph)2); 13c NMR CCDCI3) o 
13.98,41.74,47.81,48.81.61.60,64.28,90.39, 127.00, 127.65, 127.81, 127.94, 128.11, 128.93, 128.98, 
129.16, 130.73, 134.63, 135.19, 135.52, 152.19, 166.17, 172.74,200.45; HRMS(M)Found515.1943 
(Calcd for C30H29N07 515.1944); (a) 020 = -1 (15.5; CH2CI2). Anal. Calcd for C30H29N07: C 
69.89; H 5.67; N 2.72. Found: C 69.69; H 5.60; N 2.65. 
Preoarationf2J of Maanes/um Diethyl Malonate 
Magnesium ethoxide (314mg, 2.74mmoL lequlv) was added to ethyl malonateE.24 
(725mg,5.49mmot 2equiv) in THF (16mL) and the mixture was stirred at 20 oc for 2h. The 
solvent was evaporated at 20mm and finally at 1 mm to yield magnesium diethyl 
malonate as a white solid which was used in subsequent steps without further purification. 
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SECTION £.4.2 
PREPARATION OF BENZOYL OXAZOLIDINONES 
(4.22, 4.25-4.26, 4.29-4.30, 4.32-4.33) 
Preparation of C2S.4S> 3-Benzoy/-4-beozy/-2-pheny/-1.3-oxozo//din-5-on~ (4.22): 
The Schiff base saJtE.l9-E.20 (4.09) (l6.4g, 0.060mol, 1equlv) of (S)-phenylalanlne (4.08) In 
CH2Cl2 (90ml) was cooled to -20 oc, benzoyl chloride (10.4mL 0.089mot 1.5equiv) was 
added and the mixture was stirred at -20 oc for 12h and then at 4 oc for 4 days. The mixture 
was washed with H20 (lOOmL), 5% aqueous NaHC03 solution (100ml), 5% aqueous 
NaHS03 solution (100ml) and H20 (100ml), dried CMgS04) and the solvent was 
evaporated to give a residue containing, by lH NMR, trans oxazolldinone (4.22) and cis 
oxazolidinone (4.23) in a ratio of 7 : 3, respectively. The trans oxazolldinone (4.22) was 
purified by recrystallization (CH2CI2/petroleum ether): Yield 5.6g, 25%; mp 194-196 oc 
(colourless crystals) (UtE.25 184.3 °C); lH NMR (CDCI3) o 3.39 (bs, 1H, CH0 Ph),3.73 (bs, lH, 
CHbPh), 5.21 (s, H-4), 5.83 (s, H-2), 6.7Q-7.40 (m, (Ph)]s); 13c NMR (CDCIJ) o 34.89, 57.76, 91.25, 
126.64, 127.72. 128.52, 128.85, 129.82, 129.88, 130.82, 135.22, 136.13, 169.22, 171.23; (a)o20=+302° 
(c 1.0; CHCis). 
Selected lH NMR data for the trans oxazolidinone (4.23); (CDCI3) o 4.92 (bt, H-4). 
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Preparation of C2S.4R> 3-Benzoy/-4-beozyl-4-Cd{J)henytmethoxycarbony/methy0-2-
obeoy/-1 .3-oxozolldin-5-one (4.25): 
Ph 
The oxazolldinone (4.22) (2.00g, 0.0056moL lequiv) was dissolved In THF (200ml) and the 
solution was cooled to -78 oc. LIHMDS (6.8ml of 1M solution InTI-IF. 0.0068mot 1.2equlv) 
was added and the resulting yellow solution was stirred at -78 oc for 30mln. 
BrCH2C02CHPh2E.21 ( 1.88g, 0.0062mot 1. 1 equiv) was added and the solution was stirred at 
-78 oc for 2h and was then allowed to warm to 20 oc over 16h. The solution was partitioned 
between saturated aqueous NH4CI solution (150mL) and ether (lOOmL). The aqueous 
layer was separated and extracted with ether ( 1 OOmL). The combined ether extracts 
were washed with H20 (2x 50ml), dried (Na2S04) and evaporated to give a yellow solid 
(1.60g), used subsequently without further purification, which contained, by lH NMR, 67% 
desired oxazolidinone (4.25), 22% recovered BrCH2C02CHPh2 and 11% of a compound 
tentatively assigned as the dlmer (4.33) (See page 234 for more detail): 1 H NMR (CDCIJ) 
benzhydryl oxazolidinone (4.25) 8 3.34(ABq.JAa=17.6Hz, 1H,C4CH0 CD2CHPh2),3.41 (ABq. 
JAa=13.3Hz, lH, CHoPh), 4.02 (ABq. JAB= 13.3Hz, lH, CHbPh), 4.16 (ABq. JAB= 17.6Hz, lH, 
CHbC02CHPh2),5.42 (d, J=7.5Hz, (Ph)2), 6.13 (s, H-2),6.42 (m. (Ph)2). 6.63 (t, J=7.8Hz, (Ph)2), 
6.90 (m, (Ph)3),6.92 (s, CHPh2), 7.1D-7.61 (m, (Ph)t6); HRMS (M-91) Found 490.1654 (Calcd 
for C31 H24NOs 490. 1654). 1 H NMR spectroscopy revealed that < 5% of the minor 2SAS 
Isomer (4.27) had formed. 
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Prwaratlon of C2SAR> 3-Benzoyf-4-beozy/-4-carboxymetbyl-2-pheny/-1.3-oxozoUdln-5-
oneC4.29); 
Ph'-
/2 0 Ph~N~:s 0 II ••• 0 
0 
Ph OH 
Benzhydryl oxazolidlnone (4.25) (1.60g, 0.0027mol, 1equlv) was dissolved In CH2CI2 (70ml) 
and cooled to 0 oc. TFA (35mL 0.45mol. 168equiv) was added and the solution was stirred 
at 0 oc for 5min, then was diluted with CH2CI2 ( 130ml), washed with H20 (3x ·150ml) and 
extracted with 5% aqueous NaHC03 solution. The NaHCOs extracts were combined, 
cooled to 0 °C, acidified to pH 1-3 with lN HCI and extracted with ethyl acetate (3x 200ml). 
The combined ethyl acetate extracts were dried (Na2S04) and the solvent evaporated 
to yield oxazolidlnone (4.29) as a white solid (0.50g,44%): mp 207.5-211 oc 
(CH2CI2/pentane,whitecrystals); FTIR(KBr) 1797,1725,1611 and 1595cm-l; 1HNMR(CDCI3) 
o 3.26 (ABq, JAs= 18.0Hz, 1H, CH0 C02H), 3.42 (ABq. JAB= 13.4Hz, lH, CH0 Ph)A.04 (ABq. 
JAB= 13.4Hz, lH, CHbPh), 4.14 (ABq, JAs=18.0Hz, lH, CHbC02H), 5.54 (d, J=7.2Hz, (Ph)2), 6.45 (s, 
H-2),6.67 (t, J=7.8Hz, (Ph)2),6.82 (m, (Ph)2), 6.96 (m, (Ph)l), 7.06 (t, J=7.5Hz, (Ph)2), 7.17 (m, 
(Ph)]),7.42(m,(Ph)s); 13CNMR(CDCis)o38.70,42.33,66.14,91.70,125.30, 127.80,127.91. 
127.97, 128.34, 129.27, 130.93, 134.27, 135.01, 136.07, 170.32, 172.89, 173.57; HRMS(M) Found 
415.1417 (Calcd for C2sf121NOs 415.1420); (a)o20 = +64° (c 0.9; CH2C12). Anal. Calcd for 
C2sH21N0s: C 72.28; H 5.10; N 3.37. Found: C 71.81; H 5.39; N 3.42. 
PreQaratton of C2SAR> 3-Beozoy/-4-beozyl-4-chloroformylmethy/-2-pheoy/-l.3-oxozoUdlo-
5-one C4.302: 
The acid (4.29) (66mg, 0.16mmol, lequiv) was dissolved In CH2C12 (6ml) and the solution 
was cooled to 0 °C. Freshly distilled oxalyl chloride (0.69JlL 0.79mmol, Sequiv) and a 
catalytic quantity of DMF were added. The mixture was stirred at 0 oc for 2h and at 20 oc 
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for 16h. The solvent was evaporated, more CH2CI2 (2mL) was added and evaporated 
(repeated 3 times). Final traces of oxalyl chloride were removed at 1 mm to yield acid 
chloride (4.30) as a white solid (69mg, quant), which was used In subsequent steps without 
further purmcation: 1H NMR (CDCia) o 3.38 (ABq, JAs= 13.4Hz. lH, CH0 Ph),3.76 (ABq, 
JAB= 19.1Hz, lH, CHaCOCI), 3.98 (ABq, JAB= 13.4Hz, 1H, CHbPh), 4.65 (ABq. JAB= 19.1Hz, lH, 
CHbCOCI), 5.54 (dd, J= 1.1, 8.4Hz, (Ph)2),6.39 (s, H-2), 6.69 (m, (Ph)2), 6.80 (m, (Ph)2), 6.98 (m, 
CPh)l), 7.09 (m, (Ph)2), 7.20 em. CPh)l), 7.36-7.47 (m, (Ph)s). 
Pr<waratlon of C2S.4R2 3-Benzoy/-4-benzy/-4-(3-etboxycarbooy/--2-oxo-3-
tr{pbenylpbosoboranyUdeoy/prooyD-2-obeny/-l .3-oxozo//dln-5-one <4.26): 
pp~ 
METHOD A: Acid chloride (4.30) (69mg, 0.16mmoL 1 equlv) was dissolved In CH2CI2 (5ml) 
and cooled to 0 oc. PhaP=CHC02EtE.oa (111 mg. 0.32mmoL 2equiv) was added and the 
solution was stirred at 0 oc for 1.5h and at 20 oc for 4.5h. The solvent was evaporated and a 
1 H NMR spectrum of the residue revealed the presence of< 5% of the minor 2SAS isomer 
(4.28). Purification by radial chrqmatography using a lmm silica gel chromatotron plate, 
eluting with 94% CH2CI2/6% ethyl acetate yielded phosphorane (4.26) as a colourless oil 
(122mg, quant): mp 187-188.5 oc (ethyl acetate/petroleum ether, white crystals); FTIR 
(KBr) 1787,1668, 1652and 1554cm·l; lHNMRCCDCIJ)o0.72(tJ=7.1Hz,CH3),3.41 (ABq. 
JAs=13.5Hz, 1H,CH0 Ph), 3.77 (m, OCH2), 4.05 (ABq. JAs=18.5Hz, 1H, CH0 C0),4.12 CABq. 
JAa=13.5Hz, lH, CHbPh), 4.59 (ABq, JAs=l8.5Hz, lH, CHbCO), 5.33 (d,J=7.5Hz, (Ph)2), 6.06 (s, 
H-2),6.38 (d, J=7.5Hz, (Ph)2), 6.55 Ct. J=7.7Hz (Ph)2), 6.85 Ct. J=7.7Hz, (Ph)a), 7.05 (t, J=7.5Hz. 
(Ph)1),7.32-7.74(m,(Ph)2o); 31PNMR(CDCia)o 18.3; 13CNMR(CDCIJ)o 13.67,42.89,45.89(d, 
J=7.1Hz), 58.52, 66.74, 70.84 (d, J= 110.6HZ), 90.73, 125.43, 126.25 (d, J=93.2HZ), 127.22, 127.70, 
128.Ql, 128.23, 128.49 (d,.J= 12.6Hz), 128.69, 128.79, 130.96, 131.70 (d. J=2.9Hz), 133.38 (d, 
J=10.0Hz), 135.10, 136.40, 137.18, 167.37(d,J=l4.4Hz), 169.02, 174.47,192.91 (d,J=4.6Hz); HRMS 
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(FAB. M+ 1) Found 746.2681 (Calcd for C47H41 N06P 7 46.2671). Anal. Calcd for C47H4oN06P: 
C 75.69; H 5.41; N 1.88. Found: C 75.62; H 5.52; N 1.84. 
METHOD B: Oxazolidinone (4.22) (30mg, 0.08mmoL lequlv) was dissolved In THF (lOmL) 
and cooled to -78 oc. UHMDS (0.09mL 0.09mmoL 1.1 equiv) was added and the resulting 
yellow solution was stirred at -78 oc for lOmin. BrCH2COC(PPh3)CD2Et (39mg, 0.08mmol, 
1 equiv) was added and the solution was stirred at -78 oc for 2h and was then allowed to 
warm to 20 oc over 16h. The THF was evaporated and the residue partitioned between 
saturated aqueous NH4CI solution (lOml) and CH2C12 (10ml). The aqueous layer was 
separated and extracted with CH2CI2 (2x 10ml). The combined CH2CI2 extracts were 
dried (MgS04) and evaporated to give a residue (59mg) containing, by lH NMR, 15% 
phosphorane (4.26), 70% recovered BrCH2COC(PPh3)C02Et and 15% of the compound 
tentatively assigned as the dlmer (4.33) (See page 234 for data). Again. < 5% of the minor 
2SAS Isomer (4.28) was obseNed by 1 H NMR. The desired phosphorane (4.26) was not 
separated from BrCH2COC(PPh3)C02Et on silica or diol. 
Preoaratio~ of C2S.4R> 3-Benzoyl-4-benzy/-4-(3-ethoxycarbonyl-2-oxopropyl>-2-
pbenyl-1.3-oxozolldln-5-one (4.32): 
METHOD A: Carbonyl dilmldazole (COl) (23mg, 0.14mmol. l.lequlv) was added to acid 
(4.29) (50mg, 0.12mmoL 1 equiv) In ll-lF (5ml). After stirring at 20 oc for 2h, freshly prepared 
magnesium diethyl malonate (34mg, 0.12mmol, lequlv) was added and the mixture was 
stirred at 20 oc for 19h. The mixture was concentrated to 1 ml, diluted with ethyl acetate 
(5ml) and washed with H20 (4ml), 5% aqueous KHS04 solution (4ml), 5% aqueous 
NaHC03 solution (4ml) and 10% aqueous NaCI solution (4ml). The organic layer was 
dried (Na2S04) and the solvent evaporated. Purification by radial chromatography 
using a lmm silica gel chromatotron plate, eluting with 70% petroleum ether/30% ethyl 
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acetate gave p-keto ester (4.32) as an oil (91%): mp 103-104 oc (ethyl acetate/petroleum 
ether); FllR (film) 1793, 1743. 1716 and 1650cm·1; lH NMR CCDCI3) o 1.27 CtJ=7.1Hz, CH3), 3.37 
(ABq.JAs= 13.4Hz, 1H,C4CH0 Ph),3.41 CABq.JAs=19.0Hz. 1H,C4CH0 C0),3.56(ABq. 
JAB= 15.7Hz, lH, CHaC02Et),3.61 (ABq, JAs= 15.7Hz. lH, CHbC02Et).3.99 CABq. JAs= 13.4Hz, lH. 
C4CHbPh),4.22 (q, J=7.1Hz. OCH2),4.39 (ABq. JAs= 19.0Hz, lH. C4CHbC0), 5.54 (dd, J= 1.2. 
8.5Hz, (Ph)2),6.49 (s, H-2),6.68 (m, (Ph)2), 6.78 (m. (Ph)2), 6.96 (m. (Ph)l), 7.05 (m. (Ph)2). 7.17 
(m, (Ph)1), 7.41 (m, (Ph)s); 13c NMR (CDCI3) o 14.06,42.25.48.04,49.06.61.90.65.38,91.63, 
125.34. 127.76. 127.91. 127.96, 128.24. 129.02, 129.23. 129.41, 130.93, 134.45, 135.03, 136.30, 166.14. 
169.96. 172.99. 201.31; HRMS (M)Found 485.1807 (Calcd for C29H27N06 485.1838); (a.)o20 = 
+67° (c 2.0; CH2CI2). Anal. Calcd forC29H27N06: C 71.74; H 5.61; N 2.88. Found: C 70.14; H 
5.66; N 2.7 6. 
MElHOD B: Acid chloride (4.30) (52mg, 0.12mmol, lequlv) and pyridine (24J..tL 0.30mmol. 
2.5equlv) were dissolved In CH2CI2 (1ml) and cooled to 0 oc. Meldrum's acid (l8mg, 
0. 12m mol 1.03equiv), dissolved in CH2CI2 ( 1 ml). was added to the stirred solution over the 
period of 105mln. The resulting bright yellow solution was stirred at 0 oc for 1 h. 20 oc for 1 h 
and then was diluted with CH2CI2 C2mL) and poured into 2N HCI (4mL) containing crushed 
ice. The organic layer was removed and the aqueous layer was washed with CH2C12 (2x 
2mL). The combined organic extracts were washed with 2N HCI (2x 2mL), dried (MgS04) 
and the solvent evaporated to yield an oil (49mg) which was dissolved in ethanol (15ml) 
and refluxed for 2.5h. The solvent was evaporated and the residue was purified by radial 
chromatography using a 1mm silica gel chromatotron plate. eluting with 70% petroleum 
ether/30% ethyl acetate to give p-keto ester (4.32) as an oil (l2mg, 21%): lH NMR CCDCI3) 
as given above. 
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Benzoyl diener (4.33): 
LIHMDS (0.55ml of lM solution In THF. 0.55mmol, l.lequlv) was added to oxazolldlnone 
(4.22) (180mg. 0.50mmol. 1equlv) dissolved In THF (15ml) at -78 oc. The resulting yellow 
solution was stirred at -78 oc tor 2h and then 20 oc for 16h. The solution was poured onto 
cold saturated aqueous NH4CI solution (15ml) and extracted with ether (2x 15ml). The 
combined ether extracts were washed with H20 (15ml). dried (MgS04) and the solvent 
was evaporated. Purification by radial chromatography using a 1 mm slllca gel 
chromatotron plate, eluting with a gradient of ethyl acetate (1-20%) In CH2CI2 yielded the 
compound tentatively assigned as the dlmer (4.33). as a yellow oil (89mg, 62%): mp 237-
238 oc (ethyl acetate/petroleum ether, white crystals); FTIR (film) 3350, 1791 and 1667cm-1; 
lH NMR CCDCI3) o 3.61 (ABq. JAs= 13.9Hz, lH, CH0 Ph), 4.46 (ABq. JAs= 13.9Hz. lH. CHbPh),4.72 
(s. H-2), 5.26 (dd, J= 1.3, 8.5Hz, (Ph)2), 6.22 (d, J=8.8Hz, CHPhNH), 6.55 (t. J=7.8Hz. (Ph)2), 6.67 
(m, (Ph)2), 6.86 (m, (Ph)l), 6.98 (t, J=7.6Hz. (Ph)2), 7.08 (m, (Ph)l), 7.42-7.63 {m, (Ph)13), 8.08 
(m. (Ph)2), 9.52 (d, J=8.8Hz. NH); 13c NMR (CDCIJ) o 30.08, 60.75, 74.63, 90.74, 124.69, 127.46, 
127.53, 127.73, 127.94. 128.28, 128.72, 129.02, 129.21. 129.31. 129.40, 131.05. 131.81. 133.57. 133.79, 
135.13, 135.72, 137.58, 166.18,171.52,172.64; HRMS(FAB.M+l)Found567.2283(Calcdfor 
C37H31N204 567.2284). Anal. Calcd for C37H30N204: C 78.43; H 5.34; N 4.94. Found: C 
78.47; H 5.70; N 4.91. 
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SECllON E.4.3 
PREPARATION OF ENAMINO ESTERS (4.01-4.06) VIA THE INSERTION REACTION 
Preparation of 1-Ethy/ CSS> 5-benzy/-5-beozytoxycarbony/arolno-3-oxo-2-
tripheny/phosphoranvlldenehexandloate (4.40): 
PPh;, 
MeOH (48mL) followed by aqueous UOH (24mL of a 3.33N solution, 79.9mmol, l03equlv) 
were added to oxazolidinone (4.15) (600mg, 0.77mmol, lequlv) dissolved in THF (48ml). 
The mixture was refluxed for 4h, cooled to 0 oc and acidified to pH 1-3 with 2N HCI. The THF 
was evaporated and the remaining solution was extracted with ethyl acetate (3x SOmL). 
The combined ethyl acetate extracts were dried (MgS04) and the solvent was 
evaporated at 20mm, and finally at lmm for 16h, to yield keto acid phosphorane (4.40), as 
a white solid (530mg, quant), which was used In subsequent steps without further 
purification: FTIR (KBr) 3404, 1790, 1715, 1667 and 1559cm-1; lH NMR (CDCI3) o 0.74 (t,J=7.1Hz, 
CH3), 2.86 CABq. JAs=13.5Hz, 1H, CCH0 Ph),2.94 (ABq.JAs=17.6Hz, lH, CCH0 CO), 3.52 (ABq, 
i 
JAa=13.5Hz, lH,CCHbPh), 3.83 (m, CH2CH3).4,97 (ABq,JAs=12.2Hz, lH, OCH0 Ph),5.03 CABq. 
JAs=17.6Hz, lH, CCHbC0),5.29 CABq, JAa=12.2Hz, 1H, OCHbPh), 6.08 (s, NH), 6.87 (d, J=7.8Hz, 
(Ph)2), 7.09 (m, (Ph)3), 7.33-7.51 (m, (Ph)ll), 7.57 (m, (Ph)3), 7.69 (m, (Ph)6); 31p NMR (CDCI3) 
o 18.6; 13C NMR(CDCIJ) o 13.45, 37.55.41.49 (d.J=6.1Hz),59.85, 62.64,65.94, 124.44 (d, 
J=93.7Hz), 126.62, 127.94, 128.05, 128.31, 128.59, 128.82 (d. J= 13.1Hz), 129.70, 132.40 (d, J=2.1Hz), 
133.06(d.J=l0.0Hz), 135.52, 136.86, 154.26, 166.55(d,J=13.1HZ), 173.94. 192.79(d,J=4.0Hz); 
HRMS (FAB, M+ 1) Found 688.2461 (Calcd for C41H39N07P 688.2464). 
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Preparation of 1-Etby/. 6-metby/ CS$) 5-benzyt-5-benzytoxycarbony/amlno-3-oxo-2-
tr/pbeaylpbogpborqoylidenebexandloate <4.41 ): 
Keto-acid phosphorone (4.40) (89mg, 0.13mmol) was dissolved In THF (1 ml) and treated 
with an excess of freshly distilled CH2N2 In ether. The excess CH2N2 was allowed to 
evaporate at 20 <>Cover 16h and the residue was purified by radial chromatography using 
a 1mm silica gel chromatotron plate, eluting with a gradient of ethyl acetate (25-50%) in 
petroleum ether to give phosphorane (4.41) as a white solid (75mg, 82%): mp 181-185 oc 
(ethyl acetate/petroleum ether, white crystals): FTIR (KBr) 3419,.1722, 1666 and 1555cm-l; 
lH NMR (CDCI3) o 0.69 (t, J=7.1Hz, CH2CH3), 3.29 (ABq. JAs= 13.6Hz, lH, CCH0 Ph), 3.49 (s, 
OCH3),3.56 (ABq, JAB= 13.6Hz, lH, CCHbPh), 3.74 (m,4H, CH2CH3 and CCH2CO), 5.11 (ABq, 
JAs=12.7Hz, lH. OCH0 Ph), 5.21 CABq.JAs=l2.7Hz, 1H. OCHbPh), 6.22 (s, NH), 6.97 (m, (Ph)2), 
7.14 (m, (Ph)3), 7.37 (m, (Ph)n), 7.47 (m, (Ph)J), 7.61 (m, (Ph)6); 31p NMR (CDCI3) o 18.0; lJc 
NMR (CDCI3) o 13.73,40.82, 45.56 (d. J=6.1Hz), 52.04, 58.56, 62.13, 65.79, 71.79 (d, J= 110.8Hz), 
126.27 (d. J=93.7Hz), 126.50, 127.85, 127.86 (d, J= 14.1Hz), 128.33, 128.50, 130.33, 131.59 (d, 
J=3.0Hz), 132.22 (d, J= 10.0Hz), 136.21, 137.15, 154.75, 167.57 (d, J= 15.1Hz), 173.15, 193.11 (d, 
J=4.0Hz); HRMS (FAB, M+ l) Found 702.2618 (Calcd for C42H41N07P 702.2621); (cx.)o20 = +4° 
( c 3. 1; CH2CJ:2). Anal. Calcd for C42H4QN07P: C 71.89; H 5. 75; N 2.00. Found: C 71.56; H 
5.42; N 1.86. 
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Preparation of (38) (£>- and CZ>-3-benzy/-3-benzy/oxycarbooy/amlno-5-
bromoethoxycacbony/roethytldene-2-tetrahydrofuranone C4.42E and 4.42Z): 
0 0 
CBzN 
Triethylamine (58J!l, 0.44mmot 1 equiv) followed by Br2 (221!L 0.44mmot 1 equiv) were 
added to keto acid phosphorane (4.40) (300mg, 0.44mmoL lequiv), dissolved in CH2CI2 
(30ml), at 0 oc. The solution was stirred at 0 oc for 20m in and then at 20 oc for 30mln. The 
solvent was evaporated to give crude E- and Z-bromo enollactones (4.42E and 4.42Z, 
respectively) in the ratio 46% E : 54% Z, by 1 H NMR. Purification by radial chromatography 
using a 2mm silica gel chromatotron plate, eluting with CH2CI2 yielded z-enollactone 
(4.42Z) (78mg. 37%), as a white solid, which was used In subsequent steps without further 
purification: FTIR (film) 3335, 1825, 1704, 1638 and 1524cm-1; lH NMR (CDCI3) ~ 1.32 Ct. 
J=7.1Hz. CH3), 2.98 (ABq, JAB= 13.2Hz. lH, C3CH0 Ph), 3.14 CABq, JAB= 13.2Hz, 1H, C3CHbPh), 
3.49 CABq, JAa= 19.1Hz, 1H, (H-4)0 ), 3.80 (ABq, JAa=19.1Hz, 1H, (H-4)b). 4.22 (m, CH2CH3), 5.09 
(m. OCH2Ph), 5.40 var (s, NH), 7.17 em. (Ph)2). 7.34 (m, (Ph)a); 13c NMR (CDCI3) ~ 14.12, 39.07, 
42.50,60.38,62.07,67.68,90.68, 128.33, 128.42, 128.50, 128.61, 129.04, 129.92, 131.63, 135.35, 154.95, 
159.71, 162.66, 172.69; HRMS (M) Found 489.0614 (Calcd for C23H228lBrN06 489.0611); (a)o20 
= -2<> (c 1.5; CH2CJ:2). Anal. Calcd for C23H22BrN06: C 56.57; H 4.54; N 2.87. Found: C 56. 75; 
H 4.67; N 2.53. Further elution with CH2CI2 yielded E-enollactone (4.42E) (66mg, 31%), as a 
white solid, which was used In subsequent steps without further purification: FTIR (film) 
3337,1823,1712, 1642and 1523cm-1; 1HNMR(CDCI3)~ 1.29(t,J=7.1Hz,CH3);3.03(ABq, 
JAa=13.2Hz, lH, C3CH0 Ph), 3.15 (ABq. JAB= 13.2Hz, 1H, C3CHbPh), 3.37 (m, (H-4)2), 4.22 (q, 
J=7.1Hz. CH2CH3), 5.11 (m, OCH2Ph),5.40 (s, NH), 7.18 (m, (Ph)2), 7.34 (m, (Ph)a); 13c NMR 
(CDCI3) o 14.00,40.22,42.49,59.94,62.20,67.68,94.60, 128.37, 128.53, 128.62, 129.08, 129.88, 131.71, 
135.34, 154.93, 155.25, 160.72. 173.86; HRMS (M) Found 489.0608 (Calcd for C23H228lBrN06 
489.0611); (a)o20= +7° (c 0.9; CH2CJ:2). Anal. CalcdforC23H22BrN06: C 56.57; H 4.54; N 2.87. 
Found: C 56.81; H 4.60; N 2.83. 
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Preparation of C3S> (EJ-3-benzyl-3-benzy/oxycqrbonylarolno-5-
etboxycacbony/methylldene-2-tetrqbydrofuranone (4.43): 
0 
CBzN 
Keto acid phosphorane (4.40) (62mg, 0.090mmol) was dissolved In THF (7mL) and refluxed 
for 6h. The solvent was evaporated and purification by radial chromatography using a 
lmm silica gel chromatotron plate, eluting with 97% CH2C12/3% ethyl acetate yielded 
enollactone (4.43), as a pale yellow oil (37mg, 73%), which crystallized on standing at 4 oc: 
mp 106-108 oc (ethyl acetate/petroleum ether, white crystals); FnR (KBr) 3391, 1807, 1712 
and 1526cm·l; lH NMR (CDCI3) o 1.27 (t, J=7.1Hz, CH3),2.99 (ABq, JAB=l3.2Hz, lH, C3CH0 Ph), 
3.14 (ABq. JAs= 13.2Hz, 1 H, C3CHbPh), 3.50 (ABq, JAs= 19.1 Hz, 1 H, (H-4)0 ), 3.82 (ABq, 
JAs= 19.1Hz, lH, (H-4)b)A.l5 (m, CH2CH3),6.lO (m, OCH2Ph), 5.34 (s, =CH), 5.46 (s, NH), 7.18 
(m, (Ph)2), 7.32 (m, (Ph)s); 13c NMR (CDCI3) o 14.26,37.30,42.53,59.52,60.10,67.68,97.87, 
128.33, 128.41, 128.53, 128.63, 129.08, 130.08, 131.95, 135.42, 154.93, 163.62, 166.25, 173.72; HRMS 
(FAB, M+ 1) Found 410.1604 (Calcd for C23H24N06 410.1604); (a)o2° = -13° (c 0.6; CH2CJ:2). 
Anal. CalcdforC23~3N06: C 67.47; H 5.66; N 3.42. Found: C 67.70; H 5.41; N 3.51. 
Preparation of C3S,5R and/or S, 5'R and/or S> 3-Benzyl-3-benzy/oxycarbonylamlno-5-
bromoCethoxycarbonynmethyl-1-ethoxycarbonylmethyl-5-hydroxy-2-Qyrrolld/none 
Glycine ethylester hydrochloride (60mg, 0.43mmoL 3equiv) and triethylamine (5]J.tl, 
0.43mmoL 3equiv) were added to E- or Z-bromo enollactone (4.42E or 4.42Z, respectively) 
(70mg, 0.14mmoL 1 equiv), dissolved In CH2CI2 (35mL). The mixture was stirred for 16h, 
washed with H20 (35ml), dried (MgS04) and the solvent evaporated to yield bromo 
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hydroxy lactom (4.44) as on orange oil (250mg, quont) which was used in subsequent 
steps without further purification. Bromo hydroxy loctom (4.44) was obtained as a mixture 
of dlostereolsomers: 1 H NMR (CDCis) shown below (Spectrum E.02): 
Spectrum E.02 
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Preparation of C3S,SR) and C3S.5S) 3-Beozyl-3-beozy!oxycarbony/amino-1-
etboxycarbooytmetby/-5-ethoxycarbonytroethy/-5-hydroxy-2-pyrro/idjoone <4.45): 
C~Et 
Glycine ethylester hydrochloride (75mg, 0.54mmoL 2equiv) and triethylamine (71J.Ll, 
0.54mmoL 2equlv) were added to protio enollactone (4.43) (llOmg, 0.27mmol, lequiv), 
dissolved in CH2CI2 (40ml). The mixture was stirred for 16h, washed with H20 (40ml), dried 
CMgS04) and the solvent evaporated to yield protio hydroxy loctom (4.45) as a yellow oil 
(107mg, 78%), which was used in subsequent steps without further purification: FTIR (film) 
3412 and 1713cm-1; lH NMR (CDCis) o 1.25 (t, J=7.3Hz, CH3), 1.30 (t,J=7.3Hz, CH3), 2.78 (m, 4H, 
CSCH2C02Etond (H-4)2),3.14 (ABq. JAe=l3.7Hz, lH, C3CH0 Ph),3.31 CABq, JAB= 13.7Hz, lH, 
C3CHbPh),4.01 (ABq, JAe= 17.6Hz, lH, NCHa),4.12 (q, J=7.3Hz, CH2CH3).4.23 (q, J=7.3Hz, 
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CH:2CH3).4.26 (ABq.JAs=l7.6Hz, lH, NCHb). 5.03 (ABq.JAs=l2.3Hz, 1H, OCHaPh), 5.09 (ABq. 
JAs=12.3Hz, lH. OCHbPh), 5.30 (s, [1.1H), 7.22 (m, (Ph)2), 7.34 (m, (Ph)a); lH NMR (CDCI3) also 
Indicated the presence of another diastereolsomer; 12%, o 5.42 (s, NH); l3c NMR (CDCI3) 
selected resonances for both dlastereolsomers o 13.95, 13.98, 14.02,40.70.41.37,42.52, 
42.80,42.85,43.59,43.64,59.64,60.16,60.65,61.19,61.79,66.69. 67.36, 76.02,86.38, 126.46, 127.38, 
127.47, 127.53, 128.11, 128.19, 128.35; 128.43, 128.50, 128.65, 128.70, 130.44, 134.87, 136.03, 154.77, 
155.78, 168.45, 169.06, 169.62, 170.11, 173.68, 174.21; LRMS (CO 513 (5).495 (13),403 (22), 108 (14), 
91 (100). 
Preoaration of (3$) (f)- and CZ>-3-Beozy/-3-beoz.vloxycarbonylamino-5-
bromoethoxycarbooylmethylideoe-1-ethoxycarbooy/metby/-2-pyrro/ldlnone <4.01 E and 
4.01Z): 
0 0 
CBzNH 
Bromo hydroxy lactam (4.44) (0.14mmol, 1equlv) and PTSA (14mg) dissolved In 1, 2-
dichloroethane (35ml) were refluxed, with azeotropic removal of H20, for 3.5h. The 
solvent was evaporated and purification by radial chromatography using a 1 mm silica 
gel chromatotron plate, eluting with 96% CH2CI2/4% ethyl acetate yielded a pale yellow 
oil (52mg, 65%) which contained E- and Z-bromo enamino esters (4.01E and 4.01Z, 
respectively) In the ratio 15% E : 85% Z. by 1 H NMR: FTIR (film) 3351, 17 47, 1713 and 
1602cm-1; lH NMR CCDCI3) Z Isomer (4.01Z) from mixture o 1.29 (t,J=7.1Hz, CH3), 1.33 (t, 
J=7.1Hz, CH3), 3.04 (ABq. JAs= 13.2Hz, 1H, C3CH0 Ph),3.09 (ABq. JAs= 13.2Hz, 1H, C3CHbPh), 
3.42 CABq, JAs= 17.3Hz. lH. (H-4)a). 3.92 (ABq. JAs= 17.3Hz, (H-4)b). 4.25 (m, 4H, 2x CH2CH3), 
4.76 CABq. JAB= 18.4Hz, lH. NCH0 ), 4.83 CABq. JAB= 18.4Hz, lH, NCHb), 5.08 (m, 3H, OCH2Ph 
and =CH), 5.29 (s, NH), 7.13 (m, (Ph)2), 7.34 (m, (Ph)a); 1H NMR (CDCI3) E Isomer (4.01E) from 
mixture o 5.36 (s, NH); 13c NMR (CDCIJ) Z Isomer (4.01Z) from mixture o 14.08, 14.18.40.31, 
42.49, 44.89,59.09, 61.79,·61.91. 67.16, 98.67, 127.85, 128.34, 128.43, 128.54, 128.70, 130.10, 133.25, 
135.74, 148.00, 154.75, 163.55, 167.69, 176.52; HRMSCCLM+l)Found575.1125(Calcdfor 
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C27H308l BIN207 575.1217), Found 573. 1238 (Calcd for C27H307lfsrN2D7 573. 1237). Further 
elution with 70% petroleum ether/30% ethyl acetate yielded Imide (4.46) as a pale yellow 
oil (8mg, 13%): IR (film) 3350, 1790, 1715, 1630 and 1520cm·l; lH NMR (CDCJ.3) o 1.28 (t, 
J=7.1 Hz, CH3),3.04 (m, 4H, C3CH2Ph and (H-4)2), 4.22 (m, 4H, CH2CH3 and NCH2), 5.04 (ABq, 
JAB= 12.2Hz, 1H, OCH0 Ph), 5.11 (ABq~ JAB= 12.2Hz, 1H, OCHbPh), 5.34 (s. NH), 7.17 (m, (Ph)2), 
7.34 (m, (Ph)a); 13c NMR (CDCb) o 14.06,39.51,39.82,42.62,60.17,61.96,67.42, 128.13, 128.38, 
128.49, 128.63, 129.05, 130.06, 132.96, 135.56, 154.97~ 166.56~ 172.90, 176.79; HRMS (M) Found 
424.1629 (Calcd for C23H24N206 424.1634). The yields and Isomer ratios of enamlno esters 
(4.01E and 4.01Z) were the same when the reaction was carried out withE-bromo 
enollactone (4.42E) and Z-bromo enollactone (4.42Z) 
Preparation of C3S> CE>-3-Benzyl-3-beozyloxycarbooytamlno-1-ethoxycarbony/methy/-5-
ethoxycarbooy/metby/jdeoe-2-pyrrolidlnone C4.02): 
0 
Protio hydroxy lactam (4.45) (100mg, 0.20mmol, 1equlv) and PTSA (4mg) dissolved in 1 I 2-
dichloroethane (35ml) were refluxed. with azeotropic removal of H20 I for 3h. After 
cooling to 20 oc the solution was washed with H20 (lOmL), dried (MgS04) and the solvent 
was evaporated. Purification by radial chromatography using a 1 mm silica gel 
chromatotron plate, eluting with 94% CH2CI2/6% ethyl acetate yielded enamino ester 
(4.02) as a colourless oil (65mg, 68%): FllR (KBr) 3345, 1745, 1709, 1630 and 1520cm·l; lH 
NMR CCDCI3) o 1.28 Ct. J=7 .1Hz, CH3), 1.28 (t, J=7. 1Hz, CH3), 3.05 (m, C3CH2Ph), 3.38 (ABq. 
JAa=l8.6Hz, 1H, (H-4)0 ), 3.89 (ABq. JAs=l8.6Hz~ lH. (H-4)b). 4.09 (ABq. JAs=l7.6Hz, lH, NCH0 ), 
4.15 (m~ CH2CH3), 4.22 (q, J=7. 1Hz, CH2CH3), 4.43 (ABq, JAs=l7.6Hz, lH, NCHb). 4.99 (s, =CH), 
5.01 (ABq. JAs=11.8Hz, lH, OCH0 Ph), 5.10 CABq, JAs= 11.8Hz, lH, OCHbPh),5.27 (s, NH), 7.17 
(m, (Ph)2), 7.31 (m, (Ph)a); 13C NMR (CDCI3) o 14.04, 14.34,36.90,41.94,42.46,59.33,59.73, 
61.93,67.14, 92.86, 127.75, 128.30, 128.39, 128.51, 128.75, 130.12, 133.32, 135.74, 154.65, 154.81, 
166.38, 166.52, 175.56; HRMS (M) Found 494.2065 (Calcd for C27H30~07 494.2053); (a)o20 = 
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+2Q<> (c 2.3; CH2CI:z). Anal. Calcd forC27H3o~07: C 65.57; H 6.11; N 5.66. Found: C 65.87; 
H 6.39; N 5.37. 
C3S> CE>-3-benzy/-3-beozytoxycarbony/amlno-5-ethoxycarbony/roetby/ldene-l-(N-
ethoxycarbonylmethyl>-carbamoytmethyi-2-QyrroUdlnone (4.03): 
0 
METHOD A: Glycylglyclne ethylester hydrochloride (78mg, 0.40mmot 5.4equlv) and 
triethylamine (52JIL 0.40mol, 5.4equiv) were added to enollactone (4.43) (30mg, 
0.073mmol. lequlv) dissolved In L 2-dichloroethane (10mL) and the mixture was refluxed, 
with azeotroplc removal of H20, for 44h. After cooling to 20 <>C, the mixture was washed 
with H20 (lOmL), dried (MgS04) and the solvent evaporated to give a yellow oil (43mg) 
which was dissolved in 1, 2-dichloroethane (lOmL). PTSA (16mg) was added and the 
solution was refluxed, with azeotroplc removal of H20. for 4h. The solvent was 
evaporated and purification by radial chromatography using a 1 mm silica gel 
chromatotron plate, eluting with 80% CH2CI2/20% ethyl acetate yielded enamino ester 
(4.03) as a colourless oil (26mg, 64%): FTIR (film) 3339, 1748, 1694, 1633 and 1538cm·l; lH 
NMR CCDCI3Hi 1.21 (t, J=7.1Hz, CH3), 1.25 (t, J=7.1Hz, CH3), 2.97 CABq, JAB"" 13.2Hz, lH, 
C3CH0 Ph), 3.11 (ABq, JAs= 13.2Hz, lH, C3CHbPh), 3.37 (dd, J=2.0, 19.1Hz, lH, (H-4)0 ), 3.65 
CABq,JAs=l7.1Hz, 1H,NCH0 ),3.79(dd,J=l.5, l9.1Hz, 1H,(H-4)b),3.84(dd,J=5.9, 17.3Hz, 1H, 
NCHq),4.02 (dd, J=5.9, 17.3Hz, lH, NHCHb), 4.12 (q,J=7.1Hz, CH2CH3),4.14 (q, J=7.1Hz, 
CH2CH3), 4.67 (ABq. JAB= 17.1Hz, 1H, NCHb), 5.02 (s, OCH2Ph), 5.11 (s, =CH),5.42 (s, CBzNH), 
7.19 (m, (Ph)2), 7.29 (m, (Ph)8), 7.43 (bt, NHCH2); 13c NMR (CDCI3) o 14.05, 14.26, 36.87,41.37, 
42.22,44.08,59.10, 59.77, 61.15,67.69, 93.42, 128.10, 128.19, 128.53, 128.65, 128.97, 130.00, 132.51, 
135.31, 153.87,155.45, 166.10,166.68,168.88, 175.53; HRMS(M)Found551.2258(Calcdfor 
C29H33N30s 551.2268); (a)o20 = +4° (c 0.8; CH2CI:2). · 
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METHOD B: Acid (4.05) (0.035mmol, 1 equlv), DCC (7mg, 0.035mmol, lequlv), glycine 
ethylester hydrochloride (5mg, 0.040mmoL 1. lequiv) and triethylamine (5J..I.L 0.040mmoL 
1.1 equlv) In CH2CI:2 (2mL) were stirred for 16h at 20 oc. The mixture was diluted with CH2CI:2 
(5ml), washed with H20 (7ml), dried (MgS04) and the solvent evaporated. Purification 
by radial chromatography using a lmm silica gel chromatotron plate, eluting with 80% 
ethyl acetate/20% CH2CI2 yielded a white solid (15mg) which contained enamlno ester 
(4.03) (lH NMR (CDCI3) as given above), DCC and DCC by-products. 
Preoaration of (3$) CE>-3-Beozyl-3-benzyloxycarbony/amlno-1-carboxymethy/-5-
etboxycarbony/methylidene-2-pyrrolidinone C4.05): 
Tert-butyl enamino ester (4.04) (0.039mmol, lequiv) and PTSA (2mg) in benzene (lOmL) 
were refluxed, with azeotropic removal of H20. for 3h. Evaporation of the solvent yielded 
a brown oil (23mg), used subsequently without further purification, containing enamino 
ester (4.05): lH NMR (CDCI3) o 1.27 (t, J=7.1Hz, CH3), 3.01 (ABq, JAs= 13.2Hz, lH, C3CH0 Ph), 
3.07 (ABq. JAs= l3.2Hz, lH, C3CHbPh), 3.37 CABq. JAs=l8.6Hz, lH, (H-4)0 ), 3.84 (ABq, 
JAs=l8.6Hz, 1H,(H-,4)b), 4.15 (m, CH2CH3),4.23 (ABq. JAs=l7.5Hz, lH, NCH0 ),4.36 (ABq. 
JAs=l7.5Hz, lH, NCHb),5.03 (ABq. JAs=l2.2Hz, lH, OCH0 Ph), 5.06 (s, =CH), 5.07 (ABq. 
JAs=12.2Hz, lH, OCHbPh),5.38 (s, NH), 7.17 (m, (Ph)2), 7.37 (m, (Ph)a); HRMS (M) Found 
466. 1737 (Calcd for C2sH26~07 466.17 40). 
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Preparation of C3S) (E)-3-Benz.yl-3-beozy/Qxycarbony/amlno-5-
ethoxycarbony/methy/ldene-l-(fert-butoxycarbonyDmethyt-2-pyrro/ldlnone <4.04): 
i 
Hydroxy lactam (4.47) (2lmg, 0.039mmol) and PTSA (2mg) were dissolved in 1, 2-
dichloroethane (lOmL) and refluxed, with azeotroplc removal of H20, for 3h. Evaporation 
of the solvent yielded a beige oil (22mg), used subsequently without further purification, 
containing en amino ester (4.04): 1 H NMR CCDCI3) o 1.27 (t, J= 7.1 Hz, CH2CH3), 1.47 (s, 
CCCH3)3), 3.05 (m, C3CH2Ph), 3.37 (ABq, JAB=17.6Hz, lH, (H-4)0 ), 3.82-4.31 (m, 5H, CH2CH3. 
(H-4)b and NCH:i), 5.08 (m, OCH2Ph), 5.29 (s, =CH), 5.38 (s, NH), 7.17 (m, (Ph)2), 7.31 (m, 
(Ph)s). 
PrftQarat/on of C3S.5R) and C3S.5S> 3-Benzy/-3-beozv/oxycarbony/amlno-5-
ethoxvcarbony/methyl-5-hydroxv-l-Ctert-butoxycarbooy/methyD-2-Qyrrolldlnone C4.47>: 
0 
C~Et 
rert-butyl glycine hydrochloride (13mg, 0.078mmoL 2equlv) and triethylamine (lOf!L 
0.078mmol,2equiv) were added to enollactone (4.43) (l6mg, 0.039mmot lequlv) 
dissolved In CH2C12 (15 ml). The mixture was stirred for 16h at 20 °C, washed with H20 
(15mL), dried (MgS04) and the solvent evaporated to yield hydroxy lactam (4.47) as a 
colourless oil (21mg, 100%), which was used in subsequent steps without further 
purification: FTIR (film) 3412 and 1711cm·l; lH NMR (CDCI3) o 1.25 (t.J=7.1Hz, CH2CH3), 1.49 
(s, C(CH3)s), 2.78 (m, 4H, (H-4)2 and C5CH2C02Et), 3.15 (ABq, JAB= 13.7Hz, lH, C3CHaPh), 3.32 
(ABq, JAB= 13.7Hz, lH, C~CHbPh), 3.92 (ABq, JAB= 10.8Hz, lH, NCHa), 4.17 (m, CH2CH3), 4.22 
(ABq, JAB= 10.8Hz, 1 H, NCHb), 5.02 CABq, JAB= 12.2Hz, 1 H, OCH0 Ph), 5.09 (ABq. JAB= 12.2Hz, 1 H, 
OCHbPh),5.30 (s, NH), 7.20 (m, (Ph)2), 7.34 (m, (Ph)s); lH NMR (CDCI3) also indicated the 
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presence of another dlastereolsomer; 11%, o 5.41 (s, NH); 13c NMR (CDCIJ) o 14.04, 27.96, 
28.03 (minor dlastereol'iomer), 42.40. 42.61, 43.81, 60.21, 61.21, 66.71, 82.95, 86.45, 127.47, 128.18, 
128.50, 128.66, 130.50, 135.03, 136.14, 154.82, 169.14, 170.06, 174.20; HRMS CM 4 18) Found 522.2375 
(Calcd for C29H34N20a 522.2368). 
C3S. l'S> C£1-3-Benzy/4 3-beozy/oXjiCarbonylamlno-l-etboxycarbonyletby/-5-
methoxvcarbooy/methy/idene-2-pyrro/ldlnone (4.06); 
(S)-alanlne methylester hydrochloride (l89mg. 1.36mmol. 15equiv) and triethylamine 
(179j.tl. 1.36mmol, l5equlv) were added to enollactone (4.43) (37mg, 0.090mmol, 1equiv) In 
1. 2-dichloroethane (25ml) and the mixture was refluxed. with azeotropic removal of H20, 
for 43h. The solvent was evaporated and purification by radial chromatography using a 
1 mm silica gel chromatotron plate, eluting with 95% CH2CI2/6% ethyl acetate yielded 
enamino ester (4.06) as a yellow oil (35mg, 78%): FTIR (film) 3341, 17 43, 1712, 1625 and 
1522cm·l; lH NMR(CDCI3) o 1.27 (t,J=7.1Hz, CH2CH3), 1.47 (d,J=7.3Hz. NCHCH3), 2.98 (ABq. 
JAs=13.2Hz. 1H. C3CH0 Ph),3.07 (ABq.JAs=13.2Hz. lH.C3CHbPh), 3.37 (ABq.JAs=l8.6Hz, lH, 
(H-4)a), 3.67 (s, OCH3), 3.71 (ABq, JAB= 18.6Hz, 1H. (H-4)b), 3.87 (dd, J= 1.2. 18.3Hz, NCH),4.15 
(m. CH2CH3), 5.01 (m. 3H. OCH2Ph and =CH). 5.27 Cbs. NH), 7.17 (m, (Ph)2), 7.33 Cm. (Ph)s); 
13C NMR (CDCIJ) o 12.71. 14.34,36.99.42.37.49.45,52.72,59.05,59.73,67.12,93.70, 127.69, 128.22, 
128.31, 128.55, 128.78, 130.30, 133.09, 135.75, 153.42, 154.73, 166.64, 169.76, 175.36; HRMS(M+K) 
Found 533.1692 (Calcd forC27H3oN20?K 533.1690); (a)o2°= -17° Cc 1.0; CH2C12). The 13c 
NMR spectrum indicated the presence of < 5% of another dlastereolsomer. 
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SECnON E.4.4 
PREPARATION OF ENAMINO ESTERS (4.02,4.07) VIA THE ~-KETO ESTER ROUTE 
Pre.paratloo of 1-Butyl (35)-(£)-3-benzy/-3-beozy/oxycarbonylamlno-5-
etboxycarbooytroethylldeoe-2-pyrrolldlnone C4.07): 
0 
CBzNH 
TiCI4 (4J.tl, 0.037mmot 0.5equiv) was added to ~-keto ester (4.21) (35mg, 0.068mmol, 
lequlv) and butylamine (28J,tL 0.27mmot 4equlv), dissolved in toluene (lml), at 0 oc. The 
solution, which turned orange-brown upon addition of TiCI4, was allowed to warm to 20 oc 
and was then refluxed for 18h. The solvent was evaporated and purification by 
preparative tic on silica, eluting with 80% petroleum ether/20% ethyl acetate yielded 
enamino ester (4.07) as a colourless oil (2mg, 6%): lH NMR CCDCI3) o 0.90 (t, J=6.3Hz, 
CH2CH2CH3), 1.28 (t, J=7.1 Hz, OCH2CH3) I 1.30 (m, 4H, NCH2CH2CH2), 2.98 CABq~ JAs= 13.0Hz, 
lH, C3CH0 Ph), 3.03 CABq. JAs= 13.0Hz~ 1H, C3CHbPh), 3.55 (m, 3H I (H-4)0 and NCH:l), 3.80 
CABq, JAs= 18.8Hz, lH, (H-4)b), 4.15 (m, OCH2CH3), 4.98 (s, =CH), 5.05 (ABq, JAs= 12.0Hz, lH, 
OCHaPh), 5.08 CABq. JAs= 12.0Hz, lH, OCHbPh), 5.27 (s, NH), 7.15 (m, (Ph)2), 7.26 (m, (Ph)a); 
HRMS (FAB, M+ 1) Found 465.2391 (Calcd for C27H30N20s 465.2389). 
Preoaratioo of (3$) (E2-3-beozyl-3-beozyloxycarbooylamino-l-ethoxycarbooylmeth yl-5-
ethoxycarbonylmethyl/dene-2-oyuolidlnone (4.02): 
As above for the preparation of enamlno ester (4.07)1 but with TiCI4 (4J.tL 0.037mmoL 
0.5equiv) and glycine ethylesterE07 (68mg. 0.66mmol, 10equiv) In a mixture of ether (1ml) 
and toluene (1ml). Purification by preparative tic on silica. eluting with 98% CH2CI2/2% 
ethyl acetate yielded enamino ester (4.02) as a pale yellow oil (4mg. 12%): lH NMR 
(CDCI3) as given earlier (insertion method); HRMS CM) Found 494.2044 (Calcd for 
C27H3QN~7 494.2053). 
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SECTION £.4.5 
a-CHYMOTRYPSIN ASSAY 
In the wells of a mlcrotitre plate, 50mM Trls.HCI buffer, pH 7.6, ( 125~l) and 9 unit/ml a-
chymotrypsin (Sigma, ex Porcine pancreas) solution In Tris. HCI buffer, pH 7.6, (5~.l) were 
pre-incubated with either CH3CN (2~L) or 2x 1 o-4 mg/ml and 2x HT 1 mg/mL CH3CN test 
solutions of enamlno esters and enollactones (2.71, 3.04, 4.01, 4.02, 4.03, 4.06, 4.42, 4.43) 
(2~l). After 30mln at 37 oc, 1 mg/ml N-succlnyll-phenylalanlne 4-nitro anilide In 500mM 
Trls.HCI buffer, pH 7.6, (lCIOJ-tL) was added and the optical density of the solutions was 
measured at 405nm. The solutions were Incubated at 37 oc for 60min and then the optical 
density was again measured. Each sample was assayed In triplicate. 
Samples blanks in which 50mM Tris HCI buffer, pH 7.6, replaced a-chymotrypsin were run 
concurrently. 
Average absorbances were used to calculate the% inhibition (TABLE E.06). 
TABLE E.06: Results of Chymotrypsin Assay 
Compd concn* % Inhibition concn"' % Inhibition 
(mmol/l) (mmol/l) 
2.71 7.8x1o-4 0 7.8x1o-1 5 
3.04 4.9x1Q-4 0 4.9xlo-l 25 
4.01 3.5xlo-4 :.!) 3.5x1Q-1 4) 
4.02 4.0xlQ-4 0 4.0x1Q-1 4) 
4.()3 3.6x1o-4 5 3.6xlQ-l 4) 
4.06 3.9x1Q-4 0 3.9xlo-l 8) 
4A2E 4.5xlo-4 15 4.5x1o-l 4) 
4.42Z 4.5xlo-4 5 4.5xlo-1 35 
4A3 4.9x1o-4 10 4.9xlo-l 25 
* all2xl0-4 mg/mL 'Y all 2x1Q·1 mg/ml 
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SECTION E.5 
CHAPTER 5 EXPERIMENTAL 
SECTION E.5. 1 
PREPARATION OF KETO ACID AND KETO ESTER PHOSPHORANES 
Preparation of 6-Dipheny/methy/ l{tert-butyD 3-oxo-2-
trlpheoy[phosohoraoy/ldeoehexandloate <5.04): 
1 0 1Bu02C~Co,cHPh, 
PPhg 
METHOD A: A solution of monobenzhydryl succinateE.26 (5.07) (100mg, 0.34mmot 1 equlv) 
and a catalytic amount of DMF. In benzene ClOmL), was cooled to 0 oc and freshly distilled 
oxalyl chloride ( 160fll, 1.83mmol. 5equlv) was slowly added. After 30mln at 0 oc. the 
solution was allowed to warm to 20 oc and the solvent was evaporated. More benzene 
(5ml) was added and evaporated (repeated 3 times). The acid chloride (5.08) thus 
obtained was redissolved In benz~ne (lOml) and cooled to 0 oc. Ph3P=CHCo2tsuE.27 
(256mg, 0.68mmoL 2equiv) was added and the mixture was stirred at 20 oc for 16h, filtered, 
and the solvent was evaporated. Purification by radial chromatography using a 2mm 
silica gel chromatotron plate, eluting with 90% CHCI3/lO% ethyl acetate yielded 
benzhydryl phosphorane (5.04) as an oil (l98mg, 91%), which crystallized on standing: 
mp 163-164°C(ether,colourlesscrystals); IR(nujol) 1740. 1760and 1550cm-1; lHNMR 
(CDC's) 8 1.06 (s, C(CH3)3), 2.69 (t, J=7.2Hz, CH-5)2),3.27 (t, J=7.2Hz, (H-4)2),6.82 (s, CHPh2), 
7.20..7.36 (m, (Ph)w). 7.37-7.50 (m, (Ph)9), 7.61-7.69 (m, (Ph)6); 13C NMR CCDCis) 8 28.16, 29.80, 
35.21 (d, J=7.6Hz), 70.52 (d. J= 109.5HZ). 76.38, 78.48, 127.05 (d, J=93.6Hz), 127.10, 127.52, 128.41 
(d,J=l2.7Hz),l31.36(d,J=2.9Hz), 132.96(d,J:::::9.7Hz), 140.61, 167.27(d,J=13.7Hz), 172.84,194.60 1 
(d, J=4.3Hz); 3lp NMR (CDCI3) o 17.7; HRMS (FAB, M+ 1) Found 643.2610 (Calcd for 
C41H4CPsP643.2613). Anai.CalcdforC41H390sP: C76.62; H6.12. Found: C76.50; H6.20. 
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METHOD B: As for Method A except that acid chloride (5.08) was treated with 
Ph3P=CHC02fBuE.27 (lequlv) and lpr2NEt (lequiv): Yield after chromatography 27%; lH 
NMR (CDCI3) as given above. 
Pre.parqtlon of l:<tert-Buty/) 3-oxo-2-tr/Qhenyi{;Jhosphorqnylldenehexandloate C5.05): 
1 0 1Bu02C~~O.,H 
PPfla 
METHOD A: TFA (l.Oml, 13.0mmol, 170equlv) was added to a solution of benzhydryl ester 
(5.04) (50mg, 0.078mmol, 1equiv) In CH2CI2 (2ml), at 0 oc. After stirring for 5min, the solution 
was diluted with CH2CI2 (13mL), washed with water (4x 15ml), dried (MgS04) and the 
solvent was evaporated to yield keto acid phosphorane (5.05) as a colourless oil (quant), 
which crystallized on standing at 4 oc: IR (KBr) 3425, 1740, 1680 and 1540cm-1; lH NMR 
(CDCis) 8 1.05 (s, C(CH3)3), 2.55 (t, J=5.8Hz, (H-5)2), 3.32 (t, J=5.8Hz, (H-4)2), 7.34-7.71 (m, 
(Ph)a); 13c NMR (CDCis) 8 27.95, 32.00, 33.63 (d. J=7.3Hz), 73.81 (d. J= 107.6Hz), 79.90, 125.51 (d, 
J=93.7Hz), 128.78 (d. J= 12.5Hz), 132.11 (d, J=3.0Hz), 132.98 (d, J= 10.1 Hz), 166.60 (d, J= 12.4Hz), 
175.23, 196.52 (d, J=3.7Hz); 31p NMR (CDCI3) o 17.3; HRMS (FAB, M+ 1) Found 477.1834 (Calcd 
for C2sHaoOsP 477.1831). 
METHOD B: Ph3P=CHC02tsuE.27 (100mg, 0.27mmol, lequiv) was added to a stirred solution 
of succinic anhydride (27mg, 0.27mmol, 1equiv) In CH2CI2 (5ml). After 2h the solution was 
poured onto cold petroleum ether. Crystallization did not occur, hence the solvent was 
evaporated to yield a colourless solid which contained, by 1 H NMR, 46% desired keto 
acid phosphorane (5.05) (lH NMR (CDCI3) as given above), 27% recovered 
Ph3P=CHC02tsu and 27% recovered succinic anhydride. 
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Preparation of 6-Methyl Htert-butyD 3-oxo-2-tdohenylphosohoranylldenehexandloate 
METHOD A: Acid phosphorane (5.05) (Sample from Method B above) was dissolved In 
THF (2mL), cooled to 0 oc and treated with freshly distilled CH2N2 In ether. Excess CH2N2 
was allowed to evaporate at 20 oc over 16h and the residue was purified by radial 
chromatography using a lmm silica gel chromatotron plate, eluting with 80% CHCIJ/20% 
ethyl acetate to yield phosphorane (5.06) as an oil (45mg, 41% from succinic anhydride): 
mp 165-167 oc (ether, colourless crystals); IR (nujol) 1740, 1670 and 1550cm·l; lH NMR 
(CDCI3) o 1.06 (s, CCCHJ)3), 2.55 (t, J=7.0Hz, (H-5)2), 3.23 (t, J=7.0Hz, (H-4)2), 3.57 (s, OCH3), 
7.39-7.50 (m, (Ph)9), 7.64-7.71 (m, (Ph)6); l3C NMR (CDCI3) o 28.10,29.28, 35.38 (d,J=7.3HZ), 
51.30, 70.50 (d, J= 109.8HZ), 78.49, 127.15 (d, J=93.1Hz), 128.46 (d, J= 12.1Hz), 131.38 (d, J=3.0HZ), 
133.00(d, J=9.8Hz), 167.35 (d,J=13.8Hz), 174.39, 194.90 (d, J=4.5Hz); 31p NMR (CDCI3) o 17.2; 
HRMS (FAB, M+ 1) Found 491.1989 (Calcd for C29H320sP 491.1988). Anal. Calcd for 
C29i-1310sP: C 71.01; H 6.17. Found: C 71.22; H 6.35. 
METHOD B: Me02C(CH2)2COCJE.lS (176mg, 1.17mmot lequiv) was dissolved In benzene 
( lOmL) and cooled to 0 oc. Ph3P=CHCo2tsuE.27 (881 mg, 2.34mmol. 2equiv) was added 
and the mixture was stirred at 20 oc for 16h, filtered, and the solvent was evaporated. 
Purification by radial chromatography using a 2mm silica gel chromatotron plate, eluting 
with 90% CHCI3/lO% ethyl acetate yielded phosphorane (5.06) as a white solid (292mg, 
51%): lH NMR (CDCI3) as given above. 
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SECTION £.5.2 
MASS SPECTROMETRY OF KETO ACID AND KETO ESTER PHOSPHORANES 
Positive ion FAB spectra were obtained using a Kratos MS80RFA mass spectrometer 
operated at 4KV, with a resolution of 1000, scanning at 3 seconds per decade and 
equipped with an ion Tech ZN11NF saddle field FAB gun, operated at 8kV, 2mA ion current 
with xenon (Xe) as the reagent gas. High resolution results were obtalneo with a 
resolution of 7500 using polyethyleneglycol (PEG) and modified PEG's as reference 
compoundsE.28 for peak matching. The sample (4.15, 4.26,4.4D-4.41, 5.04-5.06) (5mL of 10 
mg/mL solution In CHCI3) was deposited onto a copper target containing matrix (5ml). 
The Ions observed and their relative abundances ore shown In TABLE E.07. The matrices 
used were nitrobenzyl alcohol and a 1 : 5 mixture of dithloerythrltol and dithlothreitol 
("magic bullet"). 
TABLE E.07:. Relative abundance of positive ions observed for the keto acid 
and keto ester phosphoranes (4.15, 4.26, 4.40-4.4L 5.04-5.06) in FAB. 
No m/z (relative Intensity, %) 
4.15 776 (38), 730 (35), 3<;() (35), 375 (80), 303 (100), 279 (32), 262 (51), 201 (51), 183 (80)0 
4.26 746 (81), 700 (56), 3<;() (65), 375 (89), 303 (100), 279 (26), 262 (63), 201 (38), 183 (56), 
165 (45)0 
4AO 688 (45), 642 (20),612 (21),508 (31), 3<;() (41), 375 (71), 349 (25), 303 (100), 279 (39), 
262(53),225(20),201 (38), 183(65)0 
4A1 702 (86), 656 (22), 3<;() (64), 375 (71), 303 (100),279 (21),262 (43),201 (22), 183 (38)0 
5.()4 643 (10), 569 (8), 403 (15), 347 (30),303 (30), 279 (7),262 (8), 201 (34), 183 (15), 167 
(100), 152 (12)b 
5.0S 477 (41), 403 (54), 377 (58), 347 (45), 321 (99), 303 (82), 279 (29),262 (24), 201 (21), 
183 (58), 152 (lOJ)b 
5.06 491 (41), 417 (57), 403 (11), 347 (56), 303 (100), 279 (26), 262 (15), 201 (18), 183 (32), 
152 (16)b 
a Spectra run in nitrobenzyl alcohol 
b Spectra run In "magic bullet" 
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